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The scale-up of insecticide-based interventions, including Indoor Residual Spraying (IRS) and 
Long Lasting Insecticidal Nets (LLINs), has contributed to the significant reduction of malaria 
burden in the past decade. Unfortunately, growing insecticide resistance in malaria vectors is 
threatening these successes. However, the impact of resistance, especially metabolic 
resistance, on the effectiveness of vector control tools against pyrethroid-resistant mosquito 
populations, remains a topic of debate. One of the key challenges of assessing the impact of 
metabolic resistance on the effectiveness of these insecticide-based interventions has been 
the lack of molecular markers for insecticide resistance, notably metabolic resistance. The 
recent detection of key genetic markers conferring metabolic-mediated resistance (GSTe2 
marker and CYP6P9a/b markers) is providing the opportunity to now address this question. In 
this work, we used an experimental hut trial, and the markers recently made available to 
investigate the direct impact of metabolic resistance on the effectiveness of insecticide-based 
interventions. 
 
The characterization of the area selected for experimental hut trial revealed that Anopheles 
funestus sensu stricto (s.s.) (80%) and Anopheles gambiae s.s. (20%) are the two main species. 
High levels of resistance to pyrethroids and organochlorines were noticed. Moderate 
resistance was observed against bendiocarb (carbamate) in both species, but relatively higher 
in Anopheles gambiae s.s. In contrast, full susceptibility was observed for the 
organophosphate malathion. The PBO synergist assays with pyrethroid type I and II revealed 
a significant recovery of the susceptibility in Anopheles funestus s.s. population (48.8 to 98.1% 
mortality and 38.3 to 96.5% mortality, respectively). The DDT/pyrethroid 119F-GSTe2 
resistant allele (28.1%) and the dieldrin 296S-RDL resistance (9.7%) were detected in 
Anopheles funestus s.s. The high pyrethroid/DDT resistance in Anopheles gambiae correlated 
with the high frequency of the 1014F knockdown resistance allele (63.9%). The 1014S-kdr 
allele was detected at low frequency (1.97%). The Plasmodium infection rate was 20% in 
Anopheles gambiae, whereas Anopheles funestus exhibited an oocyst infection rate of 15 and 
5% for the sporozoite infection rate. Using experimental hut trials and genotyping of a 
glutathione S-transferase resistance marker (L119F-GSTe2), we noticed that PBO-based nets 
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induced a significantly higher mortality rate than pyrethroid-only nets. Blood feeding rate and 
deterrence were significantly higher in all LLINs than control, although greater for PermaNet 
3.0 than PermaNet 2.0 but not between Olyset nets. Genotyping the the L119F-GSTe2 
mutation revealed that, for permethrin-based nets, 119F-GSTe2 resistant mosquitoes have a 
greater ability to blood feed than susceptible [Olyset Plus (OR= 3.1; P=0.00007) and Olyset 
(OR=3.0; P=0.00007)] while the opposite effect is observed for deltamethrin-based nets. For 
Olyset Plus, a significant association with exophily was observed in resistant mosquitoes 
(OR=11.7; P=0.003). Furthermore, GSTe2-resistant mosquitoes (cone assays) significantly 
survived with PermaNet 2.0 (OR=2.1; P=0.002) and even more with PermaNet 3.0 (OR=30.1; 
P<0.0001) whereas no association was observed for Olyset Plus. L119F-GSTe2 was confirmed 
to confer resistance to permethrin, Deltamethrin, and DDT. Also, genotyping of the CYP6P9a/b 
markers revealed that homozygous resistant (RR) were better able to survive exposure to 
Olyset nets than homozygous susceptible (SS) : (OR=7.03; P< 0.01) for CYP6P9a and (OR=5.1; 
P<0.01) for CYP6P9b. In addition, homozygous resistant (RR) show a greater ability to blood 
feed when compared to homozygous susceptible (SS) (OR= 3.1; p<0.001) for CYP6P9a and 
(OR= 8.01; p<0.001) for CYP6P9b. Further analysis demonstrates that mosquitoes double 
homozygous resistant (RR/RR) at both genes had by far a significant ability to reduce LLINs 
efficacy (Blood feeding: RR/RR v SS/SS; OR= 9.3; p<0.001) compared to single homozygous 
(Blood feeding RR v SS; OR= 4.5; p<0.001). 
 
This study shows the greater efficacy of PBO-based nets against pyrethroid-resistant malaria 
vectors. Reduced efficiency of LLINs and the increased ability to survive and blood feed of 
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Despite all the progress made in malaria control, the disease remains a major public health 
concern. In 2018, it was noticed 405 000 deaths from malaria worldwide and 228 million cases 
(WHO, 2019b). Children under the age of 5 accounted for two thirds (67%) of global malaria 
deaths in 2018 (WHO, 2019b). In 2018, 93% of malaria cases were found in the WHO African 
Region. More than half of all cases were in six countries: Nigeria (25% of cases); the 
Democratic Republic of the Congo (12%); Uganda (5%); Côte d'Ivoire, Mozambique and Niger 
(4% each) (WHO, 2019b). All of Cameroon’s population of 25 million inhabitants live in malaria 
endemic areas (71% living in high transmission areas and 29% living in low transmission 
settings). In 2017 in Cameroon, a total of 2,093,009 cases of malaria were confirmed by 
diagnostic test, 49% of these cases were classified as severe malaria. Malaria cases represent 
24% of all medical consultations in health facilities and 45% of all hospitalizations. Malaria 
accounts for the greatest proportion of hospitalizations in the Adamawa, Far North, and North 
regions accounting for 60%, 56%, and 56% of all hospitalizations in these regions, respectively. 
In 2017, 3195 malaria deaths were reported in health facilities, which represented 13% of all-
cause deaths. The proportion of deaths due to malaria is highest in the Far North (26%) and 
North (27%) regions (PNLP, 2018; WHO, 2019b) 
 
Malaria is transmitted by pathogens, which is an intracellular protozoan belonging to the 
genus Plasmodium discovered in 1880 by Laveran (Mouchet et al., 2004). In sub-Saharan 
Africa, An. gambiae, An. Arabiensis and An. funestus are the major malaria vectors (Ranson et 
al., 2011). The introduction of new tools, such as new diagnostics, more effective antimalarial 
medicines, and introduction of the RTS, S malaria vaccine in Ghana, Kenya, and Malawi as a 
WHO pilot program has given hope regarding malaria control (WHO, 2019b). Despite all these 
innovations, malaria control relies heavily on Insecticide-based interventions (Bhatt et al., 
2015).  
Insecticide-based interventions are reducing the malaria burden. Malaria prevalence and 
malaria incidence have been reduced by 40 % between 2000 and 2015 (Bhatt et al., 2015). 
During that same period, 663 malaria cases were averted, and insecticide-treated bed nets 
were found to be the most significant contributor to this decrease by contributing up to 68 % 
of the reduction observed (Bhatt et al., 2015). Bed nets remain the mainstay of insecticides 
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treated materials for vector control with 582 million bed nets delivered between 2014 and 
2016, out of which 505 million were delivered to sub-Saharan Africa (WHO, 2017). An 
estimated 61% of children under five living in sub-Saharan Africa slept under an ITN compared 
to 26% in 2010 (WHO, 2019b). In Cameroon, strategies against malaria rely heavily on long 
lasting insecticidal nets (LLINs) distribution. In 2011, 8 657 075 LLINs were distributed by the 
government all over the country. Between 2013 and 2015, 12 356 059 LLINs were distributed. 
The last distribution took place in 2019 and 14 697 104 LLINs were distributed. In 2017 the 
bed nets coverage in Cameroon was 76.6% (Antonio-Nkondjio et al., 2019). 
Unfortunately, growing insecticide resistance against the four insecticide classes available 
(organochlorine, organophosphate, carbamate, and especially pyrethroids the only class fully 
approved by WHO for LLINs and ITNs)- in one of the major malaria vector An. funestus (Menze 
et al., 2016; Menze et al., 2018b; Riveron et al., 2014a; Riveron et al., 2016a) is threatening 
these successes. Within the Funestus complex, An. funestus s.s. is the most widely distributed 
across Africa (Dia et al., 2013). In malaria vectors, the insecticide resistance is conferred mainly 
through target resistance and metabolic resistance (Hemingway and Ranson, 2000). The 
knockdown resistance (kdr) in the voltage-gated sodium channel is not yet selected in An. 
funestus s.l., (Irving and Wondji, 2017) Resistance in An.funestus is mainly metabolic and 
mediated fully or partially by P450 monooxygenases (Coetzee and Koekemoer, 2013; Wondji 
et al., 2012). GSTs are, besides cytochrome P450s and esterases, one of the main enzyme 
families conferring metabolic resistance to insecticides (Hemingway, 1999) either through a 
direct metabolism or by catalyzing the secondary metabolism of substrates oxidized by 
cytochrome P450s (Hemingway and Ranson, 2000). Over-expression of GST epsilon 2 (GSTe2) 
has been associated with DDT and pyrethroids resistance in several mosquito species, 
including An. gambiae (Mitchell et al., 2014), An. funestus (Riveron et al., 2014c) and Aedes 
aegypti (Lumjuan et al., 2011). In An. funestus, the structural analysis revealed that a leucine 
to phenylalanine amino acid change (L119F) in GSTe2, enlarging the substrate-binding pocket 
of the enzyme, was conferring DDT/pyrethroid resistance in West and Central African 
populations (Riveron et al., 2014c). In An. funestus s.l. The insecticide resistance is displaying 
different patterns across Africa. In Eastern and Southern Africa, metabolic resistance in 
Anopheles funestus s.l. is mediated by P450 monooxygenases (Riveron et al., 2014a; Riveron 
et al., 2013). In the same malaria vector geographically located in western and Central Africa, 
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metabolic resistance is mainly mediated by Glutathione-S-transferases epsilon 2 (GSTe2) 
(Djouaka et al., 2016b; Menze et al., 2016; Riveron et al., 2014b). 
The WHO Global Plan for Insecticide Resistance Management (GPIRM) is highlighting the need 
to assess the impact of insecticide resistance to implement proper insecticide resistance 
management (IRM) strategies to preserve the efficacy of current and future insecticides. 
However, the extent of the impact of this resistance, notably, metabolic resistance on the 
effectiveness of insecticide-based interventions such as Long lasting Insecticidal Nets (LLINs) 
remains unclear. 
Epidemiological and entomological approaches are usually considered as useful methods to 
investigate the impact of insecticide resistance (WHO, 2012a). 
However, the epidemiological approach, based on malaria prevalence and malaria incidence 
can be jeopardized by the fact that malaria transmission is affected by many confounding 
factors such as the local habitation favorable to a mosquito bite, the weather and the 
fickleness of health care system (Kleinschmidt et al., 2015; WHO, 2012a, b). Recognising the 
limitations of the epidemiological approach, the alternative is to measure entomological 
outcomes, such as relative mortality and feeding success of resistant and susceptible vectors 
in controlled conditions using experimental huts (N’Guessan et al., 2009; N’Guessan et al., 
2007b; WHO, 2012b). The limitations of this second approach are: firstly, the trial is performed 
at a small scale and secondly, the difficulty in measuring the level of resistance in individual 
mosquito due to lack of genetic markers (Strode et al., 2014; WHO, 2012b). It is, therefore, 
challenging to assess the impact of insecticide resistance, especially the metabolic resistance 
for which no DNA-based markers previously existed. This gap is a significant obstacle to the 
implementation of IRM in areas where insecticide resistance to the malaria vector is driven by 
metabolic resistance since its impact could not be assessed. However, recent efforts have 
detected major DNA-based markers for metabolic resistance for GST in both An. funestus 
(Riveron et al., 2014b), but also P450s in An. funestus (Mugenzi et al., 2019; Weedall et al., 
2019). These include a key genetic marker in the glutathione S-transferase epsilon two gene 
(GSTe2) conferring a metabolic-mediated resistance to pyrethroids and DDT in the major 
malaria vector An. funestus in West and Central Africa (Riveron et al., 2014b). Concerning the 
P450 family genes, further genomic analyses revealed a complex evolution of resistance, 
including copy number variation, transposon insertion, and gene conversion. Detection of 
causative cis-regulatory mutations allowed designing the first DNA-based P450 assays in 
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malaria vectors for the CYP6P9a (Weedall et al., 2019) and CYP6P9b genes (Mugenzi et al., 
2019). These markers now allow addressing questions regarding the direct impact of GST- and 
P450-mediated metabolic resistance on insecticide-based interventions such as LLINs. 
Taking advantage of the recent detection of these DNA-based molecular markers for 
metabolic resistance in the P450 and GST, we used experimental huts in Cameroon to assess 
the performance of several bed nets against pyrethroid resistant An. funestus, and to evaluate 
the impact of this metabolic resistance on the effectiveness of long lasting insecticidal nets. 
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1.2 Malaria History 
 
Malaria comes from the Italian word mal-aria or "bad air" as, for a long time, malaria was 
associated with marshes. This disease occurred in southern Europe and around the 
Mediterranean until the beginning of the twentieth century and was eradicated by the 
disappearance of vectors following the efforts of mosquito control and the raising of the 
standard of living. As early as the 4th century, Hippocrates had already made the first 
descriptions of the clinical manifestations of the disease characterized by chills, fever, and 
sweats. These symptoms occur according to specific daily sequences hence the names of third 
and fourth fevers. However, it is at the end of the 19th century that Alphonse Laveran noticed 
the presence of the parasite in the blood of a sick subject and that Ronald Ross discovers its 
transmission by mosquitoes (Mouchet, 2004). Nevertheless, it is to Giovanni BATTISTA GRASSI 
that we owe the knowledge of the Plasmodium development cycle in the mosquito (Wery, 
1995). 
 
1.3 Pathogenic agents of malaria 
 
The pathogens responsible for malaria are intracellular protozoa discovered in 1880 by 
Laveran (Mouchet, 2004). They are transmitted to humans following a bite of a female 
infected mosquito of the genus Anopheles. These parasites are also transmissible during blood 
transfusions or congenital (Wery, 1995). Five species of Plasmodium are at the origin of 
malaria in humans. They differ from one to another by several specific epidemiological, 
biological, and clinical characteristics: 
Plasmodium falciparum Welch, 1897 is the most widespread species. This species is strongly 
established in tropical Africa. Its incubation period is 7 to 15 days, and its longevity is less than 
one year. It is at the origin of the third malignant fever, the most lethal. It is a parasite of red 
blood cells of all ages, with erythrocytic schizogony occurring in deep organs. In case of 
complications, the parasite can pass into the central nervous system; we then speak of 
cerebral malaria (Mouchet, 2004). 
Plasmodium malariae Laveran, 1881 occurs throughout the Afro-tropical region at very 
variable frequencies of 2-45%. It is generally more common in forest areas. Its longevity is 
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about 21 days, and it mainly attacks old red blood cells. Its recrudescence can go up to 10 or 
20 years, by reactivation of latent erythrocyte forms despite the absence of hypnozoites 
(Baudon et al., 1987). 
Plasmodium vivax Grassi and Feletti, 1890 has a wide distribution but are absent in 
populations carrying Duffy antigen. This species is responsible for the most common benign 
tertian fever. Its incubation lasts about 15 days and can last up to 7 months. It is a parasite of 
young red blood cells that causes remittent fevers for a period of up to two years due to the 
presence of hypnozoites (Baudon et al., 1999). 
Plasmodium ovale Stephens, 1922 is mainly present in Africa. It causes mild benign fever. Its 
longevity is 15 days, and relapses are lasting up to 5 years due to the presence of hepatic 
hypnozoites (Danis & Mouchet, 1991, Mouchet et al., 2004). 
Plasmodium knowlesi Knowles, 1932 is genetically close to Plasmodium vivax and 
morphologically Plasmodium malariae. It was previously known as a parasite of monkeys but 
has recently been found in humans in several South Asian countries (Singh et al., 2004; 
Sermwittayawong et al., 2012). 
 
1.4 Malaria vectors 
 
The total number of Anopheles species worldwide is around 484 species (Harbach, 
2004). In Sub-Saharan Africa, about 140 Anopheles species are present. Most of them are 
members of species complex or group. The two important complex or group containing the 
majority of these species are An. gambiae complex and An. funestus group (Gillies and 
Coetzee, 1987). The major vectors in Africa are An. gambiae s.s., An. coluzzii, An. funestus s.s 
and An. arabiensis (Coetzee et al., 2013; Ranson et al., 2011; White, 1974). 
1.4.1. An. gambiae complex 
Among An. gambiae complex we can noticed: An. gambiae s.s, An. arabiensis, An. melas, An. 
quadriannulatus, An. quadriannulatus B and An. bwambae (Carnevale et al., 1992). 
These species are morphologically identical but can be quickly and simultaneously identified 
using a specific PCR based on the polymorphism of ribosomal DNA (Scott et al., 1993). 
Cytogenetic studies have shown that species of An. gambiae complex is genetically distinct 
and characterized by chromosomal inversions, which correspond to adaptations to specific 
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climatic conditions (aridity, temperature). Some of these species have strict ecological 
requirements that define their geographic distribution (Coluzzi et al., 1979). This is the case of 
An bwambae larvae, which prefer the saltwater of the Semliki forest in Uganda (White, 1985), 
larvae of An. melas and An. merus which evolve in brackish waters, respectively, on the 
western and eastern facades of Africa (Manguin et al., 1996), An. gambiae s.s. found in clear, 
shallow, sunny waters. An. quadriannulatus is widespread in southern Africa (form A) and 
Ethiopia (form B), but its zoophilic nature limits its ability to transmit malaria (Gillies and 
Coetzee, 1987; Hunt et al., 1998). The species of this complex are present in regions of 
degraded forest or humid savannah and thus occupy the entire African equatorial belt. Other 
subdivisions have been described within the species An. gambiae s.s., in particular, the 
molecular forms M and S between which the gene flows are minimal, which suggests a 
phenomenon of speciation in progress (Della Torre et al., 2002; Torre et al., 2001). 
 
 An. gambiae was recently split into two species, one remaining as An. gambiae s.s (formally 
called S form) while a new species called An. coluzzii (formally M molecular form) (Coetzee et 
al., 2013). In Cameroon beside An. funestus, An. gambiae., we can notice some vectors of local 
importance such as An. nili and An. moucheti, which are also significantly involved in malaria 








Figure 1.1: Map showing dominant malaria vector species across the world. Source: 
http://www.ajtmh.org/docserver/fulltext/14761645/70/5/486f1_C4TT.gif 
 
1.4.2 An. funestus group 
 
An. funestus is a major malaria vector in Africa. It has a wide geographic distribution covering 
the entire Afro-tropical region (Figure 1.2) (Coetzee and Koekemoer, 2013; Dia et al., 2013). 
The larval stages evolve in large bodies of clear water, permanent or semi-permanent, with 





Figure 1.2: Distribution of the 13 species of the Funestus Group in Africa, A: Anopheles 
funestus, B: An. leesoni, An. longipalpis (type A and C), An. aruni and An. parensis (Courtesy of 
Dr. S. Manguin), C: An. rivolorum, An. rivolorum-like, An. funestus-like, An. vaneedeni, An. 




Figure 1.3: Breeding sites of An. funestus. Mibellon in the Adamawa region, the republic of 
Cameroon. An. funestus breeds all over the year in the lake, which provides shaded areas 
thanks to the lake vegetation.  
 
The Funestus group includes 13 species grouped into three subgroups (Table 1.1) (Dia et al., 
2013). These are: An. funestus, An. vaneedeni, An. parensis, An. Aaruni, An. funestus-like, An. 
confuses, An. longipalpis type C, An. leesoni, An. longipalpis type A, An. rivulorum, An. 





Table 1.1: African distribution of the Funestus group (Dia et al., 2013) 
African species of the Funestus Group 
      
Subgroup species 
Geographical 
distribution  Host preference Vector role 
 An. funestus continental anthrophilic major 
  An. funestus-like local unknown unknown 
  An. Aruni local unknown unknown 
Funestus An. Confusus regional Zoophilic unknown 
  An. parensis regional unknown minor 
  An. Vaneedeni local unknown unknown 
  An. Longipalpis type C local Zoophilic unknown 
       
Minimus 
An. Leesoni continental Zoophilic minor 
An. Longipalis type A local Zoophilic unknown 
       
  An. Rivulorum continental Zoophilic minor 
  An. Rivulorum-like local unknown unknown 
Rivulorum  An. Brucei local unknown unknown 
  An.fuscivenosus local unknown unknown 
 
Several molecular biology techniques have been developed for the precise identification of 
species from the Funestus group (Cohuet et al., 2003; Koekemoer et al., 2002; Spillings et al., 
2009). The most recent is based on the polymorphism of the ITS2 region of ribosomal DNA; it 
identifies An.funestus s.s., An. vaneedeni, An. rivulorum, An. rivulorum-like, An. leesoni, An. 
parensis and An. funestus-like (Spillings et al., 2009). 
Cytogenetic studies within the species An. funestus have made it possible to characterize two 
chromosomal forms called Kiribina and Folonzo, with a contrasting polymorphism, probably 
reflecting a phenomenon of ongoing speciation (Costantini et al., 1999). 
The biology and vectorial capacity of the funestus group species are very different. Only An. 
funestus is anthropophilic and endophilic and plays an essential role in the transmission of 
malaria (Antonio-Nkondjio et al., 2002; Fontenille et al., 1997). 
Other species of the funestus group, due to their zoophilia and exophilia, are of less 
importance in medical entomology. Only An. rivulorum has been mentioned as a secondary 
vector of malaria in Tanzania (Wilkes et al., 1996). 
Despite being a major vector of malaria, An. funestus has been neglected for several decades. 
Most of the efforts are focused on the members of the gambiae complex (Coetzee and 
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Fontenille, 2004). This inattention was attributed to the difficulty of colonizing An. funestus in 
the laboratory. 
 
1.5 Malaria control 
 
Controlling malaria is appearing to be a very complicated matter, and it will be dangerous to 
consider the situation from one angle (Shiff, 2002). To control malaria efficiently, it is 
recommended to consider an integrated approach, including vector control, which can be 
based on mosquitoes biology, parasite epidemiology, and human behavior patterns (Mouchet 
and Carnevale, 1998). Malaria control relies heavly on: (i) Chemotherapy and 
Chemoprophylaxis to treat the infection caused by Plasmodium, (ii) Vector control. In addition 
to chemotherapy and vector control, rapid diagnostic tests (RDTs) play a key role in malaria 
elimination. It gives the opportunity of trained members of the community to carry out 
malaria diagnosis accurately and advise suitable treatment, reducing any delay between the 
start of fever and treatment. 
 
1.5.1 Treatment of Infection: Chemotherapy and Chemoprophylaxis 
 
Malaria control through the treatment relies on molecules belonging to several classes: 
(i) 4-aminoquinolines (chloroquine, quinine, mefloquine, amodiaquine and 
halofantrine) or 8-aminoquinolines (primaquine). 
(ii) The antifolate compounds (pyrimethamine, proguanil, chlorcycloguanil, dapsone, 
and sulfadoxine). 
(iii) The artemisinin and derivatives (artemisinin, artesunate, artemether, arteether, 
dihydroartemisinin). 
(iv) The hydroxynapthoquinone atovaquone (Schlitzer, 2008). 
The treatments from all the classes mentioned above are effective and can be advised 
depending on the severity of the disease. Chloroquine which is a member of 4-
aminoquinolines group has been the most successful single drug for the treatment and 
prophylaxis of malaria. It is a safe and affordable drug, and was effective before resistant 
strains began to emerge in the 1960. Treatments are advised according to the intensity of 
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malaria. For the treatment of acute uncomplicated malaria, artesunate-amodiaquine is 
recommended. For severe malaria cases injectable artesunate is recommended. Sulfadoxine-
pyremethamine +amodiaquine is recommended as seasonal preventive treatment of malaria. 
Chemotherapy to control malaria is threatened by the emergence of resistance to 
antimalarials that usually appear after a few years (Ashley et al., 2014; White, 2014). 
 
1.5.2 Malaria Vaccines 
 
To prevent malaria, about 38 Plasmodium falciparum, and 2 Plasmodium vivax candidate 
malaria vaccine are in the pipeline to be processed and approved (Karunamoorthi, 2014). The 
recent introduction of the RTS,S (The 'R' stands for the central repeat region of Plasmodium 
(P.) falciparum circumsporozoite protein (CSP); the 'T' for the T-cell epitopes of the CSP; and 
the 'S' for hepatitis B surface antigen) malaria vaccine in Ghana, Kenya and Malawi as a WHO 
pilot program has given hope regarding malaria control (WHO, 2019b). 
 
1.5.3 Vector control 
 
The absence of a 100 % effective vaccine introduced for clinical used to make malaria 
prevention to rely on chemotherapy and vector control programs at the moment. Vector 
control holds chemical methods and biological methods. 
 
1.5.3.1 Biological method 
 
To maintain the efforts put in place to fight against malaria, we need to explore other methods 
to circumvent insecticide resistance. The biological approach to control malaria transmission 
relies on  method like the use of fungus. A recent study showed improved efficacy of an 
arthropod toxin expressed by fungus against resistant mosquitoes (Bilgo et al., 2017; Lovett 
et al., 2019). Other important fungal considered in vector control belong to the genera of 
Coelomomyces, Culicinomyces, Beauveria, Metarhizium, Lagenidium, and Entomophthora 
(Yassine et al., 2012). 
Microbial agent residue like B. thuringiensis var. israelensis, serotype H14 (Bti) is widely used 













scale based program where Bti was applied weekly in Dar Es Salaam has contributed to the 
reduction of malaria infection prevalence (Geissbühler et al., 2009). Bti has been shown to be 
non-toxic for humans mammals, birds, fish and plant and very efficient to control Culex pipiens
(Altalhi, 2005).
In addition, biological methods using the intracellular bacterium Wolbachia can transform the 
popultion. This method is particularly attractive since this maternally-inherited agent offers a 
potent  mechanism  to  invade  natural  populations  through  cytoplasmic  incompatibility
(Moreira et al., 2009). When Wolbachia are introduced into mosquitoes, they interfere with 
pathogen  transmission  and  influence  life  traits  such as  lifespan (McMeniman  et  al.,  2009).
Aedes  aegypti infected  with  Wolbachia  from Drosophila  melanogaster has successfully  
invaded two natural Aedes aegypti populations from Austria a few months after their release
(Hoffmann  et  al.,  2011).  This  investigation  has  demonstrated  that Wolbachia-infected 
mosquitoes have contributed to the reduction of dengue virus transmission. The results of this 
study  indicate  that Wolbachia-based  strategies  can  be  considered as  a  good  approach  to 
control Dengue 
 
1.5.3.2 Physical approaches 
 
The physical methods to control malaria consist of the cleaning of the environment. These 
include drainage of stagnant body water, regular cleaning of the wet patch, verification of 
windows, and other openings. Research conducted in the Tanzanian city of Dar es Salaam by 
the Liverpool School of Tropical Medicine and the Ifakara Health Institute demonstrates that 
covering the window with untreated net can suppress the population and intensely reduce 
malaria prevalence. The study also provided evidence that increasing coverage of complete 
window screening was linked with reduced biting densities of Anopheles gambiae complex 
and Anopheles funestus group (Killeen et al., 2019). One of the most important approach to 
reduce malaria transmission is Larval source management (LSM) (Fillinger and Lindsay, 2011). 
Larviciding and environmental management were the only tools available to contain malaria 
in the early twentieth century. 
 
1.5.3.3 Chemical method 
 
38 
For chemical methods, four insecticides classes are available: organochlorine (DDT), 
pyrethroid such as permethrin (type I), Deltamethrin (type II), organophosphate (malathion) 
and carbamates (Bendiocard) (WHO, 2017). The Organochlorine and Pyrethroid are targeting 
the voltage-gate sodium channel in insect neurons (Brogdon and McAllister, 1998) The 
Organophosphate and carbamates are targeting the acetylcholine-esterase in the synapse of 
the insect system nervous. The chemical method is implemented through insecticide-treated 
materials such as Long-lasting insecticidal nets (LLINS) and Indoor residual spray (IRS). 
LLINs: At the moment, vector control relies heavily on LLINS. LLINS is one of the most effective 
tools that we have at the moment for vector control, it acts as a physical barrier, and the sub-
lethal effect of pyrethroid contributes to reducing mosquito's density (Bhatt et al., 2015; Maia 
et al., 2018; Richardson et al., 2018). Several LLNs brands have been requalified by WHO 
(WHO, 2019a). 
LLINS including Piperonyl butoxide (PBO): LLINs treated with two different active ingredients 
(each with a different mode of action) are on the table as options to ensure the continued 
effectiveness of LLINs. Beside the nets with two different active ingredients, we already have 
nets treated with a pyrethroid combined with a synergist to contribute to the maintenance of 
the effectiveness of pyrethroid-only nets. Piperonyl butoxide (PBO) is a ‘synergist’ that can 
boost the effectiveness of certain insecticides against resistant mosquito populations. PBO 
inhibits the inner defense mechanisms of insects, the most important are the cytochromes 
P450, a superfamily of enzymes containing monooxygenases P450 which is the primary route 
of detoxification in insects, causing the oxidative breakdown of insecticides like pyrethroid 
(Gleave et al., 2018). 
 
Table 1.2: List of WHO Prequalified LLINs for vector Control (adapted from (WHO, 2019a) 
LLINs Manufacturer Active ingredient 
Olyset Net  Sumitomo Chemical Co., Ltd Permethrin (1000 mg/m2)  
Olyset Plus  Sumitomo Chemical Co., Ltd 
Permethrin (1000 mg/m2) + 
Piperonyl Butoxide (1%) 




Interceptor G2  BASF SE  
Alpha-cypermethrin (100 
mg/m2) + Chlorfenaypr (200 
mg/m2)  
Royal Sentry  Disease Control Technology, LLC  
Alpha-cypermethrin (261 
mg/m2)  
Royal Sentry 2.0  Disease Control Technology, LLC  
Alpha-cypermethrin (203 
mg/m2)  
Royal Guard (120 
denier) Disease Control Technology, LLC  
Alpha-cypermethrin (5.5 g/kg) + 
Pyriproxyfen (5.5 g/kg 
PermaNet 2.0 (75 
denier) Vestergaard S.A.  Deltamethrin (1.8 g/kg)  
PermaNet 2.0 (100 
denier) Vestergaard S.A.  Deltamethrin (1.4 g/kg)  
PermaNet 3.0 (roof) Vestergaard S.A.  
Deltamethrin (4 g/kg) +  
Piperonyl Butoxide (25 g/kg)  
PermaNet 3.0 
(side/75 denier) Vestergaard S.A.  Deltamethrin (2.8 g/kg)  
PermaNet 3.0 
(side/100 denier) Vestergaard S.A.  Deltamethrin (2.1 g/kg)  
Duranet LLIN  Shobikaa Impex Private Limited  
Alpha-cypermethrin (261 
mg/m2)  
MiraNet  A to Z Textile Mills Ltd  
Alpha-cypermethrin (180 
mg/m2)  
MAGNet  V.K.A. Polymers Pvt Ltd  
Alpha-cypermethrin (261 
mg/m2)  
VEERALIN  V.K.A. Polymers Pvt Ltd  
Alpha-cypermethrin (216 
mg/m2) + Piperonyl Butoxide 
(79 mg/m2) 
Yahe LN (75 denier) 
Fujian Yamei Industry & Trade Co 
Ltd Deltamethrin (1.85 g/kg) 
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Yahe LN (100 denier) 
Fujian Yamei Industry & Trade Co 
Ltd Deltamethrin (1.4 g/kg) 
SafeNet Mainpol GmbH 
Alpha-cypermethrin (200 
mg/m2) 
Yorkool LN (75 
denier) 
Tianjin Yorkool International 
Trading Co., Ltd Deltamethrin (1.8 g/kg) 
Yorkool LN (100 
denier) 
Tianjin Yorkool International 
Trading Co., Ltd Deltamethrin (1.4 g/kg) 
Panda Net 2.0 
LIFE IDEAS Biological Technology 
Co., Ltd. Deltamethrin (76 mg/m2) 
Tsara Boost NRS Moon netting FZE 
Deltamethrin (440 mg/m2)+ 
Piperonyl Butoxide (120 mg/m2) 
Tsara Soft NRS Moon netting FZE Deltamethrin (80 mg/m2) 
Tsara Plus (Roof) NRS Moon netting FZE 
Deltamethrin (3 g/kg) 
+Piperonyl Butoxide (11 g/kg) 
Tsara Plus (side) NRS Moon netting FZE Deltamethrin (2.5 g/kg) 
 
IRS: At the moment, vector control relies heavily on tools like IRS. IRS should be considered in 
comparison to LLINs, and the most appropriate should be chosen according to the 
environment. IRS is not easy to implement because it is costly so the coverage cost can be a 
stopping factor. We also have the logistic aspect, because of logistic concern IRS can be 
challenging to apply. However, many manufacturers are releasing new formulations showing 
great results. Some of them are listed below (WHO, 2019a). 
 
 
Table 1.3: List of some WHO Prequalified IRS forVector Control (adapted from (WHO, 2019a) 





Sumitomo Chemical Co., 
Ltd. 
Clothianidin, WG 50% WG 
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Larviciding: The purpose of this method is to reduce the larva density to reduce the vectorial 
capacity of the vector. Temephos, Malathion, and pirimiphos-methyl are used for this 
achievement (WHOPES, 2013), but the non-persistence of these insecticides in the breeding 
site makes this method to require constant spray in water. Because of this reason, this method 
appears to be expensive. However, in the context of the rapid increase in insecticide 
resistance, outdoor malaria transmission, and the changing behaviour of malaria vectors, 
larviciding when it is well could add value to malaria control (Antonio-Nkondjio et al., 2018).  
 
1.6 Insecticide resistance 
 
Insecticide resistance is defined as "a heritable change in the sensitivity of a pest population 
that is reflected in the repeated failure of a product to achieve the expected level of control 
when used according to the label recommendation for that pest species" (IRAC, 2018). 
Insecticide resistance is conferred mainly through target resistance and metabolic resistance, 
which are grouped as physiological resistance. In addition reduced penetration resistance and 
behavioral resistance are also observed (Hemingway and Ranson, 2000; IRAC, 2010). 
 
1.6.1 Target site resistance 
 
Most of the insecticide classes target a specific action site in the nervous system. Target-site 
resistance takes place when this action site is modified. As a result of this modification, the 
insecticide effect on the mosquito is reduced. Three types of target resistance are observed: 
The voltage-gate sodium channel modification (knock-down resistance: Kdr) responsible of 








Syngenta Crop Protection 
AG 
Pirimiphos‐methyl 300g/L CS 
ICON CS ‐ ITN Kit 





Fendona 10 SC BASF SE Alpha‐cypermethrin  9.6%  SC 
K‐Othrine WG250 Bayer S.A.S. Deltamethrin  25% (250 g/kg)  WG; WG‐SB 
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organochlorine and pyrethroid resistance (Hemingway and Ranson, 2000; Martinez‐Torres et 
al., 1998), acetylcholine-esterase modification responsible of organophosphate and 
carbamate resistance (Weill et al., 2004) and the gamma aminobutyric acid (GABA) 
modification responsible of dieldrin resistance (RDL) (Wondji et al., 2011).  
Knockdown resistance (Kdr): Kdr resistance has been detected in several insect species, 
including many mosquitoes such as An. gambiae, Culex pipiens, and Aedes aegypti 
(Hemingway and Ranson, 2000). The most common mutation is observed at the 1014 codon 
position with leucine to phenylalanine replacement (L1014F), as also found in An. gambiae 
(Martinez‐Torres et al., 1998). However, another mutation is observed in the same codon in 
both and An gambiae and An. arabiensis with a Leucine to Serine replacement (L1014S), which 
was originally observed in East Africa (Hemingway and Ranson, 2000) while the L1014F is 
predominant in West Africa. The studies carried out until now revealed no Kdr presence in An. 
funestus (Irving and Wondji, 2017; Wondji et al., 2012). However recent analysis of the 
polymorphism of a portion of the voltage-gated sodium channel gene (VGSC) of An. funestus 
from Cameroon (Gounougou) confirm the absence of the L1014F/S Kdr mutation but revealed 
3 novel amino acid changes I877L, V881L, and A1007S. However, no association was 
established between VGSC polymorphism and pyrethroid/DDT resistance (Menze et al., 2016). 
Acetylcholinesterase: Acetylcholinesterase mutation is due to glycine to serine substitution 
(G119S) in many mosquito species. G119S has been reported in West Africa in An. gambiae 
(Weill et al., 2004). The same mutation has also been found in An arabiensis (Casimiro et al., 
2006). But never found in and An. funestus (Cuamba et al., 2010). Recently, a study by (Ibrahim 
et al., 2016) detected in An. funestus population from Southern Africa a novel mutation 
(N485I) associated with carbamate resistance (Ibrahim et al., 2016). 
GABA receptor: Several mutations conferring insecticide resistance have been detected in 
insects (Corbel and N’Guessan, 2013). For the malaria vector, Anopheles gambiae, alanine to 
glycine substitution in the Rdl locus is conferring resistance to dieldrin (Du et al., 2005). The 
A296S mutation in the Gaba receptor has also been described and associated with Dieldrin 
resistance in Anopheles funestus population from Cameroon and Burkina Faso (Wondji et al., 
2011). However, this mutation was not observed in An. funestus population from the Eastern 
and Southern parts of Africa (Malawi, Uganda and Mozambique).  
Although dieldrin is not used any more, this mutation is still present in the Anopheles funestus 
population from the Northern part of Cameroon even if decreasing over time. In 2006 the RR 
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genotype frequency of RDL in Northen Cameroon was around 80% , then 30% in 2012 and less 
than 5%  in 2015 (Menze et al., 2016). This is  due to a recovery of susceptibility since the 
selection pressure has been removed (Menze et al., 2016). 
 
1.6.2 Metabolic resistance 
 
All insects possess enzymatic systems that detect toxin and initiate the metabolism of these 
compounds to detoxify their body. Metabolic resistance takes place when the insecticide 
cannot reach the target site because of the detoxification action of specific enzyme families. 
This type of resistance occurs through different potential mechanisms, including Gene 
amplification, gene up-regulation, and allelic variation. Three enzyme families are primarily 
involved in detoxification: monooxygenases, glutathione-Transferases, and esterase (IRAC, 
2011), although other families are also associated (Hemingway and Ranson, 2000). 
 
Cytochrome P450 monooxygenases: Cytochrome monooxygenases are an important enzyme 
group present in almost all animals, and they play a major role in detoxification (Feyereisen, 
1999; Scott, 1999). Monooxygenases have been involved in resistance to several insecticide 
classes in many mosquito species across Africa. Monooxygenases have been associated with 
a pyrethroid, organophosphate, and carbamate resistance (Hemingway and Ranson, 2000). In 
An. funestus two duplicated cytochrome P450 genes CYP6P9a and CYP6P9b have been 
associated with pyrethroid resistance in the southern part of Africa (Mozambique and Malawi) 
(Amenya et al., 2008; Riveron et al., 2013; Wondji et al., 2009) as well as the CYP6M7 gene 
(Riveron et al., 2017b). CYP6P3 and CYP6M2 have also been associated with pyrethroid 
resistance in An. gambiae in Benin and Nigeria (Djouaka et al., 2011; Mitchell et al., 2012; 
Müller et al., 2008). A recent study by (Riveron et al., 2017b) revealed that CYP6P9a, CYP6P9b, 
and CYP6M7 genes, involved in pyrethroid resistance in An. funestus were found upregulated 
in Anopheles funestus population from Congo after qRT-PCR using non-exposed mosquitoes 
(Riveron et al., 2017b). 
 
Glutathione-S-transferases: Glutathione-S-transferases (GSTs) are mainly involved in DDT 
resistance (Hemingway and Ranson, 2000). Using genome-wide transcriptional and functional 
analyses combined with structural and population genetics studies, we conclusively 
44 
demonstrated that a single amino acid change in the binding pocket of the glutathione-s-
transferase epsilon 2 (GSTe2) gene, coupled with increased transcription, confers a high level 
of DDT resistance and cross-resistance to pyrethroids in the major African malaria vector An. 
funestus (Figure 1.4) (Riveron et al., 2014b). The same study detected, for the first time, a 
molecular resistance marker for metabolic resistance and designed a DNA-based diagnostic 
assay currently use to identify and map the distribution of resistance conferred by Gste2  
across Africa. GSTs have been associated with DDT resistance in An. funestus population across 
several countries in Africa including Benin in West Africa (Djouaka et al., 2016a) but also 
Cameroon in Central Africa (Menze et al., 2016) through a mutation in the GSTe2 gene 
(L119F)(Figure 1.5) (Riveron et al., 2014). 
 
 
Figure 1.4: Topology of GSTe2 showing the C- and N-terminals, the GSH binding pocket (G-
site) and the substrate-binding pocket (H-site). AU, arbitrary units; BN, Benin; GSH, 
glutathione; MAL, Malawi; MW, molecular weight; UG, Uganda; vol, volume. Adapted from 























Figure 1.5: The geographical distribution of L119F allele across Africa in Anopheles funestus. 
sl population (Riveron et al., 2014b). 
Esterase: The selection pressure due to the use of organophosphate and carbamate has led 
to the overexpression of non-specific carboxylesterases(CCE) in many species including 
mosquitoes, aphids, and cockroaches (Hemingway et al., 2004). Several studies have 
associated CCE in the hydrolysis or sequestration of ester bonds in insecticides (Corbel and 
N’Guessan, 2013). Carboxylesterases have been associated with temephos resistance in Ae 
aegypti (Poupardin et al., 2014). Bioassays on Ae. aegypti larvae from Thailand detected a high 
level of temephos resistance with ratios ranging from 3.5 fold in Chiang Mai to nearly ten fold 
in Nakhon Sawan (NS) province. Synergist assays and microarray results suggested and 
increased activities of carboxylesterase. Gene profilindg have shown that carboxylesterase 
genes (CCEae3a) were up to 60 time upregulated when comparing sample resistant to 
temephos  to susceptible (Poupardin et al., 2014). 
In Culex quinquefasciatus population known as a major vector of human disease and an 
important target of the vector control program, insecticide resistance has been related to 
esterase (Gordon and Ottea, 2012). 
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In Anopheles sinensis a major malaria vector in eastern Asia, resistance to pyrethroid has been 
associated with Carboxyl esterases, RNA-seq spotted five overexpressed CCE genes, and qRT-
PCR identified 12 overexpressed CCE genes. The main CCE genes linked with pyrethroid 
resistance were the α-esterase ten and acetylcholinesterase 1 (Wu et al., 2018). 
Gene profiling analysis in An. funestus population has detected some candidate 
carboxylesterases genes overexpressed (Riveron et al., 2014a). Current studies are going on 
for their validation. 
 
1.6.3 Penetration resistance 
 
Massive use of insecticide have contributed to the selection of a more sophisticated resistance 
mechanism. Penetration resistance refers to some changes in the cuticle that will reduce the 
diffusion of insecticide in the insect body (Balabanidou et al., 2018). A review by Balabanidou 
et al has identified two main mechanisms by which penetration resistance is occurring: (i) The 
cuticle thickening and (ii) The altering of cuticle composition. These cuticular modifications 
are happening as a result of the over-expression of several genes, cuticular protein, and ABC 
transporters. The upregulation of CYP4G16 and laccase two have also been identified as 
responsible of cuticular modifications (Balabanidou et al., 2018). 
In An. gambiae population, the contribution to cuticle changes in insecticide resistance has 
been assessed. Microscopy studies and characterization of lipid extracts have demonstrated 
that resistant mosquitoes had a thicker cuticle and a significant increase in cuticular 
hydrocarbon content. The overexpression of CYP4G16 and CYP4G17 has been associated with 
the increase in cuticular hydrocarbon content (Balabanidou et al., 2016). 
In An. funestus population from South Africa, pyrethroid resistance has been associated with 
changes in the thickness of the cuticle. A positive correlation between mean cuticle thickness 
and time knockdown during exposure to permethrin was observed. In addition the mean 
cuticle thickness was significantly high in samples resistant to permethrin compared to 
susceptible (Wood et al., 2010). Besides metabolic based resistance with is the main 
insecticide resistance mechanisn in An funestus population, penetration resistance is rising as 









   
   
   
   
 
     
   







   







Insects  can respond to  insecticide  exposure  by  changing  their  behavior  to  avoid  the  lethal 
effect  of  the  insecticide.  In  some  cases, metabolic  resistance  and  target  resistance  are 
supported by behavioral resistance (IRAC, 2010). A change of biting behavior was observed in
An funestus population from 2 villages in Benin after massive LLINs coverage (Moiroux et al., 
2012). Human-landing catch was conducted indoor and outdoor in Lokohouè and Tokoli, two 
localities  in  Benin. The  study was  carried out one year  before  the  LLIN  coverage  and three 
years later. During the study, the median catching time and the proportion of outdoor biting 
were compared. In Tokoli the percentage of outdoor biting moved from 45 to 681 %. Just one 
year after the LLINs coverage. In the next village, we notice 26% of the An. funestus population 
biting after 6 am. This evaluation was proof of change in biting behavior (Moiroux et al., 2012). 
Studies  are  going  on  to  evaluate  and  give  more  evidence  of  behavioral  resistance  as  a
mechanism of resistance with genetics and a heritable basis (Zalucki and Furlong, 2017).
1.7 Evolution of Insecticide resistance
Insecticide resistance including all the four classes of insecticides is now noticed all over Africa
(Antonio-Nkondjio et al., 2017; Djouaka et al., 2016c; Menze et al., 2016; Menze et al., 2018b;
Mulamba et al., 2014b; Riveron et al., 2016b). Resistance to pyrethroids, the insecticide class, 
commonly used in LLINs, is increasing rapidly. Pyrethroid resistance has been noticed in many
An. gambiae populations across  Africa. In An.  gambiae s.s. population  from  Côte  d'Ivoire, 
resistance  to cyfluthrin,  lambda-cyhalothrin,  alpha-cypermethrin,deltamethrin, and 
permethrin  was  observed.  Using  the  same  population,  resistance  was  also  observed with 
deltamethrin-impregnated nets (Chandre et al., 1999). Further studies in Côte d'Ivoire in 2012 
in the locality of Tsassodji have confirmed the resistance to permethrin (mortality: 42.0%), to 
deltamethrin  (mortality: 58.8%)  and  lambda-cyhalothrin  (mortality:67.7%)  in An  gambiae
population (Alou et al., 2012). An gambiae from Mibellon in Cameroon was also found highly 
resistant to pyrethroid with mortality ranging from 0% to 4.44% (Menze et al., 2018b). 
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Beside pyrethroid resistance, organophosphate and carbamate resistance were also found. 
An. gambiae s.l. from Bouake in Côte d'Ivoire was found to be resistant to carbamates 
(bendiocarb and carbosulfan) with mortalities ranging from 13.9% to 67% (Zoh et al., 2018). 
Organophosphate resistance was observed in An. gambiae population from Benin. After 30 
minutes of exposure to CDC bottles treated with fenitrothion.  An. gambiae from Tanguieta 
and Malanville, two localities in Benin were found resistant with mortalities ranging from 
57.14% (Malanville) to 76.72% (Tanguieta) (Aïzoun et al., 2013). 
In An. funestus population, insecticide resistance to diverse classes of insecticides such as 
pyrethroids, carbamates, organochlorines, and organophosphate are increasingly reported 
across Africa although with contrasting patterns (Cuamba et al., 2010; Djouaka et al., 2016a; 
Menze et al., 2016; Menze et al., 2018b; Mulamba et al., 2014b; Riveron et al., 2016b). In 
southern Africa, An. funestus populations are highly resistant to pyrethroids and carbamates 
(Cuamba et al., 2010; Morgan et al., 2010; Riveron et al., 2016b; Wondji et al., 2012) whereas 
populations from East Africa remain fully susceptible to carbamates but are resistant to 
pyrethroids and DDT (Kawada et al., 2011; Mulamba et al., 2014a; Mulamba et al., 2014b). In 
West Africa, An funestus populations have been reported to be resistant to pyrethroids, DDT, 
and moderately resistant to carbamates (Djouaka et al., 2016a; Menze et al., 2016; Menze et 
al., 2018b; Riveron et al., 2016b). 
 
1.8 Impact of the resistance to insecticides on the effectiveness of vector 
control tools 
 
The extent of the impact of insecticide resistance, notably, metabolic resistance on the 
effectiveness of insecticide-based interventions such as Long-lasting Insecticidal Nets (LLINs) 
remains unclear. There is currently an intense debate with sometimes opposite results as 
published recently (Kleinschmidt et al., 2018a; Protopopoff et al., 2018a) on the impact of 
insecticide resistance on the effectiveness of insecticide-based interventions. This is illustrated 
with two recent publications, one highlighting the limited impact of resistance from a 
multicentre study (Kleinschmidt et al., 2018a) whereas a randomized control trial comparing 
PBO-net vs pyrethroid only revealed a significant epidemiological benefit with PBO nets 
highlighting a negative impact of resistance (Protopopoff et al., 2018a). This contrasting result 
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shows the challenge of addressing this fundamental question. However, the lack of resistance 
markers for metabolic resistance has been one of the limiting factors. 
 
Two approaches (epidemiological and entomological) are usually considered as useful 
methods to investigate the impact of insecticide resistance (WHO, 2012b). However, the 
epidemiological approach relaying on malaria cases investigation is not suitable since malaria 
transmission is affected by many confounding factors (Kleinschmidt et al., 2015; WHO, 2012b). 
These confounding factors, such as the local habitation favorable to the mosquito bite, the 
weather, and the fickleness of the health care system, can blind the real link between 
Insecticide resistance and malaria transmission. Recognising the limitations of the 
epidemiological approach, the alternative is to measure entomological outcomes, such as 
relative mortality and feeding success of resistant and susceptible vectors in controlled 
conditions using experimental huts (N’Guessan et al., 2009; N’Guessan et al., 2007b; WHO, 
2012b). 
 




Experimental hut trial was used in Benin to check the efficacy of ITN (Lambdacyalothrin) in 
two localities of Benin: Ladji an area where mosquitoes are highly resistant with a high level 
of Kdr and Malanville an area where mosquitoes are susceptible. In Ladji, reduction of the 
efficacy of the insecticide was noticed with a low mortality rate (29.8%) and a high level of 
blood-feeding (82%). In Malanville where mosquitoes were susceptible, the mortality was 
around 98.5%, and the blood-feeding 3% (N'Guessan et al., 2007b). These results highlight the 
fact that Insecticide resistance is changing the efficacy of nets. Unfortunately, in this case, the 
direct impact of kdr could not be assessed as both populations had different genotype 









1.8.2 Case in South Africa where pyrethroid resistance led to the increased of malaria cases 
 
In 1996 a national decision was made to switch from DDT to Pyrethroid using IRS. A few years 
later, a strident increase of malaria cases was observed. The bioassays performed revealed 
that An. funestus was resistant to Pyrethroid and susceptible to DDT. These mosquitoes also 
showed a sporozoite rate of 5.4 %, which is high compare to what usually observed in South 
Africa. When they reverted to DDT, they noticed a reduction of malaria transmission 
(Hargreaves et al., 2000). This observation further highlights the fact that insecticide 
resistance reducing the efficacy of IRS negatively impact malaria transmission. 
 
1.8.3 Other studies on the impact of insecticide resistance on the effectiveness of vector 
control tools 
 
A study by (Strode et al., 2014) presented a systematic review and Meta-analysis, including 
cone assays, tunnel assays in the laboratory and field studies using experimental hut from 
many authors. Cone assays showed reduced knockdown and mortality associated with a high 
level of resistance. For tunnel assay, because of a high level of resistance, reduced efficacy of 
ITNs was also observed when looking at the mortality and passage of mosquitoes through the 
net (Strode et al., 2014). For experimental hut, independently of the resistance profile, a clear 
difference in the entomological outcomes was observed when compared to the treated hut 
to the untreated. However, a large amount of heterogeneity between the different studies 
creates a situation where it was difficult to conclude. A strong recommendation to people 
involved in the area to standardize the protocol was raised. For example, the characterization 
of the resistance pattern before the study, the season, the rotation of the sleepers, the 
washing procedure, decontamination of the hut, and exclusion of males from the analysis 
were suggested for standardization (Strode et al., 2014). 
Another study by (Churcher et al., 2016b), used a Meta-analyses of bioassay studies and 
experimental hut trials (figure 1.8)to demonstrate how emerging insecticide resistance is 
changing the number of malaria cases. Transmission dynamic models reveal that even very 
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low level of resistance can increase malaria incidence because of a reduction of mosquito’s 
mortality For example only 30% of resistance in a population with 10% malaria prevalence 
could cause an additional 245 malaria cases per 1000 per year (Churcher et al., 2016b). 
 
Figure 1.6: Average probability that blood-feeding mosquitoes will be killed, deterred from 
entering, exit without feeding or successfully feed and survive during a single feeding attempt 
and how this changes with the population prevalence of pyrethroid resistance. From 
(Churcher et al., 2016b). 
 
1.9 Evaluation of the impact of metabolic resistance 
 
1.9.1 DNA-based marker for GST-based metabolic resistance 
 
The first DNA-based diagnostic for target-site resistance was established two decades ago 
(Martinez-Torres et al. 1998). Detecting DNA-based markers for metabolic resistance has been 
more challenging. The lack of markers for metabolic resistance has made it difficult to monitor 
its spread in the field, and assess its real impact on ongoing control interventions and malaria 
transmission. However, recent significant progress has been made. The first success was the 
case of the GST-based metabolic resistance with the detection of a Leucine-to-Phenylalanine 
amino acid change at position 119 in the GST epsilon 2 (GSTe2) in the major malaria vector 
An. funestus (Riveron et al 2014). Over-expression of GST epsilon 2 (GSTe2) has been 
associated with DDT and/or pyrethroids resistance in several mosquito species, including An. 
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gambiae (Mitchell et al., 2014), An. funestus (Riveron et al., 2014c) and Aedes aegypti 
(Lumjuan et al., 2011). 
In An. funestus, the role of the L119F mutation, with the resistant allele being more efficient 
at metabolizing DDT, was confirmed by functional characterization of recombinant GSTe2. It 
has also been demonstrated that GSTe2 directly metabolizes the pyrethroid permethrin 
(Riveron et al., 2014b). Structural analysis revealed that a leucine to phenylalanine amino acid 
change (L119F) in GSTe2, enlarging the substrate-binding pocket of the enzyme, was 
conferring DDT/pyrethroid resistance in West and Central African populations (Riveron et al., 
2014c) (Figure 1.9). Based on this Riveron et al 2014 also designed a TaqMan assay to detect 
the three genotypes of the mutation. The TaqMan assay was later used for genotyping alive 
and dead mosquitoes after exposure to DDT and pyrethroid and to demonstrate using the odd 
ratio that GSTe2-L119F correlates with DDT and Pyrethroid resistance (Riveron et al., 2014b). 
Further studies confirm the role of allelic variation of the gene as GAL4-UAS transgenic 
expression in Drosophila flies demonstrates that the resistant 119F allele is conferring a high 
level of resistance to DDT and permethrin when compared to the L119 (Riveron et al., 2017a). 
In addition, this single amino acid change was used to design a simple field applicable DNA-
based diagnostic tool (Tchouakui et al., 2019c) (Figure 1.10). 
 
Figure 1.7: Image representing the substrate biding pocket from Benin (purple) and Uganda 
(green). The H site's representation demonstrates how the DDT docks well into the GSTe2 in 
mosquitoes from Benin and does not with the GSTe2 in mosquitoes from Uganda. Adapted 
from (Riveron et al., 2014b). 
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Figure 1.8: Allele-Specific -PCR for genotyping of the L119F-GSTe2 mutation. (a) Amplification 
by PCR of the GSTe2 gene in An. funestus s.s. (b) Agarose gel of AS-PCR showing the L119F 
GSTe2 mutation in An. funestus s.s. at 849 bp. Resistant at 523 bp, susceptible at 312 bp, and 
heterozygote mosquitoes at both 523 bp and 312 bp. Adapted from (Tchouakui et al., 2019a). 
1.9.2 DNA-based marker for Cytochrome P450-based metabolic resistance 
 
1.9.2.1 DNA-based marker for CYP6P9a 
 
Regarding P450 family genes, further genomic analyses revealed a complex evolution of 
resistance, including copy number variation, transposon insertion, and gene conversion. From 
An. funestus samples across Africa, 800-bp sequence immediately upstream of CYP6P9a were 
compared to detect cis-regulatory mutations controlling CYP6P9a/b-based pyrethroid 
resistance. Following the comparison, very low diversity was observed in the genomes of 
mosquitoes from different regions. However, mosquitoes from southern Africa consistently 
showed different polymorphisms when compared to other Africa regions. This polymorphism 
was including the presence of an AA insertion eight bp upstream of a putative CCAAT box 
through an A/C substitution (Figure 1.11) (Weedall et al., 2019). 
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The detection of causative cis-regulatory mutations allowed designing the first DNA-based 
P450 assay in malaria vectors (Weedall et al., 2019). An image of the gel showing how the 3 
CYP6P9a genotypes detected is present in chapter 2 (section 2.4.4; Figure 2.12). 
These molecular markers recently made available are providing a unique opportunity to now 
address questions regarding the direct impact of metabolic resistance on insecticide-based 












Figure 1.9: Polymorphic sites and haplotypes across Africa showing AA insertion eight bp 
upstream of a putative CCAAT box through an A/C substitution and genetic diversity patterns 
of an 800bp cis-regulatory genomic fragment of CYP6P9a Africa-wide. Haplotypes are labeled 
with prefixes from the country. CMR is Cameroon, GHA is Ghana, BEN is Benin, TNZ is Tanzania, 
DRC is the Democratic Republic of Congo, MOZ is Mozambique, STH is Southern Africa, MWI 
is Malawi, ZMB is Zambia, EST/CNT is East/Central Africa, FANG is FNG. Adapted from (Weedall 
et al., 2019). 
 
1.9.2.2 DNA-based marker for CYP6P9b 
 
Transcriptional and genomic analysis of An. funestus mosquitoes across Africa showed 
complex and diverse molecular changes underlying insecticide resistance trough differential 
gene expression patterns and genomic signatures like cis-acting regulatory elements 
regulating the expression of detoxification genes. To understand the potential regulatory 
elements controlling the over-expression of CYP6P9b, the full 1 kb intergenic region between 
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CYP6P9b and CYP6P5 in individual resistant (FUMOZ) and susceptible (FANG) mosquitoes was 
amplified and sequenced. An indel of 3 bp (AAC) was consistently observed with a deletion in 
the resistant FUMOZ and presence in susceptible FANG. Based on this, a DNA-based diagnostic 
assay to detect CYP6P9b-mediated resistance was designed (Figure 1.12) (Mugenzi et al., 
2019). An image of the gel showing how the 3 CYP6P9b genotypes detected is present in 











Figure 1.10: Sequences showing fixed variations linked with CYP6P9b-mediated pyrethroid 
resistance, including the AAC insert only found in resistant mosquitoes and the C/T variant 
tightly linked to the resistant haplotype. Adapted from (Mugenzi et al., 2019). 
1.10 Development of new insecticide products for vector control  
 
The high level of resistance observed among the Anopheles population (Menze et al., 2016; 
Menze et al., 2018b; Riveron et al., 2017b) is a concern for the vector control program in 
Cameroon and Africa. In addition, the reduced efficacy of bed nets currently used in public 
health associated with a high level of resistance is also reported (Allossogbe et al., 2017; 
Churcher et al., 2016a; N’Guessan et al., 2007b). This reduced efficacy of the product available 
for vector control at the moment due to the high level of resistance in Anopheles field 
population is an urgent call for the need to develop new products (Zaim and Guillet, 2002). To 
raise this issue, the Innovative Vector Control Consortium (IVCC) is working hard in 
collaboration with Bill et Melinda Gates, chemical industry, and academia to find new products 
for vector control (Hemingway et al., 2006). This collaboration aims to provide by 2023 new 
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chemical and technological tools to reduce the burden of malaria, Dengue, and other vector-
borne diseases  (Hemingway, 2014). 
Some products with different mode of action previously used in the agricultural sector are 
now implemented in public health for vector control. Chlorfenapyr, for example, a pyrrole 
insecticide was found to be very efficient against Ace1 and Kdr resistant mosquitoes after a 
simulation of experimental hut trial (N’guessan et al., 2007a). After experimental hut using 
ITNs and IRS Chorfenapyr was also found to be successful in killing pyrethroid-resistant 
Anopheles gambiae and Culex quinquefasciatus (N’Guessan et al., 2009). A duo nets made by 
the combination chlorfenapyr mixed with alpha-cypermethrin was found to be effective 
against resistant mosquitoes in West Africa (N’Guessan et al., 2016). Another study comparing 
chlorfenapyr IRS + Interceptor LN (alpha-cypermethrin) vs interceptor G2 LN (duo nets 
combining chlorfenapyr + alpha-cypermethrin) vs Interceptor LN alone in Cove in Benin was 
also done. The combination of pyrethroid + Chlorfenarpyr was found to be more effective 
when compared to pyrethroid alone (Ngufor et al., 2017a). This efficiency of the mixture is 
due to the fact that the chlorfenapyr with a different mode of action increased the mass killing 
while the pyrethroid with the repellent effect provided the personal protection (Ngufor et al., 
2017a). 
 
Fludora® Fusion is a new product for vector control developed by Bayer. This product is the 
first IRS application combining two insecticides with a different mode of actions (the 
neonicotinoid insecticide clothianidin and the pyrethroid insecticide deltamethrin). Fludora 
shows great results against resistant mosquitoes using experimental hut in Benin with 80% 









Figure 1.11: Mortality obtained with wild An. gambiae s.s. in operational conditions in Benin 
using mixture clothianidin 200 mg/m2+deltamethrin 25 mg/m2 (WP 56.25). Adapted from 
(Agossa et al., 2018). 
Another study in Cove in Benin also demonstrated good performance of fludora at different 











Figure 1.12: Mortality against wild pyrethroid-resistant An gambiae in operational conditions 
on different wall surfaces. Bars with a similar letter are not significantly different at 5%. DM = 
deltamethrin, CT = clothianidin. Adapted from (Ngufor et al., 2017b). 
SumiShield™ 50WG is an Indoor Residual Spray (IRS) containing a new Mode of Action active 
ingredient. The active ingredient is made of clothianidin 50% w/w a water-dispersible granule 
(WG). SumiShield 50WG is odorless, has low toxicity, readily dilutes in water, and is easy to 
transport. Between 2016 and 2017, a trial to determine the efficacy of SumiShield 50WG, 
against wild Anopheles arabiensis was carried out in the in Moshi village in the Republic of 
Tanzania. The biological efficiency of Sumishield was assessed in Moshi in Tanzania. An 
optimal efficacy was observed for up to six months post spray and 100% mortality of 
mosquitoes by 144 to 168 hours post-exposure to treated surfaces (Kweka et al., 2018). 
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Figure 1.13: Residual efficacy observed after 30 minutes of exposure to SumiShield 50WG 
treated surfaces in houses in Moshi village in Tanzania. It was adapted from (Kweka et al., 
2018). 
 
Besides new insecticide formulation, a new combination called Olyset duo made of 
permethrin + an insect growth regulator that disrupts the maturation of oocytes in mosquitoes 
was also tested (Ngufor et al., 2016b). The offspring of blood-fed Anopheles gambiae exposed 
to Olyset duo after the experimental hut trial was reduced by 71% with unwashed net and by 
43% with washed (Ngufor et al., 2016b). A cluster-randomized controlled trial in Burkina Faso 
also demonstrates the reduction of malaria incidence after the introduction of Olyset Duo. 
The prevalence of malaria went from 2·0 episodes per child-year when using standard bed 
nets to 1·5 episodes per child-year in the group using Olyset Duo (incidence rate ratio 0·88 
[95% CI 0·77-0·99; p=0·04]) (Tiono et al., 2018). 
New technology like Microencapsulation used with an existing insecticide like chlorpyrifos 
methyl can increase their residual activity (N'Guessan et al., 2010b). The creation of new 
technology to deliver insecticide is also an option to improved vector control. Insecticide-
treated wall linings (ITWL) and Long-lasting pyrethroid treated plastic sheeting, also known as 
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a durable lining (DL) were developed to improve the delivery of insecticide and improve vector 
control (Messenger et al., 2012; Sharma et al., 2009). 
 
1.11 Insecticide Resistance management  
 
The idea behind insecticide resistance management is to preserve and extend the continued 
effectiveness of actual and future insecticides. As a response to the WHO assembly and the 
board Roll Back Malaria, the global plan for insecticide resistance management (GPIRM) was 
designed in 2012. This plan now acknowledges that if strong measures are not taken to 
monitor insecticide resistance to preserve the continued effectiveness of current and future 
insecticide or to prevent the spread of resistance, consequences could be calamitous for 
vector control programs (WHO, 2012b). 
To tackle the problem, several methods such a: i) Rotation, ii) Mosaic, iii) Combination, and iv) 
Mixtures have been suggested. All these techniques are based on two principles: 1) a fitness 
cost principle based on the recovery of the mosquitoes' susceptibility when the selection 
pressure is removed (rotation and mosaics). 2) Overcoming and challenging the resistance by 
putting in place strategy to kill resistant mosquitoes (mixtures and combination) (Denholm 




Mixtures are when two or more compounds of different insecticide classes are mixed to make 
a single product or formulation so that the mosquito is guaranteed to come into contact with 




In a combination of interventions, two control interventions are used in a house (e.g., 
pyrethroids on nets and an insecticide of a different class on the walls (Kleinschmidt et al., 






In this method, two or preferably more, insecticides with different modes of action are rotated 
from one year to the next (WHO, 2012b) (Figure 1.16). There is no recent case of the use of 
this method in vector control, and it was introduced once a long time ago in West Africa to 
control black flies (KURTAK et al., 1987). 
 
 





Mosaic spraying: one compound is used in one geographic area and a different compound in 
neighboring regions, the two being in different insecticide classes (GPIRM, 2012). The aim of 
this is to create a dilute effect that will slow down the selection of the resistance (figure 1.16). 
The mosaic method was tested in Mexico to control Anopheles albimanus.  Despite the 
observation of enzymes activity patterns variation, the probability of high-level resistance 
development when using mosaic regime was significantly lower when compared to the rate 
obtained when using pyrethroid alone (Fgure 1.16). (IRAC, 2014a). Mosaic is also used in LLINs 
fabrication to produce the two-in-one bed nets. These nets are usually treated with two 




1.12 Study objectives 
 
1.12.1 General objectives 
 
The WHO Global Plan for Insecticide Resistance Management (GPIRM) highlighted the need 
to investigate how insecticide resistance is changing the efficiency of bed nets to implement 
suitable insecticide resistance management strategies (IRM) in order to preserve the efficacy 
of current and future insecticides. However, the extent of the Impact of this resistance, 
notably, metabolic resistance on the effectiveness of insecticide-based interventions such as 
Long-lasting Insecticidal Nets (LLINs) remains unclear. Taking advantages of the markers 
recently made available, this study aims to investigate the impact of insecticide resistance on 
the effectiveness of vector control tools against the major African malaria vector An.funestus 
The rise of insecticide resistance may jeopardize the efficiency of vector control tools since 
resistance can reduce their efficacy. The hypothesis is that resistant mosquitoes (RR or RS) will 
be more able to survive exposure to insecticide and will have a greater ability to take the blood 
meal. If this happens, we will be able to conclude that insecticide resitance is reducing the 
effectiveness of bed nets. 
We will try to answer the following question: Can metabolic resistance to pyrethroids reduce 
the effectiveness of bed nets by increasing the ability of the mosquitoes to survive and to 
bloodfed when exposed to bed nets? 
 
1.12.2 Specific objectives 
 
The specific aims are: 
1. To determine the bionomics and insecticides resistance profiling of malaria vectors at 
a selected site for experimental hut trials in central Cameroon (Chapter 3). 
 
2. To evaluate using experimental hut, the performance of PBO-based and pyrethroid-
only nets against the malaria vector An. funestus and to investigate how GSTe2 
metabolic mediated resistance is impacting that performance (Chapter 4). 
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3. To evaluate the performance of PBO-based and pyrethroid-only nets against the hybrid 
lab strain Fumoz-Fang and to investigate how duplicated CYP6P9a and CYP6P9b 




































Several experiments were carried out during this thesis. To assess the performance of bed 
nets against free-flying mosquitoes and released mosquitoes, experimental huts were used 
following the WHO guidelines (WHO 2013). WHO susceptibility tests were carried out to 
assess the resistance profile of the local population of mosquitoes. Cone test was carried out 
to control the quality of bed nets using a susceptible lab strain. Cone tests were also used to 
assess the performance of bed nets against resistant mosquitoes in lab conditions. To 
characterize the local population in the site where the experimental station is located, 
TaqMan was used for genotyping of the resistance molecular markers, including Kdr and Ace 
1, and evaluate the Plasmodium infection rate. Standard PCR was used for molecular 
identification of species and to establish the species diversity. PCR-RFLP was carried out to 
genotype the P450 markers, and AS-PCR was used for the GSTe2 marker. 
 
2.1 Experimental hut trial 
 
2.1.1 Study site and Experimental hut design 
 
The experimental hut station is located in Mibellon (6°4′60′′N, 11°30′0′′E), a village in 
Cameroon located in the Adamawa Region; Mayo Banyo Division and Bankim Sub-division. At 
the experimental station, 12 huts built following the World Health Organisation (WHO) 
standard, are available for a wide range of experimental hut trials. An.  funestus s.s. is the main 
malaria vector in the area (Menze et al., 2018b). Mansonia sp, and Culex sp are also present 
in the area. Mosquitoes in the area are highly resistant to pyrethroids and DDT, as described 
in chapter 3. The trial was carried out for 12 weeks during the rainy season from 10th July to 
16th October 2016. 
 
The huts were built following the prototype recommended by WHO for the West African 
region (WHO, 2013d). The hut was constructed on a concrete base of cement surrounded by 
a drain channel to trap ants. The walls were made from concrete bricks and plastered inside 
and outside with a plaster made from a mixture of cement and sand. The roof was made from 
corrugated iron, and the ceiling was made from plywood. The four windows located on three 
sides of the hut were designed to create an angle with a 2 cm gap, which will facilitate the 
entry of mosquitoes flying upward and prevent the mosquitoes from escaping once they have 
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entered the hut. A veranda trap was built at the back of the hut according to WHO protocol 
(WHO, 2013b) (Figure 2.1). A curtain was used as a separation between the veranda and the 
rest of the hut. Before bedtime, each sleeper was required to raise the curtain to allow 
mosquitoes to take refuge in the veranda. In the morning, it was recommended that the 
sleeper lowers the curtain before starting the collection, to allow a separate collection of 
mosquitoes in the veranda and the hut. In this study the experimental hut design was used in 
several occasions. To assess the performance of Olyset, Olyset Plus, PermaNet 2.0 and 
PermaNet 3.0 against Anopheles funestus from Mibellon  and to see how GSTe2 impact that 
performance,the mosquitoes were collected during 12 weeks (72 nights) between July and 
October 2016. The latin square design (Chapter 4; Section 4.2.5) was applied first for six weeks, 
but the number of mosquitoes collected was not enough, so we added another 6 weeks. To 
assess the performance of Olyset, Olyset Plus, PermaNet 2.0 and PermaNet 3.0 against the 
crossing Fumoz-Fang to see how CYP6P9a and b genes affect that performance, 50 to 100 







Figure 2.1: Mibellon experimental station in the republic of Cameroon A) Design of the 
experimental huts used at the experimental station in Mibellon, Cameroon. B) Volunteer 
sleeping in the huts during the study. 
 
2.1.2 Mosquito collection 
 
Mosquitoes were collected every morning, using hemolysis tubes from: (i) inside the nets, (ii) 
in the room: floor, walls and roof, and (iii) in the veranda exit trap. Mosquitoes collected from 
each compartment were kept separately in a bag to avoid any mixing between samples from 
different compartments. (Figure 2.2). Samples were transferred to the laboratory for 
identification. After identification, samples were then classified as dead, alive, blood-fed, or 
unfed (Appendix 1). The ‘alive’ samples were kept in the paper cup and provided with sugar 
solution for 24 hours and mortalities monitored. Samples were then kept adequately in 
labelled Eppendorf tubes with Silicagel for dead and in RNA later for Alive (Figure 2.3). 
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Figure 2.2: Sampling of mosquitoes from the huts: A) Hemolysis tubes used to collect 
mosquitoes in the huts at the Mibellon experimental station in Cameroon. B) Bags used to 
kept samples collected per compartment (V=veranda, C=case, M=mosquito nets). 
 
Figure 2.3: Sample storage after collection: Mosquitoes are kept in labeled Eppendorf tube 
and transferred at -20 ͦC for further analysis. 
 
2.1.3 Bed nets performance assessment 
 
The performance of the bed nets was expressed relative to control (untreated nets) (Appendix 
1) in term of: 
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i-Deterrence/entry rate: the reduction in hut entry relative to control. Deterrence (%) 
= 100 x (Du – Dt) / Du, where Du is the total number of mosquitoes found in the untreated hut 
(control), and Dt is the total number of mosquitoes in the treated hut. 
ii-Entry rate (%) = 100 x (Ht/Hn) where Ht is the total number of mosquitoes found in 
the hut, and Hn is the total number of mosquitoes collected in all the six huts. 
iii-Exophily: the proportion of mosquitoes found exited in the veranda trap. 
Exophily (%) = 100 x (Ev/Et) where Ev is the total number of mosquitoes found in veranda, and 
Et is the total number of both inside the hut and veranda. 
iv-Blood feeding rate (BFR). This rate was calculated as follows: Blood feeding rate = 
(N mosquitoes fed) x 100 / total N mosquitoes. Where “N mosquitoes fed” was the number of 
mosquitoes fed, and “total N mosquitoes” was the total number of mosquitoes collected. 
v-Blood-feeding inhibition (BFI): the reduction in blood-feeding in comparison with 
the control hut. Blood feeding inhibition is an indicator of personal protection (PP). More 
precisely, the personal protection effect of each bed net is the reduction of blood-feeding 
percentage induced by the net when compared to control. The protective effect of each bed 
net can be calculated as follows: Personal protection (%) = 100 x (Bu – Bt) / Bu, where Bu is the 
total number of blood-fed mosquitoes in the huts with untreated nets and Bt is the total 
number of blood-fed mosquitoes in the huts with treated nets (WHO, 2013b). 
vi-Immediate and delayed mortality: the proportion of mosquitoes entering the hut 
that is found dead in the morning (immediate death) or after being caught alive and held for 
24 h with access to sugar solution (delay mortality) (WHO, 2013b). In this study, we focused 
on the overall mortality calculated as follows: Mortality (%) = 100 x (Mt/MT) where Mt is the 
total number of mosquitoes found dead in the hut and MT is the total number of mosquitoes 
collected in the hut. 
 
2.2 Susceptibility tests 
 
To carry out the susceptibility test, blood-fed Anopheles mosquitoes were collected every 
morning between 06:00 and 11:00 in the households from Mibellon. Mosquitoes were 
obtained using this method since An. funestus, which is the principal vector in the area, has 
breeding site difficult to access. The household owners gave verbal consent before starting 
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mosquito collection. Mosquitoes were collected in January 2017 using the Prokopack 
electrical aspirator (John W Hook, Gainesville, FL, USA) and kept in netted paper cups that 
were stored in a cool box. Samples were later transported to the insectary of the LSTM 
Research Unit at OCEAC in Yaoundé (Cameroon) with standard insectary condition 
(temperature was 25%±2, and the humidity 80%±10). As previously described, the field-
caught females were morphologically identified according to morphological keys (Gillies and 
Coetzee, 1987). Mosquitoes were then kept 4 to 5 days until they became fully gravid and 
induced to lay eggs using the forced eggs-laying method (Morgan et al., 2010). Eggs obtained 
from individual mosquitoes were pooled in cups for hatching and then transferred in trays 
where Tetramin® baby fish food was used for feeding. (Cuamba et al., 2010; Morgan et al., 
2010). The F1 obtained were tested in WHO tube to assess their susceptibility against 
deltamethrin 0.05% and permethrin 0.75%.  (Figure 2.4). For each test, four replicates of 25 
mosquitoes were used. Knockdown was recorded after 1 hour and mortality after 24h 
following WHO guidelines (WHO, 2016). Mortality between 98–100% indicates the 
susceptibility of the mosquitoes. Mortality of less than 98% suggests suspected resistance 
whereas mortality of less than 90%, means the resistance of mosquitoes The test was 
validated if the mosquito mortality in control was less than 5%. But with a mortality more than 
20%, the test was invalid and had to be repeated. On the other hand, if the mortality was 
between 5 and 20%, the overall mortality of the exposed mosquitoes is corrected by applying 









Figure 2.4: Mosquitoes collections and bioassays. A) Blood fed indoor resting mosquitoes 
were collected using an electrical aspirator in Cameroon during this study B) Susceptibility test 
following WHO protocol using F1 samples performed in the insectary at the LSTM Research 
Unit, CRID in Cameroon. 
 
2.3 Cone assays 
 
Cone assays were carried out on several bed nets to assess their performance in lab 
conditions. These tests were carried out using fragments of LLINs (30 cm × 30 cm). Ten unfed 
2-5 day-old females mosquitoes were introduced into each cone placed on the LLIN for 3 min. 
After exposure, the mosquitoes were removed from the cones using a mouth aspirator and 
then transferred into paper cups and provided a 10% sugar solution. Mosquito knock-down 
was recorded after 60 min. A negative control (untreated net) was included in each series of 
cone tests. Mortality post-exposure was recorded after 24 h of observation. The temperature 
was around 25  ̊C ± 2 ̊ C and humidity 80% ± 10 % during the assays (Figure 2.5). 
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Figure 2.5: Cone bioassay of long-lasting insecticidal mosquito nets performed in the insectary 
of the LSTM research Unit in Cameroon during this study. 
 
2.4 Molecular characterization in terms of species diversity and molecular 
base of the resistance 
 
Beside field and insectary work, a range of molecular analysis was conducted in the 











Figure 2.6: Performing molecular assays at the LSTM Research Unit in Cameroon during this 
study. 
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2.4.1 PCR species identification for An.s funestus group. 
 
For the species identification by cocktail PCR, the mixture was made of one (1) μl DNA (see 
DNA extraction protocol in appendix 2), in a total volume of 25 μl. 0.85 μl (10μM) of the 
universal primer forward and reverse were used. Six other primers (Table 2.1) for the most 
common member of An. funestus group was also used. The DNA was amplified using a 
thermocycler (Gene Amp PCR System 2700, Singapore). The PCR machine was set according 
to the following condition: 94⁰C-2min (denaturation), 35 cycles of 94⁰C -30 seconds 
(denaturation), 45⁰C 30 seconds (annealing), 72⁰C -40 seconds (extension), and a final 
extension at 72⁰C -5 (Appendix 3). A mixture of 2 μl of loading buffer and three μl of PCR 
product was run on a 1.5% gel containing 5ul of Ethidium bromide. The gel was run at 120 
volts for 45 min in 1xTAE buffer(Figure 2.7) and the bands visualized using the Trans-
illuminator G box (SynGene) connected to a PC with the software gene snap (SynGene, UK). 
(Koekemoer et al., 2002). 
 
Table 2.1: Species-specific primer sequences and temperatures included in the PCR species 











Figure 2.7: PCR species identification performed using some samples from Mfou (locality in 
the centre of Cameroon). Lane 1 and 14 DNA marker, lane 3-positive control, lane 2-negative 
control, and lane 4 to 13 An. funestus s.s. 
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2.4.2 TaqMan for Plasmodium infection rate evaluation 
 
Collected An. funestus females were dissected in two parts: the head and thorax together and 
the abdomen separately. Genomic DNA was extracted separately from the head/thorax and 
abdomen and the oocyst and the sporozoite rate evaluated using the TaqMan assay (Bass et 
al., 2008) on MX 3005 machine (Agilent, Santa Clara, CA, USA). For An. gambiae, due to the 
low number of samples, the whole mosquito was used, and only the overall Plasmodium 
infection rate estimated. One µl of DNA sample was used as a template in a 3-step PCR 
program with denaturation at 95̊C for 10 min followed by 40 cycles of 15 sec at 95̊C and 1 min 
at 60C̊. The primers (Falcip+: TCT-GAA-TAC-GAA-TGT-C, OVM+: CTG-AAT-ACA-AAT-GCC, Plas-
F: GCT-TAG-TTA-CGA-TTA-ATA-GGA-GTA-GCT-TG, Plas r: GAA-AAT-CTA-AGA-ATT-TCA-CCT-
CTG-ACA) were used together with two probes labeled with fluorophores: FAM to detect 
Plasmodium falciparum, and HEX to identify Plasmodium ovale, Plasmodium vivax and 
Plasmodium malariae. Plasmodium falciparum samples and a mix of Plasmodium ovale, 
Plasmodium vivax and Plasmodium malariae were used as positive controls (Figure 2.8). 
 
 
Figure 2.8: Taqman results (scatter plot) showing the distribution of P. falciparum and P. OVM. 
Two probes labelled with fluorophores: FAM to detect Plasmodium falciparum, and HEX to 
detect Plasmodium ovale, Plasmodium vivax and Plasmodium malariae. 
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2.4.3 TaqMan for L1014F, L1014S kdr and A296S-RDL genotyping 
 
TaqMan genotyping assays were performed in 10 μl volume containing 1× Sensimix (Bioline), 
80× primer/probe mix, and one μl template DNA. Probes were labeled with two specific 
fluorophores FAM and HEX, FAM, to detect the resistant allele and HEX to detect the 
susceptible allele. The assay was performed on an Agilent MX3005 real-time PCR machine with 
cycling conditions of 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 
min as described previously (Bass et al., 2007; Djouaka et al., 2016b) (Figure 2.8 and 2.9). 
 
Figure 2.9: Genotyping Taqman results (scatter plot) showing the three genotypes detected. 




Figure 2.10: Genotyping Taqman results (scatter plot) showing the three genotypes detected. 
Image describing the 3 genotypes of the Kdr West L1014F mutation. 
 
2.4.3 Genotyping of the L119F-GSTe2 marker using the allele-specific PCR 
  
Samples classified as dead, alive, blood-fed, unfed, room, and veranda were used for DNA 
extraction using the Livak protocol (Appendix 1) (Livak, 1984). The L119F-GSTe2 mutation was 
genotyped to assess how the glutathione S-transferase gene, GSTe2, impacts the performance 
of the bed nets. An allele-specific PCR (Tchouakui et al., 2019d; Tchouakui et al., 2018) was 
used to detect the three genotypes of the L119F-GSTe2 mutation (RR, RS, and SS). The PCR 
was carried out using 10 mM of each primer and 1 µL of gDNA as the template in 15 µL reaction 
containing 10X Kapa Taq buffer A, 0.2 mM dNTPs, 1.5 mM MgCl2, 1 U Kapa Taq (Kapa 
Biosystems, Wilmington, MA, USA). Amplification was carried out using thermocycler 
parameters:  95ᵒ C for 5 min; 30 cycles of 94ᵒ C for 30 sec, 58ᵒ C for 30 sec, 72ᵒ C for 45 sec, 
final extension at 72ᵒ C for 10min. The following primers were used: L119F-Fwd: ATG ACC AAG 
CTA GTT CTG TAC ACG CT; L119F-Rev: TTC CTC CTT TTT ACG ATT TCG AAC T; L119F-Res1: CGG 
GAA TGT CCG ATT TTC CGT AGA AtAA; L119-F-Sus1: CAT TTC TTA TTC TCA TTT ACA GGA GCG 
TAaTC. PCR products were separated on 2% agarose gel by electrophoresis. The bands 
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corresponding to different genotypes were interpreted as described by (Tchouakui et al., 
















Figure 2.11: Agarose gel describing the genotyping of L119F-GSTe2 mutation. A) Gel showing 
the amplification of GSTe2 gene in An. funestus s.s. B) AS-PCR is showing the L119F gste2 
mutation in An. funestus s.s. 849 bp (Resistant), 523 bp (susceptible), 523 bp, and 312 bp 
(heterozygote). 
 
2.4.4 Genotyping of the CYP6P9a-R maker using PCR-RFLP 
 
The PCR was carried out using 10 mM of each primer and 1 µL of gDNA as the template in 15 
µL reaction containing 10X Kapa Taq buffer A, 25 mM dNTPs, 25 mM MgCl2, 1 U Kapa Taq 
(Kapa Biosystems, Boston, MA, USA). Amplification was carried out using thermocycler 
parameters: 95ᵒ C for 5 min; 35 cycles of 94ᵒ C for 30 sec, 58ᵒ C for 30 sec, 72ᵒ C for 45 sec, 
and a final extension at 72ᵒ C for 10min. The following primers were used: RFLP6P9aF forward 
primer 5’-TCCCGAAATACAGCCTTTCAG-3; RFLP6P9aR reverse primer 5’-
ATTGGTGCCATCGCTAGAAG-3’. Three μL of the PCR product were migrated on 1.5% agarose 
gel. The expected PCR product is 450bp. The digestion with Taq 1α followed all this. (Taq 1α 
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0.2 μL, PCR product 5 μL, 10x NEBuffer 1 μL, distilled water 3.8 μL, total reaction volume). This 
mix was incubated at 65°C for 2 hours. Three μL of the digestion product was migrated on 2% 
gel. Amplicons from resistant mosquitoes were cut into two bands with sizes of 350bp and 
100 bp, and the susceptible remains undigested with the band at 450bp (Figure 2.12). 
Figure 2.12: Agarose gel showing the results of the PCR-RFLP for CYP6P9a genotyping: 
Amplicons from resistant mosquitoes are cut into two bands with sizes of 350bp and 100 bp 
and the susceptible remains undigested with the band at 450bp. 
 
2.4.5 Genotyping of the CYP6P9b-R maker using PCR-RFLP 
 
The PCR was carried out using 10 mM of each primer and 1 µL of gDNA as template in 15 µL 
reaction containing 10X Kapa Taq buffer A, 25 mM dNTPs, 25 mM MgCl2, 1 U Kapa Taq (Kapa 
Biosystems, Boston, MA, USA). Amplification was carried out using thermocycler parameters:  
95ᵒ C for 5 min; 35 cycles of 94ᵒ C for 30 sec, 58ᵒ C for 30 sec, 72ᵒ C for 45 sec, and a final 
extension at 72ᵒ C for 10min. The following primers were used: 6p9brflp_0.5F 5’-
CCCCCACAGGTGGTAACTATCTGAA-3’; 6p9brflp_0.5R 5’-TTATCCGTAACTCAATAGCGATG-3’. 
Three μL of the PCR product were migrated on 1.5% agarose gel. The expected PCR product is 
550bp. The digestion with the Tsp451 restriction enzyme followed all this. (Tsp4510.2 μL, PCR 
product 5 μL, 10x NEBuffer 1 μL, distilled water 3.8 μL, total reaction volume). This mix was 
incubated at 65°C for 2 hours. Three μL of the digestion product was migrated on 2% gel. 
Amplicons from susceptible mosquitoes were cut into two bands with sizes 400bp and 150 bp, 
and the resistant mosquito remains undigested with the band at 550bp (Figure 2.13). 
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Figure 2.13: Agarose gel showing the results of the PCR-RFLP for CYP6P9b genotyping 
Susceptibles cut in two bands with sizes 400bp and 150 bp and the resistant remains 
undigested with the band at 550bp. 
 
2.4.6 Data analysis 
 
Experimental hut trial: To calculate the proportion of each entomological outcomes and the 
level of significance between the treatments and between the control for each entomological 
outcomes, the XLSTAT software (Addinsoft, Berkeley, CA, USA) was used. To conteract the 
problem of multiple comparison, the bonferroni correction was applied using an alpha of 0.01 
as the cut off for significance. The numbers of mosquitoes collected in the huts with different 
treatments were analyzed by negative binomial regression. The effects of the treatments on 
each of the main proportional entomological outcomes (exophily, blood-feeding, and 
mortality) were assessed using binomial generalized linear mixed models (GLMMs) with a logit 
link function, fitted using the ‘lme4’ package for R 3.6. (R Development Core Team, 2019) 
(Ngufor et al., 2016a; Toe et al., 2018a). A separate model was fitted for each outcome and 
each mosquito species. In addition to the fixed effect of each treatment, each model included 
random effects to account for the following sources of variation: between the huts used in the 
studies; between the sleepers who slept in the huts; between the ten weeks of the trial 
(Appendix 4). 
 
Test of association between the genes (GSTe2 and CYP6P9a/b) and the entomological 
outcomes: To investigate the association between the genes and the ability of the mosquitoes 
to survive, blood feed or escape, Vassar stats were used to estimate the Odds ratio based on 
a fisher exact probability test with a 2x2 contingency table. 
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Hut effect analysis: The one-way analysis of variance (ANOVA) using Prism 7.0 (GraphPad, San 
Diego, CA, USA) was used to determine whether there were any statistically significant 
differences between the means of the mosquitoes collected from the six huts (Appendix 5). 
For all the analyses in this study, an alpha of 0.05 was used as the cut off for significance. 
 
Construction of graph: Most of the graphs in this documents was constructed using the 

















Chapter 3: Bionomics and insecticides resistance profiling of malaria 
vectors at a selected site for experimental hut trials in central 
Cameroon  
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3.1 Context of the study 
 
Despite the recent progress made in reducing the malaria burden in sub-Sahara Africa through 
the deployment of insecticide-based interventions such as long-lasting insecticidal nets (LLINs) 
and indoor residual spraying (IRS), malaria remains an important health issue (Bhatt et al., 
2015). Malaria control in Cameroon has recently witnessed a significant scale-up of vector 
control interventions through the distribution of LLINs, pushing up the bed net coverage to 
70.9% of the population (MICs, 2014; PNLP, 2016, 2018). However, the effectiveness of these 
insecticide-based control tools is threatened by the emergence of insecticide resistance in 
major malaria vectors across African countries, including Cameroon (Menze et al., 2016; WHO, 
2012a, b; WHO/GPIRM, 2012). It is imperative to design and implement suitable resistance 
management strategies to preserve the efficacy of existing tools. The characterisation of 
malaria vectors will maximize the impact of control intervention. The elucidation of resistance 
profiles and mechanisms underlying this resistance will improve resistance management for a 
better choice of control tools. The lack of such information has prevented evidence-based 
implementation of control intervention limiting the outcome of control. 
Furthermore, the characterization of the impact of resistance on the effectiveness of control 
tools is also a key knowledge to guide control programs. Such an assessment of resistance 
impact needs approaches such as experimental hut trials. Use of experimental huts since it 
provides an opportunity to measure entomological outcomes, such as relative mortality and 
feeding success of resistant and susceptible vectors in controlled conditions is one of the best 
approaches to assess the impact of resistance on the efficacy of control intervention (Churcher 
et al., 2016b; N'Guessan et al., 2007b; Ngufor et al., 2017a). 
 This chapter presents a full characterization of the main malaria vectors in the area selected 
for experimental hut trial, including their species diversity, susceptibility profiles. It 
investigates the molecular basis of the resistance to insecticides and 
their Plasmodium infection rate. Characterization of the vectors present in the area will help 
to improve the design of vector control interventions, to better understand the resistance 
threats and then help assess the extent to which resistance even impacts the outcome of 





3.2.1 Study sites 
 
Adult Anopheles mosquitoes were collected from Mibellon (6°46′N, 11°70′E), a village in 
Cameroon located in the Adamawa region, Mayo Banyo Division and Bankim Sub-division. The 
Adamawa region is in the mountainous area forming a transition between Cameroon’s 
forested south and savanna north. Mibellon is located in close proximity to permanent water 
bodies, including a lake and swamps, which provide suitable breeding sites for mosquitoes. 
Human activities are mainly fishing, hunting, and subsistence farming, including maize, 
watermelon, and coffee plantations. A survey in the area revealed a high usage of insecticides 
in the coffee and watermelon farms. These insecticides are mainly pyrethroids, 
neonicotinoids, and carbamates (Menze et al., 2018b).  
 
3.2.2 Mosquito collection and rearing 
 
The blood-fed Anopheles mosquitoes were collected every morning between 06:00 and 11:00 
in the houses. Mosquitoes were collected using this method since An. funestus which is the 
major vector in the area, has breeding sites difficult to access. Mosquitoes were collected and 
reared, as describes in Chapter 2. 
 
3.2.3 Species identification 
 
The field-caught females were morphologically identified according to morphological keys as 
previously described (Gillies and Coetzee, 1987). After genomic DNA extraction using the Livak 
method (Livak, 1984), PCR species identification was performed as described (Koekemoer et 
al., 2002) to identify Anopheles funestus group members as described in chapter 2, whereas 
the SINE PCR (Santolamazza et al., 2008) was used to differentiate members of the 




3.2.4 Plasmodium falciparum infection rate 
 
Sixty collected An. funestus females were dissected in two parts: the head and thorax together 
and the abdomen separately. Genomic DNA was extracted separately from the head/thorax 
and abdomen and the oocyst and the sporozoite rate evaluated using the TaqMan assay (Bass 
et al., 2008) in MX 3005 (Agilent, Santa Clara, CA, USA). For An. gambiae, due to the low 
number of mosquitoes, the whole mosquito was used, and only the overall Plasmodium 
infection rate estimated as described in method chapter 2. 
 
3.2.5 Insecticide susceptibility assays 
 
Following WHO protocol (WHO, 2016), F1 An. funestus sensu stricto (s.s.) and Anopheles 
gambiae s.s. mosquitoes aged between 2 and 5 days were exposed to different classes of 
insecticides. These included the Type I (permethrin; 0.75%) and type II (deltamethrin; 0.05%) 
pyrethroids and the pseudo-pyrethroids, etofenprox (0.05%), the organochlorine DDT (4%), 
the organophosphate malathion (5%) and the carbamates: bendiocarb (0.1%) and propoxur 
(0.1%). For each test, mosquitoes exposed to untreated papers were used as control. The 
assay was carried out at temperatures of 25 ̊ C ± 2 ̊ C and 80% ± 10% relative humidity, as 
described in chapter 2. 
 
3.2.5.1 PBO synergist assays 
 
Piperonyl butoxide function as an inhibitor of P450s. To investigate the possible involvement 
of cytochrome P450s in the observed resistance, female An. funestus s.s. were pre-exposed to 
4% PBO for 1 hr and immediately exposed to DDT (4%), permethrin (0.75%) and deltamethrin 
(0.05%) for 60 min. The mortality was assessed after 24 hrs and compared with mortality 
obtained for mosquitoes not pre-exposed to PBO.  
 
3.2.5.2  Cone assays  
 
To assess the efficacy of common insecticide-treated nets, cone assays were performed using 
five types of LLINs (Olyset Plus, Olyset Net, Yorkool, PermaNet 2.0, and PermaNet 3.0 (side). 
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These tests were carried out using pieces of LLINs (30 cm × 30 cm). These nets were selected 
based on the fact we wanted to test pyrethroid-only and also PBO-based nets. Before being 
involved in the study, the quality of bednets was assessed by exposing them to a susceptible 
lab strain. Five replicates of ten unfed mosquitoes (An. funestus s.s. and An. gambiae s.s.) 
females aged 2 to 5 days were introduced into each cone placed on the LLIN for 3 min (WHO, 
2013a). After exposure, the mosquitoes were removed from the cones using a mouth 
aspirator and then transferred into paper cups and fed with 10% sugar solution. Numbers of 
mosquitoes knocked-down were recorded after 60 min. A negative control (untreated net) 
was included in each of the LLIN cone tests. Post-exposure mortality was recorded after 24 hr 
of observation. The assay was carried out at a temperature of 25oC ± 2oC and 80% ± 10% 
relative humidity. 
 
3.2.6 Genotyping of L119F-GSTe2: metabolic resistance marker in An. funestus s.s. 
 
The L119F-GSTe2 mutation was genotyped to assess the role played by the glutathione S-
transferase gene in the DDT and pyrethroid resistance observed in Mibellon as described 
previously (Riveron et al., 2014a). An allele-specific PCR (Tchouakui et al., 2019b) was used to 
detect the 3 genotypes of the L119F-GSTe2 mutation. See details in chapter 2.  
 
3.2.7 Genotyping of A296S-RDL in An. funestus s.s. 
 
TaqMan genotyping assays were performed in 10 μl volume containing 1× Sensimix (Bioline), 
80× primer/probe mix and 1 μl genomic DNA. The probes were labeled with two distinct 
fluorophores FAM and HEX, FAM to detect the resistant allele and HEX to detect the 
susceptible allele. The assay was performed on an Agilent MX3005 real-time PCR machine with 
cycling conditions of 95°C for 10 min, followed by 40 cycles at 95°C for 15 sec and 60°C for 1 
min as described previously (Djouaka et al., 2016a). See more details in chapter 2. 
 
3.2.8 L1014F and L1014S kdr genotyping in An. gambiae 
 
The L1014F-kdr mutation and the L1014S-kdr responsible for DDT and pyrethroid resistance 
in An. gambiae s.l. were genotyped in Mibellon mosquitoes. The reaction mixture of 10 μl final 
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volume containing 1× Sensimix (Bioline), 80× primer/probe mix and 1 μl template DNA was 
used for this assay. The probes were labeled with two distinct fluorophores: FAM to detect 
the resistant allele and HEX to detect the susceptible allele. The test was performed on an 
Agilent MX3005 real-time PCR machine with cycling conditions of 95°C for 10 min, followed 
by 40 cycles at 95°C for 15 sec and 60°C for 1 min as previously described (Bass et al., 2007). 
 
3.2.9 G119S ace-1 genotyping in An. gambiae  
 
The G119S ace-1 is responsible for organophosphate and carbamate resistance in An. gambiae 
s.l. was genotyped in Mibellon mosquitoes. Ten μl volume containing 1× Sensimix (Bioline), 
80× primer/probe mix, and one μl template DNA. Probes were labeled with two specific 
fluorophores FAM and HEX, FAM to detect the resistant allele, HEX to detect the susceptible 
allele. The assay was performed on an Agilent MX3005 real-time PCR machine with cycling 
conditions of 95°C for 10 min, followed by 40 cycles at 95°C for 15 sec and 60°C for 1 min (Bass 




3.3.1 Field collection 
 
A total of 722 adult female Anopheles mosquitoes were collected indoor at Mibellon, out of 
which 584 (80.1%) were morphologically identified as Anopheles funestus group, and the 
remaining 138 (19.9%) identified to be Anopheles gambiae complex.  
 
3.3.2 Species diversity among An. funestus group and An. gambiae complex 
 
Out of the 120 An. funestus s.l. mosquitoes randomly selected and tested, An. funestus s.s. 
was found to be the only member of the group present at Mibellon. For An.gambiae s.l., out 
of 89 samples analyzed all of them were found to be An. gambiae s.s. (formerly S form).  
 
3.3.3 Insecticide susceptibility bioassays with samples from Mibellon 
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Susceptibility profile of An. funestus s.s. A total of 2,700 F1 mosquitoes were tested to assess 
the resistance profile to seven insecticides (Figure. 3.1). An. funestus s.s. (females and males) 
were resistant to type I and type II pyrethroids. For permethrin (Type I), mortality was 48.88 
± 5.76% for females and 90.72 ± 3.77% for males. For deltamethrin (Type II), mortality was 
38.34 ± 5.79% for females and 53.96 ± 11.37% for males. However, mortality was higher for 
the pseudo-pyrethroid etofenprox, with a mortality rate of 82.9 ± 8.7% for females and 97.83 
± 2.17% for males (Figure 3.1A). For the organochlorine DDT, resistance was observed with a 
mortality rate of 55.28 ± 8.28% for females and 83.78 ± 3.13% for males (Figure 3.1A). For the 
carbamates, a possible resistance was observed against bendiocarb with 90.67 ± 4.3% 
mortality for females and 95.06 ± 1.97% for males (Figure 3.1A) whereas a near full 
susceptibility was observed for propoxur with 98.41 ± 1.59% mortality for females and 100% 
mortality for males (Figure 3.1A). Full susceptibility was observed for the organophosphate 
malathion with 100% mortality for both sexes (Figure 3.1A). 
 
PBO synergist assays with Anopheles funestus s.s. Pre-exposure of Anopheles funestus s.s. to 
PBO led to the recovery of the susceptibility to both pyrethroids type I and II with increased 
mortality observed after PBO exposure from 48.88 ± 5.76% to 98.81 ± 3.77% for permethrin 
and from 38.34 ± 5.79% to 96.54 ± 1.16% mortality for deltamethrin (Figure  3.1B). Partial 
recovery was observed for DDT with increased susceptibility from 55.28 ± 8.28% to 84.16 ± 






Figure 3.1: Susceptibility profile of An. funestus to insecticides 
A) Recorded mortalities following 60-min exposure of An. funestus s.s. from Mibellon to 
different insecticides. Data are shown as mean ± SEM. B) Activities of PBO combined to 
permethrin, deltamethrin, and DDT on An. funestus s.s. from Mibellon. Data are shown as 
mean ± SEM. 
 
Susceptibility profile of An. gambiae s.s. A total of 971 An. gambiae s.s. were tested to assess 
the resistance profile to seven insecticides. The An. gambiae s.s. population was highly 
resistant to type I and type II pyrethroids (Figure 4.2). For permethrin, mortality was 0 ± 0% 
for females and 4.44 ± 2.42% for males (Figure 3.2). A very high level of resistance was also 
observed with deltamethrin with no mortality for females and 1.52 ± 1.52% for males (Figure 
3.2). Resistance was also observed for the pseudo-pyrethroid etofenprox with a mortality rate 
of 9.92 ± 7.66% for females and 13.46 ± 3.93% for males (Figure 3.2). A high level of resistance 
to the organochlorine DDT was observed with a mortality rate of 1.39 ± 1.39% for females and 
1.85 ± 1.85% for males (Figure 3.2). For the carbamate bendiocarb, mortality rates of 66.23 ± 
2.6% for females and 59.2 ± 3.73% for males were recorded. However, full susceptibility was 
observed for propoxur (Figure 3.2). For the organophosphate malathion, a near-full 
susceptibility was found with a mortality rate of 98.25 ± 1.75% for females and 98.48 ± 1.52% 
for males (Figure 3.2). 
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Figure 3.2: Susceptibility profile of Anopheles gambiae to insecticides. Recorded mortalities 
following 60-min exposure of Anopheles gambiae s.s. Mibellon to different families of 
insecticide. Data are shown as mean ± SEM. 
 
3.3.4 Assessment of bed net efficacy with cone assays for An. funestus 
 
Test of the efficacy of pyrethroid-only and PBO based-nets was performed with cone assays 
in Anopheles funestus s.s showing very low mortality rates recorded against most of the nets 
tested. The mortality rates were 2.78 ± 2.78%, and 2.5 ± 2.5%, for Olyset Net and Olyset Plus, 
respectively; 0 ± 0% and 48.33 ± 6.49% for PermaNet 2.0 and PermaNet 3.0 side, respectively; 





Figure 3.3: Cone assays with various nets for An. funestus and An. gambiae 
(A) Recorded mortalities following 3-min exposure by cone assay of An. funestus s.s. (B) An. 
gambiae s.s. from Mibellon to Olyset, Olyset Plus, Yorkool, PermaNet 2.0, and PermaNet 3.0 
(side). Data are shown as mean ± SEM. 
 
3.3.5 Assessment of bed net efficacy with cone assays in An. gambiae s.s 
 
Similarly, Anopheles gambiae s.s showed low mortality rates with the bed nets tested. The 
mortality rates were 3.13 ± 3.13% and 4.55 ± 4.55% for Olyset Net and Olyset Plus, 
respectively; 4.77 ± 2.76% and 19.09 ± 6.22% for PermaNet 2.0 and PermaNet 3.0 side, 
respectively; and, 0 ± 0% mortality for Yorkool (Figure 3.3B). 
 
3.3.6 Molecular basis of the insecticide resistance in An. funestus s.s. population 
 
L119F-GSTe2 detection in An. funestus s.s. From 110 F0 females collected from the field, 7 
were homozygous resistant (RR) (6.3%), 48 were heterozygous (RS) (43.2%), and 55 were 
homozygous susceptible (SS) (49.5 %). Overall, the frequency of the 119F resistant allele was 
28 and 72% for the L119 susceptible allele (Figure 3.4). The Hardy-Weinberg equilibrium has 
been checked for the GSTe2. It has been found that the population was not in Hardy-Weinberg 
equilibrium (x2 = 0.75; ddl=2; α=0.1). This population is under a pressure that has disrupted 
the equilibrium of the population in favour of the homozygote resistant mosquitoes. 
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296S-RDL detection in An. funestus s.s. Out of the 92 samples genotyped, 3 were RR (3.2%), 
12 were RS (13.1%), and 75 were SS (83.7%) with the frequency of resistant allele of only 9.7% 
and susceptible allele of 90.3% (Figure 3.4). The Hardy-Weinberg equilibrium has been 
checked for the RDL. It has been found that the population is in Hardy-Weinberg equilibrium 




Figure 3.4: Genotypic frequencies of RDL and GSTe2 mutation in Anopheles funestus 
population in Mibellon. 
 
3.3.7 Molecular basis of insecticide resistance in An gambiae s.s. 
 
L1014F/L1014S kdr detection in Anopheles gambiae s.s. Out of 72 samples genotyped, 22 
were RR (30.5%) 48 were RS (66.6%), and 2 were SS (2.7%) with a frequency of the resistant 
allele 1014F of 63.9% and the susceptible L1014 allele of 36.1%. Out of the 76 samples 
genotyped for the L1014S marker, 3 were RS (3.9%), and 73 were SS (96.1%). Thus a very low 
frequency of 1.97% was recorded for the resistance allele (Figure 3.5). For the L1014F, the 
Hardy-Weinberg equilibrium has been checked for the RDL. It has been found that the 
population is in Hardy-Weinberg equilibrium (x2 = 7.28; ddl=2; α=0.005. For the L1014S, it was 
not not possible to calculate the Hardy-Weinberg equilibrium since the number RR individual 
in the population was equal to zero. 
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G119S ace-1 detection in Anopheles gambiae s.s. Out of 50 samples genotyped, neither RR 
nor RS were detected as all the samples were found to be SS (Figure 3.5). For the G119S ace-
1, it was not not possible to calculate the Hardy-Weinberg equilibrium since the number of RR 
and RS individual in the population was zero. 
 
Figure 3.5: Genotypic frequencies of Kdr- L1014F, L1014S, and G119S ace-1 mutation in 
Anopheles gambiae population in Mibellon. 
3.3.8 Plasmodium infection rate in the An. funestus s.s. population in Mibellon 
 
A total of 60 An. funestus from Mibellon were tested for Plasmodium infection using TaqMan 
from the head-thorax and the abdomen separately. The analysis of the head and thorax 
revealed 3 (5%) mosquitoes infected, which included 2 (3.3%) Plasmodium falciparum and 1 
(1.7%) infection which is either Plasmodium ovale, Plasmodium vivax or Plasmodium malariae. 
However, 8 (15%) mosquitoes were detected infected when the abdomen was examined, 
including 5 (8.3 %) Plasmodium falciparum, 3 (5%) infections which are either Plasmodium 
ovale, Plasmodium vivax or Plasmodium malariae and 1 (1.7%) mixed infections (Figure. 3.6). 
92 
 
Figure 3.6: Plasmodium infection rate in malaria vectors from Mibellon in 2017 (A) 
Plasmodium infection rate in An. funestus s.s. with head and thorax. (B) Plasmodium infection 
rate in An. funestus s.s. with abdomen only. (C) Plasmodium infection rate in An. gambiae s.s. 
for whole mosquitoes. 
 
3.3.9 Plasmodium infection rate in the An.s gambiae s.s. population in Mibellon 
 
A total of 60 An. gambiae were tested for Plasmodium infection from the whole body. The 
analysis revealed 12 (20%) mosquitoes infected, which included 11 (18.3 %) P. falciparum and 




Characterization of malaria vector populations is a prerequisite for the implementation of 
successful vector control interventions and for assessing the impact of insecticides resistance. 
This study comprehensively characterized the main malaria vectors in Mibellon, a location in 
Cameroon chosen for the implementation of experimental huts to assess the efficacy of 
insecticide-based interventions.  
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3.4.1 Species composition 
 
Out of the nine species of An. funestus group described, only Anopheles funestus s.s. was 
detected in Mibellon. This result is similar to the one observed in the northern part of 
Cameroon, in Gounougou, where Anopheles funestus s.s. was 99.5% of the total collection and 
Anopheles leesoni was 0.5% (Menze et al., 2016). The predominance of Anopheles funestus 
s.s. in the Anopheles funestus group is also mentioned in West Africa, as observed at Kpome 
in Benin (Djouaka et al., 2016a). The focus on indoor blood-fed mosquito collection in this 
study may have prevented from collecting the outdoor resting members of the group. 
Nevertheless, this is in contrast with the distribution of members of this group observed in 
eastern and southern parts of Africa where several members are collected indoors. For 
instance, in Uganda An. parensis was found predominantly indoor (Mulamba et al., 2014a; 
Mulamba et al., 2014b). Similarly, many other species of the An. funestus group has been 
collected indoors in southern Africa, including An. parensis, An. leesoni and An. rivulorum 
(Hargreaves et al., 2000; Riveron et al., 2015; Vezenegho et al., 2013). For the An. gambiae 
complex, An. gambiae s.s. previously known as S form was the only species found. This result 
is similar to previous observations showing that Anopheles gambiae s.s. was the main species 
in localities south of the Adamawa mountains, characterized by humid savannah and forested 
areas (Simard et al., 2009; Wondji et al., 2005a). 
 
 
3.4.2 The multiple insecticide resistance in both major vectors is a challenge for vector 
control 
 
The multiple resistance pattern observed in this An. funestus population is similar to the 
pattern observed in the northern part of the country, with the exception of bendiocarb 
resistance, which was higher in the north (Menze et al., 2016). This result suggests that 
resistance in Anopheles funestus is widespread in Cameroon and could be a concern for 
effective insecticide-based control tools against this vector. An. funestus is highly resistant to 
both types I and II pyrethroids. The resistance observed in Mibellon seems higher than in 
Gounougou (2012). This difference could be due to the length of time between the two studies 
as resistance could have increased since 2012, when the study at Gounougou was carried out. 
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It could also be evidence that the pyrethroid resistance level in An. funestus in Cameroon is 
rising. This increase could be due to the massive distribution of LLINs implemented by the 
Cameroonian Government in the past five years. Mibellon is also located in an area where 
agriculture is the main activity, and agricultural use of pesticides could be another factor that 
is driving the increase in resistance level. A similar level of increase of pyrethroid resistance 
was observed in southern Malawi (Riveron et al., 2015) and also reported in Uganda for 
Anopheles funestus (Mulamba et al., 2014b). The high recovery of susceptibility observed after 
PBO exposure for deltamethrin, permethrin, and DDT suggests that cytochrome P450 genes 
are playing a significant role in these resistance patterns. Altogether, this resistance to 
pyrethroids should be of great concern for malaria control programs in Cameroon. If no strong 
action is taken to manage it, there is a risk that the massive distribution of pyrethroid-
impregnated LLINs taking place in Cameroon could be jeopardized. The possible resistance 
observed to the carbamate bendiocarb in Anopheles funestus population shows that such 
insecticide should be ruled out as an alternative to pyrethroid for IRS. The full susceptibility to 
the organophosphate malathion, as also demonstrated across the continent so far, suggests 
that this insecticide class is the most suitable for IRS against this species. The President Malaria 
Initiative’s plan to perform IRS in Cameroon should, therefore, consider using 
organophosphates such as pirimiphos-methyl (Actellic) to maximize the impact of such 
intervention. 
 
Very high level of resistance to several classes of insecticides, including organochlorine, 
pyrethroid, and carbamate, was also observed in Anopheles gambiae s.s. population. This high 
resistance in Anopheles gambiae is in line with the increased resistance reported in this 
species in several sites across Cameroon (Antonio-Nkondjio et al., 2011; Antonio-Nkondjio et 
al., 2017; Etang et al., 2003; Fossog Tene et al., 2013; Nwane et al., 2013). The resistance in 
Anopheles gambiae was higher than in An. funestus for most insecticides (e.g., no mortality 
against permethrin in An. gambiae vs 40.9% in An. funestus) suggesting a greater selection 
operating in An. gambiae. This could be explained by a selection of resistance from breeding 
sites contaminated with insecticides used for the protection of the crops. As An. gambiae 
breeding sites are often located at the vicinity of crops, the selection could be greater in this 
species compared to An. funestus because of mosquito-breeding sites in Mibellon, where 
there is a large lake that insecticides from farms drain into.  
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3.4.3 Bio-efficacy of LLINs in cone assays 
 
The low mortality rates observed with permethrin and deltamethrin for both species in 
Mibellon correlated with the reduced bio-efficacy of most LLINs observed with cone assays, 
including PBO-based nets such as Olyset Plus. This loss of efficacy may be due to selection 
pressure induced by the massive distribution of bed nets by the government (MICs, 2014; 
PNLP, 2016) in addition to the use of pesticide for farming in the area. For both species, the 
mortality for all the nets is very low, except for PermaNet 3.0 (side). For An. funestus, the 
mortality rates for all LLINs are lower than has been recently reported from other countries 
such, as DR Congo (Riveron et al., 2018a).  However, because cone assays could underestimate 
the efficacy of LLINs, as they do not assess their additional excito-repellent effect (WHO, 
2013c), studies with experimental huts are needed to establish the impact of resistance on 
LLINs in this region . 
 
3.4.4 Predominance of metabolic resistance in An. funestus contrasts with a high 
frequency of knockdown resistance in An. gambiae 
 
The near-full recovery observed for pyrethroids in Anopheles funestus after pre-exposure to 
PBO indicates that resistance is mainly conferred by metabolic resistance, particularly by 
cytochrome P450s (Wondji et al., 2009). This is in line with previous reports of the absence of 
kdr in this species in Cameroon (Menze et al., 2016) and across Africa (Irving and Wondji, 
2017). The frequency of the 119F-GSTe2-resistant allele in Mibellon field population (28%) is 
lower than in the northern part of Cameroon in Gounougou (52%) (Menze et al., 2016) or in 
Ghana (44.2 %) (Riveron et al., 2014b) and Benin (56.25%) (Djouaka et al., 2016a). The 
frequencies in Mibellon are closer to that observed in the eastern part of Africa in Uganda 
(20.4%) (Morgan et al., 2010; Mulamba et al., 2014b). GSTe2 has been shown to confer cross-
resistance between DDT and pyrethroids (Riveron et al., 2014b). The partial recovery of DDT 
susceptibility after PBO assays suggests that GSTe2 is probably playing a role in the resistance 
in this An. funestus s.s. population. 
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The frequency of the 296S-RDL-resistant allele is only 9.7%, which is lower than was observed 
in the northern region at Gounougou. This low frequency could be as a result of recovery to 
susceptibility for dieldrin after this insecticide was removed from public and agricultural 
sectors in Cameroon, as observed in Gounougou where the frequency of this mutation went 
down from 80% in 2006 to 40% in 2012 and 14.6% in 2015 (Menze et al., 2016; Wondji et al., 
2011). Such a reversal of resistance is encouraging for the implementation of resistance 
management strategies. 
 
The very high resistance levels to pyrethroids in Anopheles gambiae s.s. (no mortality to 
permethrin), correlates with the high frequency of the 1014F kdr allele (63.9%). This is in line 
with other reports from Africa where high pyrethroid resistance in Anopheles gambiae s.l. has 
been associated with nearly fixed kdr allele in the population, as observed recently in DR 
Congo (Riveron et al., 2018a), or previously in Côte d’Ivoire (Edi et al., 2012). However, this 
high level of kdr is in contrast to the very low frequency of the 1014S kdr allele in Mibellon is 
similar to previous reports across Cameroon showing that this marker, originally present in 
East Africa, has now migrated to Central and West Africa although still at very low frequencies 
(Nwane et al., 2011). Overall, the fact that 1014F kdr frequency is not fixed in Mibellon in the 
presence of such high pyrethroid and DDT resistance suggests that other mechanisms are 
playing an important role, probably metabolic resistance, as shown for other Anopheles 
gambiae s.l. populations in Cameroon (Antonio-Nkondjio et al., 2015; Etang et al., 2003; 
Fossog Tene et al., 2013). Further investigation of the resistance mechanisms will help 
elucidate the molecular basis driving resistance in this population. The total absence of the 
119S ace-1 mutation is in line with the susceptibility of this population to organophosphate 
and carbamate as this mutation is responsible for organophosphate and carbamate resistance 
(Edi et al., 2014; Weill et al., 2004). But as this allele has recently been detected in other 
regions of Cameroon (Elanga et al 2019), more attention should be paid to its occurrence in 
Mibellon in the future. 
 
3.4.5 Roles of both An funestus and An gambiae in malaria transmission 
 
This study further confirms the role of An. funestus in malaria transmission with a sporozoite 
infection rate of 5%. This is lower compared to that observed (Cohuet et al., 2004b) in Nkoteng 
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where Plasmodium falciparum infection rate was found to be 8.6%. In Benin (Kpome), 
Anopheles funestus population was found with high Plasmodium infection during the dry 
season (infection rate of 18.2 %), although from the whole mosquitoes (Djouaka et al., 2016a). 
The higher infection rate found in abdomen (15%) significantly differs (P=0.009) from the 
infection rate observed in the head and thorax (5%). This result further supports the significant 
barriers that the midgut plays in preventing oocyst migration to the salivary gland (Hillyer et 
al., 2007). The number of Anopheles gambiae s.s. infected with Plasmodium (20%) is higher 
compared to Anopheles funestus s.s. (15%). This rate is very high compared to previous results 
in Cameron (6.5-8.1%) (Cohuet et al., 2004a). This could be linked to the higher level of 
insecticide resistance in the Anopheles gambiae population, because they are resistant and 




Multiple resistance observed in both An. funestus s.s. and An. gambiae s.s. at Mibellon in 
central Cameroon is a concern for ongoing insecticide-based interventions, although the full 
susceptibility to organophosphate offers an alternative to IRS. However, the impact of such 
multiple resistances on the effectiveness of insecticide-based control interventions needs to 
be evaluated, notably through experimental huts. The presence of resistance in both major 















Chapter 4: A comparative experimental hut evaluation of PBO-
based and pyrethroid-only nets against the malaria vector 
Anopheles funestus reveals a loss of bed nets efficacy partially 
linked to GSTe2 metabolic resistance   
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4.1. Context of the study 
 
The scale-up of insecticide-based interventions, including Long Lasting Insecticidal Nets (LLINs) 
and Indoor Residual Spraying (IRS), has significantly contributed to the considerable reduction 
of malaria burden in the past decade(Bhatt et al., 2015). Unfortunately, growing insecticide 
resistance in malaria vectors is threatening these successes. However, the impact of 
resistance, notably metabolic resistance, on the effectiveness of vector control tools against 
pyrethroid-resistant mosquito populations, remains a topic of debate. Indeed, some studies 
have suggested that pyrethroid resistance does not yet impact the effectiveness of LLINs 
(Kleinschmidt et al., 2018b) whereas others have revealed a negative impact (Protopopoff et 
al., 2018b). Furthermore, to help manage resistance, novel LLINs with the piperonyl butoxide 
(PBO), an insecticide synergist, have been designed by various manufacturers (Corbel et al., 
2010; N'Guessan et al., 2010a; Pennetier et al., 2013b). However, no assessment of how 
metabolic resistance impacts the efficacy of these nets has been performed. One of the key 
challenges of assessing the impact of metabolic resistance on the effectiveness of these 
insecticide-based interventions has been the lack of molecular markers for resistance, notably 
metabolic resistance, as the phenotype is not easily associated with the outcome of the 
interventions. Recent efforts have detected a key genetic marker in the glutathione S-
transferase epsilon 2 gene (GSTe2) conferring a metabolic-mediated resistance to pyrethroids 
and Dichlorodiphenyltrichloroethane (DDT) in the major malaria vector Anopheles funestus in 
West and Central Africa (Riveron et al., 2014c). Besides cytochrome P450s and esterases, GSTs 
are, one of the main enzyme families conferring metabolic resistance to insecticides 
(Hemingway and Ranson, 2000) either through a direct metabolism or by catalyzing the 
secondary metabolism of substrates oxidized by cytochrome P450s (Hemingway and Ranson, 
2000). Over-expression of GST epsilon 2 (GSTe2) has been associated with DDT and 
pyrethroids resistance in several mosquito species, including An. gambiae (Mitchell et al., 
2014), An. funestus (Riveron et al., 2014c) and Aedes aegypti (Lumjuan et al., 2011). In An. 
funestus, genomic and structural analyses revealed that a leucine to phenylalanine amino acid 
change (L119F) in GSTe2, has enlarged the substrate-binding pocket of the enzyme,  conferring 
DDT/pyrethroid resistance in West and Central African populations (Riveron et al., 2014b). 
This single amino acid change was used to design a simple field applicable DNA-based 
diagnostic tool. It was first a TaqMan assay (Riveron et al., 2014b), and later an allelic specific 
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PCR (Tchouakui et al., 2019c), providing the opportunity to address questions regarding the 
direct impact of GST-mediated metabolic resistance on insecticide-based interventions such 
as LLINs. 
The pyrethroid resistance in An. funestus across Africa is driven by metabolic resistance 
(Riveron et al., 2013; Riveron et al., 2017b; Weedall et al., 2019; Weedall et al., In Press) as no 
knockdown resistance (kdr) has been reported so far for this species (Irving and Wondji, 2017). 
This predominance of the metabolic resistance mechanism in An. funestus through over-
expression of detoxification genes such as GSTe2 or CYP6P9a/b makes this vector suitable to 
assess the impact of metabolic resistance on control interventions. This has been done for the 
global resistance and kdr, and it is therefore important to evaluate the impact of metabolic 
resistance since these mechanisms are more likely to lead to control failure (Tchigossou et al., 
2018; Weedall et al., 2019). The presence of the GST-mediated metabolic resistance in An. 
funestus populations such as in Cameroon (Menze et al., 2016; Menze et al., 2018a; Riveron 
et al., 2014b) also provides the opportunity to assess how the effectiveness of PBO-based nets 
is impacted when malaria vectors exhibit other type of metabolic resistance than cytochrome 
P450-based resistance which have been so far the only focus of synergists. 
Two methods (epidemiological and entomological) are considered as useful methods to 
investigate the impact of insecticide resistance (WHO, 2012b). However, the epidemiological 
approach relaying on malaria cases investigation is not suitable since malaria transmission is 
affected by many confounding factors (Kleinschmidt et al., 2015; WHO, 2012b). The 
entomological approach since it provides an opportunity to measure entomological outcomes, 
such as relative mortality and feeding success of resistant and susceptible vectors in controlled 
conditions remains the method of choice.(N’Guessan et al., 2007b; WHO, 2012b). It also 
provides the relevant samples to assess how metabolic resistance impacts the effectiveness 
of LLINs as done previously to determine the impact of target site mutations such as kdr 
(Ngufor et al., 2014a). 
To better inform countries of the usefulness of PBO nets to control pyrethroid-resistant 
mosquitoes in the face of the greater cost of PBO nets, here we compared the performance 
of conventional pyrethroid-only nets (Olyset, PermaNet 2.0 and Yorkool) versus PBO-based 
LLINs (Olyset Plus and PermaNet 3.0) against a pyrethroid-resistant An. funestus population 
from Cameroon using experimental huts. Furthermore, we took advantage of the L119F-
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GSTe2 DNA-based diagnostic assay (Riveron et al., 2014b), to assess the impact of GST-
mediated metabolic resistance on the performance of these five LLINs. 
 
4.2 Material and Methods 
 
4.2.1 Study area 
 
The experimental hut station is located in Mibellon (6°4′60′′N, 11°30′0′′E), a village in 
Cameroon located in the Adamawa Region; Mayo Banyo Division and Bankim Sub-division as 
described in Chap 3. At the experimental station, 12 huts built following the World Health 
Organisation (WHO) standard, are available for a wide range of experimental hut trials. An.  
funestus s.s. is the main malaria vector in the area (Menze et al., 2018b). Mansonia sp, and 
Culex sp are also present in the area. Mosquitoes in the area are highly resistant to pyrethroid 
and DDT, as described in chapter 3. The trial was carried out for 12 weeks during the rainy 
season from 10th July to 16th October 2016. 
 
4.2.2 Experimental hut construction 
 
My experience as a PhD student started with the construction of the experimental station. 
The section 4.2.2.1 describes the positioning of the hut in the field. The section 4.2.2.2 
describes the plan and the dimension of the hut and the The section 4.2.2.3 describes the 




4.2.2.1 Hut position on the land 
 
The plan, including several huts in many rows, was built in mosaic since we do not want the 
huts to face each other (Figure 4.1). The huts are built in the direction of the bresding sites. If 
the huts are facing each other, the front row may hide the entrance of the second row. This 
is reason why we suggested to put them in mosaic formation. 
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Figure 4.1: Disposition of huts on the land before the construction. Image explaining how 
huts should be positioned on the ground. 
 
4.2.2.2 Plan and design of the hut 
 
Construction plan and design of huts came from the prototype recommended by WHO for 
West African. The hut is constructed on a concrete base measuring 5.6 m x.5.6m surrounded 




Figure 4.2: Dimensions considered during the construction of the experimental station in 
Mibellon Cameroon. The figure also describes each side of the hut. 
 
4.2.2.3 Construction of the hut 
 
The walls were made from concrete bricks and plastered inside and outside with a plaster 
made from a mixture of cement and sand. The roof is made from corrugated iron, and the 
ceiling is made from plywood (Figure 4.3). 
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Figure 4.3: Different steps of hut construction. A) Huts are built on a concrete base surrounded 
by a narrow moat to exclude scavenging ants. B) Construction following the plan and the 
dimensions. C) Plastering of walls made from a mixture of cement. D) The final version of the 
hut. 
 
4.2.2.3 Window design and construction 
 
The 4 windows located on three sides of the hut are designed to create an angle with a 2 cm 
gap, which will facilitate the entry of mosquitoes flying upward and prevent the mosquitoes 
from escaping once they have entered the hut (Figure 4.4). 
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Figure 4.4: Design of windows for experimental following a specific design. 
 
4.2.2.4 Selection of sleepers and functioning of hut. 
 
A curtain is used as a separation between the veranda and the rest of the hut (Figure 4.5). 
Before bedtime, each sleeper is required to raise the curtain to allow mosquitoes to take 
refuge in the veranda. In the morning, it is recommended that the sleeper lowers the curtain 
before starting the collection to allow a separate collection of mosquitoes in the veranda and 
in the hut. Sleepers were selected from the inhabitant of Mibellon. The selection was made 
according to gender and age. It was not advised to work with people aged less than 17 years 
old. After the screening, volunteers were trained and evaluated before the trial. The sleepers 
signed an informed consent form. The volunteers were regularly followed in the health care 




Figure 4.5: Curtain separating the veranda trap from the rest of the hut. 
 
4.2.3 Net treatment / Arm comparison 
 
During the experimental hut trial, five LLINs and one untreated net as negative control were 
compared (Table 4.1). These included three pyrethroid-only LLINs (PermaNet 2.0, Olyset, and 
Yorkool) and two PBO-based nets (PermaNet 3.0 and Olyset Plus) (Table1) (Figure 4.6). 
Manufacturers provided all nets except Yorkool, which was locally purchased. Each net was 
holed according to WHO protocol (WHO, 2013b), generating six holes (4 cm × 4 cm) per net, 
two on each of the long sides, and one on each of the short sides (Figure 4.7). The  purpose of 
making holes in the nets is to facilitate the assessment of the bloodfeeding inhibition (BFI). 
 
 




Figure 4.7: Net holed according WHO recommendations. Six holes (4 cm × 4 cm) per net, two 




Table 4. 1: Description of the long-lasting insecticidal nets used 
Treatment arm Description Manufacturer 
Untreated 100% polyester with no insecticide Local market 
Olyset 8.6 × 10−4 kg/m2 (2%) of permethrin 
incorporated into polyethylene 
Sumitomo Chemical 
Olyset Plus 8.6 × 10−4 kg/m2 (2%) of permethrin and 4.3 
× 10−4 kg/m2 (1%) of PBO incorporated into 
polyethylene 
Sumitomo Chemical 
PermaNet 2.0 100% polyester coated with 1.8 g/kg of 
deltamethrin 
Vestergaard Frandsen 
PermaNet 3.0 Combination of 2.8 g/kg of deltamethrin 
coated on polyester with strengthened 
border (side panels) and deltamethrin (4.0 
g/kg) and PBO (25 g/kg) 
Vestergaard Frandsen 
Yorkool 100% polyester coated with 1.8 g/kg of 
deltamethrin 
Yorkool International Co 
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4.2.3 Hut effect 
 
Before the study, the hut effect was assessed to evaluate any specific attractiveness of huts. 
It is essential to know if some huts are more attractive than others, even if this can be 
corrected by the Latin square design rotation or during the data analysis. Untreated nets were 
hung in the six huts used for the study, and for three weeks, between the 10th and 29th May 




Cone bioassays were performed at the beginning of the study using the An. coluzzii susceptible 
Ngousso laboratory strain. This was done to confirm the quality of the 5 bed nets used in the 
study. Cone bioassays were also done in the insectary using F1 progeny from field-collected 
An. funestus from Mibellon (See details of rearing and cone test in Chapter 2 methods). For 
PermaNet 2.0, PermaNet 3.0 (side and top), Olyset and Olyset Plus beside an untreated control 
net, 5 batches of 10 unfed females, 2-5 days old, were exposed to each bed net using WHO 
cone assays for three minutes (WHO, 2013d). They were then transferred into a holding paper 
cup container, and the knockdown was checked after 60 min and the mortality after 24 hours 
post-exposure during which mosquitoes were provided a 10 % sugar solution. Bioassays were 
also performed to generate highly resistant (alive after 90 min exposure) and highly 
susceptible (dead after 30 min) mosquitoes against 0.75% permethrin, 0.05% deltamethrin, 
and 4% DDT WHO papers. The 30- and 90-minutes exposure tests were performed in separate 
tubes, then scored 24hr post-exposure, and the samples used to assess the association 
between L119F-GSTe2 genotypes and resistance to these insecticides. 
 
4.2.5 Experimental hut trial 
 
The experimental hut trial was done following the protocol described in the guidelines for 
laboratory and field-testing of long-lasting insecticidal nets (WHO, 2013b) (See methods in 
chspter 2). To correct any specific attractiveness observed during the hut effect assessment, 
bed nets were rotated according to the Latin design square rotation (Figure 4.8) (WHO, 2013b) 
(Figure 4.8) so that at the end of the study, each net would have spent six days in each hut. 
Six volunteer males were selected to sleep in the room from 20:00 GMT to 5:00 GMT in the 
morning. The sleepers were also rotated so that at the end of the week, each sleeper would 
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have spent one night in each hut. The rotation of the sleepers was done to correct any bias 
due to any specific attractiveness from the sleepers (Ngufor et al., 2014b). 
 
 
Figure 4.8: Bed nets rotation according to the Latin design square rotation. 
 
4.2.6 Mosquito collection 
 
Mosquitoes were collected every morning, using hemolysis tubes from: (i) inside the nets, (ii) 
in the room: floor, walls and roof, and (iii) in the veranda exit trap. Mosquitoes collected from 
each compartment were kept separately in a bag to avoid any mixing between samples from 
different compartments. (Figure 2.2). Samples were transferred to the laboratory for 
identification. After identification, samples were then classified as dead, alive, blood-fed, or 
unfed (Appendix 1). The ‘alive’ samples were kept in the paper cup and provided with sugar 
solution for 24 hours and mortality was monitored. Dead mosquitoes were then kept 
adequately in labelled Eppendorf tubes with silica gel  and live mosquitoes stored in RNA later  
(Figure 2.3). 
 
4.2.7 Bed nets performance assessment  
 
The performance of the bed nets was expressed relative to control (untreated nets) (Appendix 
1) in term of: 
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i-Deterrence/entry rate: the reduction in hut entry relative to control. Deterrence (%) = 100 
x (Du – Dt) / Du, where Du is the total number of mosquitoes found in the untreated hut 
(control), and Dt is the total number of mosquitoes in the treated hut. 
ii-Entry rate (%) = 100 x (Ht/Hn) where Ht is the total number of mosquitoes found in the hut, 
and Hn is the total number of mosquitoes collected in all the six huts. 
iii-Exophily: the proportion of mosquitoes found exited in the veranda trap. 
Exophily (%) = 100 x (Ev/Et) where Ev is the total number of mosquitoes found in veranda, and 
Et is the total number of both inside the hut and veranda. 
iv-Blood feeding rate (BFR). This rate was calculated as follows: Blood feeding rate = (N 
mosquitoes fed) x 100 / total N mosquitoes. Where “N mosquitoes fed” was the number of 
mosquitoes fed, and “total N mosquitoes” was the total number of mosquitoes collected. 
v-Blood-feeding inhibition (BFI): the reduction in blood-feeding in comparison with the control 
hut. Blood feeding inhibition is an indicator of personal protection (PP). More precisely, the 
personal protection effect of each bed net is the reduction of blood-feeding percentage 
induced by the net when compared to control. The protective effect of each bed net can be 
calculated as follows: Personal protection (%) = 100 x (Bu – Bt) / Bu, where Bu is the total 
number of blood-fed mosquitoes in the huts with untreated nets and Bt is the total number 
of blood-fed mosquitoes in the huts with treated nets (WHO, 2013). 
vi-Immediate and delayed mortality: the proportion of mosquitoes entering the hut that is 
found dead in the morning (immediate death) or after being caught alive and held for 24 h 
with access to sugar solution (delay mortality) (WHO, 2013). In this study, we focused on the 
overall mortality calculated as follows: Mortality (%) = 100 x (Mt/MT) where Mt is the total 
number of mosquitoes found dead in the hut and MT is the total number of mosquitoes 
collected in the hut. 
 
4.2.8 Ethical clearance 
 
The national ethics committee for health research of Cameroon approved the protocol of the 
study (ID:2016/03/725/CE/CNERSH/SP) (Appendix 6). Written, informed and signed consent 
was obtained from sleepers before starting the trials. The consent form provided all the 
information and the evaluation process about the study. Information was translated in local 
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language when needed. All the volunteers involved in the study were followed-up and treated 
when showing malaria symptoms. 
 
4.2.9 Data analysis 
 
Experimental hut trial: To calculate the proportion of each entomological outcomes and the 
level of significance between the treatments and between the control for each entomological 
outcomes, the XLSTAT software (Addinsoft, Berkeley, CA, USA) was used. To conteract the 
problem of multiple comparison, the bonferroni correction was apply using an alpha of 0.01 
as the cut off for significance. 
The effects of the treatments on each of the main proportional entomological outcomes 
(exophily, blood-feeding, and mortality) were assessed using binomial generalized linear 
mixed models (GLMMs) with a logit link function, fitted using the ‘lme4’ package for R 3.6 (Toe 
et al., 2018a; WHO, 2013a). A separate model was provided for each outcome and each 
mosquito species. In addition to the fixed effect of each treatment, each model included 
random effects to account for the following sources of variation: between the six huts used in 
the studies; between the six sleepers who slept in the huts; between the six weeks of the trial. 
 
Test of association between L119F-GSTe2-mutation and the entomological outcomes: To 
investigate the association between the L119F-GSTe2 mutation and the ability of the 
mosquitoes to survive, blood feed or escape, the online Vassar stats software were used to 
estimate the Odds ratio based on a fisher exact probability test with a 2x2 contingency table. 
 
Hut effect analysis: The one-way analysis of variance (ANOVA) using Prism 7.0 was used to 
determine whether there were any statistically significant differences between the means of 
the mosquitoes collected from the 6 huts.  
 
4.2.10 Impact of the L119F-GSTe2 mutation on insecticide-treated nets 
 
The samples collected during the investigation on the performance of nets were grouped in 
several categories: dead, alive, blood-fed, unfed, room and veranda, and inside nets. The 
L119F-GSTe2 mutation was genotyped in each group using an Allele Specific-PCR. This allows 
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a direct measure of the relative survival and feeding success of resistant and susceptible 
insects in the presence of the different bed nets. 
Genotyping 
Samples classified as dead, alive, blood-fed, unfed, (Appendix 6) room, and veranda were used 
for DNA extraction using the Livak protocol (Livak, 1984). The L119F-GSTe2 mutation was 
genotyped  to assess how the glutathione S-transferase gene, GSTe2, impacts the 
performance of the bed nets. An allele-specific PCR (Tchouakui et al., 2019d; Tchouakui et al., 
2018) was used to detect the three genotypes of the L119F-GSTe2 mutation (RR, RS, and SS). 




4.3.1 Cone assays using the An. coluzzii susceptible lab strain Ngousso 
 
At the beginning of the study, each bed net was exposed to the An. coluzzii susceptible lab 
strain Ngousso using WHO cone assays. Olyset Plus and PermaNet 3.0 showed a mortality of 
100±00 %, PermaNet 2.0 showed 93.3±3.33% mortality and Olyset and Yorkool gave mortality 
rates of 96.97±3.33% and 96.3±3.7 % respectively. In contrast, no death was recorded for the 
untreated net (Figure. 4.9A).  
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Figure 4.9: Quality control before the experimental hut trial in Mibellon: Species composition 
in Mibellon.  A) Quality control of the efficacy of all the five nets checked against the 
susceptible laboratory strain of An. coluzzii Ngousso and LLINs efficacy testing using cone 
assays against the pyrethroid-resistant An. funestus population from Mibellon, Cameroon. B) 
The number of mosquitoes collected during the hut effect assessment; C) Average of An. 
funestus. ss collected by hut during the 18 days of the hut effect investigation. 
 
4.3.2 Cone assays with An. funestus from the field (Mibellon) 
 
Olyset and Olyset plus showed mortality of 5.63±3.2% and 67.23±3.4%, respectively, when 
exposed to the F1 population of An. funestus from Mibellon using WHO cone assays. PermaNet 
2.0 showed 25.06±5.06% mortality, and PermaNet 3.0 side and PermaNet 3.0 top gave 
71.04±3.33 % and 100±0 % respectively whereas no mortality was recorded for the Yorkool 
and the untreated net (Figure 4.9A). 
 
4.3.3 Hut effect 
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After 18 days of collections, a total of 1,147 mosquitoes were collected in the huts with the 
untreated net. Out of the 1,147, 488 were females An. funestus, 428 An. funestus males, 195 
Mansonia spp, 32 Culex sp, and 4 An. rufipes. The average of An. funestus females collected 
per room after 18 days ranged from 3 to 8 per day (Figure. 4.9C). No significant difference 
(P=0.09; DF=5) between the numbers of mosquitoes collected in the different huts was 
observed (Figure. 4.9C). 
 
4.3.4 Mosquito abundance 
 
A total of 5,015 mosquitoes were collected in 6 huts by human volunteers sleeping in the huts 
for 12 weeks, corresponding to 432 man-nights. Out of the mosquitoes collected, 1,458 (29%) 
were An. funestus. s.s. females, 2,421 (48%) were An. funestus males, 1,063 (21%) were 
Mansonia spp, 03 (0.06%) were An. gambiae ss., 69 (1.4%) were Culex sp and 04 (0.08%) were 
Aedes sp (Figure 4.10A). However, only female An. funestus and Mansonia sp, due to its 








Figure 4.10: Performance of the five LLINs in experimental hut trials against pyrethroid-
resistant An. funestus in Cameroon. A) Mosquito species composition during the experimental 
hut study. B) Assessment of deterrence (entry rate) and exophily of free-flying An. funestus in 
Mibellon for the five LLINs during the trial. C) The proportion of mortality and blood-feeding 
rate for the five LLINs against An. funestus. 
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Table 4.2: Results of the performance of the five brands of LLINs against wild An. funestus females in experimental huts 
Treatments 
 Control  Yorkool PermaNet 2.0 PermaNet 3.0 Olyset Olyset Plus 
Females caught 390 303 237 153 176 199 
Exophily% 6.9 17.2 17.7 17.0 29.0 22.1  
95% Confidence limits 4.40-9.44) (12.92-21.41) (12.85-22.58) (11.04-22.94) (22.27-35.68) (16.34-27.88) 
P value   <0.001 <0.001 <0.001 <0.001 <0.001 
Blood fed (%) 40.8 23.8 19.8 15.7 15.3 18.1 
95% Confidence limits (35.89-45.65) (18.97-28.55) (14.75-24.91) 9.92-21.45) 10.02-20.67) (12.74-23.44) 
P value   <0.001 <0.001 <0.001 <0.001 <0.001 
Blood feed inh. (%) 0.0 41.71 51.36 61.52 62.37 55.63 
Personal protection (%) 0.0 54.71 70.44 84.90 83.01 77.35 
Overall mortality (%) 5.4 7.6 12.2 30.1 9.7 25.1 
95% Confidence limits (31.14-7.62) (4.61-10.57) (8.06-16.41) (22.80-37.33) (5.29-14.02) (19.10-31.15) 
P value   ns <0.01 <0.001 ns <0.001 
Immediate mortality 2.6 4.6 5.4 27.6 6.1 18.3 
P value - ns ns <0.001 <0.05 <0.001 
Entry rate 29.3 20.78 16.25 10.4 12.07 13.6 
P value   <0.001 <0.05 <0.001 <0.0001 <0.001 
Deterrence (%) 0.0 22.3 39.2 60.8 54.9 49.0 
PV, P-value; CI, Confidence interval; ns=Non Significant 
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Table 4.3: Results of the performance of the five brands of LLINs against wild Mansonia spp in experimental huts  
  Control  Yorkool PermaNet 2.0 PermaNet 3.0 Olyset Olyset Plus 
Total 342 159 142 216 141 163 
Exophily% 42.4 26.4 37.3 31.9 28.4 31.3 
95% Confidence limits (37.16-47.64) (19.56-33.27) (29.37-45.28) (25.73-38.16) (20.93-35.81) (24.17-38.41) 
P-value   <0.001 ns <0.01 <0.01 <0.01 
Blood feeding (%) 30.1 22.0 16.2 9.3 15.6 20.2 
95% Confidence limits (25.25-34.98) (15.57-28.45) (10.14-22.26) (5.39-13.12) (9.61-21.59) (14.08-26.41) 
P-value   ns <0.01 <0.001 <0.001 <0.01 
Blood feeding inhibition. (%) 0.0 26.91 46.22 69.26 48.19 32.78 
Personal protection (%) 0.0 66.01 77.66 80.53 78.64 67.96 
Overall mortality (%) 37.4 49.1 51.4 65.5 40.4 68.1 
P-value   <0.01 <0.01 <0.001 ns <0.001 
Immediate mortality 36,8 48,4 46,5 62 39 65 
P-value   ns ns <0.001 <0.001 <0.001 
Entry rate 29.3 12.1 14.1 12.2 18.56 13.6 
P-value   <0.001 <0.001 <0.01 <0.001 <0.001 
Deterrence (%) 0.0 53.5 58.5 36.8 58.8 52.3 
PV, P-value; CI, Confidence interval;ns=Non Significant 
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4.3.5 Performance of the nets against An. funestus s.s. population 
 
4.3.5.1 Deterrent effect/Entry rate 
 
Overall, when compared to control, the three pyrethroid-only nets (PermaNet 2.0, Olyset, and 
Yorkool) showed different performance with PermaNet 2.0, presenting the highest mortality 
rate (54.9%) (Table 4.2). When comparing the two PBO nets (Olyset Plus and PermaNet 3.0), 
both demonstrated a high deterrent effect (49.0% and 60.8 %) (Table 4.2). 
In comparison to control, the entry rate was significantly reduced in all the huts with the five 
LLINs with the deterrence rates ranging from 22.3% for Yorkool to 60.8% for PermaNet 3.0. 
PermaNet 3.0 had a significantly higher deterrence compared to PermaNet 2.0 (P=0.0001), 
but this was not the case for Olyset Plus (49%) over Olyset (54.9%) (P=0.09). (Table 4.2). 
 
4.3.5.2 Induced exophily rate 
 
Overall, when compared to control, the three pyrethroid-only nets (PermaNet 2.0, Olyset, and 
Yorkool) showed different performances with Olyset presenting the highest exophily rate 
(29.0%) compared to an average of 17% for PermaNet 2.0 and Yorkool (Table 4.2). When 
comparing the two PBO nets (Olyset Plus and PermaNet 3.0) in exophily, no significant 
difference was observed (P=0.1). A low exophily rate was recorded in the control hut for An. 
funestus s.s. (6.9%). However, the exophily rate was significantly higher in the hut with Olyset 
(15.3%; P=0.0001), Olyset Plus (18.1%; P=0.0001), PermaNet 2.0 (19.8%; P=0.0001), PermaNet 
3.0 (15.7%; P=0.0004) and Yorkool (23.8%; P=0.0001) compared to the control hut (Figure. 
5.2C and table 4.2). No significant difference is observed between the five tested LLINs. A 
significant high exophily activity was observed during week 2 and week 9 (P<0.05) (Appendix 
7). 
 
4.3.5.3 Mortality (overall mortality) 
 
Overall, when compared to control, the three pyrethroid-only nets (PermaNet 2.0, Olyset, and 
Yorkool) showed different performance with PermaNet 2.0, presenting the highest mortality 
rate (12.2%) compared to 7.6% and 9.7% respectively for Yorkool and Olyset (Table 4.2). When 
comparing the two PBO nets (Olyset Plus and PermaNet 3.0) in mortality, no significant 
difference was observed (P=0.4). 
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Low mortality rates were recorded in the control hut for An. funestus s.s. (5.4%). However, 
the mortality rate was significantly higher in the hut with Olyset Plus (25.1%; P=0.001), 
PermaNet 2.0 (12.2%; p=0.002), and PermaNet 3.0 (30.1%; P=0.0001) compared to the control 
hut. The mortality rate was significantly higher with the two PBO-based nets than all the 
pyrethroid-only nets (P<0.001). However, no significant variation was observed between the 
mortality in the huts with Olyset (9.7 %; P=0.06) and Yorkool (7.6 %; P=0.2) compared to 
control (Fig. 4.10B; table 4.2). ). It is also clear from our analysis that mortalities obtained were 
not influenced by the sleepers (P˃0.05), by the huts (P˃0.05) and by the weeks (P˃0.05) 
(Appendix 8). 
 
4.3.5.4 Blood feeding inhibition (BFI) 
 
Overall, when compared to control, the three pyrethroid-only nets (PermaNet 2.0, Olyset and 
Yorkool) showed different performance with Olyset presenting the highest Blood Feeding 
Inhibition (BFI) rate (62.3.2%) compared to 41.71% and 51.36% respectively for Yorkool and 
PermaNet 2.0 (Table 4.2). When comparing the two PBO nets (Olyset Plus and PermaNet 3.0) 
in mortality, no significant difference was observed (P=0.5). 
High blood feeding rates were recorded in the control hut (40.8%). However, the blood-
feeding rate (BFR) was significantly lower in the hut with Olyset (BFR=15.3; BFI= 62.5%; 
P<0.0001), Olyset Plus (BFR=18.1%; BFI=55.6%; P=0.001), PermaNet 2.0 (BFR=19.8%; 
BFI=48.5%; P=0.0001), PermaNet 3.0 (BFR=15.7%; BFI=61.5%; P<0.0001) and Yorkool 
(BFR=23.8%; BFI=41.7%; P<0.0001) compared to the control hut (Figure. 4.10B; Table 4.2). 
PermaNet 3.0 had a higher BFI than PermaNet 2.0, but this was not the case for Olyset Plus 
compared to Olyset, although the differences were not significant (P=0.2). We noticed a 
significant reduction of the blood-feeding in hut 4 (P<0.05) and a significant increased during 
week 12 (P<0.05) (Appendix 9). These fluctuations were corrected by a rotation based on Latin 
square design (Table 4.2). 
 
4.3.5.5 Personal protection (PP) 
 
Overall, when compared to control, the three pyrethroid-only nets (PermaNet 2.0, Olyset and 
Yorkool) showed different performance with Olyset presenting the highest Blood Feeding 
Inhibition (BFI) rate (83.01%) compared to 54.71% and 70.44% respectively for Yorkool and 
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PermaNet 2.0 (Table 4.2). When comparing the two PBO nets (Olyset Plus and PermaNet 3.0) 
in mortality, no significant difference was observed (P=0.5). 
The poorest performance in terms of PP was recorded with Yorkool (54.7%). PermaNet 3.0 
provided a higher PP when compared to PermaNet 2.0 but not significant (84.9% vs 70.4%; 
P˃0.05). No significant difference was observed when comparing the PP provided by Olyset 
and Olyset Plus (83 vs 77.3 %; P˃0.05) (Table 4.2). 
 
4.3.6 Performance of the nets against Mansonia spp. population 
 
4.3.6.1 Deterrent effect 
 
In comparison to control, the entry rate was significantly reduced for the five LLINs with 
deterrence rates ranging from 36.8% for PermaNet 3.0 to 58.8% for Olyset. Contrary to An. 
funestus, PermaNet 2.0 had a higher deterrence rate (58.5%) compared to PermaNet 3.0 
(36.8%) (P=0.05) and similar for Olyset (58.8%) compared to Olyset Plus (52.3%) (Table 4.3). 
 
4.3.6.2 Induced exophily rate 
 
A higher exophily rate was recorded in the control hut for Mansonia spp (42.4%) than An. 
funestus (6.9%) (P<0.05). However, the exophily rate of Mansonia spp, was significantly lower 
in the hut with Olyset (28.4%; P<0.01), Olyset Plus (31.3%; P<0.01), PermaNet 3.0 (31.9%; 
P<0.01) and Yorkool (26.4%; P<0.001) compared to the control hut. For PermaNet 2.0 no 




The overall mortality rate recorded in the control hut for Mansonia spp was 37.4%. However, 
this rate was significantly higher in the hut with Olyset Plus (68.1%; P<0.001), PermaNet 2.0 
(51.4%; P˃0.05) and PermaNet 3.0 (65.3%; P<0.001) compared to the control. No significant 
variation was observed between the mortality in the huts with Olyset (40.4%; P˃0.05) and 
Yorkool (49.1%; P˃0.05) compared to control (Table 4.3). The two PBO nets PermaNet 3.0 and 
Olyset Plus had a significantly higher mortality rate than the pyrethroid-only nets PermaNet 
2.0 and Olyset (Table 4.3). 
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4.3.6.4 Blood feeding inhibition (BFI) 
 
Overall, when compared to control, the three pyrethroid-only nets (PermaNet 2.0, Olyset, and 
Yorkool) showed different performances with Yorkool presenting the highest Blood Feeding 
rate (22.0%) compared to 16.2% and 15.6% respectively for PermaNet 2.0  and Olyset (Table 
4.3). When comparing the two PBO nets (Olyset Plus and PermaNet 3.0) in Blood feeding, a 
significant difference was observed (P=0.001). The blood-feeding rate recorded in the control 
hut for Mansonia spp was 30.1%. However, this rate was significantly lower in the hut with 
Olyset (15.6%; BFI=48.1%; P<0.01), Olyset Plus (20.2%; 32.7%; P=0.0009), PermaNet 2.0 
(16.2%; BFI=42.6%; P<0.01) and PermaNet 3.0 (9.3%; BFI=69.26%; P<0.001) compared to the 
control hut. No significant variation was observed between the blood-feeding rate for Yorkool 
hut (22%; BFI=26.91%; P˃0.05) compared to control (Table 4.3). PermaNet 3.0 had 
significantly higher BFI when compared to PermaNet 2.0 (P=0.02) and Olyset Plus (P=0.001). 
 
4.3.6.5 Personal protection (PP) 
 
The lowest PP was recorded with Yorkool (66.01%), whereas PermaNet 3.0 provided a higher 
PP but not significant when compared to PermaNet 2.0 (83.5% vs 77.6%; P˃0.05) but higher 
than the Olyset nets (P=0.03). No significant difference was observed when comparing the PP 
provided by Olyset and Olyset Plus (48.1 % vs 32.7 %; P˃0.05) (Table 4.3). 
 
4.3.7 Validation of the association between L119F-GSTe2 and resistance to pyrethroids and 
DDT in Mibellon 
 
Before assessing the impact of L119F-GSTe2 on LLINs, we first confirm its role in conferring 
pyrethroid/DDT resistance in this population by establishing the association between this 
marker and the ability to survive exposure to the pyrethroids used for Olyset (permethrin) and 
PermaNet (deltamethrin) nets besides DDT. Correlation analysis between L119F - GSTe2 
genotypes and deltamethrin revealed that homozygote resistant mosquitoes were 
significantly more likely to survive exposure to deltamethrin than both homozygotes 
susceptible SS (OR=4.6; P<0.001) and heterozygotes (OR=3.75; P<0.001). However, there was 
no significant difference between RS and SS ( Figure 4.11D; Table 4.4). A similar pattern was 
observed for permethrin (Figure. 4.11E; Table 4.4). Analysis of the correlation with DDT 
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revealed a much stronger association between L119F and DDT resistance as RR exhibited a 
greater ability to survive exposure to DDT than SS (OR=66.7; P<0.001) and also more than RS 
(OR=4.8; P<0.001). Contrary to both pyrethroids heterozygote RS mosquitoes are also more 
able to survive exposure to DDT than homozygote susceptible (OR=14.0: P<0.001) (Figure 


























Table 4.4. Impact of GSTe2 on the ability of field population An. funestus to survive using 
samples from cone assays. 
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Olyset Plus  
40 alive vs 40 dead 
  
Cone assays 
  OR PV CI 
RR vs SS 1.1 ˃0.05 0.4-2.7 
RS vs SS 0.9 1.0 0.5-1.8 
RR vs RS 1.1 ˃0.05 0.4-2.7 
R v S 1.04 1.0 0.5-1.8 
PermaNet 2.0 
46 alive vs 34 dead 
RR vs SS 2.09 <0.01 1.1-4.2 
RS vs SS 2.3 <0.001 1.2-4.4 
RR vs RS 0.8 ˃0.05 0.3-2.4 
R vs S 1.8 <0.01 0.9-3.5 
PermaNet 3.0 
39 alive vs 31 dead 
RR vs SS 30.1 <0.001 0.8-5.3 
RS vs SS 2.4 <0.01 1.3-4.5 
RR vs RS 12.3 <0.001 1.5-98.6 
R vs S 3.8 <0.001 1.8-7.7 
                                 WHO bioassays  
Deltamethrin 
38 alive vs 38 dead 
  OR PV CI 
RR vs SS 4.6 <0.001 2.5-8.4 
RS vs SS 1.22 ˃0.05 0.69-2.15 
RR vs RS 3.75 <0.001 2.1-6.8 
R vs S 2.80 <0.01 1.54-5.1 
Permethrin 
28 alive vs 37 dead 
RR vs SS 4.8 <0.001 2.66-8.8 
RS vs SS 1.6 ˃0.05 0.86-2.8 
RR vs RS 3.1 <0.001 1.7-5.5 
R vs S 2.99 <0.001 1.7-5.3 
DDT 
29 alive vs 30 dead 
RR vs SS 66.7 <0.001 27.1-164 
RS vs SS 14.0 <0.001 6.3-31.2 
RR vs RS 4.8 <0.001 2.4-9.5 





Figure 4. 11: Association between L119F-GSTe2 mutation and ability to survive exposure to 
LLINs (cone assays) and WHO papers (bioassays): A) Genotype distribution of L119F-GSTe2 
between alive and dead mosquitoes after exposure to Olyset Plus showing no association; B) 
Genotype distribution of L119F-GSTe2 between alive and dead mosquitoes after exposure to 
PermaNet 2.0 showing a significantly increased ability of resistant mosquitoes to survive (R vs 
S: P<0.008); C) Genotype distribution of L119F-GSTe2 between alive and dead mosquitoes 
after exposure to PermaNet 3.0 showing a significantly greater ability of resistant mosquitoes 
to survive than that seen for PermaNet 2.0 (RR vs SS: OR= 30.1; P<0.0001). D) Genotype 
distribution of L119F-GSTe2 between alive (90min) and dead (30min) mosquitoes after 
exposure to deltamethrin showing a significantly greater ability of homozygote resistant 
mosquitoes to survive (RR vs SS: OR=4.6; P<0.0001); E) Similarly for permethrin, homozygote 
resistant mosquitoes exhibit a significantly greater ability of to survive (RR vs SS: OR=4.8; 
P<0.0001); F) For DDT, a much greater ability of mosquitoes with the resistance allele to 
survive exposure to DDT papers (RR vs SS: OR=66.7; P<0.0001). 
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4.3.8 Comparative analysis of the impact of L119F-GSTe2 mutation on the efficacy of 
pyrethroid-only and PBO-based nets 
 
4.3.8.1 Impact on mortality 
 
Due to the low number of dead mosquitoes (5), the impact of GSTe2 resistance on mortality 
was not assessed for Olyset net. No correlation was observed between the presence of  L119F-
GSTe2 mutation and the ability of mosquitoes to survive exposure to Olyset Plus (26 dead and 
110 alive) when comparing the allelic frequency (OR=0.85; P=0.78; CI 0.45-1.59). A similar 
result was observed between RR vs SS (OR=0.61; P=0.39; CI 0.22-1.66), RS vs SS (OR=1.02; P=1; 
CI 0.56-1.8) and RR vs RS (OR=0.59; P=0.31; CI 0.21-1.68) (Figure. 4.12.A; Table 4.5). 
 
Table 4.5: Impact of L119F-GSTe2 mutation on the ability of various insecticide-treated nets 
to kill mosquitoes 
      Mortality   
  Genotype OR PV CI 
Olyset Plus RR vs SS 0.61 ˃0.05 0.22-1.66 
 
RR vs RS 0.59 ˃0.05 0.21-1.68 
 
RS vs SS 1.02 1 0.56-1.8 
  R vs S 0.85 ˃0.05 0.45-1.59 
PermaNet 3.0 RR vs SS 3.47 ˃0.05 1-11.9 
 
RR vs RS 3.56 ˃0.05 1-12.7 
 
RS vs SS 0.97 1 0.53-1.76 
  R vs S 1.42 ˃0.05 0.74-2.7 
PermaNet 2.0 RR vs SS / / / 
 
RR vs RS / / / 
 
RS vs SS 1.1 1 0.6 
  R vs S 1.18 ˃0.05 0.6-2.2 
 
Similarly, no significant association was observed between the presence of the mutation and 
the ability to survive exposition to PermaNet 2.0 (24 dead and 89 alive mosquitoes) when 
using the allelic frequency (OR=1.18; P=0.51; CI 0.6-2.2) (Table 4.5) as well as the genotypic 






Figure 4.12: Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy 
looking at the mortality rate after exposure to LLINs: A) Genotype distribution of L119F-GSTe2 
between alive and dead mosquitoes after exposure to Olyset Plus showing no association; B) 
Genotype distribution of L119F-GSTe2 between alive and dead mosquitoes after exposure to 
PermaNet 2.0 showing no association; C) Genotype distribution of L119F-GSTe2 between alive 
and dead mosquitoes after exposure to PermaNet 3.0 showing a trend of increased ability to 
survive in resistant mosquitoes but (P=0.08). Only 5 dead mosquitoes were recorded for 
Olyset, preventing assessment for this LLIN. 
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For PermaNet 3.0, no significant association was observed between the mutation and the 
ability to survive when using the allelic frequency (OR=1.42; P=0.65; CI 0.74-2.7) (Table 4.5) 
but comparing the genotypic frequency of RR vs SS provided a higher Odds ratio close to 
significance (OR=3.47; P=0.08; CI 1-11.9) (Figure. 4.12C). 
 
4.3.8.2 Impact on blood feeding 
 
For Olyset net, a significant association was observed between the 119F_GSTe2 resistance 
allele and an increased ability to blood feed (21 blood-fed and 92 unfed) when comparing the 
allelic frequencies (OR=2; P=0.047; CI 1.06-3.7) and the genotypic frequency of RS v SS 
(OR=2.97; P<0.001; CI 1.6-5.3) (Figure. 4.13A; Table 4.6). 
 
Figure 4.13: Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy for 
blood-feeding ability: A) Genotype distribution of L119F-GSTe2 between blood-fed and unfed 
mosquitoes after exposure to Olyset showing a significant increased ability to blood feed for 
resistant mosquitoes; B) Genotype distribution of L119F-GSTe2 between blood-fed and unfed 
mosquitoes after exposure to Olyset Plus showing a significant increased ability to blood feed 
for resistant; C) Genotype distribution of L119F-GSTe2 between blood-fed and unfed 
mosquitoes after exposure to PermaNet 2.0 showing an inverse marginal increased ability to 
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blood feed for homozygote susceptible SS compared to homozygote resistant RR (P<0.05) ; D) 
Genotype distribution of L119F-GSTe2 between blood-fed and unfed mosquitoes after 
exposure to PermaNet 3.0 showing an increased ability to blood feed of susceptible 





























Table 4.6: Impact of L119F-GSTe2 mutation on the efficacy of various bed nets to prevent 
blood feeding. 








RR vs SS 3.3 0.037 1.19-9.2 
RR vs RS 1.07 0.87 0.38-3.02 
RS vs SS 3.08 0.0016 1.67-5.66 
R vs S 2.23 0.018 1.2-4.1 
Mosquitoes in room 
RR vs SS 12.3 0.0004 2.5-60.4 
RR vs RS 1.46 0.69 0.29-7.2 
RS vs SS 8.42 0.0001 4.37-16.2 





RR vs SS 2.6 0.39 0.6-11.7 
RR vs RS 0.89 0.64 0.2-3.9 
RS vs SS 2.97 0.0002 1.65-5.35 
R vs S 2 0.047 1.06-3.7 
Blood feeding in room 
RS vs SS 3 0.0002 1.67-5.4 









RR vs SS inf     
RR vs RS inf 
  
RS vs SS 0.5 0.04 0.26-0.92 
R vs S 0.35 0.011 0.17-0.73 
Blood feeding in room 
RS vs SS 0.41 0.015 0.21-0.77 








 RR vs SS 0.4 0.04 0.1-1.56 
RR vs RS 0.48 0.33 0.12-1.9 
RS vs SS 0.8 0.65 0.47-1.5 
R vs S 1.31               0.2 0.6-2.5 
 
For the Olyset Plus net, when considering the blood feed and unfed samples from the room 
only (23 blood-fed and 49 unfed), a significant association was found between L119F-GSTe2 
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and an increased ability to blood feed when comparing the allelic frequencies (OR=4.5; 
P=0.0001; CI 2.26-9.2). An even stronger association was observed when comparing the 
genotype frequencies between RR vs SS (OR=12.3; P=0.0004 CI 2.5-60.4) and RS vs SS 
(OR=8.42; P<0.001; CI 4.37-16.2). But no association was established when comparing RR v RS 
(OR=1.46; P=0.69; CI 0.29-7.2) (Figure. 4.13.B; Table 4.6). No association was also obtained 
when comparing RR v RS (OR=1.07; P˃0.05; CI 0.38-3.02) when using the total number for 
blood-fed and unfed mosquitoes collected in all the compartments of the hut (33 blood-fed 
and 103 unfed).  
For PermaNet 2.0, no association was observed when comparing the allelic frequency R vs S 
(OR=1.05; P=0.5; CI 0.55-2.01) (Figure. 4.13.C; Table 4.6). But an association was observed 
when comparing genotypic frequency RS vs SS (OR=1.4; P=0.0064; CI 0.77-2.53).  
For PermaNet 3.0, a negative association was observed between the mutation and the ability 
to blood feed as resistant mosquitoes significantly blood-fed less than susceptible when 
comparing the allelic frequency (OR=0.35; P<0.05; CI 0.17-0.73) and the genotypic frequency 
of RS vs SS (OR=0.5; P=0.04; CI 0.26-0.92) (Figure 4.13D; Table 4.6). 
 
4.3.8.3 Impact on exophily 
 
For Olyset, no association was observed between the L119F-GSTe2 mutation and exophily (67 
in the room and 48 in veranda) when comparing the allelic frequency (OR=1.17; P=0.89; CI 
0.6-2.2) (Table 4.6) and the genotypic frequency RS vs SS (OR=1.18; P=0.77; CI 0.6-2.1) (Figure. 
4.14A; Table 4.7). 
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Figure 4.14: Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy -
exophily: A) Genotype distribution of L119F-GSTe2 between indoor (Room) and outdoor 
(verandah) mosquitoes after exposure to Olyset showing no association; B) Genotype 
distribution of L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes after 
exposure to Olyset Plus showing a significant increased ability to exit the room when 
considering all mosquitoes; C) A greater association is observed with exophily with Olyset Plus 
when only analyzing unfed mosquitoes. D) Genotype distribution of L119F-GSTe2 between 
indoor (Room) and outdoor (verandah) mosquitoes after exposure to PermaNet 2.0 showing 
a significant association (RS vs SS: OR=1.35; P<0.01) E) Genotype distribution of L119F-GSTe2 
between indoor (Room) and outdoor (verandah) mosquitoes after exposure to PermaNet 3.0 

















RR vs SS 3.1 0.09 1.1-9 
RR vs RS 2.48 0.13 0.83-7.42 
RS vs SS 1.25 0.29 0.67-2.26 
R vs S 1.1 0.3 0.6-2.2 
unfed alive  
RR vs SS 11.76 0.003 2.59-53.4 
RR vs RS 3.9 1 0.8-18.59 
RS vs SS 2.99 0.001 1.58-5.6 






        
RS vs SS 1.18 0.77 0.6-2.1 









RR vs SS 1.22 1 0.46-3.2 
RR vs RS 1.68 0.3 0.6-4.7 
RS vs SS 0.59 0.09 0.31-1.12 









RS vs SS 1.35 0.009 0.75-2.43 
R vs S 1.22 0.77 0.65-2.3 
unfed alive  
RS vs SS 3.37 0.0001 1.84-6.17 
R vs S 1.8 0.13 0.99-3.38 
 
 
For Olyset Plus, an association was observed between the mutation and the ability to escape 
to the veranda when considering the allelic frequency (OR=3.4; P=0.0008; CI 1.67-6.9) (Table 
4.6). An even stronger association was observed between the mutation and a preference for 
the veranda when comparing RR vs SS (OR=11.76; P=0.003; CI 2.59-53.4), RS vs SS (OR=2.99; 
P=0.0013; CI 1.58-5.65). But no significant association was observed between RR vs RS 
(OR=3.9; P=1; CI 0.8-18.59) (Figure. 414-C; Table 4.7). 
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For PermaNet 2.0, an association was observed between the L119F-GSTe2 mutation and the 
ability to exit the room when comparing the genotypic frequency RS vs SS (OR=1.35; P=0.009; 
CI 0.75-2.3). A stronger association was observed when assessing the impact only among the 
unfed mosquitoes for RS vs SS (OR=3.37; P=0.0001; CI 01.84-6.17) but not at the allelic level 
(Fig 14-D; Table 4.7).  
For PermaNet 3.0, no association was observed between the L119F-GSTe2 mutation and a 
preference for the room or the veranda when comparing the allelic frequency (OR=0.94; P=1; 
CI 0.5-1.8) (Table 4.6). The same trend was observed when comparing the genotypic frequency 
RR vs SS (OR=1.22; P=1; CI 0.46-3.2), RS vs SS (OR=0.59; P=0.09; CI 0.31-1.12) RR vs RS 
(OR=1.68; P=0.3; CI 0.6-4.7) (Figure 4.14E; Table 4.7). 
 
4.3.9 Correlation between L119F-GSTe2 and mortality from cone assays 
 
Due to the low number of dead mosquitoes obtained from the experimental huts, the impact 
of the L119F-GSTe2 on the ability of mosquitoes to survive exposure to various nets was 
assessed using samples from cone assays. Only few dead were obtained for Yorkool and Olyset 
preventing the assessment of these nets. 
Olyset Plus: No association was observed between the mutation and the mortality (40 dead 
vs 40 alive mosquitoes) at both allelic level (OR=1.04; P=1; CI 0.5-1.8) and genotypic for RR vs 
SS (OR=1.1; P˃0.05; CI 0.4-2.7) (Figure4.11A; Table 4.4). 
PermaNet 2.0: Resistant 119F-GSTe2 mosquitoes exhibited a greater ability to survive than 
susceptible mosquitoes (34 dead and 46 alive) at both allelic level (OR=1.8; P<0.01; CI 0.9-3.5) 
and genotypic frequency RR v SS (OR=2.09; P<0.01; CI 1.1-4.2) (Figure 11B; Table 4.4). 
PermaNet 3.0: Resistant 119F-GSTe2 mosquitoes, when exposed to PermaNet 3.0, showed a 
greater ability to survive than susceptible mosquitoes even than with PermaNet 2.0 at allelic 
level (OR=3.8; P<0.001; CI 1.8-7.7). A higher correlation was further observed when comparing 
the genotypic frequencies for RR vs SS (OR=30.1; P<0.001; CI 3.8-234), RS vs SS (OR=2.4; 
P<0.01; CI 1.3-4.5) and RR vs RS (OR=12.3; P<0.001; CI 1.8-7.7) (Figure. 4.11C; Table 4.4). This 
result applies only to PermaNet 3.0 side net as no mosquito survived exposure to PermaNet 





There is a growing concern that pyrethroid resistance will reduce the effectiveness of LLINs. 
However, the extent of such impact remains unknown, particularly in the context of metabolic 
resistance such as it is the case in the malaria vector An. funestus. This study has taken 
advantage of the dominating presence of metabolic resistance in An. funestus and the recent 
availability of a simple DNA-based diagnostic tool for GST-mediated resistance to pyrethroids, 
to establish the impact of metabolic resistance on the effectiveness of both pyrethroid-only 
and PBO-based LLINs against An. funestus. 
 
4.4.1 PBO-based nets are more effective than pyrethroid-only nets against pyrethroid 




The mortality rates obtained in this study with experimental huts were generally low (7.3 to 
30.1%). But such mortality levels are similar to those observed in other experimental hut 
studies, including in Benin (N'Guessan et al., 2010a) or recently in Burkina Faso, where the 
mortality rates ranged from 9.5% to 46.1% in two locations of high pyrethroid resistance in 
An. gambiae (Toe et al., 2018b). However, higher mortality has been observed for another 
highly resistant pyrethroid-resistant population of An. gambiae in Ivory Coast (Yaokoffikro) for 
PermaNet 3.0 (54%) and PermaNet 2.0 (34.7%) (Koudou et al., 2011) than seen here for the 
An. funestus population in Mibellon, which could potentially be associated with differences in 
resistance mechanisms. The low level of mortality observed is likely due to the level of 
pyrethroid resistance in An. funestus in Mibellon with permethrin mortality around 48.88 ± 
5.76% and deltamethrin mortality around 38.34 ± 5.79% (Menze et al., 2018a). Nevertheless, 
despite the ongoing resistance, both PBO-based nets induced significantly higher mortality 
than the pyrethroid-only LLINs against both An. funestus and Mansonia spp. This higher 
mortality of PermaNet 3.0 and Olyset Plus with An. funestus is also in line with the cone assay 
results. However, PermaNet 3.0 (Top) presented higher mortality for both huts and cone 
assays than Olyset Plus due to higher concentration of PBO than in olyset as also seen for An. 
gambiae in Burkina Faso (Toe et al., 2018b). Overall, the higher mortality with both PBO-nets 
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suggests that, in areas of pyrethroid resistance, these new generation LLINs (PermaNet 3.0 
and Olyset Plus) provide better protection against both malaria vectors and nuisance 
mosquitoes such as Mansonia spp.. 
 
4.4.1.2 Blood feeding 
 
The blood-feeding rate of all the five nets, an indicator of the personal protection provided by 
the net, was significantly lower (≤23.8%; P<0.001) compared with the untreated control 
(40.8%). However, the blood-feeding inhibition rate was higher for PermaNet 3.0 (61.5%) than 
PermaNet 2.0 (51.4%) this was not the case between Olyset Plus (55.6%) and Olyset (62.4%). 
Similar results have been obtained for An. gambiae in Benin (Pennetier et al., 2013b) where 
comparable blood feeding inhibition rates were observed for Olyset Plus (85%) and Olyset 
(82%) despite the greater mortality rate with Olyset Plus (81%) vs 42% for Olyset. The same 
pattern of blood feeding inhibition was observed here for An. funestus and Mansonia spp. 
with PermaNet 3.0 providing the highest inhibition level in Mansonia spp. whereas Olyset Plus 
was even lower than Olyset. 
Over all, synergist nets with PBO  (PermaNet 3.0)  tend to provide better personal protection 
in terms of BFI when compared to pyrethroid only nets. This may be explained by the fact 
mosquitoes are killed by PBO nets before blood feeding. As recommendation to the Cameroon 
government which relies mainly on LLINs to control malaria, the message is that even if PBO  
nets are performing better that pyrethroid only nets, the personal protection provided is still 
very low ( around 30%).  We recommend next generation nets like Royal guard which prevent 




The excito-repellency effect of all the nets was at least twice higher compared to control, 
showing that An. funestus mosquitoes were affected by the repellent effect of pyrethroids. 
These results are in line with previous findings demonstrating the repellent effect of 
pyrethroid nets against Anopheles mosquitoes (Koudou et al., 2011; N'Guessan et al., 2007b). 
No significant difference was observed in the level of exophily between the conventional nets 
compared to the synergist suggesting that PBO did not impact the repellent effect of 
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pyrethroids. Comparing An. funestus to Mansonia spp., revealed a significant difference in 
terms of exophily with only 6.9% of An. funestus exiting the hut with untreated net whereas 
42.4% Mansonia spp. exited the room with a control net. This is different from the previous 
observation in Ivory Coast, where a similar exophily (~35%) was observed for both An. 
gambiae and Mansonia spp. in experimental huts (Koudou et al., 2011). Furthermore, while 
all the 5 LLINs significantly increased the exophily rate for An. funestus, this was not the case 
in Mansonia spp with no significant change observed probably as Mansonia spp are more 
exophilic (Kumar et al., 1992). 
 
4.4.2 GSTe2 mediated metabolic resistance is reducing the efficacy of LLINs: Case from tube 
test 
 
With the design of the L119F-GSTe2 diagnostic tool (Riveron et al., 2014b), this study has 
investigated for the first time, the impact of GST-mediated metabolic resistance on the 
efficacy of LLINs. The significant correlation observed in this population between genotypes 
of this marker and resistance to both pyrethroids and also DDT further confirms the major role 
played by GSTe2 in the resistance against these insecticides. This highlights the fact that 
metabolic resistance should not be tackled only by focusing on cytochrome P450s. 
 
4.4.3 GSTe2 mediated metabolic resistance is reducing the efficacy of LLINs: analysis done 
with samples from experimental hut trial 
 
A significant association was observed between the blood-feeding ability of An. funestus and 
the L119F-GSTe2 mutation as mosquitoes with the 119F resistance allele have significantly 
higher blood-feeding rates compared to those with L119 susceptible allele against Olyset Net 
(P<0.001) and Olyset plus (P<0.001). This suggests that L119F-GSTe2 mutation likely 
contributes to an increased malaria transmission as every additional bite increases the chance 
of sporozoite to be passed to the populations. This is particularly a concern as 119F-RR 
resistant mosquitoes have also been shown to live longer (Tchouakui et al., 2019d; Tchouakui 
et al., 2018) and to have a greater vectorial capacity to transmit Plasmodium (Tchouakui et al., 
2019a) . However, it is noticeable that the impact of L119F-GSTe2 on blood-feeding ability is 
mainly seen for Olyset Plus and Olyset LLINs impregnated with permethrin but presented an 
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opposite effect for PermaNet 3.0 and 2.0 both impregnated with deltamethrin. The cause of 
such difference between permethrin- and deltamethrin-based nets is unclear at this point 
since the greater blood-feeding in the Olyset net is not associated with greater survivorship. 
This is particularly true as a similar significant association was observed between L119F 
genotypes and resistance to both insecticides in this An. funestus population. Further work 
will be needed to establish the cause of this difference between permethrin and deltamethrin 
nets. Similar genotype/phenotype studies performed to assess the impact of the knockdown 
target-site resistance (kdr) on resistance did not reveal such a significant association with 
blood-feeding potentially since kdr frequency was already very high in tested An. gambiae 
population (Ngufor et al., 2014a). However, the indirect comparison of kdr effect in two 
separate populations of An. gambiae in Benin; one with high kdr frequency (Ladji) and another 
with low frequency (Malanville) did suggest that kdr could also impact the efficacy of LLINs 
(N'Guessan et al., 2007a). 
Interestingly, the L119F-GSTe2 mutation was also associated with an increased exophily for 
Olyset Plus and PermaNet 2.0, suggesting that the increased expression of GSTe2 could impact 
mosquito’s behavior, helping them avoid exposure to insecticides. Similarly, over-expression 
of carboxylesterase in Culex pipiens (Berticat et al., 2004) has been previously associated with 
a behavioral change as resistant mosquitoes were found to have reduced mobility (Berticat et 
al., 2004) supporting that metabolic resistance could impact mosquitoes’ behavior in the 
presence of insecticide-based interventions. 
No significant association was observed between L119F-GSTe2 and mortality in the 
experimental huts samples for all LLINs potentially due to the low number of dead mosquitoes, 
which did not provide statistical power coupled with a lower frequency of RR in this location. 
However, a trend was observed for PermaNet 3.0 with an increased proportion of 119F 
homozygote resistant mosquitoes able to survive exposure to this LLIN than both homozygote 
susceptible L119-SS (OR= 3.47; P=0.08) and heterozygotes (OR=3.46; P=0.1). 
 
4.4.4 Impact of the GSTe2 mediated metabolic resistance on the efficacy of LLIN using cone 
bioassays 
 
This trend for a correlation was supported by results with samples from cone assays where a 
robust association was observed between L119F-GSTe2 and the ability to survive exposure to 
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PermaNet 3.0 (side) (OR=30.1) and PermaNet 2.0 although at lower extent (OR=2.09). The lack 
of association observed with Olyset Plus could be explained by the effect of PBO, which for 
this net is incorporated on the entire net, whereas for PermaNet 3.0, PBO is only on the top. 
The PermaNet 3.0 used here is only the side without PBO. Despite that, it is surprising that a 
greater impact was seen on PermaNet nets as contrary results were observed for blood-
feeding where GSTe2 impacted more the Olyset nets but not the PermaNet. One reason why 
a greater association is found with PermaNet 3.0 (side) could be the fact that with higher 
deltamethrin concentration than PermaNet 2.0, mosquitoes surviving exposure to PermaNet 
3.0 are those likely to be much more resistant because of a greater expression of GSTe2 and 
other cytochrome P450s. So, the higher dose of deltamethrin in PermaNet 3.0 has further 
selected mosquitoes with 119F-GSTe2 resistant alleles than with the lower dose in PermaNet 
2.0. This is also likely the reason why a trend of a greater ability to survive was seen in the 
experimental hut for PermaNet 3.0 ( Tableau 4.5). 
It is also a reminder that mosquitoes displaying several resistance mechanisms than just P450-
based resistance could avoid even PBO-based nets as when cytochrome P450 enzymes are 
inhibited by PBO, mosquitoes bearing other mechanisms, as in this case the 119F resistance 
allele, are able to better survive exposure to PBO-based nets. However, this cannot explain 
why such results were not observed with Olyset Plus, the other PBO-net. Further work is 
needed to elucidate the full interaction of GSTe2 and LLINs. However, the spread of a GSTe2-
mediated metabolic resistance-conferring the ability of mosquitoes to survive exposure to 
synergist LLINs will constitute a concern at a time when such nets are gradually being 
introduced to fight pyrethroid-resistant mosquitoes. GST resistance will also need to be taken 




This study has revealed a loss of efficacy of LLINs against pyrethroid-resistant populations of 
An. funestus in Cameroon using experimental huts. However, PBO based nets (PermaNet 3.0 
and Olyset Plus) are more efficient than conventional pyrethroid-only nets. Noticeably, the 
GST-mediated metabolic resistance not impacted by PBO is a severe threat to the continued 
effectiveness of the PBO-based LLINs, and the impact of this mechanism also needs to be 
taken into account to maximize the efficiency of LLINs. One option could be to generate new 
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mosaic LLINs, also incorporating the Diethyl Maleate (DEM) beside PBO to inhibit GST 




4.6 Ethics approval and consent to participate 
 
The national ethics committee for health research of Cameroon validates the protocol of the 















Chapter 5: Duplicated CYP6P9a and CYP6P9b cytochrome p450 
genes significantly reduced the efficacy of bed nets against 
pyrethroid-resistant Anopheles funestus in an experimental hut 
trial. 
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5.1 Context of the study 
 
Despite the recent reduction in Africa's malaria burden (Dhiman, 2019), insecticide resistance 
poses a serious threat to the continued effectiveness of the major control tools such as 
insecticide-treated nets (Churcher et al., 2016b). Metabolic resistance has been shown to 
provide a higher risk of control failure (Hemingway et al., 2016; Riveron et al., 2019), notably 
the one driven by cytochrome P450s. In the previous chapter, we showed that GST-mediated 
metabolic resistance could impact of the efficacy of bed nets, but nothing is known for P450-
based resistance before this study because of the lack of suitable DNA-based markers for this 
resistance. Thanks to the recent design of molecular markers for the duplicated CYP6P9a/b, 
we are in a great position for the first time to assess how P450-based pyrethroid resistance is 
impacting the efficacy of nets, including pyrethroid-only and PBO nets. 
P450s are playing a role of high importance in insecticide resistance, notably pyrethroid 
resistance in malaria vectors. P450s are consistently found over-expressed in relation to 
resistance (Amenya et al., 2008; Djouaka et al., 2008; Riveron et al., 2014a; Riveron et al., 
2013; Wondji et al., 2009). Several P450s such as CYP6P9a/b, CYP6M7, CYP6AA1, CYP6P4a/b, 
CYP6P2, and CYP6P5 have been found overexpressed in multiple resistant populations of An. 
funestus across Africa, althought most of them are still waiting to be validated (Ibrahim et al., 
2016; Mulamba et al., 2014a; Riveron et al., 2014a). In An. gambiae from West Africa, P450s 
such as CYP6P3 and CYP6M2 were found overexpressed (Djouaka et al., 2008). CYP6P9a/b 
genes were found to be the major ones involved in pyrethroid resistance in the southern part 
of Africa. CYP6P9a is more expressed in Malawi in both Resistant (R)-Susceptibe (S) (Fold 
Change (FC) 62.7) and Control (C)-S (FC69.7) than in Mozambique (FC 38.5 and FC 37.9 for R-
S and C-S, respectively). The CYP6P9b pattern was observed in Mozambique in both R-S 
(FC50.2) and C-S (FC64.9) (Riveron et al., 2013). Comparative functional analysis of CYP6P9a and 
CYP6P9b confirmed that both genes can confer resistance independently to both types I 




Figure 5.1: Bioassays results with transgenic strains for CYP6P9a and CYP6P9b. A) Test with 
deltamethrin on transgenic line B) Test with permethrin on transgenic Act5C-CYP6P9a. C) Test 
with deltamethrin on transgenic Act5C-CYP6P9b. D) Test with permethrin on transgenic 
Act5C-CYP6P9b. It is adapted from (Riveron et al., 2013). 
 
Work started early by Amenya et al 2008 and, more importantly, Wondji et al 2009) detected 
the duplicated CYP6P9a and b using quantitative trait locus (QTL) mapping sequencing of 
Bacterial artificial chromosomes (BAC) clones and gene expression. The genomic organization 
of these genes and the evidence of duplication have been demonstrated. However, their 
expression is not always the same, so they do not always act as a single unit. This is highlighting 
the need of assessing the effect of these duplicated genes separately (Amenya et al., 2008; 
Riveron et al., 2013; Wondji et al., 2009). 
Based on all these observations on CYP6P9a/b, further investigations indicated that 
mosquitoes from southern Africa consistently showed different polymorphism when 
compared to other Africa regions. This polymorphism included an AA insertion 8 bp upstream 
of a putative CCAAT box through an A/C substitution. This was used to generate the CYP6P9a 
marker. Concerning the CYP6P9b, an indel of 3 bp (AAC) was consistently observed with a 
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deletion in the resistant FUMOZ and presence in susceptible FANG. Based on this, a DNA-
based diagnostic assay to detect the CYP6P9b-mediated resistance was designed (Mugenzi et 
al., 2019; Weedall et al., 2019). 
 
Elucidating how insecticide resistance is changing the effectiveness of LLINs using these 
markers is key to established appropriate insecticide resistance management strategies to 
prevent the resurgence of malaria (Hemingway, 2017). The probability that increasing 
insecticide resistance will affect the efficacy of these interventions cannot be ignored 
(Churcher et al., 2016b; Strode et al., 2014; WHO, 2018). However, assessing the impact of 
metabolic resistance is critical since it can lead to control failure. Some malaria vectors such 
as An. funestus where pyrethroid resistance is mainly metabolic (Irving and Wondji, 2017) 
provide a suitable opportunity to assess this. The impossibility to evaluate the impact of 
insecticide resistance on the effectiveness of control tools such as LLINs due to the lack of 
molecular marker for metabolic resistance in all the major malaria vectors in Africa, including 
An. gambiae and An. funestus is a major obstacle to develop evidence-based resistance 
management strategies. 
 
Using theses markers, a significant association was observed between permethrin resistance 
and the CYP6P9a/b genotype. For CYP6P9b as example, a significant high correlation was 
observed when comparing the surviving ability RR vs. SS (OR = infinity; P = 1.1 × 10−50) and 
RS vs. SS (OR = 715; P = 2.4 × 10−45). These data  validating of the role of CYP6P9a/b in the 
resistance is the reason why we have relied on such test for our study investigating the impact 
of insecticide resistance. 
 
This study aims to assess the impact of P450- resistance on the performance of pyrethroid-
only and PBO-based nets against the pyrethroid-resistant An. funestus mosquitoes using a 
hybrid laboratory strain. This study revealed that P450-based metabolic resistance 






5.2.1 Location of the experimental station used for the releasing 
 
The experimental station is located at Mibellon (6°4′60′′N, 11°30′0′′E), a village in Cameroon 
located in the Adamawa Region; Mayo Banyo division and Bankim Sub-division. (See method 
Chapter 2,  Section 2.1.1). 
 
5.2.2 Laboratory strain: Fumoz/Fang crossing 
 
The crossing was done using two laboratory strain. An. funestus from Angola (FANG) and An. 
funestus from Mozambique (FUMOZ). During rearing, the pupae of each strain were kept 
individually in Falcon tubes (15ml) locked with a piece of cotton. After the emergence of pupae 
in the Falcon tube, the males and the females were separated. 50 males and 50 females  that 
emerged separately were then released in a cage for the crossing. More details about the 




FUMOZ is a resistant laboratory strain selected from An. funestus s.s. Resistance in that strain 
has been selected over generations after exposure to 0.1% lambda-cyhalothrin. WHO tube 
assays in successive generations F2 to F4 showed increased resistance with each successive 















   
  
    
   
  
Figure  5.2: Recorded  mortalities  following  60-min  exposure  and 24-h  post-exposure 
observation for three  generations  of An.  funestus selected after  exposure  to  0.1%  lambda- 
cyhalothrin. A) Males: F2 (n = 1592), F3 (n = 1023) and F4 (n = 910). B) Females: F2 (n = 1566), 
F3 (n = 1020) and F4 (n = 1037). Adapted from (Hunt et al., 2005).
5.2.2.2 FANG
FANG is a susceptible laboratory strain selected from An. funestus s.s and colonized from
Calueque in southern Angola since 2002 as mentioned by (Wondji et al., 2005b).
5.2.2.3 Crossing
The hybrid strain was obtained after a crossing of FUMOZ (resistant lab strain with resistance 
mediated by CYP6P9a and b at the fixed level) and Fang (susceptible lab strain). After the initial 
F1 generation obtained from the reciprocal crosses of 50 males and 50 females of both strains, 
the hybrid strain was reared to F5 and F6 generation, which were used for the releasing in the 
huts (Figure 5.3). The Crossing was done in both direction, female FUMOZ x male FANG (Figure 






Figure 5.3: reciprocal crossing between the highly pyrethroid-resistant strain FUMOZ-R 
(originally from Mozambique) and the fully susceptible FANG strain (originated from Angola). 
A) Female FUMOZ crosses with male FANG. B) Male FUMOZ crosses with female FANG. 
 
 
5.2.3 Experimental hut design 
 
The huts were built following the prototype recommended by WHO for the West African 
region (See Chapter 2, Section 2.1.1 ).  
 
5.2.4 Hut treatment / Arm comparison 
 
During the experimental hut trial, four insecticide treated nets were used:   Olyset, Olyset Plus, 




Cone bioassays were performed at the beginning of the study using susceptible laboratory 
strain Anopheles coluzzii from Ngousso. This was done to confirm the quality of the five bed 
nets involved in the study. Cone bioassays were also done in the insectary using the reciprocal 
hybrid strain to confirm the role of CYP6P9a/b in resistance. A fragment of PermaNet 2.0, 
PermaNet 3.0, Olyset, and Olyset Plus was used for the cone test. See details of the protocol 
in chapter 2. Five batches of 10 unfed females, aged 2-5 days old, were exposed to each bed 
net using WHO cone assays for three minutes. They were then transferred into the holding 
paper cup containers. The knockdown was checked after 60 min and the mortality after 24 
hours. WHO tube assays were also done, dead/ alive mosquitoes were obtained and 
genotyped to further to confirm the role of CYP6P9a/b in resistance. 
 
5.2.6 Experimental hut trial  
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The experimental hut trial was done in this case not using the wild population. The hybrid lab 
strain Fumoz-Fang was reared in the insectary and released in the treated hut every evening. 
A number varying from 50 to 100 were released every night and collected in the morning.  
 
5.2.6 1 Latin square design rotation and volunteer sleepers 
 
Usually, the Latin square design rotation was applied to correct the specific attractiveness that 
some huts may have due to their position (WHO, 2013b). Because a fixed number of 
mosquitoes were released every night in the huts selected for the study, the rotation was not 
necessary in this case. Six volunteering men were selected to sleep in the room from 20:00 
GMT to 5:00 GMT in the morning. The sleepers were rotated so that each sleeper would have 
spent one night in each hut at the end of the week. The sleeper's rotation was done to correct 
any bias due to any specific attractiveness from the sleepers. 
 
5.2.6 2 Releasing and recapture 
 
Every test night, each volunteer was installed in the different hut selected for the study. 50 to 
100 mosquitoes from the lab strain Fumoz/Fang were equally released in the huts. Mosquitoes 
were collected every morning, using hemolysis tubes from: (i) inside the nets, (ii) in the room: 
floor, walls and roof, and (iii) in the veranda exit trap. Mosquitoes collected from each 
compartment were kept separately in a bag to avoid any mixing between samples from 
different compartments. (Figure 2.2). Samples were transferred to the laboratory for 
identification. After identification, samples were then classified as dead, alive, blood-fed, or 
unfed (Appendix 1). The ‘alive’ samples were kept in the paper cup and provided with sugar 
solution for 24 hours and mortalities monitored. Dead mosquitoes were then kept adequately 
in labelled Eppendorf tubes with Silicagel for dead and live mosquitoes stored in RNA later 
(Figure 2.3). 
 
5.2.7 Bed nets performance assessment  
 
The performance of the bed nets was expressed relative to control (untreated nets) 
(Appendix 1) in term of: 
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i-Deterrence/entry rate: the reduction in hut entry relative to control. Deterrence (%) 
= 100 x (Du – Dt) / Du, where Du is the total number of mosquitoes found in the untreated hut 
(control), and Dt is the total number of mosquitoes in the treated hut. 
ii-Entry rate (%) = 100 x (Ht/Hn) where Ht is the total number of mosquitoes found in 
the hut, and Hn is the total number of mosquitoes collected in all the six huts. 
iii-Exophily: the proportion of mosquitoes found exited in the veranda trap. 
Exophily (%) = 100 x (Ev/Et) where Ev is the total number of mosquitoes found in veranda, and 
Et is the total number of both inside the hut and veranda. 
iv-Blood feeding rate (BFR). This rate was calculated as follows: Blood feeding rate = 
(N mosquitoes fed) x 100 / total N mosquitoes. Where “N mosquitoes fed” was the number of 
mosquitoes fed, and “total N mosquitoes” was the total number of mosquitoes collected. 
v-Blood-feeding inhibition (BFI): the reduction in blood-feeding in comparison with 
the control hut. Blood feeding inhibition is an indicator of personal protection (PP). More 
precisely, the personal protection effect of each bed net is the reduction of blood-feeding 
percentage induced by the net when compared to control. The protective effect of each bed 
net can be calculated as follows: Personal protection (%) = 100 x (Bu – Bt) / Bu, where Bu is 
the total number of blood-fed mosquitoes in the huts with untreated nets and Bt is the total 
number of blood-fed mosquitoes in the huts with treated nets (WHO, 2013). 
vi-Immediate and delayed mortality: the proportion of mosquitoes entering the hut 
that is found dead in the morning (immediate death) or after being caught alive and held for 
24 h with access to sugar solution (delay mortality) (WHO, 2013). In this study, we focused on 
the overall mortality calculated as follows: Mortality (%) = 100 x (Mt/MT) where Mt is the total 
number of mosquitoes found dead in the hut and MT is the total number of mosquitoes 
collected in the hut. 
5.2.8 Confirming role of CYP6P9a/b in conferring resistance in hybrid strains 
 
Before assessing the impact of CYP6P9a/b on the effectiveness of LLINs using the experimental 
huts, the role of CYP6P9a/b in conferring resistance was evaluated in laboratory conditions 






WHO bioassays were conducted with 0.75% permethrin and 0.05% deltamethrin for 30 min 
and 90 min. For each insecticide, four replicate of 25 mosquitoes from the hybrid strains were 
used (see more details regarding the bioassays in Chapter 2). Alive mosquitoes after 90 min of 
exposure and those dead after 30 min of exposition were then genotyped to establish the 
association between the CYP6P9a/b-R resistant allele and the ability of mosquitoes to survive 
to these insecticides. 
 
5.2.8.2 Cone assays 
 
Cone test bioassays were conducted with a fragment of Olyset, Olyset Plus, PermaNet 2.0 and 
PermaNet 3.0 (sides and top). The resistant hybrid strains FUMOZ-FANG were used (see more 
details regarding cone test protocol in Chapter 2). Alive and dead mosquitoes obtained after 
exposure were then genotyped. The association between the CYP6P9a/b resistant allele and 
the ability of mosquitoes to survive to these insecticides was established. 
 
5.2.9 Impact of the duplicated P450 gene, CYP6P9a and CYP6P9b on the performance of 
bed nets 
 
The samples collected during the investigation on the performance of nets were grouped in 
several categories: dead, alive, blood fed, unfed; room and veranda. The CYP6P9a and 
CYP6P9b were genotyped in each group using the RFLP-PCR. This allowed a direct measure of 
the relative survival and feeding success of resistant and susceptible insects in the presence 
of different bed nets. 
 
5.2.9 1 Genotyping of CYP6P9a/b using sample from the laboratory 
 
The CYP6P9a and CYP6P9b were genotyped using dead and alive mosquitoes obtained after 
cone test and WHO tube tests with the hybrid strain to confirm the role of CYP6P9a/b in the 
resistance observed. A PCR–RFLP (Mugenzi et al., 2019; Weedall et al., 2019) was used to 
detect the three genotypes for each gene as detailed in chapter 2 methodology. 
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5.2.9 2 Genotyping of CYP6P9a/b using sample from experimental hut
The CYP6P9a and CYP6P9b were also genotyped to assess how these P450 genes are impacting 
the  performance  of  bed  nets.  A PCR–RFLP (Mugenzi  et  al., 2019; Weedall  et  al., 2019) was
used to detect the three genotypes for each gene, as detailed in Chapter 2 methodology.
5.2.10 Statistical analysis
Experimental hut trial: To calculate the proportion of each entomological outcome and the 
level of significance between the treatments and the control, the XLSTAT software (Addinsoft, 
Berkeley, CA, USA) was used, as done previously (Badolo et al., 2014; Chouaibou et al., 2006). 
The numbers of mosquitoes collected in the huts with different treatments were analyzed by 
negative binomial regression. The effects of the treatments on each of the main proportional 
entomological  outcomes  (exophily,  blood-feeding,  and  mortality)  were  assessed  using 
binomial generalized linear mixed models (GLMMs) with a logit link function, fitted using the
‘lme4’ package for R 3.6. (R Development Core Team, 2019) (Ngufor et al., 2016a; Toe et al., 
2018). A separate model was fitted for each outcome and each mosquito species. In addition 
to the fixed effect of each treatment, each model included random effects to account for the 
following sources of variation: between the huts used in the studies; between the sleepers 
who slept in the huts; between the ten weeks of the trial (Appendix 4).
Test  of  association  between  the  genes  (CYP6P9a/b)  and  the  entomologicaloutcomes:
To investigate the association between the genes and the ability of the mosquitoesto survive, 
blood feed or escape, Vassar stats were used to estimate the odds ratio based ona fisher 
exact probability test with a 2x2 contingency table.  
 
Hut effect analysis: The one-way analysis of variance (ANOVA) using Prism 7.0 (GraphPad, San 
Diego, CA, USA) was used to determine whether there were any statistically significant 
differences between the means of the mosquitoes collected from the six huts (Appendix 5). 
For all the analyses in this study, an alpha of 0.05 was used as the cut off for significance. 
 
Construction of graph: Most of the graphs in this document were constructed using the 
software Prism 7.0 (GraphPad, San Diego, CA, USA). 
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5.2.11 Ethical clearance 
 
The national ethics committee for health research of Cameroon approved the protocol of the 
study (ID:2016/03/725/CE/CNERSH/SP) (Appendix 6). Written, informed, and signed consent 
was obtained from sleepers before starting the trials. The consent form provided all the 
information and the evaluation process about the study. Information was translated into the 
local language when needed. All the volunteers involved in the study were followed-up and 




5.3.1 Susceptibility test 
 
Susceptibility profiles of the FUMOZ-FANG and FANG-FUMOZ strains: The WHO tube test 
performed with the reciprocal FANG-FUMOZ strains revealed that both hybrid strains were 
resistant to pyrethroids and carbamates and moderately resistant to DDT (93% mortality) 
(Figure 5.4). However, a significant difference was observed for deltamethrin with a higher 
mortality rate recorded for the strain generated from crossing females FUMOZ_R to males 
FANG (48.5%) than in the strain from females FANG and males FUMOZ_R (77.3%). In addition 
it was also noticed that FUMOZ (females) x FANG (males) were more resistant to deltamethrin 
than permentrin (48.5% vs 80.7%) (Figure 5.4). Based on the fact that both reciprocal strains 




Figure 5.4: Susceptibility profile of both reciprocal the strain FUMOZ-FANG and Fang-Fumoz 
to insecticides. Recorded mortalities following 60-min exposure of both reciprocal strains to 
Permethrin, Deltamethrin, Bendiocard, and DDT. 
 
Susceptibility profiles of the FUMOZ-FANG strains obtained after 30 and 90 min of 
exposition: The bioassays performed with the reciprocal FANG-FUMOZ strains revealed that 
the hybrid strains were resistant to permethrin with mortality of 81.30±6.59 % and 
39.28±1.59% respectively for 90 min and 30 min. Resistance was also observed with 
deltamethrin with a mortality of 86.36±3.11 % and 42.28±2.48 %, respectively, for 90 min and 









Figure  5.5: Susceptibility  profile  of  the  hybrid  strain  Fumoz-Fang  to  insecticides.  Recorded 
mortalities  following  30-min  and 90-min  exposure  of  the  hybrid  strain  Fumoz-Fang to 
pyrethroid type I (permethrin) and to type II (deltamethrin). Data are shown as mean ± SEM. 
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5.3.2 Quality control and performance of the nets in the laboratory against the hybrid 
strain 
 
All the four nets used in the study were first exposed to the susceptible lab strain Kisumu for 
quality control. The mortality for Olyset, Olyset Plus, Permanet2.0 and PermaNet 3.0 side and 
top was 100% (Figure 5.6). In the laboratory, Anopheles funestus from the hybrid strain was 
exposed to bed nets using WHO cone assay. Olyset and Olyset plus showed mortality of 
30.09±11.52 %, and 48.91±14.78 % respectively. PermaNet 2.0 showed 31.07±3.75% mortality 
and PermaNet 3.0 side and PermaNet 3.0 top gave 40.66 ±6.69 % and 100±0 % mortalities 
respectively (Figure 5.6). Overall, PBO-synergist nets were more effective than pyrethroid-only 
nets. (Figure 5.6). 
 
Figure 5.6: Assessment of net quality: Recorded mortalities following 3 min exposure to 
various nets with cone assays using Kisumu, An. gambiae susceptible lab strain and recorded 
mortalities following 3 min exposure by cone using An. funestus (crossing Fumoz-Fang-F5). 
 
5.3.3 Mosquitoes released during the study. 
 
A total number of 1385 mosquitoes from the hybrid strain FUMOZ-FANG, generation F5-F6 
were released during the study. 356 samples were released in the control hut, 270 in the hut 
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treated with PermaNet 2.0, 322 in the hut treated with PermaNet 3.0, 224 for Olyset and 213 
for Olyset Plus. 
 
5.3.4 Validating the role of CYP6P9a/b in pyrethroid resistance in the hybrid FUMOZ-FANG 
strains before any field studies 
 
5.3.4.1 Validating the role of CYP6P9a_R in pyrethroid resistance in the hybrid FUMOZ-FANG 
before the experimental hut 
 
Using the hybrid FUMOZ/FANG strains, the role of the CYP6P9a_R allele in the observed 
pyrethroid resistance was confirmed. WHO bioassays showed a mortality of 39.0% and 42.3% 
after 30 minutes’ exposure and mortality rates of 81.3% and 86.3% after 90 minutes’ 
exposure, respectively to permethrin and deltamethrin (Figure 5.7). The odds ratio of surviving 
exposure to permethrin when homozygous for the resistant CYP6P9a_R allele (RR) was high 
at 693 (CI 88-5421; P<0.0001) compared to the homozygous susceptible (SS) (Figure 5.7). The 
OR was 131 (CI 27-978; P<0.0001) when comparing RR to RS, indicating that the resistance 
conferred by CYP6P9a is additive. 
 
 
Figure 5.7: Role of CYP6P9a in pyrethroid resistance using Fumoz-Fang, the hybrid lab strain. 
Distribution of the CYP6P9a genotypes according to resistance phenotypes. 
 
5.3.4.2 Validating the role of CYP6P9b_R in pyrethroid resistance in the hybrid FUMOZ-FANG 
strains before the experimental hut 
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To confirm the ability of CYP6P9b_R marker to foresee pyrethroid resistance phenotype in An. 
funestus, The hybrid strain FUMOZ-FANG at the F6 generation. The genotyping of the same 
strain that was used previously to validate the CYP6P9a (Weedall et al., 2019) shown that 
those remaining alive after exposure to permethrin for 180 minutes are mainly homozygote 
resistant (20.83%) and heterozygotes (75%) with only two being homozygote susceptible. 
Among the 47 mosquitoes found dead after 30 min exposure to permethrin (highly 
susceptible), 97.87% were found homozygote susceptible, and one remaining was a 
heterozygote (Figure 5.8). A strong association was perceived between permethrin resistance 
and the CYP6P9b genotype when comparing RR vs SS (OR= infinity; P=1.1x10-50) and RS vs SS 
(OR=715; P=2.4x10-45) (Figure. 5.8). 
 
Figure 5.8: Role of CYP6P9b in pyrethroid resistance. Distribution of the CYP6P9b genotypes 
according to resistance phenotypes. 
 
5.3.4.3 Validation of the role of CYP6P9a and CYP6P9b in conferring resistance using 
samples from cone assays 
 
Using dead and alive obtained after cone test in the laboratory condition, CYP6P9a 
homozygous resistant mosquitoes (RR) and heterozygous (RS) were significantly more able to 
survive exposure to PermaNet 2.0 PermaNet 3.0 side; Olyset and Olyset Plus than homozygote 
susceptible (Table 5.1; figure 5.9) For example Olyset show a strong association between the 
gene and the ability to survive when comparing RR v SS (OR=35.1; P<0.00001) and RS v SS 
(OR=34.6; P<0.00001) for the CYP6P9a. The same trend when looking at the allelic frequency 
R v S (OR=7.7; p<0.05) (Table 5.1; figure 5.9). Concerning the CYP6P9b homozygous resistant 
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mosquitoes (RR) and heterozygous (RS) were significantly more able to survive exposure. A 
strong association between the gene and the ability to survive when comparing RR v SS 
(OR=32.4; P<0.00001) and RS v SS (OR=97.3; P<0.00001) (Table 5.1; figure 5.9). 
 
Table 5.1: CYP6P9a and CYP6P9b genes reducing the efficacy of Olyset Net against pyrethroid 
resistant An. funestus after cone assay in the laboratory. 
 
    OR P value CI OR P value CI 
Mortality 
Olyset   CYP6P9a     CYP6P9b   
  RR vs SS 35.1 <0.00001 11.0-111.2 32.4 <0.00001 10.8-97.3 
  RS vs SS 34.6 <0.00001 14.4-83.52 97.3 <0.00001 34.2-277.1 
  RR vs RS 0.9 1.0 0.3-2.8 3.0 ˃0.05 0.9-9.4 
  R vs S 7.7 <0.001 3.9-15.2 11.1 <0.001 5.2-23.4 
Olyset Plus RR vs SS 6.4 <0.001 2.3-17.4 9.7 <0.001 3.2-29.1 
  RS vs SS 7.2 <0.001 2.6-20.14 17.9 <0.001 5.7-55.8 
  RR vs RS 1.1 ˃0.05 0.6-2.0 1.8 ˃0.05 0.9-3.5 
  R vs S 2.0 0.02 1.1-3.7 2.2 <0.01 1.2-4.1 
      CYP6P9a     CYP6P9b   
PermaNet 
2.0 
RR vs SS 
239.0 
<0.001 
48.3-1182.9 NA NA NA 
  RS vs SS 63.0 <0.001 15.6-254.1 NA NA NA 
  RR vs RS 3.7 <0.01 1.3-10.3 7.5 <0.001 2.5-21.7 
  R vs S 10.2 <0.0001 5.2-19.8 26.9 <0.05 12.6-57.1 
PermaNet 
3.0 
RR vs SS 
81.0 
<0.001 
20.5-319.7 NA NA NA 
 RS vs SS 6.5 <0.01 1.7-25.4 NA NA NA 
 RR vs RS 12.0 <0.001 5.5-25.9 15 <0.05 6.9-32.7 




Figure 5.9: Association between the duplicated CYP6P9a/b genes and the ability to survive 
exposure to Olyset Plus net after cone assays: A) Genotype distribution of CYP6P9a between 
alive and dead mosquitoes after exposure to Olyset showing strong association (RR vs SS: 
P<0.001); B) Genotype distribution of CYP6P9b between alive and dead mosquitoes after 
exposure to Olyset showing strong association (RR vs SS: P<0.001). 
 
5.3.4.4 Validating the role of CYP6P9a combined to CYP6P9b in pyrethroid resistance in the 
hybrid FUMOZ-FANG strains before the experimental hut 
 
The role of CYP6P9b and CYP6P9a in pyrethroid resistance assessed revealed that both genes 
are combined additively to increased the level of resistance. All mosquitoes carrying the 
double homozygote resistant genotypes (RR/RR) were all alive after 180 minutes exposure. 
However, only half of the homozygote resistant for CYP6P9b were also homozygote resistant 
for CYP6P9a with the other half only heterozygotes for CYP6P9a (Figure 5.10.A). Double 
heterozygote mosquitoes (RS/RS) were mostly alive (66.7%) with 10.4% RR/RR and 16.7% 
RR/RS (Figure 5.10.B) suggesting possible fitness cost related with having double resistance 
alleles for both genes. All the dead mosquitoes were found to be RR/RR, RR/RS or RS/RS; this 






Figure 5.10: CYP6P9a and CYP6P9b combined additively to confer a higher level of resistance. 
XX/YY is the combination of both genes : XX represent the CYP6P9a and YY the CYP6P9b A) 
Distribution of the combined genotypes of both CYP6P9a and CYP6P9b, showing that both 
genotypes combined to increase the pyrethroid resistance. B) Frequency of various 
combinations of genotypes between CYP6P9a and CYP6P9b in F8 hybrid strain (FUMOZ_X_Fang) 
suggesting independent segregation of genotypes of both genes in this hybrid strain. 
 




Analysis of mortality rates revealed very high mortality of the hybrid FUMOZ-FANG strain 
against PBO-based nets with mortality of 99.1% for Olyset Plus and 98.8% for PermaNet 3.0. 
In contrast, lower mortality was observed for the pyrethroid-only nets with mortality rates of 
only 56.7% for Olyset and 31.4% for PermaNet 2.0. Very low mortality was observed in the 
untreated control net (9.9%) (Figure 5.11; Table 5.2). For the entire study, the PBO – based 
nets were found to be more effective with mortality closed to 100 % when compared to 
conventional nets. This is certainly due to the fact that in the hybrid strain the resistance is 






5.3.5.2 Blood feeding 
 
The blood-feeding rate did not significantly differ when comparing control (7.8%) to Olyset 
(11.6% P˃0.05) and Olyset Plus (5.6%; P˃0.05), but the blood-feeding was higher in Olyset 
compared to Olyset Plus (11.6% v 5.6%; P=0.013) (Figure 5.11 and Table 5.2). 
The blood-feeding was high in PermaNet 2.0 compared to PermaNet 3.0 (10.2% v 6.8%) but 
not in a significant way (P=0.1). PermaNet 3.0 provided a higher personal protection compared 
to PermaNet 2.0 but not significantly (79.04 % vs 73.34%; P= 0.09)(Figure 5.11). The same 
trend was already observed with Olyset and Olyset Plus. This is because the synergist net was 
faster in killing the mosquitoes before they blood fed.  
For PermaNet Nets, blood feding was significant reduced in PermaNet 2.0 (10.2%; P<0.0001) 
and PermaNet 3.0 (6.8%; P<0.0001) when compared to control (27.8.8%) (Figure 5.11 and 
Table 5.2). 
 
Table 5.2: Performance of Olyset, Olyset Plus, PermaNet 2.0 and PermaNet 3.0 Plus against 
An. funestus females (crossing Fumoz-Fang-F5) in experimental hut trial 
Treatments 





Control  Olyset Olyset Plus 
Total 366 274 322 141 224 213 
Exophily% 11.5 15.0 15.8 13.5 23.7* 7.5* 
blood fed (%) 28.7 10.2* 6.8* 8.5 11.6NS 5.6NS 
blood feed inhibition. (%) 0.0 64.38 76.18 0.0 NS NS 
Personal protection (%) 0.0 73.34 79.04 0.0 -53 NA 00 NA 
Mortality (%) 9.9 31.4* 98.8* 9.9 56.7* 99.1* 
NA: Sample size too low in the control to make the calculation. NS: Non Significant 
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Figure 5.11: Performance of LLINs against the hybrid strain in Experimental hut. A) The 
proportion of mortality, blood-feeding and exophily rate for PermaNet 2.0 and PermaNet 3.0. 
B) The percentage of mortality, blood-feeding and exophily rate for Olyset, Olyset Plus. 
 
5.3.5 CYP6P9a is reducing the efficacy of bed nets in Experimental hut trial. 
 
5.3.5.1 CYP6P9a impacting Mortality 
 
Genotyping of the CYP6P9a maker allowed us to assess the impact of P450-based metabolic 
resistance on the loss of efficacy of PermaNet 2.0. Because most of the mosquitoes released 
in the PermaNent 3.0 huts died, the impact of the CYP6P9a on the ability to survive exposure 
to LLIN was assessed only for PermaNet 2.0. To avoid confounding effects from blood-feeding, 
or net entry or exophily status, the distribution of the CYP6P9a genotypes was assessed firstly 
only among unfed mosquitoes collected in the room. This revealed a highly significant 
difference in the frequency of the three genotypes between the dead and alive mosquitoes 
(P<0.0001) (Figure 5.12). Analysis of the correlation between each genotype and mortality 
revealed that CYP6P9a homozygous resistant mosquitoes (RR) show an increased ability of the 
mosquitoes to survive exposure to the PermaNet 2.0 when compared to homozygote 




Figure 5.12: Association between duplicated CYP6P9a gene and ability to survive exposure to 
PermaNet 2.0 in experimental hut trial: Genotype distribution of CYP6P9a between alive and 
dead mosquitoes after exposure to PermaNet 2.0 showing strong association (RR vs SS: 
P<0.001). 
 
Genotyping Olyset-exposed mosquitoes revealed that CYP6P9a homozygous resistant 
mosquitoes (RR) were also significantly more able to survive exposure to Olyset than 
homozygote susceptible (SS) (OR=5.0; P<0.001 for CYP6P9a) (Table 5.4; Figure 5.13) 
 
 
Figure 5.13: Association between duplicated CYP6P9a gene and ability to survive exposure to 
Olyset in experimental hut trial: Genotype distribution of CYP6P9a between alive and dead 





5.3.5.2 CYP6P9a impacting the Blood feeding 
 
Analysis of the impact of the CYP6P9a resistance on blood-feeding ability revealed that 
homozygote resistant mosquitoes (RR) were more likely to blood feed than homozygote 
susceptible (SS) but not significantly (OR= 1.75;P˃0.05) when exposed to PermaNet 2.0 in 
experimental hut (Figure 5.14; Table 5.3). 
 
 
Figure 5.14: Association between duplicated CYP6P9a gene and ability to blood feed when 
exposed to PermaNet 2.0 in experimental hut trial. CYP6P9a-R allele increases the ability of 
resistant mosquitoes of taking a blood meal in contrast to susceptible ones when exposed to 
PermaNet 2.0. 
The impact of the CYP6P9a gene on the blood-feeding ability of the mosquitoes exposed to 
Olyset was assessed. This revealed that homozygote resistant mosquitoes (RR) were 
significantly more likely to blood feed than homozygote susceptible (SS) (OR= 5;P=0.001) 





Figure 5.15: Association between duplicated CYP6P9a gene and ability to blood feed when 
exposed to Olyset in experimental hut trial. CYP6P9a-R allele increases the strength of resistant 
mosquitoes of taking a blood meal in contrast to susceptible ones when exposed to Olyset. 
For PermaNet 3.0, the same observation was done when comparing RR v RS individuals (OR= 
2.6; P<0.01) for PermaNet 3.0 (Table 5.3). For Olyset Plus Net, the impact of the CYP6P9a 
resistance on blood feeding ability was also assessed, revealing that homozygote RR 
mosquitoes are significantly more likely to blood feed than heterozygote RS (OR= 6.3; 
P<0.001). (Table 5.4). 
Samples collected in the control hut were also genotyped. Genotypes distribution in control 
showed no difference between unfed and fed for genotypes proving that difference observed 
in other huts are not random (Figure 5.16). 
 
Figure 5.16: Mosquitoes exposed to untreated nets show no difference between unfed and 
fed for CYP6P9a genotypes. 
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Table 5.3: Correlation between genotypes of CYP6P9a, CYP6P9b, mortality and blood-feeding 
after exposure to PermaNet 2.0 and PermaNet 3.0 in experimental huts. 
 
 OR P value CI OR P value CI 
Mortality 
PermaNet 2.0  CYP6P9a   CYP6P9b  
Unfed RR vs SS 34.9 <0.001 15.8-77.1 109.3 <0.001 40.7-293.2 
 RS vs SS 19.9 <0.001 9.7-40.9 34.7 <0.001 14.6-82.5 
 RR vs RS 1.75 ˃0.05 0.81-3.8 3.14 <0.01 1.4-6.9 
 R vs S 6.25 <0.001 3.3-11.7 7.2 <0.001 3.8-13.4 







 RS vs SS 5.3 <0.001 2.8-9.8 21.9 <0.001 8.7-55.1 
 RR vs RS 2.04 <0.001 1.1-3.7 2.8 <0.01 1.48-5.2 
 R vs S 3.17 <0.05 1.78-5.65 4.7 <0.001 2.6-8.7 
Blood feeding 
PermaNet 







 RR vs RS 2.5 ˃0.05 1.09-5.75 0.92 ˃0.05 0.49-1.7 
 RS vs SS 0.7 ˃0.05 0.28-1.7 1.68 1 0.79-3.5 
 R vs S 1.43 ˃0.05 0.82-2.5 0.94 1 0.5-1.6 
PermaNet 







 RR vs RS 2.6 <0.01 1.43-4.7 2.4 <0.01 1.31-4.39 
 RS vs SS 1.74 ˃0.05 0.87-3.47 2.1 ˃0.05 0.73-6.03 









Table 5.4: Correlation between genotypes of CYP6P9a, CYP6P9b, mortality and blood feeding 




  OR P value CI OR P value CI 
Mortality 
Olyset   CYP6P9a     CYP6P9b   
Unfed room RR vs SS 5.0 =0.001 2.01-12.4 15.0 <0.001 4.48-50.30 
  RS vs SS 1.8 ˃0.05 0.8-3.9 6.0 <0.001 1.9-18.75 
  RR vs RS 2.7 ˃0.05 1.6-6.08 2.4 1.0 1.2-4.8 
  R vs S 2.04 <0.05 1.1-3.6 2.5 <0.01 1.4-4.5 
All samples RR vs SS 7.03 <0.01 2.5-19.4 5.1 <0.01 1.8-14.6 
  RS vs SS 2.1 ˃0.05 0.8-5.7 1.9 1.0 0.7-5.3 
  RR vs RS 3.1 ≤0.05 1.6-6.1 2.5 <0.01 1.3-4.8 
  R vs S 2.4 <0.01 1.3-4.3 2.4 <0.01 1.3-4.3 
Blood feeding 
Olyset   CYP6P9a     CYP6P9b   
Room RR vs SS 4.5 <0.01 1.9-10.3 10.01 <0.001 4.1-24.9 
  RS vs SS 0.8 1.0 0.3-1.7 0.8 1.0 0.3-2.2 
  RR vs RS 5.4 <0.001 2.6-10.88 11.1 <0.001 5.3-23.03 
  R vs S 2.3 <0.01 1.3-4.1 4.7 <0.001 2.5-8.1 
All samples RR vs SS 3.1 <0.001 1.2-7.8 8.01 <0.001 2.4-25.9 
  RS vs SS 1.2 <0.01 0.5-2.8 1.8 1.0 0.5-5.8 
  RR vs RS 3.7 <0.001 1.9-7.1 4.3 <0.001 2.3-8.1 
  R vs S 1.99 <0.05 1.1-3.5 2.9 <0.001 1.5-5.4 
Olyset   CYP6P9a     CYP6P9b   
All samples RR vs SS 2.05 ˃0.05 0.9-4.4     
  RS vs SS 0.3 <0.05 0.1-0.7     
  RR vs RS 6.3 <0.001 3.1-12.5     
  R vs S 2.0 <0.05 1.1-3.5       
 
 
5.3.6 CYP6P9b is reducing the efficacy of bed nets. 
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5.3.6.1 CYP6P9b impacting the Mortality 
 
To measure the impact of CYP6P9b on the efficiency of LLINs, the effect was assessed on 
mosquitoes exposed to PermaNet 2.0 in experimental hut since the number of live mosquitoes 
collected in hut treated with PermaNet 3.0 was very low. The impact of CYP6P9b genotypes 
on the ability of mosquitoes to survive exposure to PermaNet 2.0 was firstly evaluated on the 
unfed samples collected only in the room. This was to exclude bias caused by feeding or 
exophiliy. This investigation showed that the three genotypes were detected and were 
significantly different in their distributions (P<0.0001) (Figure 5.17). The analysis also revealed 
that CYP6P9b homozygote resistant (RR) were significantly more able to survive exposure to 
PermaNet 2.0 than homozygotes-susceptible mosquitoes (SS) (OR=109.3; CI=40.7-293.2; 
P<0.0001) (Table 5.3). The association between the CYP6P9b and the survival ability was found 
to be more robust compared to the one observed for CYP6P9a using the same mosquito 
samples (OR=34.9; CI=15.8-77.1; P<0.0001) (Table 5.3). 
 
 
Figure 5.17: Distribution of CYP6P9b genotypes between dead and alive mosquitoes after 
exposure to PermaNet 2.0 net in experimental huts showing that CYP6P9b_R significantly 
allows mosquitoes to survive exposure to this insecticide-treated net. 
Similarly, the heterozygote mosquitoes (RS) demonstrated a greater ability to survive 
compared to homozygote susceptible (SS) when exposed to PermaNet 2.0 (OR=34.7; CI=14.6-
82.5; P<0.0001) (Table 5.3). The fact that the homozygote resistant mosquitoes (RR) present 
a greater ability to survive compared to heterozygotes (RS) (OR=3.14; CI=1.4-6.9: P=0.0058) 
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demonstrate the additive role of the resistant allele at the CYP6P9b locus in conferring 
resistance. In addition, a strong association was also observed between the gene and the 
ability to survive when comparing the allelic frequency (R vs S; OR=7.2; CI=3.813.4; P<0.0001) 
(Table 5.3). The same trend showing a strong association between the CYP6P9b genotypes 
and the mortality was also observed when analyzing all the samples dead and alive including 
the blood-fed and the one collected in the veranda (Table 5.3). 
 
Genotyping of Olyset-exposed mosquitoes revealed that CYP6P9b homozygous resistant 
mosquitoes (RR) were also significantly more able to survive exposure to Olyset than 
homozygote susceptible (SS) (OR=15.6; P<0.001) (Table 5.4; Figure 5.18). 
 
Figure 5.18: Association between CYP6P9b gene and the ability to survive when exposed to 
Olyset in experimental hut trial. CYP6P9b-R allele increases the ability of resistant mosquitoes 
to survive in contrast to susceptible ones when exposed to Olyset. 
 
5.3.6.2 CYP6P9b impacting the Blood feeding  
 
The effect of the CYP6P9b gene was measured on the aptitude to take the blood meal when 
exposed to PermaNet 3.0. A strong association was observed between CYP6P9b genotypes 
and the ability to blood-feed. Homozygote resistant mosquitoes (RR) were more able to 
bloodfeed when compared to homozygote susceptible mosquitoes (SS) (OR=5; CI=1.7-14.6; 
P=0.0001) (Table 5.3; Figure 5.19). Similar strong association was also observed when 
comparing homozygote resistant (RR) to heterozygotes (RS) (OR=2.4: CI=1.3-4.3; P=0.0085).  
When comparing RS to SS, no significant association was observed between the CYP6P9b 
168 
genotypes and an increased ability to bloodfed (OR=2.1; CI=0.73-4.39; P ˃0.05) (Table 5.3; 
Figure 5.19). 
Nevertheless, for PermaNet 2.0 no association was observed between the CYP6P9b genotypes 
and the blood feeding (P ˃0.05) (Table 5.3; Figure 5.20.A) Samples from control hut were also 
genotyped and no difference between unfed and fed for genotypes were noticed proving that 
difference observed in treated huts are not random (Figure 5.20.B). 
 
Figure 5.19: Distribution of CYP6P9b genotypes between blood-fed and unfed mosquitoes 
after exposure to the PBO-based net PermaNet 3.0 showing that CYP6P9b_R allele increases 













Figure  5.20: impact  of  the CYP6P9b-mediated  pyrethroid  resistance  on  blood  feeding  after 
exposure  to  insecticide-treated  nets: A) Distribution  of CYP6P9b genotypes  between  blood 
fed and unfed mosquitoes after exposure to the pyrethroid-only net PermaNet 2.0 showing 
no effect of CYP6P9b for this net. B) is for the untreated nets showing no correlation between
CYP6P9b genotypes and blood feeding success. 
 
Genotyping Olyset-exposed mosquitoes revealed that CYP6P9b homozygous resistant 
mosquitoes (RR) were also significantly more able to blood feed when exposed to Olyset than 
homozygote susceptible (OR=10.01; P<0.001) (Table 5.4; Figure 5.18). 
 
 
Figure 5.21: Association between the duplicated CYP6P9b gene and the ability to blood-feed 
when expose to Olyset in experimental hut trial. CYP6P9b-R allele increases the ability of 
resistant mosquitoes of taking a blood meal in contrast to susceptible ones when exposed to 
Olyset 
170 
5.3.7 CYP6P9a combines with CYP6Pb to further reduce the efficacy of bed nets 
 
Since, it has been observed that CYP6P9a and CYP6P9b was not necessarily linked, the 
combined effect at both genes on mortality and blood feeding was assessed. 
 
5.3.7.1 Impact of CYP6P9a combines with CYP6Pb on mortality 
 
PermaNet 2.0 : Examination of the effect of combined genotypes on the mortality using 
samples exposed to PermaNet 2.0 has furthermore established the independent segregation 
of genotypes at both genes. Double homozygote resistant mosquitoes (RR/RR) at both genes 
demonstrate by far a greater capacity to survive when exposed to PermaNet 2.0 compared to 
all the other combinations (Figure 5.21. A). This result is indicating that mosquitoes double 
homozygote resistant at CYP6P9a locus combines with CYP6Pb act additively to provide a 
more resistance to pyrethroids causing at a high level the reduction of the performance of 
LLINs. In addition,the additive effect of both genes acting together was reinforced by the fact 
that mosquito double homozygote resistant (RR/RR) at both genes were more able to survive 
when compared to double susceptible (SS/SS) (OR=76.5 ; CI=15-387). 
Table 5.5: Correlation between genotypes of CYP6P9a, CYP6P9b, mortality and blood feeding 
after exposure to PermaNet 2.0 and PermaNet 3.0 in experimental huts. 
 
    Mortality      
  OR PV CI 
 RR/RR vs SS/SS 76.5 <0.00001 15.1-387.7 
PermaNet 2.0 RR/RR vs RS/SS 47.7 <0.00001 12.6-181.01 
 RR/RR vs RR/SS 6.1 0.01 1.2-29.2 
 RR/RR vs RR/RS 1.6 0.82 0.5-5.07 
  RR/RR vs RS/RS 3.2 0.042 1.1-9.4 
 RR/RS vs SS/SS 29.6 <0.00001 6.3-139.4 
 RR/RS vs RS/SS 48.1 <0.00001 10.5-221.5 
 RR/RS vs RR/SS 3.8 0.011 0.9-16.02 
 RR/RS vs RS/RS 2 0.15 0.8-4.8 
    Blood feeding   
  OR PV CI 
 RR/RR vs SS/SS 6.5 <0.0001 2.2-19.1 
PermaNet 3.0 RR/RR vs RS/SS 2.86 <0.00001 1.5-5.4 




Figure 5.22: CYP6P9a combines with CYP6P9b to further reduce mortality when mosquitoes 
are exposed to insecticide-treated nets A) Combined genotype distribution in mosquitoes, 
demonstrating that double homozygote at both genes presents an increased survival rate 
when exposed to PermaNet 2.0. B) increased capacity to survive exposure to PermaNet 2.0 of 
the double homozygote resistant (RR/RR) at both genes compared to other genotypes 
supporting the additive resistance effect of both genes. C) increasing survival rate when 
exposed to PermaNet 2.0 when comparing RR/RS and RS/RS. 
 
For Olyset: A comparison of the distribution of both sets of genotypes revealed that 
mosquitoes double homozygotes resistant (RR/RR) at both genes also had by far a significant 
ability to survive Olyset  exposure to Olyset than all other combinations showing that both 
genes act additively to confer a greater resistance to pyrethroids with a higher reduction of 
Olyset efficacy (Table 5.6). The additive effect was further confirmed as RR/RR mosquitoes 
had the greatest ability to survive Olyseexposure when compared to double susceptible 
(SS/SS) (OR= 8.61; P<0.01) (Table 5.6; Figure 5.23). A significantly high ability to survive is also 
observed in RR/RR when compared to other combinations such as against RR/RS (OR= 12.2; 
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CI=3.0-49.9 P<0.0002) and RR/SS (OR= 2.0; CI=0.3-13.3 P<0.01) No significant difference was 
observed between RR/RR and RR/SS (OR= 1.8; CI=0.3-11.2 P˃0.05) (Table 5.5). 
 
Table 5.6: CYP6P9a and CYP6P9b acting together further increase the ability of An. funestus 
(crossing Fumoz-Fang-F5) to survive and blood feed against Olyset after experimental hut trial. 
  
CYP6P9a/b combined  
  
    Mortality all   
  
OR PV CI 
 
RR/RR vs SS/SS 8.61 <0.01 1.8-39.1 
Olyset RR/RR vs RS/SS 1.8 ˃0.05 0.3-11.2 
 
RR/RR vs RR/SS 2.0 <0.01 0.3-13.3 
 
RR/RR vs RR/RS 12.2 <0.001 3.0-49.9 
  RR/RR vs RS/RS 2.6 1.0 1.2-5.5 
     
Olyset   Bloodfeeding all   
  
OR PV CI 
 
RR/RR vs SS/SS 8.1 ≤0.05 2.4-27.58 
 
RR/RR vs RS/SS 2.4 <0.05 0.5-11.1 
 
RR/RR vs RR/SS 1.4 1.0 0.2-8.2 
 
RR/RR vs RR/RS 1.8 ˃0.05 0.7-4.7 
 
RR/RR vs RS/RS 5.8 <0.001 2.8-12.05 
 
  Bloodfeeding Room only 
 
RR/RR vs SS/SS 9.3 <0.001 3.5-24.8 
 
RR/RR vs RS/SS 1.5 ˃0.05 0.2-8.9 
 
RR/RR vs RR/SS 1.5 ˃0.05 0.2-8.9 
 
RR/RR vs RR/RS 0.5 1.0 0.1-1.7 





Figure 5.23: Increased capacity to survive exposure to Olyset of the double homozygote 
resistant (RR/RR) at both genes compared to other genotypes supporting the additive 
resistance effect of both genes. 
 
5.3.7.2 Impact of CYP6P9a combined with CYP6P9b on Bloodfeeding 
 
After the examination of the combined genotype distribution for blood feeding, a continuing 
reduction of the effect is perceived for genotypes RR/RR>RS/RS>SS/SS. This was using 
mosquitoes collected in room treated with PermaNet 2.0 (Figure 5.24.A). The analysis also has 
shown that double homozygote-resistant mosquitoes (RR) were significantly more able to 
blood feed when compared to double homozygote susceptible (SS) after exposition to 
PermaNet 3.0 in experimental huts (Table 5.5; Figure 5.24.B). 
 
 
Figure 5.24: Distribution of the combined genotypes of both CYP6P9a and CYP6P9b after 
exposure to PermaNet Nets revealing an additive effect of both genes in increasing the ability 
to blood feed. A) For PermaNet 2.0 B) For PermaNet 3.0. 
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A comparison of the distribution of both sets of genotypes in mosquitoes from the hybrid 
strain exposed to Olyset revealed a significant increase ability to blood feed for double 
homozygote resistant mosquitoes with highest significance against double homozygote 




The discovery of the resistance markers linked with P450-mediated resistance currently offers 
an exceptional tool to screen pyrethroid resistance in field populations of the major malaria 
vectors such as An. funestus. 
Assessing the impact of insecticide resistance on the effectiveness of insecticide-treated 
control tools is crucial in order to implement suitable insecticide resistance management 
(IRM) strategies as recommended by the global plan for resistance management 
strategies(WHO, 2012a). The aim of this is to be able to fill the information gap required to 
plan appropriate IRM in order to preserve the efficacy of current and future insecticides. 
However, the extent of the impact of this resistance, notably, metabolic resistance on the 
effectiveness of bed nets is not well assessed due to the lack of markers to track and quantify 
the resistance. In this study, we use markers recently made available (Mugenzi et al., 2019; 
Weedall et al., 2019) to see how insecticide resistance is changing the efficacy of insecticide-
based interventions such as LLINs. But more importantly, it also uniquely allows one to assess 
the interplay between P450 genes in the overall genetic variance to resistance as seen here 
between CYP6P9a and CYP6P9b. 
 
5.4.1 Comparative assessement of efficacy of Pyrethroid-only vs PBO nets in the context of 
metabolic resistance 
 
The performance of pyrethroid only nets was not similar. Olyset presented a higher mortality 
compared to PermeNet 2.0 (56.7% vs 31.4%; P<0.0001). The performance of the PBO nets 
Olyset Plus and PermanNet 3.0 was very similar (99.1%vs 98.8%). 
When comparing the performance of conventional nets vs synergist ones, we observed a The 
better performance of PBO nets as observed in other studies (Pennetier et al., 2013a; Toe et 
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al., 2018a). The high mortality observed with PBO nets against the hybrid strain Fumoz/Fang 
is due to the fact the mechanisms underlying the resistance in this population are mainly 
CYP6P9a and CYP6P9b which are inhibited by PBO (Mugenzi et al., 2019; Riveron et al., 2013; 
Weedall et al., 2019). These results demonstrate that PBO-net are a solution for P450-
resistance. 
The efficacy of nets observed in this study confirm the loss in efficacy of the pyrethroid only 
nets against An. funestus s.s. as observed all over the continent. This loss of efficacy was 
observed in Mozambique (Glunt et al., 2015; Riveron et al., 2019) in Malawi (Riveron et al., 
2015), in Congo (Riveron et al., 2018b) and Cameroon (Menze et al., 2020; Menze et al., 
2018b). Overall, similarly to this study, it has been noticed that PBO-nets demonstrate a better 
performance compared to pyrethroid-only(Pennetier et al., 2013a; Toe et al., 2018a). The very 
high mortality observed in this study with Olyset Plus and PermaNet 3.0 against P450 resistant 
mosquitoes suggests that PBO nets can be the solution in an area where resistance is mediated 
by P450. In the absence of Kdr in An. funestus (Irving and Wondji, 2017), the loss of efficacy of 
PBO nets against P 450 resistant mosquitoes (Riveron et al., 2019) suggest that we should pay 
attention to other resistance mechanisms like cuticular resistance that may be taking place. 
 
5.4.2 Impact of the CYP6P9a/b gene on the performance of Bed nets 
 
Since the number of live mosquitoes collected in hut treated with PermaNet 3.0 and Olyset 
Plus was very low, it was not possible using samples from experimental hut to assess the 
association between the presence of the resistant alleles and the ability to survive when 
exposed to PBO nets. However, after cone test where the exposition time is just 3 minutes 
compared to overnight with experimental huts, we were able to obtained enough dead and 
alive after exposition to PBO nets. When comparing the impact of CYP6P9a/b on Pyrethroid 
only nets and PBO nets using samples from cone assays we noticed that the impact of CYP6P9a 
on Pyrethroid only nets was higher when compared to PBO nets. (Olyset, OR= 35.1; P<0.00001 
vs Olyset Plus, OR= 6.4; P<0.001 and PermaNet 2.0, OR=239.0; P<0.001 vs PermaNet 3.0, 
OR=81.0; P<0.001). The same trend was observed with the CYP6P9b genes (Table 5.1). This can 
be explained by the fact that the addition of the PBO in the synergist net inhibits the 
cytochrome P450 enzymes (Amenya et al., 2008). 
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PermaNet nets from Vestergaard and Olyset from Sumitomo nets have shown reduced 
performance against CYP6P9a and CYP6P9b resistant mosquitoes. For both nets, strong 
association was observed between the resistant alleles and the increased ability of the 
mosquitoes to survive after exposure to these nets. Nevertheless, the impact of CYP6P9a and 
CYP6P9b seems to be higher on PermaNet nets which are impregnated with deltamethrin 
compared to Olyset nets impregnated with Permethrin (Olyset, OR= 35.1; P<0.00001 vs 
PermaNet 2.0, OR=239.0; P<0.001 and Olyset Plus, OR= 6.4; P<0.001 vs PermaNet 3.0, 
OR=81.0; P<0.001) (table 5.1). It seems that the hybrid strain is more resistant to type II 
insecticide. This is in correlation with what has been observed during the WHO bioassays 
(Figure 5.1) where the mosquitoes were more resistant to deltamethrin than permentrin 











It will be useful to assess the impact of those genes on the performance of nets impregnated 
with Alpha-cypermethrin like Duranet to check how CYP6P9a and CYP6P9b impact different 
pyrethroid type.
Looking  at  the  odd  ratio  obtained,  a  stronger  association  was  observed  between
CYP6P9a/CYP6P9b and  the  loss  of  efficacy  of  nets  (result  chapter  5)  compared  to GSTe2
(Chapter 4). The impact was higher with P450 genes certainly because CYP6P9a and CYP6P9b
are  the  primary  resistance  mechanism  in  the  population  used  (Fumoz-Fang).  On  the  other 
hand, in the An. funestus population from Mibellon, the GSTe2 acts beside other mechanisms, 
since the GSTe2 genotypic frequency for RR in Mibellon is around 20% (Chapter 3).
However, one of the key message from this study is that a greater reduction of bed net efficacy 
is  observed  when  both  CYP6P9b  combines  with  CYP6P9a  as  double  homozygote  resistant 
mosquitoes by far were able to survive exposure to pyrethroid-only nets than all genotypes 
revealing the greater risk that Super resistance may caused to insecticide-based interventions 
and  supporting  the  concern  highlighted  in  the  WHO  global  plan  for  insecticide  resistance 
management that if nothing is done pyrethroid resistance could lead to increase the burden 
of malaria in Africa.
The impact of CYP6P9a and CYP6P9b is major concern for vector control program. It is calls for 
novel nets not relying on pyrethroids in the future. However, the impact of these resistance 
alleles  on the efficacy of LLINs  in natural  populations remains to be established as we  only
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performed a test with hybrid strain from two laboratory strains. Such work must be done 




This study, through the experimental hut, reveals that insecticide resistance driven by 
CYP6P9a and b is reducing the efficiency of bed nets, mainly standard nets. The wide spread 
of Insecticide resistance and the way it changes the efficacy of nets is a threat for vector 
control and an urgent call to put out a new product for vector control. Despite the high 
mortality observed with PermaNet 3.0, the CYP6P9a/b resistant mosquitoes were able to 
blood feed before dying. This increased ability of resistant mosquitoes to blood-fed is critical 
because blood feeding is a key factor for malaria transmission. The greater reduction of 
efficacy of insecticide-treated nets observed in double resistant mosquitoes is a major concern 
for the sustainability of insecticide-based interventions relying on pyrethroid notably LLINs 
and where such resistance is present. Since the mechanisms underlying the resistance in the 
lab strain Fumoz-Fang are P450, PBO-nets should be preferably deployed for greater impact 
although ultimately novel insecticide-treated nets like Interceptor G2 ) (aphalcypermethrin 
and chlofenapyr and Royal Guard (alphacypermethrin and Pyriproxyfen) not relying on 

















































The WHO through GPIRM is emphasizing the necessity to investigate the impact of insecticide 
resistance to implement suitable insecticide resistance management strategies (IRM) to help 
preserve the efficacy of current and future insecticides. However, the extent of the impact of 
insecticide resistance, notably, metabolic resistance on the efficiency of vector control such 
as  Long-lasting  Insecticidal  Nets  (LLINs)  remains  unclear. Taking  advantages  of  the  markers 
recently made available, this study has investigated the impact of insecticide resistance on the 
effectiveness  of  vector  control  tools  against Anopheles  funestus, a  major  African  malaria 
vector. During the project, the following questions were adressed: i) Is metabolic resistance 
to insecticides in An. funestus reducing the effectiveness of vector control tools such as LLINs 
and IRS? ii) Can metabolic resistance to pyrethroids alter the vectorial capacity of An. funestus
by changing key factors such as mortality rate and the ability of the mosquito to take its blood 
meal  in  the  presence  of  the  insecticide,  jeopardizing  vector  control  programs? To  answer 
these questions, we went through three mains objectives: 1) Determine the bionomics and 
insecticides resistance profiling of malaria vectors at a selected site for experimental hut trials 
in central Cameroon. 2) Evaluate using experimental hut, the performance of PBO-based and 
pyrethroid-only  nets  against  the  malaria  vector An.  funestus and  to  investigate how GSTe2
metabolic  mediated  resistance  is  impacting  that  performance and  3)  Evaluate  the 
performance of PBO-based and pyrethroid-only nets against the hybrid lab strain Fumoz-Fang 
and to examine how duplicated CYP6P9a and CYP6P9b cytochrome P450 genes are impacting
that performance (Chapter 5).
6.1 Characterization of malaria vectors to maximize the impact of control
intervention 
 
The lack of information such as resistance profiles and mechanisms involved has prevented 
evidence-based implementation of control intervention limiting the outcome of control. It was 
imperative to achieve the characterization of malaria vectors to maximize the impact of 
control intervention and to implement suitable resistance management strategies to preserve 
the efficacy of existing tools. Regarding the level of resistance in malaria vectors against bed 
nets in the area, we strongly suggest to the government for the future to consider IRS with 
organophosphate like Actellic. Furthermore, the characterization of the effects of resistance 
on the effectiveness of control tools is also a crucial knowledge to guide control programs. 
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This  is the reason why we focused on the characterization of this area selected for the 
experimental hut trial. 
Looking at the species diversity, An. funestus s.s. (80%) is the primary malaria vector in 
Mibellon, followed by An. gambiae s.s. (20%) previously known as S form. This study also 
confirms the role of An. funestus in malaria transmission with a sporozoite infection rate of 
5%. Multiple resistance was observed in both An. funestus s.s. and An. gambiae s.s. at 
Mibellon. This is a concern for ongoing insecticide-based interventions although the full 
susceptibility to organophosphate offers an alternative to IRS. The insecticide resistance 
observed reemphasise the need to assess the impact of such multiple resistances on the 
effectiveness of insecticide-based control interventions to improve vector control strategies. 
The presence of resistance in both major vectors makes this area suitable for such studies. 
We went further to investigate the mechanisms underlying the insecticide resistance 
observed. The recovery observed for pyrethroids in An. funestus after pre-exposure to PBO 
indicates that metabolic resistance, particularly cytochrome P450s, play a role in that 
resistance. The frequency of the 119F-GSTe2-resistant allele in Mibellon field population 
(28%) is lower than in the northern part of Cameroon in Gounougou (52%) and closer to that 
observed in the eastern part of Africa in Uganda (20.4%). However, GSTe2 seems to play a role 
in the resistance found in Mibellon. The frequency of the 296S-RDL-resistant allele is only 
9.7%. This low frequency could be as a result of recovery to susceptibility for dieldrin after this 
insecticide was removed from public and agricultural sectors in Cameroon. The very high 
resistance levels to pyrethroids in Anopheles gambiae s.s. (no mortality to permethrin), 
correlates with the high frequency of the 1014F kdr allele (63.9%). The total absence of the 
119S ace-1 mutation is in line with the susceptibility of this population to organophosphate 
and carbamate as this mutation is responsible for organophosphate and carbamate. Having 
all these pieces of information will undoubtedly guide the National Malaria control program 
to improve their strategies. 
 




To better inform countries of the usefulness of PBO nets to control pyrethroid-resistant 
mosquitoes in the face of the greater cost of PBO nets, here we compared the performance 
of conventional pyrethroid-only nets (Olyset, PermaNet 2.0 and Yorkool) versus PBO-based 
LLINs (Olyset Plus and PermaNet 3.0) against a pyrethroid-resistant An. funestus population 
from Cameroon using experimental huts. The mortality rate was significantly higher with the 
two PBO-based nets than all the pyrethroid-only This study has revealed a loss of efficacy of 
LLINs against pyrethroid-resistant populations of An. funestus in Cameroon using 
experimental huts. However, PBO-based nets (PermaNet 3.0 and Olyset Plus) are more 
efficient than conventional pyrethroid-only nets (P<0.001). These results demonstrate that 
the mass killing provided by PBO nets is higher compared to Pyrethroid only nets. In addition, 
the personal protection offered by PBO nets was also found to be higher. Noticeably, the GST-
mediated metabolic resistance not impacted by PBO is a serious threat to the continued 
effectiveness of the PBO-based LLINs and the impact of this mechanism also needs to be taken 
into account to maximize the efficiency of LLINs. One option could be to generate new mosaic 
LLINs also incorporating the Diethyl Maleate (DEM) beside PBO to inhibit GST metabolic 
activity and further increase the efficacy of these nets. 
 
6.3 GSTe2 linked to the increased ability of An. funestus from Mibellon to 
Blood feed in the presence of bednets. 
 
For Olyset net, a significant association was observed between the 119F_GSTe2 resistance 
allele and an increased ability to blood feed (21 blood-fed and 92 unfed) when comparing the 
allelic frequencies (OR=2; P=0.047; CI 1.06-3.7) and the genotypic frequency of RS v SS 
(OR=2.97; P<0.001; CI 1.6-5.3) (Figure. 4.4A; Table 4.5). For the Olyset Plus net, when 
considering the blood feed and unfed samples from the room only (23 blood-fed and 49 
unfed), a significant association was found between L119F-GSTe2 mutation and an increased 
ability to blood feed when comparing the allelic frequencies (OR=4.5; P=0.0001; CI 2.26-9.2). 
An even stronger association was observed when comparing the genotype frequencies 
between RR vs SS (OR=12.3; P=0.0004 CI 2.5-60.4) and RS vs SS (OR=8.42; P<0.001; CI 4.37-
16.2). This is a clear sign that insecticide resistance can change the performance of LLINs. 











   
 




   





6.4 Performance of PBO nets vs pyrethroid only nets against the hybrid strain 
FUMOZ -FANG
As previously reported, reduced efficacy of pyrethroid only nets was observed against hybrid 
strain. This study showed a very high mortality of the hybrid FUMOZ/FANG strain against PBO- 
based nets with mortality of 99.1% for Olyset Plus and 98.8% for PermaNet 3.0. In contrast, 
lower mortality was observed for the pyrethroid-only nets with mortality rates of only 56.7% 
for Olyset and 31.4% for PermaNet 2.0. (Table 5.2). Overall, the PBO-based nets were found 
to be more effective with mortality closed to 100 % when compared to conventional nets. This 
could be due to the fact that in the hybrid strain, the resistance is driven by the P450 genes. 
These results suggest that PBO based nets are still a solution in an area where resistance is 
medisted  by  P450. As  a  perspective,  such  studies  need  to  be  carried  out  using  a  natural 
population from Mozambique, since in this study a laboratory strain was used. The advantage 
of using the wild mosquitoes is that we have a realistic view of the vector population. However 
the challenge with the wild mosquitoes in is achieving a sufficient sample size. Alternatively,
we can release large numbers in order to have enough samples for the genotyping in the lab.
6.5 CYP6P9a/b linked with reduced performance of bed nets.
This  study, through the experimental  hut, reveals  that  insecticide  resistance  driven  by
CYP6P9a/b is reducing the efficiency of standard nets widely used for a vector control program 
in Africa since it cost less than synergist nets. The wide sprays of the Insecticide resistance and 
the way it changes the efficacy of nets is a threat for vector control and an urgent call to put 
out a new product for vector control interventions. Despite the high performance of PermaNet 
3.0, the CYP6P9a/b resistant mosquitoes were able to blood feed before dying. This increased 
ability to blood fed of resistant mosquitoes is critical because blood feeding is a critical factor 
for  malaria  transmission. The  greater  reduction  of  efficacy  of  insecticide-treated  nets 
observed  in  double  resistant  mosquitoes  is  a  major  concern  for  the  sustainability  of 
insecticide-based interventions relying on pyrethroid notably LLINs and where such resistance 
is present. The high mortality observed with with PermaNet 3.0 and Olyset Plus against Fumoz




PBO-nets should be preferably deployed for greater impact. For resistant mosquitoes where 
P 450 are not the main mechanisims, novel insecticide-treated nets not relying on pyrethroids 
should be envisaged. 
The major limitationof this study is thatis that it was conducted in controlled conditions using 
experimental hut with nets holed on each side. This may be not an exact representation of what 
is happening in the real situation. The protocol used for this study is a standardized protocol from 
WHO. This protocol suggests that the sleeping time, the type of hut  may differ from the  social 
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Appendix 2: LIVAK DNA extraction Protocol 
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Appendix 4: Data base presenting the distribution of treatments in different huts during the 
first week of the study. Similar data following the Latin square rotation are available for the 
others 11 weeks of the study. This data based is the one used for R analysis. 0= control, 
1=Yorkool; 2=PermaNet 2.0; 3=PermaNet 2.0, 4=Olyset, 5=Olyset Plus. S1-6= Sleepers 1-6. 
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Appendix 7: Linear mixed effect model analysis showing different sources of variations that 
may influenced the exophily. 
 
                    Value         Std.Error      p-value 
(Intercept)    16.249764    7.725620        0.0364 
 sleeper2    -4.932549     5.953246        0.4081 
 sleeper3    -0.300115     6.150593        0.9611 
 sleeper4     7.972452     5.568319         0.1534 
 sleeper5     4.356004     5.718595         0.4469 
 sleeper6     2.547911     5.839805         0.6630 
Hut2             2.962492     5.533332          0.5928 
Hut3            -5.224913     5.754090          0.3647 
Hut4             4.504248     5.614402          0.4231 
Hut5           -6.310800      5.844721          0.2813 
Hut6           -6.974816      5.522378          0.2077 
Week2        19.753810     7.828069          0.0122 
Week3         8.457334      7.436382          0.2565 
Week4        -6.289393      8.023420          0.4338 
Week5         4.201448      7.381160          0.5697 
Week6        -5.579260      7.661576          0.4671 
Week7        -3.276825      8.130004          0.6872 
Week8         9.517598      7.753166          0.2207 
Week9        17.027261     8.521754          0.0468 
   
Week10      -5.011175      7.652644          0.5132 
Week11      -21.324423    15.600047        0.1728 




Appendix 8: Linear mixed effect model analysis showing different sources of variations that 
may influenced the mortality 
 
                   Value          Std.Error       p-value 
(Intercept)  13.432237   8.932373       0.1339 
sleeper2     2.261362     6.402623       0.7242 
sleeper3    -6.058720     6.611833       0.3603 
sleeper4     2.695107     5.986638       0.6530 
sleeper5     4.570812     6.153108        0.4582 
sleeper6    -0.733462    6.278762        0.9071 
Hut2          5.200011     5.953404       0.3832 
Hut3          2.809049     6.189717       0.6503 
Hut4          5.747833    6.040292        0.3422 
Hut5          5.557012    6.289644        0.3778 
Hut6          0.028410    5.947106        0.9962 
Week2      8.142864     8.423385        0.3346 
Week3     -6.702629     7.995142        0.4026 
Week4      2.918904     8.626829        0.7354 
Week5      5.451842     7.936171        0.4927 
Week6    -4.389710      8.239292        0.5946 
Week7    -8.807101      8.743382        0.3147 
Week8     0.442853      8.344017        0.9577 
Week9     4.040681      9.164440        0.6596 
Week10   -8.851122     8.229572        0.2831 
Week11   18.293036    16.88172        0.2795 
Week12  -10.562736    7.696463        0.1711 
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Appendix 9: Linear mixed model effect analysis showing different sources of variations that 
may influenced the Blood feeding. 
 
                     Value         Std.Error      p-value 
(Intercept)  22.223943  9.227391      0.0167 
Sleeper 2   3.777416    6.544700       0.5643 
Sleeper 3   6.917576    6.758355       0.3070 
Sleeper 4   4.361940    6.119352       0.4766 
Sleeper 5   1.186007    6.289840       0.8506 
Sleeper 6   0.869160    6.417971       0.8924 
Hut2        -4.436482     6.085664       0.4667 
Hut3        -6.593280     6.327146       0.2984 
Hut4        -13.011677   6.174456       0.0360 
Hut5        -4.729087     6.429454       0.4627 
Hut6        -2.846225     6.079594       0.6401 
Week2      5.612935     8.610579       0.5151 
Week3      6.941759     8.172390       0.3964 
Week4      1.370215     8.818114       0.8766 
Week5      2.453404     8.112139       0.7626 
Week6      -9.002432    8.422083       0.2861 
Week7      -2.650813    8.937378       0.7670 
Week8       7.169607    8.529541       0.4014 
Week9       15.988995   9.367762       0.0891 
Week10     11.157829   8.412140       0.1859 
Week11     11.782806   17.263001     0.4955 
Week12     15.895848   7.867071       0.0444 
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Abstract 
Background: Malaria vectors are increasingly developing resistance to insecticides across Africa. The impact of such 
resistance on the continued effectiveness of insecticide-based interventions remains unclear due to poor characteri-
zation of vector populations. This study reports the characterization of malaria vectors at Mibellon, a selected site in 
Cameroon for experimental hut study, including species composition, Plasmodium infection rate, resistance profiles 
and mechanisms.
Methods: Indoor resting blood-fed Anopheles mosquitoes were collected from houses at Mibellon in 2017 and 
forced to lay eggs to generate  F1 adult mosquitoes. Insecticides susceptibility bioassays were performed on the  F1 
adult mosquitoes following the WHO protocol to assess resistance profile to insecticides. The molecular basis of resist-
ance and Plasmodium infection rate were investigated using TaqMan genotyping.
Results: Anopheles funestus sensu stricto (s.s.) was predominant in Mibellon (80%) followed by Anopheles gambiae 
s.s. (20%). High levels of resistance to pyrethroids and organochlorides were observed for both species. Moderate 
resistance was observed against bendiocarb (carbamate) in both species, but relatively higher in An. gambiae s.s. In 
contrast, full susceptibility was recorded for the organophosphate malathion. The PBO synergist assays with perme-
thrin and deltamethrin revealed a significant recovery of the susceptibility in Anopheles funestus s.s. population (48.8 
to 98.1% mortality and 38.3 to 96.5% mortality, respectively). The DDT/pyrethroid 119F-GSTe2 resistant allele (28.1%) 
and the dieldrin 296S-RDL resistant (9.7%) were detected in An. funestus s.s. The high pyrethroid/DDT resistance in 
An. gambiae correlated with the high frequency of 1014F knockdown resistance allele (63.9%). The 1014S-kdr allele 
was detected at low frequency (1.97%). The Plasmodium infection rate was 20% in An. gambiae, whereas An. funestus 
exhibited an oocyst rate of 15 and 5% for the sporozoite rate.
Conclusion: These results highlight the increasing spread of insecticide resistance and the challenges that control 
programmes face to maintain the continued effectiveness of insecticide-based interventions.
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Background
Despite the recent progress made in reducing malaria 
burden in sub-Sahara Africa through insecticide-based 
interventions, such as long-lasting insecticidal nets 
(LLINs) and indoor residual spraying (IRS), malaria 
remains an important health issue [1]. Malaria control 
in Cameroon has recently witnessed a significant scale-
up of vector control intervention through the distribu-
tion of LLINs, pushing up the bed net coverage to 70.9% 
of the population [2, 3]. However, the effectiveness of 
these insecticide-based control tools is threatened by the 
emergence of insecticide resistance in major malaria vec-
tors across African countries, including Cameroon [4, 
5]. There is, therefore, a need to design and implement 
suitable resistance management strategies to preserve the 
efficacy of existing tools. Use of experimental huts is one 
of the best approaches employed to assess the impact of 
resistance on the efficacy of control intervention, such as 
LLINs and IRS [6–8]. However, monitoring the efficacy 
of these insecticide-based interventions requires a good 
characterization of the vectors present in the areas under 
control, importantly, their species composition, insecti-
cides resistance profiles and resistance mechanisms.
In Cameroon, the main malaria vector species are 
members of the Anopheles gambiae sensu lato (s.l.) com-
plex and the Anopheles funestus s.l. group [5, 9–13]. 
However, these species are not evenly distributed [14–16] 
and their insecticide resistance profiles vary nationwide 
[5, 14, 17–20]. Therefore, it is important to characterize 
local populations in order to assess the impact of vector 
control interventions.
This study provides a thorough characterization of 
mosquito vector populations in an area selected for 
experimental hut trials in Cameroon. The site is located 
in a geographical transition between forested south and 
savannah north. This study presents a full characteriza-
tion of the main malaria vectors in Mibellon, including 
their species diversity, susceptibility profiles and investi-




Adult Anopheles mosquitoes were collected from Mibel-
lon (6°46′N, 11°70′E), a village in Cameroon located in 
the Adamawa region, Mayo Banyo Division and Bankim 
Sub-division. The Adamawa region is in the mountainous 
area forming a transition between Cameroon’s forested 
south and savanna north. Mibellon is located in close 
proximity to permanent water bodies, including a lake 
and swamps which provide suitable breeding sites for 
mosquitoes. Human activities are mainly fishing, hunting 
and subsistence farming, including maize, watermelon 
and coffee plantations. A survey in the area revealed a 
high usage of insecticides in the coffee and watermelon 
farms. These insecticides are mainly pyrethroids, neoni-
cotinoids and carbamates.
Mosquito collection and rearing
The blood-fed Anopheles mosquitoes were collected 
every morning between 06:00 and 11:00 in the houses. 
Verbal consent was given by the household owners before 
starting mosquito collection. Mosquitoes were collected 
in January 2017 using the Prokopack electrical aspirator 
(John W Hook, Gainesville, FL, USA) and kept in netted 
paper cups that were stored in a cool box. Samples were 
later transported to the insectary of the LSTM Research 
Unit in Yaoundé (Cameroon).
Mosquitoes were kept 4–5  days until they became 
fully gravid and then induced to lay eggs using the forced 
eggs-laying method [21]. The eggs were put in paper cup 
containing water for them to hatch. After hatching the 
larvae were placed in trays and reared to adult mosqui-
toes [21, 22].
Species identification
The field-caught females were sorted according to mor-
phological keys as previously described [23]. After 
genomic DNA extraction using the Livak method [24], 
PCR species identification was performed as described 
[25] to identify An. funestus group members. Whereas 
the SINE PCR [26] was used to differentiate members of 
the An. gambiae s.l. complex.
Plasmodium falciparum infection rate
Sixty collected An. funestus females were cut in two 
parts: the head and thorax together and the abdomen 
separately. Genomic DNA was extracted separately from 
head/thorax and abdomen and the oocyst and the sporo-
zoite rate evaluated using the TaqMan assay [27] using 
MX 3005 (Agilent, Santa Clara, CA, USA). For An. gam-
biae, due to low number of mosquitoes, the whole mos-
quito was used and only the overall Plasmodium infection 
rate estimated. One µl of DNA sample was used as tem-
plate in a 3-step PCR programme with a denaturation at 
95 °C for 10 min followed by 40 cycles of 15 s at 95 °C and 
1 min at 60 °C. The primers (Falcip + : TCT-GAA-TAC-
GAA-TGT-C, OVM + : CTG-AAT-ACA-AAT-GCC, 
Plas-F: GCT-TAG-TTA-CGA-TTA-ATA-GGA-GTA-
GCT-TG, Plas r: GAA-AAT-CTA-AGA-ATT-TCA-CCT-
CTG-ACA) were used together with two probes labelled 
with fluorophores: FAM to detect Plasmodium falcipa-
rum, and HEX to detect Plasmodium ovale, Plasmodium 
vivax and Plasmodium malariae. Plasmodium falcipa-
rum samples and a mix of P. ovale, P. vivax and P. malar-
iae were used as positive controls.
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Insecticide susceptibility assays
Following WHO protocol [28],  F1 An. funestus sensu 
stricto (s.s.) and An. gambiae s.s. mosquitoes aged 
between 2 and 5 days were exposed to pyrethroids: per-
methrin (0.75%), deltamethrin (0.05%) and etofenprox 
(0.05%), the organochlorine: DDT (4%), the organophos-
phate: malathion (5%) and the carbamates: bendiocarb 
(0.1%) and propoxur (0.1%). For each test, mosquitoes 
exposed to untreated papers were used as control. The 
assay was carried out at temperatures of 25 °C ± 2 °C and 
80% ± 10% relative humidity.
PBO synergist assays
To investigate the possible involvement of cytochrome 
P450  s in the observed resistance, female An. funestus 
s.s. were pre-exposed to 4% piperonyl butoxide (PBO) 
for 1 h and immediately exposed to DDT (4%), perme-
thrin (0.75%) and deltamethrin (0.05%) for 60 min. The 
mortality was assessed after 24  h and compared with 
mortality obtained for mosquitoes not pre-exposed to 
PBO.
Cone assays
Cone assays were performed using five types of LLINs 
(Olyset Plus, Olyset Net, Yorkool, PermaNet 2.0 and 
PermaNet 3.0 (side). These tests were carried out using 
pieces of LLINs (30 cm × 30 cm). Ten unfed mosquitoes 
(An. funestus s.s. and An. gambiae s.s.) females aged 
2–5 days were introduced into each cone placed on the 
LLIN for 3  min. After exposure, the mosquitoes were 
removed from the cones using a mouth aspirator and 
then transferred into paper cups and fed with 10% sugar 
solution. Numbers of mosquitoes knocked-down were 
recorded after 60 min. A negative control (untreated net) 
was included in each of the LLIN cone test. Post-expo-
sure mortality was recorded after 24  h of observation. 
The assay was carried out at temperature of 25 °C ± 2 °C 
and 80% ± 10% relative humidity.
Genotyping of L119F‑GSTe2: metabolic resistance marker 
in Anopheles funestus s.s.
The L119F-GSTe2 mutation was genotyped to assess 
the role played by the glutathione S-transferase gene in 
the DDT and pyrethroid resistance observed at Mibel-
lon as described previously [29]. An allele specific PCR 
(Tchouakui et al., unpublished) was used to detect the 3 
genotypes of the L119F-GSTe2 mutation. Amplification 
was carried out using PCR parameters of 95 °C for 5 min; 
30 cycles of 94 °C for 30 s, 58 °C for 30 s, 72 °C for 45 s, 
final extension at 72 °C for 10 min. The primers employed 
for the genotyping are: L119F-Fwd: ATG ACC AAG 
CTA GTT CTG TAC ACG CT; L119F-Rev: TTC CTC 
CTT TTT ACG ATT TCG AAC T; L119F-Res1: CGG 
GAA TGT CCG ATT TTC CGT AGA AtAA; L119-F-
Sus1: CAT TTC TTA TTC TCA TTT ACA GGA GCG 
TAaTC.
Genotyping of A296S‑RDL in Anopheles funestus s.s.
TaqMan genotyping assays were performed in 10 μl vol-
ume containing 1 × Sensimix (Bioline), 80 × primer/
probe mix and 1  μl genomic DNA. The probes were 
labelled with two distinct fluorophores FAM and HEX, 
FAM to detect the resistant allele and HEX to detect the 
susceptible allele. The assay was performed on an Agilent 
MX3005 real-time PCR machine with cycling conditions 
of 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s 
and 60 °C for 1 min as described previously [30].
L1014F and L1014S kdr genotyping in Anopheles gambiae
The L1014F-kdr mutation and the L1014S-kdr respon-
sible for DDT and pyrethroid resistance in An. gambiae 
s.l. were genotyped in Mibellon mosquitoes. The reac-
tion mixture of 10 μl final volume containing 1 × Sensi-
mix (Bioline), 80 × primer/probe mix and 1  μl template 
DNA was used for this assay. The probes were labelled 
with two distinct fluorophores: FAM to detect the resist-
ant allele and HEX to detect the susceptible allele. The 
assay was performed on an Agilent MX3005 real-time 
PCR machine with cycling conditions of 95 °C for 10 min, 
followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min 
as previously described [31].
G119S ace‑1 genotyping in Anopheles gambiae
The G119S ace-1 responsible to organophosphate and 
carbamate resistance in An. gambiae s.l. was genotyped 
in Mibellon mosquitoes. Ten μl volume containing 
1 × Sensimix (Bioline), 80 × primer/probe mix and 1  μl 
template DNA. Probes were labelled with two specific 
fluorophores FAM and HEX, FAM to detect the resist-
ant allele, HEX to detect the susceptible allele. The assay 
was performed on an Agilent MX3005 real-time PCR 
machine with cycling conditions of 95 °C for 10 min, fol-
lowed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min.
Results
Field collection
A total of 722 adult female Anopheles mosquitoes were 
collected indoor at Mibellon out of which 584 (80.1%) 
were morphologically identified as An. funestus group 
and the remaining 138 (19.9%) identified to be An. gam-
biae complex.
Species diversity among Anopheles funestus group 
and Anopheles gambiae complex
Out of the 120 An. funestus s.l. mosquitoes randomly 
selected and tested, An. funestus s.s. was found to be the 
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only member of the group present at Mibellon. For An. 
gambiae s.l., out of 89 samples analysed all of them were 
found to be An. gambiae s.s. (S form).
Insecticide susceptibility bioassays with samples 
from Mibellon
Insecticide susceptibility bioassays in An. funestus s.s.
A total of 2700  F1 mosquitoes were tested to assess the 
resistance profile to seven insecticides (Fig. 1). Anopheles 
funestus s.s. (females and males) were resistant to type I 
and type II pyrethroids. For permethrin (Type I), mor-
tality was 48.88 ± 5.76% for females and 90.72 ± 3.77% 
for males. For deltamethrin (Type II), mortality was 
38.34 ± 5.79% for females and 53.96 ± 11.37% for males. 
However, mortality was higher for the pseudo-pyrethroid 
etofenprox with mortality rate of 82.9 ± 8.7% for females 
and 97.83 ± 2.17% for males (Fig.  1a). For the organo-
chlorine DDT, resistance was observed with mortality 
rate of 55.28 ± 8.28% for females and 83.78 ± 3.13% for 
males (Fig. 1a). For the carbamates, a possible resistance 
was observed against bendiocarb with 90.67 ± 4.3% mor-
tality for females and 95.06 ± 1.97% for males (Fig.  1a) 
whereas a susceptibility was observed for propoxur with 
98.41 ± 1.59% mortality for females and 100% mortality 
for males (Fig.  1a). Full susceptibility was observed for 
the organophosphate malathion (Fig. 1a).
Insecticide susceptibility bioassays in An. gambiae s.s.
A total of 971 An. gambiae s.s. were tested to assess the 
resistance profile to seven insecticides. The An. gambiae 
s.s. population was highly resistant to type I and type II 
pyrethroids (Fig. 2). For permethrin, mortality was 0 ± 0% 
for females and 4.44 ± 2.42% for males (Fig. 2). Very high 
level of resistance was also observed with deltamethrin 
with no mortality for females and 1.52 ± 1.52% for males 
(Fig.  2). Resistance was also observed for the pseudo-
pyrethroid etofenprox with mortality rate of 9.92 ± 7.66% 
for females and 13.46 ± 3.93% for males (Fig.  2). High 
level of resistance to the organochlorine DDT was 
observed with mortality rate of 1.39 ± 1.39% for females 
and 1.85 ± 1.85% for males (Fig.  2). For the carbamate 
bendiocarb, mortality rates of 66.23 ± 2.6% for females 
and 59.2 ± 3.73% for males were recorded, however, full 
susceptibility was observed for propoxur (Fig. 2). For the 
organophosphate malathion, a near full susceptibility was 
observed with mortality rate of 98.25 ± 1.75% for females 
and 98.48 ± 1.52% for males (Fig. 2).
PBO synergist assays with An. funestus s.s.
Pre-exposure of An. funestus s.s. to PBO led to recov-
ery of the susceptibility to both pyrethroids type I and II 
with an increased mortality observed after PBO exposure 
from 48.88 ± 5.76% to 98.81 ± 3.77% for permethrin and 
from 38.34 ± 5.79% to 96.54 ± 1.16% mortality for del-
tamethrin (Fig.  1b). Partial recovery was observed for 
DDT with increased susceptibility from 55.28 ± 8.28% to 
84.16 ± 5.37% mortality after exposure to PBO (Fig. 1b).
Susceptibility profile against bed nets by cone assays
Insecticide susceptibility with cone assays in An. funestus s.s.
Low mortality rates were recorded against most of 
the nets tested. The mortality rates were 2.78 ± 2.78%, 
and 2.5 ± 2.5%, for Olyset Net and Olyset Plus, respec-
tively; 0 ± 0% and 48.33 ± 6.49% for PermaNet 2.0 and 
Fig. 1 Susceptibility profile of Anopheles funestus to insecticides. a Recorded mortalities following 60-min exposure of An. funestus s.s. from Mibellon 
to different insecticides. Data are shown as mean ± SEM. b Activities of PBO combined to permethrin, deltamethrin and DDT on An. funestus s.s. 
from Mibellon. Data are shown as mean ± SEM
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PermaNet 3.0, respectively; and, 0 ± 0% for Yorkool 
(Fig. 3a).
Insecticide susceptibility cone assays in An. gambiae s.s.
Similarly, An. gambiae s.s showed low mortality rates 
with the bed nets tested. The mortality rates were 
3.13 ± 3.13% and 4.55 ± 4.55% for Olyset Net and Olyset 
Plus, respectively; 4.77 ± 2.76% and 19.09 ± 6.22% for 
PermaNet 2.0 and PermaNet 3.0, respectively; and, 
0 ± 0% mortality for Yorkool (Fig. 3b).
Fig. 2 Susceptibility profile of Anopheles gambiae to insecticides. Recorded mortalities following 60-min exposure of An. gambiae s.s. Mibellon to 
different families of insecticide. Data are shown as mean ± SEM
Fig. 3 Cone assays with various nets for Anopheles funestus and Anopheles gambiae. a Recorded mortalities following 3-min exposure by cone assay 
of An. funestus s.s. b Anopheles gambiae s.s. from Mibellon to Olyset, Olyset Plus, Yorkool, PermaNet 2.0 and PermaNet 3.0 (side). Data are shown as 
mean ± SEM
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Molecular basis of the insecticide resistance in An. funestus 
s.s. population
L119F‑GSTe2 detection in An. funestus s.s.
From 110  F0 females collected from the field 7 were 
homozygous resistant (RR) (6.3%), 48 were heterozygous 
(RS) (43.2%) and 55 were homozygous susceptible (SS) 
(49.5%). Overall, the frequency of the 119F resistant allele 
was 28 and 72% for the L119 susceptible allele.
RDL‑A296S detection in An. funestus s.s.
Out of the 92 samples genotyped, 3 were RR (3.2%), 12 
were RS (13.1%) and 75 were SS (83.7%) with frequency 
of resistant allele of only 9.7% and susceptible allele of 
90.3%.
Molecular basis of insecticide resistance in An. gambiae s.s.
L1014F/L1014S kdr detection in An. gambiae s.s.
Out of 72 samples genotyped, 22 were RR (30.5%) 48 
were RS (66.6%) and 2 were SS (2.7%) with frequency of 
the resistant allele 1014F of 63.9% and the susceptible 
L1014 allele of 36.1%. Out of the 76 samples genotyped 
for the L1014S marker, 3 were RS (3.9%) and 73 were SS 
(96.1%), thus a very low frequency of 1.97% was recorded 
for the resistance allele.
G119S ace‑1 detection in An. gambiae s.s.
Out of 50 samples genotyped, neither RR nor RS were 
detected as all the samples were found to be SS.
Plasmodium infection rate in the An. s funestus s.s. 
population in Mibellon
A total of 60 An. funestus from Mibellon were tested for 
Plasmodium infection using TaqMan from the head-
thorax and from the abdomen separately. The analy-
sis of the head and thorax revealed 3 (5%) mosquitoes 
infected, which included 2 (3.3%) P. falciparum and 1 
(1.7%) infection which is either P. ovale, P. vivax or P. 
malariae. However, 8 (15%) mosquitoes were detected 
infected when the abdomen was examined, including 5 
(8.3%) P. falciparum, 3 (5%) infections which are either 
Fig. 4 Plasmodium infection rate in malaria vectors from Mibellon in 2017. a Plasmodium infection rate in An. funestus s.s. with head and thorax. b 
Plasmodium infection rate in An. funestus s.s. with abdomen only. (C) Plasmodium infection rate in An. gambiae s.s. for whole mosquitoes
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P. ovale, P. vivax or P. malariae and 1 (1.7%) mixed 
infections (Fig. 4).
Plasmodium infection rate in the An. gambiae s.s. 
population in Mibellon
A total of 60 An. gambiae were tested for Plasmodium 
infection from the whole body. The analysis revealed 12 
(20%) mosquitoes infected, which included 11 (18.3%) P. 
falciparum and 1 (1.7%) mixed infection (Fig. 4).
Discussion
Characterization of malaria vector populations is a 
prerequisite for the implementation of successful vec-
tor control interventions and for assessing the impact 
of insecticides resistance. This study comprehensively 
characterized the main malaria vectors in Mibellon, a 
location in Cameroon chosen for the implementation of 
experimental huts to assess the efficacy of insecticide-
based interventions.
Species composition
Out of the 9 species of An. funestus group described, only 
An. funestus s.s. was detected in Mibellon. This result is 
similar to the one observed in the northern part of Cam-
eroon, in Gounougou, where An. funestus s.s. was 99.5% 
of the total collection and Anopheles leesoni was 0.5% [5]. 
The predominance of An. funestus s.s. in the An. funes-
tus group is also mentioned in West Africa as observed 
at Kpome in Benin [30]. The focus on indoor blood-fed 
mosquito collection in this study may have prevented to 
collect the outdoor resting members of the group. Never-
theless, this is in contrast with the distribution of mem-
bers of this group observed in eastern and southern parts 
of Africa where several members are collected indoors. 
For instance, in Uganda Anopheles parensis was found 
predominantly indoors [32, 33]. Similarly, many other 
species of the An. funestus group have been collected 
indoors in southern Africa, including An. parensis, An. 
leesoni and Anopheles rivulorum [34–36]. For the An. 
gambiae complex, An. gambiae s.s., previously known as 
S form, was the only species found. This result is similar 
to previous observations showing that An. gambiae s.s. 
was the main species in localities south of the Adamawa 
mountains, characterized by humid savannah and for-
ested areas [10, 37].
The multiple insecticide resistance in both major vectors 
is a challenge for vector control
The multiple resistance pattern observed in this An.s 
funestus population is similar to the pattern observed 
in the northern part of the country, with the exception 
of bendiocarb resistance which was higher in the north 
[5]. This result suggests that resistance in An. funestus 
is widespread in Cameroon and could be a concern for 
effective insecticide-based control tools against this vec-
tor. Anopheles funestus is highly resistant to both type I 
and II pyrethroids. The resistance observed in Mibellon 
seems higher than in Gounougou (2012). This difference 
could be due to the length of time between the two stud-
ies as resistance could have increased since 2012 when 
the study at Gounougou was carried out. It could also 
be evidence that the pyrethroid resistance level in An. 
funestus in Cameroon is increasing. This increase could 
be due to the massive distribution of LLINs implemented 
by Cameroonian Government in the past 5 years. Mibel-
lon is also located in an area where agriculture is the 
main activity, and agricultural use of pesticides could be 
another factor that is driving the increase in resistance 
level. A similar level of increase of pyrethroid resistance 
was observed in southern Malawi [35] and also reported 
in Uganda for An. funestus [32]. The high recovery of sus-
ceptibility observed after PBO exposure for deltamethrin, 
permethrin and DDT suggests that cytochrome P450 
genes are playing a significant role in these resistance 
patterns. Altogether, this resistance to pyrethroids should 
be of great concern for malaria control programmes 
in Cameroon. If no strong action is taken to manage it, 
there is a risk that the massive distribution of pyrethroid-
impregnated LLINs taking place in Cameroon could be 
jeopardized. The possible resistance observed to the car-
bamate bendiocarb in An. funestus population shows that 
such insecticide should be ruled out as an alternative to 
pyrethroid for IRS. The full susceptibility to the organo-
phosphate malathion, as also demonstrated across the 
continent so far, suggests that this insecticide class is the 
most suitable for IRS against this species.
Very high level of resistance to several classes, includ-
ing organochlorine, pyrethroid and carbamate, was 
also observed in An. gambiae s.s. population. This high 
resistance in An. gambiae is in line with the increased 
resistance reported in this species in several sites across 
Cameroon [14, 17–20]. The resistance in An. gambiae 
was higher than in An. funestus for most insecticides 
(e.g., no mortality against permethrin in An. gambiae 
vs 40.9% in An. funestus) suggesting a greater selection 
operating in An. gambiae. This could be explained by a 
selection of resistance from breeding sites contaminated 
with insecticides used for the protection of the crops. As 
An. gambiae breeding sites are often located at the vicin-
ity of crops, the selection could be greater in this species 
compared to An. funestus because of mosquito-breeding 
sites in Mibellon, where there is a large lake that insecti-
cides from farms drain into.
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Bio‑efficacy of LLINs in cone assays
The low mortality rates observed with permethrin and 
deltamethrin for both species in Mibellon correlated with 
the reduced bio-efficacy of most LLINs observed with 
cone assays including PBO-based nets such as Olyset 
Plus. This loss of efficacy may be due to selection pres-
sure induced by the massive distribution of bed nets by 
the government [2, 3] in addition to the use of pesticide 
for farming in the area. For both species, the mortality for 
all the nets is very low except for PermaNet 3.0 (side). For 
An. funestus, the mortality rates for all LLINs are lower 
than has been recently reported from other countries 
such, as DR Congo [38]. However, because cone assays 
could underestimate the efficacy of LLINs, as they do not 
assess their additional excito-repellent effect [39], future 
studies with experimental huts are needed to establish 
the impact of resistance on LLINs in this region.
Predominance of metabolic resistance in An. funestus 
contrasts with high frequency of knockdown resistance 
in An. gambiae
The near full recovery observed for pyrethroids in An. 
funestus after pre-exposure to PBO indicates that resist-
ance is mainly conferred by metabolic resistance par-
ticularly by cytochrome P450s [40]. This is in line with 
previous reports of the absence of kdr in this species in 
Cameroon [5] and across Africa [41]. The frequency of 
the 119F-GSTe2-resistant allele in Mibellon field popu-
lation (28%) is lower than in the northern part of Cam-
eroon in Gounougou (52%) [5] or in Ghana (44.2%) [42] 
and Benin (56.25%) [30]. The frequencies in Mibellon are 
closer to that observed in the eastern part of Africa in 
Uganda (20.4%) [21, 32]. GSTe2 has been shown to con-
fer cross-resistance between DDT and pyrethroids [42]. 
The partial recovery of DDT susceptibility after PBO 
assays suggests that GSTe2 is probably playing a role in 
the resistance in this An. funestus s.s. population.
The frequency of the 296S-RDL-resistant allele is only 
9.7%, which is lower than was observed in the northern 
region at Gounougou. This low frequency could be as a 
result of recovery to susceptibility for dieldrin after this 
insecticide was removed from public and agricultural 
sectors in Cameroon, as observed in Gounougou where 
the frequency of this mutation went down from 80% 
in 2006 to 40% in 2012 and 14.6% in 2015 [5, 43]. Such 
reversal of resistance is encouraging for the implementa-
tion of resistance management strategies.
The very high resistance levels to pyrethroids in An. 
gambiae s.s. (no mortality to permethrin), correlates with 
the high frequency of the 1014F kdr allele (63.9%). This is 
in line with other reports from Africa where high pyre-
throid resistance in An. gambiae s.l. has been associated 
with nearly fixed kdr allele in the population, as observed 
recently in DR Congo [38], or previously in Côte d’Ivoire 
[44]. However, this high level of kdr is in contrast to fre-
quencies observed in other locations across Cameroon 
as highlighted by a recent review [17]. The very low 
frequency of the 1014S kdr allele in Mibellon is simi-
lar to previous reports across Cameroon showing that 
this marker, originally present in East Africa, has now 
migrated to Central and West Africa although still at very 
low frequencies [45]. Overall, the fact that 1014F kdr fre-
quency is not fixed in Mibellon in the presence of such 
high pyrethroid and DDT resistance suggests that other 
mechanisms are playing an important role, probably 
metabolic resistance as shown for other An. gambiae s.l. 
populations in Cameroon [18, 19, 46]. Further investiga-
tion of the resistance mechanisms will help elucidate the 
molecular basis driving resistance in this population. The 
total absence of the 119S ace-1 mutation is in line with 
the susceptibility of this population to organophosphate 
and carbamate as this mutation is responsible for organo-
phosphate and carbamate resistance [47, 48].
Malaria transmission roles of both vectors
This study further confirms the role of An. funestus in 
malaria transmission with sporozoite infection rate of 5%. 
This is lower compared to that observed [49] in Nkoteng 
where P. falciparum infection rate was found to be 8.6%. 
In Benin (Kpome), An. funestus population was found 
with high Plasmodium infection during the dry season 
(infection rate of 18.2%), although from the whole mos-
quitoes [30]. The higher infection rate found in abdomen 
(15%) compared to head and thorax (5%) in this study 
further supports the significant barriers that the midgut 
plays in preventing oocyst migration to salivary gland 
[50]. The number of An. gambiae s.s. infected with Plas-
modium (20%) is higher compared to An. funestus s.s. 
(15%). This rate is very high compared to previous results 
in Cameron (6.5–8.1%) [12]. This could be linked to the 
higher level of insecticide resistance in the An. gambiae 
population, because they are resistant and live longer, 
which could increase their ability to be infected.
Conclusion
Multiple resistance observed in both An. funestus s.s. 
and An. gambiae s.s. at Mibellon in central Cameroon 
is a concern for ongoing insecticide-based interventions 
although the full susceptibility to organophosphate offers 
an alternative to IRS. However, the impact of such mul-
tiple resistance on the effectiveness of insecticide-based 
control interventions needs to be evaluated, notably 
through experimental huts. The presence of resistance 
in both major vectors makes this area suitable for such 
studies.
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Abstract: Growing insecticide resistance in malaria vectors is threatening the effectiveness of
insecticide-based interventions, including Long Lasting Insecticidal Nets (LLINs). However,
the impact of metabolic resistance on the effectiveness of these tools remains poorly characterized.
Using experimental hut trials and genotyping of a glutathione S-transferase resistance marker
(L119F-GSTe2), we established that GST-mediated resistance is reducing the efficacy of LLINs
against Anopheles funestus. Hut trials performed in Cameroon revealed that Piperonyl butoxide
(PBO)-based nets induced a significantly higher mortality against pyrethroid resistant An. funestus than
pyrethroid-only nets. Blood feeding rate and deterrence were significantly higher in all LLINs than
control. Genotyping the L119F-GSTe2 mutation revealed that, for permethrin-based nets, 119F-GSTe2
resistant mosquitoes have a greater ability to blood feed than susceptible while the opposite effect is
observed for deltamethrin-based nets. For Olyset Plus, a significant association with exophily was
observed in resistant mosquitoes (OR = 11.7; p < 0.01). Furthermore, GSTe2-resistant mosquitoes
(cone assays) significantly survived with PermaNet 2.0 (OR = 2.1; p < 0.01) and PermaNet 3.0 (side)
(OR = 30.1; p < 0.001) but not for Olyset Plus. This study shows that the efficacy of PBO-based nets
(e.g., blood feeding inhibition) against pyrethroid resistant malaria vectors could be impacted by
other mechanisms including GST-mediated metabolic resistance not affected by the synergistic action
of PBO. Mosaic LLINs incorporating a GST inhibitor (diethyl maleate) could help improve their
efficacy in areas of GST-mediated resistance.
Keywords: malaria; Long Lasting Insecticidal Nets; insecticide resistance; metabolic resistance;
glutathione S-transferase; Anopheles funestus; piperonyl butoxide
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1. Introduction
The scale-up of insecticide-based interventions including Long Lasting Insecticidal Nets (LLINs)
and Indoor Residual Spraying (IRS) has significantly contributed to the considerable reduction of
malaria burden in the past decade [1]. Unfortunately, growing insecticide resistance in malaria vectors
beside drugs resistance, lack of vaccine and reduced donor funding are threatening these successes.
However, the actual impact of resistance, notably metabolic resistance, on the effectiveness of vector
control tools against pyrethroid resistant mosquito populations remains a topic of debate especially
when using entomological outcomes. Indeed, some studies have suggested that pyrethroid resistance
does not yet impact the effectiveness of LLINs [2] whereas others have revealed a negative impact [3].
Furthermore, to help manage resistance, novel LLINs with the piperonyl butoxide (PBO), an insecticide
synergist, have been designed by various manufacturers [4–6]. A randomized control trial comparing
PBO-based nets to pyrethroid-only nets [3] led WHO to recommend in 2017 that national malaria
control programmes and their partners should consider the deployment of pyrethroid-PBO nets in areas
where the main malaria vector(s) have pyrethroid resistance that is: (a) confirmed, (b) of intermediate
level, and (c) conferred (at least in part) by a monooxygenase-based resistance mechanism [7]. However,
it remains unclear how these pyrethroid-PBO nets will performed when other mechanisms such as
GST-based metabolic resistance are driving the resistance. One of the key challenges of assessing the
impact of such metabolic resistance on the effectiveness of insecticide-based interventions such as LLINs
has been the lack of molecular markers for resistance, as this phenotype is not easily associated with
the outcome of the interventions. Recent efforts have detected a key genetic marker in the glutathione
S-transferase epsilon 2 gene (GSTe2). This marker confer metabolic-mediated resistance to pyrethroids
and dichlorodiphenyl-trichloroethane (DDT) in the major malaria vector Anopheles funestus in West
and Central Africa [8]. Besides cytochrome P450s and esterases, GSTs are, one of the main enzyme
families conferring metabolic resistance to insecticides [9] either through a direct metabolism or by
catalyzing the secondary metabolism of substrates oxidized by cytochrome P450s [9]. Over-expression
of GST epsilon 2 (GSTe2) has been associated with DDT and/or pyrethroids resistance in several
mosquito species including An. gambiae [10], An. funestus [8] and Aedes aegypti [11]. In An. funestus,
genomic and structural analyses revealed that a leucine to phenylalanine amino acid change (L119F) in
GSTe2, has enlarged the substrate-binding pocket of the enzyme, conferring DDT/pyrethroid resistance
in West and Central African populations [8]. This single amino acid change was used to design a
simple field applicable DNA-based diagnostic tool [12] providing the opportunity to address questions
regarding the direct impact of GST-mediated metabolic resistance on insecticide-based interventions
such as LLINs.
The pyrethroid resistance in An. funestus across Africa is driven by metabolic resistance [13–15] as
no knockdown resistance (kdr) has been reported so far for this species [16]. This predominance of
the metabolic resistance mechanism in An. funestus through over-expression of detoxification genes
such as GSTs or P450s makes this vector suitable to assess the impact of metabolic resistance on control
interventions. The presence of the GST-mediated metabolic resistance in An. funestus populations such
as in Cameroon [8,17,18] provides the opportunity to assess how the effectiveness of PBO-based nets is
impacted when malaria vectors exhibit other type of metabolic resistance than cytochrome P450-based
resistance which have been so far the only focus of synergists.
Experimental hut studies are the method of choice to evaluate the efficacy of LLINs against
mosquito populations using entomological indices as a proxy for potential epidemiological
impact [19,20]. It also provides relevant samples to assess how metabolic resistance impacts the
effectiveness of LLINs as done previously to assess impact of target site mutations such as kdr [21].
Here, we assessed the performance of conventional pyrethroid-only nets versus PBO-based against
a pyrethroid resistant An. funestus population from Cameroon using experimental huts. Furthermore,
we took advantage of the L119F-GSTe2 DNA-based diagnostic assay [8], to assess the impact of
GST-mediated metabolic resistance on the performance of these five LLINs.
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2. Materials and Methods
2.1. Study Area
The experimental hut station was located in Mibellon (6◦4′60′′N, 11◦30′0′′ E), a village in Cameroon
located in the Adamawa Region; Mayo Banyo Division and Bankim Sub-division. The Adamawa
region is in the mountainous zone forming a transition between Cameroon’s forested south and savanna
north. Malaria transmission is perennial with a high transmission as shown by very high infection rate
of Plasmodium infection caused by Plasmodium falciparum but also P. malariae [12]. The village was
located in close proximity to permanent water bodies including a lake and swamps which provide
suitable breeding sites for An. funestus s.l. Human activities are mainly fishing, hunting and subsistence
farming including maize, watermelon and coffee plantations. At the experimental station, 12 huts built
following the World Health Organisation (WHO) standard [22], were available for a wide range of
experimental hut trials. An. funestus s.s. was the main malaria vector in the area [18]. Mansonia sp.,
and Culex sp. were also present in the area. Anopheles mosquitoes in the area were highly resistant
to pyrethroid and DDT [18]. The trial was carried out for 10 weeks during the rainy season between
10 July and 16 October 2016.
2.2. Experimental Hut Design
The huts are built following the prototype recommended by WHO for the West African region [22].
The hut is constructed on a concrete base surrounded by a drain channel to trap ants. The walls are
made from concrete bricks and plastered inside and outside with a plaster made from a mixture of
cement and sand. The roof is made from corrugated iron and the ceiling is made from plywood. The 4
windows located on three side of the hut are designed to create an angle with a 2 cm gap, which will
facilitate the entry of mosquitoes flying upward and prevent the mosquitoes from escaping once they
have entered the hut. A veranda trap is built at the back of the hut according to WHO protocol [23].
A curtain is used as a separation between the veranda and the rest of the hut. Before bedtime, each
sleeper is required to raise the curtain to give mosquitoes the opportunity to take refuge in the veranda.
In the morning, it is recommended that the sleeper lowers the curtain before starting the collection, to
allow a separate collection of mosquitoes in the veranda and in the hut.
2.3. Net Treatment/Arm Comparison
During the experimental hut trial, four LLINs and one untreated net as negative control were
compared (Table 1). These included two pyrethroid-only LLINs (PermaNet 2.0 and Olyset) and two
PBO-based nets (PermaNet 3.0 and Olyset Plus) (Table 1). Each net was holed according to WHO
protocol [23]. Six holes were generated (4 cm × 4 cm) per net, two on each of the long sides and one on
each of the short sides.
Table 1. Description of the long-lasting insecticidal nets used.
Treatment Arm Description Manufacturer
Untreated 100% polyester with no insecticide Local market
Olyset 8.6 × 10−4 kg/m2 (2%) of permethrin incorporated into polyethylene Sumitomo Chemical
Olyset Plus 8.6 × 10
−4 kg/m2 (2%) of permethrin and 4.3 × 10−4 kg/m2 (1%) of Piperonyl butoxide
(PBO) incorporated into polyethylene
Sumitomo Chemical
PermaNet 2.0 100% polyester coated with 1.8 g/kg of deltamethrin Vestergaard Frandsen
PermaNet 3.0 Combination of 2.8 g/kg of deltamethrin coated on polyester with strengthened border(side panels) and deltamethrin (4.0 g/kg) and PBO (25 g/kg) Vestergaard Frandsen
2.3.1. Hut Effect
Prior to the study, the hut effect was assessed to evaluate any specific attractiveness of huts.
Untreated nets were hung in the six huts used for the study, and during 3 weeks, between the 10 and
29 May 2016, volunteers sleeping underneath collected mosquitoes each morning.
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2.3.2. Bioassays and Cone Assays
Cone bioassays were performed at the beginning of the study using the An. coluzzii susceptible
Ngousso laboratory strain. This was done to confirm the quality of the five bed nets used in the study.
Cone bioassays were also done in the insectary using F1 progeny from field collected Anopheles funestus
from Mibellon. For PermaNet 2.0, PermaNet 3.0 (side and top), Olyset and Olyset Plus beside an
untreated control net, five batches of 10 unfed females, 2–5 days old, were exposed to each bed nets
using WHO cone assays for three minutes [22]. They were then transferred into a holding paper cup
containers and the knock down was checked after 60 min and the mortality after 24 h post-exposure
during which mosquitoes were provided sugar solution. Bioassays were also performed to generate
highly resistant (alive after 90 min exposure) and highly susceptible (dead after 30 min) mosquitoes
against 0.75% permethrin, 0.05% deltamethrin and 4% DDT WHO papers. The 30 and 90 min exposure
tests were performed in separate tubes then scored 24 h post-exposure. For each test 4 replicates of 25
mosquitoes were used. The samples were then used to assess the association between L119F-GSTe2
genotypes and resistance to these insecticides.
2.4. Experimental Hut Trial
The experimental hut trial was carried out during 60 night following the protocol described in the
guidelines for laboratory and field-testing of long-lasting insecticidal nets [23]. To correct any specific
attractiveness observed during the hut effect assessment, bed nets were rotated according to the Latin
design square rotation [23] so that at the end of the study each net would have spent six days in each
hut. The huts were cleaned weekly before the rotation of the nets. Six volunteer males were selected to
sleep in the room from 20:00 GMT in the evening to 5:00 GMT in the morning. The sleepers were also
rotated every day so that at the end of the week each sleeper would have spent one night in each hut.
The rotation of the sleepers was done to correct any bias due to any specific attractiveness from the
sleepers. In addition, the sleepers were blinded to the treatments.
2.4.1. Mosquito Collection
Mosquitoes were collected every morning, using hemolysis tubes from: (i) inside the nets, (ii)
in the room: floor, walls and roof, and (iii) in the veranda exit trap. Mosquitoes collected from each
compartment were kept separately in a bag to avoid any mixing between samples from different
compartments. Samples were then classified as dead, alive, blood fed or unfed. The ‘alive’ samples
were kept in the paper cup and provided with sugar solution for 24 h and mortalities monitored.
The field-caught females were sorted according to morphological keys as previously described [24].
Mosquitoes belonging to the An. funestus group were species identified to species specific level using a
cocktail PCR as previously described [25].
2.4.2. Bed Nets Performance Assessment
The performance of the bed nets were expressed relative to control (untreated nets) in term of:
i. Deterrence/entry rate: the reduction in hut entry relative to control. Deterrence (%) = 100 × (Du
− Dt)/Du, where Du is the total number of mosquitoes found in untreated hut (control) and Dt
is the total number of mosquitoes in the treated hut.
ii. Entry rate (%) = 100 × (Ht/Hn) where Ht is the total number of mosquitoes found in the hut
and Hn is the total number of mosquitoes collected in all the 5 huts.
iii. Exophily (Excito-repellency): the proportion of mosquitoes found exited in the veranda trap
Exophily (%) = 100 × (Ev/Et) where Ev is the total number of mosquitoes fund in veranda and
Et is the total number of both inside the hut and veranda.
iv. Blood feeding rate (BFR). This rate was calculated as follows: Blood feeding rate = (N mosquitoes
fed) × 100/total N mosquitoes. Where “N mosquitoes fed” was the number of mosquitoes fed,
and “total N mosquitoes” was the total number of mosquitoes collected.
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v. Blood-feeding inhibition (BFI): the reduction in blood-feeding in comparison with the control
hut. Blood feeding inhibition is an indicator of personal protection (PP). More precisely, the
personal protection effect of each bed net is the reduction of blood feeding percentage induced
by the net when compared to control. The protective effect of each bed net can be calculated
as follows:
vi. Personal protection (%) = 100 × (Bu − Bt)/Bu, where Bu is the total number of blood-fed
mosquitoes in the huts with untreated nets and Bt is the total number of blood-fed mosquitoes
in the huts with treated nets [23].
vii. Immediate and delay mortality: the proportion of mosquitoes entering the hut that are found
dead in the morning (immediate mortality) or after being caught alive and held for 24 h
with access to sugar solution (delay mortality) [23]. In this study we focused on the overall
mortality calculated as follows: Mortality (%) = 100 × (Mt/MT) where Mt is the total number
of mosquitoes found dead in the hut and MT is the total number of mosquitoes collected in
the hut.
2.4.3. Ethical Clearance
The National Ethics Committee for Health Research of Cameroon approved the protocol of the
study (ID:2016/03/725/CE/CNERSH/SP). Written, informed and signed consent was obtained from
sleepers before starting the trials. The consent form provided all the information and the evaluation
process about the study. Information was translated in local language when needed. All the volunteers
involved in the study were followed-up and treated when showing malaria symptoms. All methods
were performed in accordance with the relevant guidelines and regulations.
2.5. Impact of the L119F-GSTe2 Mutation on Insecticide-Treated Nets
The samples collected during the investigation on the performance of nets were grouped in
several categories: dead, alive, blood fed, unfed; room and veranda and inside nets. The L119F-GSTe2
mutation was genotyped in each group using an Allele Specific-PCR. This allows a direct measure
of the relative survival and feeding success of resistant and susceptible insects in the presence of the
different bed nets.
2.6. Genotyping
Samples classified as dead, alive, blood fed, unfed, room and veranda were used for DNA
extraction using the Livak protocol [26]. The L119F-GSTe2 mutation was genotyped to assess how the
glutathione S-transferase gene, GSTe2, impacts the performance of the bed nets. An allele specific
PCR [27,28] was used to detect the three genotypes of the L119F-GSTe2 mutation (homozygote
resistant:RR, heterozygote resistant: RS and homozygote susceptible: SS). The PCR was carried out
using 10 mM of each primer and 1 µL of gDNA as template in 15 µL reaction containing 10× Kapa Taq
buffer A, 0.2 mM dNTPs, 1.5 mM MgCl2, 1 U Kapa Taq (Kapa Biosystems, Wilmington, MA, USA).
Amplification was carried out using thermocyclic parameters: 95 ◦C for 5 min; 30 cycles of 94 ◦C for
30 s, 58 ◦C for 30 s, 72 ◦C for 45 s, and final extension at 72 ◦C for 10 min. The following primers were
used: L119F-Fwd: ATG ACC AAG CTA GTT CTG TAC ACG CT; L119F-Rev: TTC CTC CTT TTT ACG
ATT TCG AAC T; L119F-Res1: CGG GAA TGT CCG ATT TTC CGT AGA AtAA; L119-F-Sus1: CAT
TTC TTA TTC TCA TTT ACA GGA GCG TAaTC. PCR products were separated on 2% agarose gel
by electrophoresis. The bands corresponding to different genotypes were interpreted as previously
described [12,28].
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2.7. Data Analysis
2.7.1. Experimental Hut Trial
To calculate the proportion of each entomological outcomes and the level of significance between
the treatments and between the control for each entomological outcomes, the XLSTAT software
(Addinsoft, Berkeley, CA, USA) was used, as done previously [29,30]. The numbers of mosquitoes
collected in the huts with different treatments were analysed by negative binomial regression. The effects
of the treatments on each of the main proportional entomological outcomes (exophily, blood feeding
and mortality) were assessed using binomial generalized linear mixed models (GLMMs) with a logit
link function, fitted using the ‘lme4’ package for R 3.6. (R Development Core Team, 2019). A separate
model was fitted for each outcome and for each mosquito species. In addition to the fixed effect of
each treatment, each model included random effects to account for the following sources of variation:
between the five huts used in the studies; between the five sleepers who slept in the huts; between the
ten weeks of the trial.
2.7.2. Test of Association between L119F-Mutation and the Entomological Outcomes
To investigate the association between the GSTe2 mutation and the ability of the mosquitoes to
survive, blood feed or escape, Vassar stats was used to estimate the Odds ratio (OR) based on a fisher
exact probability test with a 2 × 2 contingency table.
2.7.3. Hut Effect Analysis
The one-way analysis of variance (ANOVA) using Prism 7.0 (GraphPad, San Diego, CA, USA)
was used to determine whether there were any statistically significant differences between the means
of the mosquitoes collected from the six huts. In this study, for all the analyses, an alpha of 0.05 was
used as the cut off for significance.
3. Results
3.1. Cone Assays Using the An. gambiae Susceptible Lab Strain Ngousso
At the beginning of the study each bed net was exposed to the An. coluzzii susceptible lab strain
Ngousso using WHO cone assays. Olyset plus and PermaNet 3.0 showed a mortality of 100 ± 00%,
PermaNet 2.0 showed 93.3 ± 3.33% mortality and Olyset gave mortality rate of 96.97 ± 3.33% whereas
no mortality was recorded for the untreated net (Figure 1A).
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(A) Quality control of the efficacy of all the four nets checked against the susceptible laboratory strain of
Anopheles gambiae Ngousso and LLINs efficacy testing using cone assays against the pyrethroid resistant
An. fun stus population from Mibellon, Cameroon; (B) Nu ber of mosquitoes collected during the hut
effect assessment; (C) Average of Anopheles funestus. ss collected by hut during the 18 days of the hut
effect investigation.
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3.2. Cone Assays with An. Funestus from the Field (Mibellon)
Olyset and Olyset plus showed mortality of 5.63 ± 3.2%, and 67.23 ± 3.4% respectively when
exposed to the F1 population of An. funestus from Mibellon using WHO cone assays. PermaNet 2.0
showed 25.06 ± 5.06% mortality and PermaNet 3.0 side and PermaNet 3.0 top gave 71.04 ± 3.33%
and 100 ± 0% respectively whereas no mortality was recorded for the Yorkool and the untreated net
(Figure 1A).
3.3. Hut Effect
After 18 days collections, a total of 1147 mosquitoes were collected in the huts with untreated net.
Out of the 1147, 488 were females An. funestus, 428 An. funestus males, 195 Mansonia spp., 32 Culex sp.,
and four An. rufipes. The average of An. funestus females collected per room after 18 days ranged
from 3 to 8 per day (Figure 1C). No significant difference (p = 0.09; DF = 5) between the numbers of
mosquitoes collected in the different huts was observed (Figure 1C).
3.4. Mosquito Abundance
A total of 4656 mosquitoes were collected in five huts by human volunteers sleeping in the huts
for 10 weeks corresponding to 360 man-nights. Out of the mosquitoes collected 1155 (25%) were
An. funestus. s.s. females, 2421 (52%) were An. funestus males, 1004 (22%) were Mansonia spp., 03 (0.06%)
were An. gambiae ss., 66 (1%) were Culex sp. and 04 (0.08%) were Aedes sp. (Figure 2A). However, only
female An. funestus and Mansonia sp., due to its significant nuisance in this area, were considered for
analysis (Tables 2 and 3).
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Table 2. Results of the performance of the five brands of LLINs against wild An. funestus females in
experimental huts.
Treatments
Control PermaNet 2.0 PermaNet 3.0 Olyset Olyset Plus
Females caught 390 237 153 176 199
Exophily% 6.9 17.7 *** 17.0 *** 29.0 *** 22.1 ***
95% Confidence limits 4.40–9.44) (12.85–22.58) (11.04–22.94) (22.27–35.68) (16.34–27.88)
Blood fed (%) 40.8 19.8 *** 15.7 *** 15.3 *** 17.2 ***
95% C nfidence limits (35 89–45.65) (14.75–24.91) 9.92–21.45) 10.02–20.67) (1 .74–23.44)
Blood feed inh. (%) 0.0 51.36 61.52 62.37 55.63
Personal protection (%) 0.0 70.44 84.90 83.01 77.35
Overall mortality (%) 5.4 12.2 ** 30.1 *** 9.7 * 25.1 ***
95% Confidenc limits (31.14–7.62) (8.06–16.41) (2 .80–37.33) (5.29 14.02) (19.10 31.15)
Immediate mortality 2.6 5.4 27.6 *** 6.1 * 18.3 ***
entry rate 33.7 20.5 * 13.2 *** 15.2 *** 13.6 ***
Deterrence (%) 0.0 39.2 60.8 54.9 49.0
* = p < 0.05 ** = p < 0.01 *** = p < 0.001.
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Table 3. Results of the performance of the four brands of LLINs against wild Mansonia spp. in
experimental huts.
Control PermaNet 2.0 PermaNet 3.0 Olyset Olyset Plus
Total 342 142 216 141 163
Exophily% 42.4 37.3 * 31.9 ** 28.4 ** 31.3 **
95% Confidence limits (37.16–47.64) (29.37–45.28) (25.73–38.16) (20.93–35.81) (24.17–38.41)
Blood feeding (%) 30.1 16.2 ** 9.3 *** 15.6 *** 20.2 **
95% Confidence limits (25.25–34.98) (10.14–22.26) (5.39–13.12) (9.61–21.59) (14.08–26.41)
Blood feeding inh. (%) 0.0 46.22 69.26 48.19 32.78
Personal protection (%) 0.0 77.66 80.53 78.64 67.96
Overall mortality (%) 37.4 51.4 ** 65.5 *** 40.4 ** 68.1 ***
Immediate mortality 36.8 46.5 62.0 *** 39.0 *** 65.0 ***
Entry rate 34.0 14.1 *** 21.5 ** 14.0 *** 16.2 ***
Deterrence (%) 0.0 58.5 36.8 58.8 52.3
* = p < 0.05 ** = p < 0.01 *** = p < 0.001.
3.5. Performance of the Nets against An. Funestus s.s. Population
3.5.1. Deterrent Effect/Entry Rate
In comparison to control, the entry rate was significantly reduced in all the huts for the five LLINs
with the deterrence rates ranging from 39.2% for PermaNet 2.0 to 60.8% for PermaNet 3.0. PermaNet
3.0 had a significantly higher deterrence compared to PermaNet 2.0 but this was not the case for Olyset
Plus (49%) over Olyset (54.9%) (Table 2).
3.5.2. Induced Exophily Rate
A low exophily rate was recorded in the control hut for An. funestus s.s. (6.9%). However, the
exophily rate was significantly higher in the hut with Olyset (29.0%; p < 0.001), Olyset Plus (22.1%;
p < 0.001), PermaNet 2.0 (17.7%; p < 0.001) and PermaNet 3.0 (17.0%; p < 0.001) compared to the control
hut (Figure 2A and Table 2). No significant difference is observed between the five tested LLINs.
A significant high exophily activity was observed during week 2 and week 9 (p < 0.05) (Table S1).
3.5.3. Mortality (Overall Mortality)
Low mortality rates were recorded in the control hut for An. funestus s.s. (5.4%). However, the
mortality rate was significantly higher in the hut with Olyset Plus (25.1%; p < 0.01), PermaNet 2.0
(12.2%; p < 0.01) and PermaNet 3.0 (30.1%; p < 0.001) compared to the control hut. The mortality rate
was significantly higher with the two PBO-based nets than all the pyrethroid-only nets (p < 0.001).
However, no significant variation was observed between the mortality in the huts with Olyset (9.7 %;
p > 0.05) compared to control (Figure 2B and Table 2). It is also clear from our analysis that mortalities
obtained were not influenced by the sleepers (p > 0.05), by the huts (p > 0.05) and by the weeks (p > 0.05)
(Table S2).
3.5.4. Blood Feeding Inhibition (BFI)
High blood feeding rates were recorded in the control hut (40.8%). However, the blood feeding
rate (BFR) was significantly lower in the hut with Olyset (BFR = 15.3; BFI = 62.3%; p < 0.001), Olyset
Plus (BFR = 18.1%; BFI = 55.6%; p < 0.001), PermaNet 2.0 (BFR = 19.8%; BFI = 51.3%; p < 0.001) and
PermaNet 3.0 (BFR = 15.7%; BFI = 61.5%; p < 0.001) compared to the control hut (Figure 2B and Table 2).
PermaNet 3.0 had a higher BFI than PermaNet 2.0 but this was not the case with Olyset Plus compared
to Olyset although the differences were not significant. We noticed a significant reduction of the blood
feeding in hut 4 (p < 0.05) (Table S3).
3.5.5. Personal Protection (PP)
The lowest performance in terms of PP was recorded with PermaNet 2.0 (70.44%). PermaNet 3.0
provided a higher PP when compared to PermaNet 2.0 but not significant (84.9% vs. 70.4%; p > 0.05).
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No significant difference was observed when comparing the PP provided by Olyset and Olyset Plus
(83 vs. 77.3%; p > 0.05) (Table 2).
3.6. Performance of the Nets against Mansonia spp. Population
3.6.1. Deterrent Effect
In comparison to control, the entry rate was significantly reduced for the four LLINs with
deterrence rates ranging from 36.8% for PermaNet 3.0 to 58.8% for Olyset. Contrary to An. funestus,
PermaNet 2.0 had a higher deterrence rate (58.5%) compared to PermaNet 3.0 (36.8%) and similar for
Olyset (58.8%) compared to Olyset Plus (52.3%) (Table 3).
3.6.2. Induced Exophily Rate
A higher exophily rate was recorded in the control hut for Mansonia spp. (42.4%) than An. funestus
(6.9%). However, the exophily rate of Mansonia spp., was significantly lower in the hut with Olyset
(28.4%; p < 0.01), Olyset Plus (31.3%; p < 0.01) and PermaNet 3.0 (31.9%; p < 0.01) compared to the
control hut. For PermaNet 2.0 no significant difference was observed when compared to control (37.3%;
p > 0.05) (Table 3).
3.6.3. Mortality
The overall mortality rate recorded in the control hut for Mansonia spp. was 37.4%. However,
this rate was significantly higher in the hut with Olyset Plus (68.1%; p < 0.001), PermaNet 2.0 (51.4%;
p > 0.05) and PermaNet 3.0 (65.3%; p < 0.001) compared to the control. No significant variation was
observed between the mortality in the huts with Olyset (40.4%; p > 0.05) compared to control (Table 3).
The two PBO nets PermaNet 3.0 and Olyset Plus had a significantly higher mortality rate than the
pyrethroid-only nets PermaNet 2.0 and Olyset (Table 3).
3.6.4. Blood Feeding Inhibition (BFI)
The blood feeding rate recorded in the control hut for Mansonia spp. was 30.1%. However, this rate
was significantly lower in the hut with Olyset (15.6%; BFI = 48.1%; p < 0.01), Olyset Plus (20.2%; 32.7%;
p < 0.001), PermaNet 2.0 (16.2%; BFI = 46.2%; p < 0.01) and PermaNet 3.0 (9.3%; BFI = 69.26%; p < 0.001)
compared to the control hut. PermaNet 3.0 had higher BFI than all the other nets but this was not
significant when compared to PermaNet 2.0 and Olyset Plus.
3.6.5. Personal Protection (PP)
The lowest PP was recorded with Olyset Plus (67.96%) whereas PermaNet 3.0 provided a higher
PP but not significant when compared to PermaNet 2.0 (80.5% vs. 77.6%; p > 0.05) but higher than the
Olyset nets. No significant difference was observed when comparing the PP provided by Olyset and
Olyset Plus (78.6% vs. 67.9%; p > 0.05) (Table 3).
3.7. Comparative Analysis of the Impact of L119F-GSTe2 Mutation on the Efficacy of Conventional and
PBO-Based Nets
Impact on Mortality
Due to the low number of dead mosquitoes (5) the impact on mortality could not be assessed for
Olyset net. No correlation was observed between the L119F-GSTe2 mutation and the ability to survive
exposure to Olyset Plus (26 dead and 110 alive) when comparing the allelic frequency (OR = 0.85;
p > 0.05; CI 0.45–1.59). A similar result was observed for the genotypic frequencies including between
RR vs. SS (OR = 0.61; p > 0.05; CI 0.22–1.66), RS vs. SS (OR = 1.02; p = 1; CI 0.56–1.8) and RR vs. RS
(OR = 0.59; p > 0.05; CI 0.21–1.68) (Figure 3A and Table 4).
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Figure 3. Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy for blood
feeding ability: (A) Genotype distribution of L119F-GSTe2 between blood fed and unfed mosquitoes
after exposure to Olyset showing a significant increased ability to blood feed for resistant mosquitoes;
(B) Genotype distribution of L119F-GSTe2 between blood fed and unfed mosquitoes after exposure to
Olyset Plus showing a significant increased ability to blood feed for resistant; (C) Genotype distribution
of L119F-GSTe2 between blood fed and unfed mosquitoes after exposure to PermaNet 2.0 showing
an inverse marginal increased ability to blood feed for homozygote susceptible SS compared to
homozygote resistant RR (p < 0.05); (D) Genotype distribution of L119F-GSTe2 between blood fed
and unfed mosquitoes after exposure to PermaNet 3.0 showing an increased ability to blood feed of
susceptible mosquitoes compared to resistant mosquitoes (R vs. S: OR = 0.29 p < 0.05).
Table 4. Impact of L119F-GSTe2 mutation on the ability of various insecticide-treated nets to
kill mosquitoes.
Mortality
Genotype OR PV CI
Olyset Plus
RR vs. SS 0.61 >0.05 0.22–1.66
RR vs. RS 0.59 >0.05 0.21–1.68
RS vs. SS 1.02 1 0.56–1.8
R vs. S 0.85 >0.05 0.45–1.59
PermaNet 3.0
RR vs. SS 3.47 >0.05 1–11.9
RR vs. RS 3.56 >0.05 1–12.7
RS vs. SS 0.97 1 0.53–1.76




RS vs. SS 1.1 1 0.6
R vs. S 1.18 >0.05 0.6–2.2
Similarly, no significant association was observed for PermaNet 2.0 between the mutation and the
ability to survive (24 dead and 89 alive mosquitoes) when comparing the allelic frequency (OR = 1.18;
p > 0.05; CI 0.6–2.2) (Table 4) as well as the genotypic frequency of RS vs. SS (OR = 1.1; p = 1; CI 0.6–6.6)
(Figure S1B and Table 4).
For PermaNet 3.0, no significant association was observed between the mutation and the ability to
survive when comparing the allelic frequency (OR = 1.42; p > 0.05; CI 0.74–2.7) (Table 4) but comparing
the genotypic frequency of RR vs. SS provided a higher Odds ratio close to significance (OR = 3.47;
p > 0.05; CI 1–11.9) (Figure S1C).
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3.8. Impact on Blood Feeding
For Olyset net, a significant association was observed between the 119F_GSTe2 resistance allele and
an increased ability to blood feed (21 blood fed and 92 unfed) when comparing the allelic frequencies
(OR = 2; p < 0.05; CI 1.06–3.7) and the genotypic frequency of RS v SS (OR = 2.97; p < 0.001; CI 1.6–5.3)
(Figure 3A and Table 5).
Table 5. Impact of L119F-GSTe2 mutation on the efficacy of various bed nets to prevent blood feeding.
Genotype OR PV CI
Olyset Plus
RR vs. SS 3.3 <0.05 1.19–9.2
RR vs. RS 1.07 >0.05 0.38–3.02
RS vs. SS 3.08 <0.01 1.67–5.66
R vs. S 2.23 <0.05 1.2–4.1
Mosquitoes in Room
RR vs. SS 12.3 <0.001 2.5–60.4
RR vs. RS 1.46 >0.05 0.29–7.2
RS vs. SS 8.42 <0.001 4.37–16.2
R vs. S 4.56 <0.001 2.26–9.2
Olyset
RR vs. SS 2.6 >0.05 0.6–11.7
RR vs. RS 0.89 >0.05 0.2–3.9
RS vs. SS 2.97 <0.001 1.65–5.35
R vs. S 2 <0.05 1.06–3.7
Blood feeding in Room
RS vs. SS 3 <0.001 1.67–5.4
R vs. S 1.71 >0.05 0.89–3.3
PermaNet 3.0
RR vs. SS inf
RR vs. RS inf
RS vs. SS 0.5 <0.05 0.26–0.92
R vs. S 0.35 <0.05 0.17–0.73
Blood feeding in Room
RS vs. SS 0.41 >0.05 0.21–0.77
R vs. S 0.29 >0.05 0.14–0.63
PermaNet 2.0
RR vs. SS 0.4 >0.05 0.1–1.56
RR vs. RS 0.48 >0.05 0.12–1.9
RS vs. SS 0.8 >0.05 0.47–1.5
R vs. S 1.31 >0.05 0.6–2.5
For Olyset Plus net, when considering the blood feed and unfed samples from the room only (23
blood fed and 49 unfed) a significant association was found between L119F-GSTe2 and an increased
ability to blood feed when comparing the allelic frequencies (OR = 4.5; p < 0.001; CI 2.26–9.2). An
even stronger association was observed when comparing the genotype frequencies between RR vs. SS
(OR = 12.3; p < 0.001; CI 2.5–60.4) and RS vs. SS (OR = 8.42; p < 0.001; CI 4.37–16.2). But no association
was established when comparing RR v RS (OR = 1.46; p > 0.05; CI 0.29–7.2) (Figure 3B and Table 5).
No association was also obtained when comparing RR v RS (OR = 1.07; p > 0.05; CI 0.38–3.02) when
genotyping all the mosquitoes fed and unfed collected in in the hut treated with Olyset (33 blood fed
and 103 unfed).
For PermaNet 2.0, no association was observed when comparing the allelic frequency R vs. S
(OR = 1.31; p > 0.05; CI 0.55–2.01) (Figure 3C and Table 5). But an association was observed when
comparing genotypic frequency RS vs. SS (OR = 1.4; p < 0.001; CI 0.77–2.53).
For PermaNet 3.0, a negative association was observed between the mutation and the ability to
blood feed as resistant mosquitoes significantly blood fed less than susceptible when comparing the
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allelic frequency (OR = 0.35; p < 0.05; CI 0.17–0.73) and the genotypic frequency of RS vs. SS (OR = 0.5;
p < 0.05; CI 0.26–0.92) (Figure 3D and Table 5).
3.9. Impact on Exophily
For Olyset, no association was observed between the L119F-GSTe2 mutation and exophily (67 in
room and 48 in veranda) when comparing the allelic frequency (OR = 1.17; p > 0.05; CI 0.6–2.2) (Table 4)
and the genotypic frequency RS vs. SS (OR = 1.18; p > 0.05; CI 0.6–2.1) (Figure 4A and Table 6).
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Figure 4. Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy -exophily:
(A) Genotype distribution of L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes
after exposure to Olyset showing no association; (B) Genotype distribution of L119F-GSTe2 between
indoor (Room) and outdoor (verandah) mosquitoes after exposure to Olyset Plus showing a significant
increased ability to exit the room when considering all mosquitoes; (C) A greater association is observed
with exophily with Olyset Plus when only analyzing unfed mosquitoes; (D) Genotype distribution of
L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes after exposure to PermaNet
2.0 showing a significant association (RS vs. SS: OR = 1.35; p < 0.01); (E) Genotype distribution of
L119F-GSTe2 between indoor (Room) and outdoor (verandah) mosquitoes after exposure to PermaNet
3.0 showing no association.
For Olyset Plus, an association was observed between the mutation and the ability to escape
to the veranda when onsidering the allelic frequency (OR = 3.4; p < 0.001; CI 1.67–6.9) (Table 6).
An even stronger association was observed between the mutation and a preference for the veranda
when comparing RR vs. SS (OR = 11.76; p < 0.01; CI 2.59–53.4), RS vs. SS (OR = 2.99; p < 0.01;
CI 1.58–5.65). But no significant association was observed between RR vs. RS (OR = 3.9; p = 1; CI
0.8–18.59) (Figure 4B,C and Table 6). For PermaNet 2.0, an association was observed between the
L119F-GSTe2 mutation and the ability to exit the room when comparing the genotypic frequency RS
vs. SS (OR = 1.35; p < 0.01; CI 0.75–2.3). A stronger association was observed when assessing the
impact only among the unfed mosquitoes for RS vs. SS (OR = 3.37; p < 0.001; CI 01.84–6.17) but not
at the allelic level (Figure 4D and Table 6). For PermaNet 3.0, no association was observed between
the L119F-GSTe2 mutation and a preference for the room or the veranda when comparing the allelic
frequency (OR = 0.94; p = 1; CI 0.5–1.8) (Table 6). The same trend was observed when comparing
the genotypic frequency RR vs. SS (OR = 1.22; p = 1; CI 0.46–3.2), RS vs. SS (OR = 0.59; p > 0.05; CI
0.31–1.12) RR vs. RS (OR = 1.68; p > 0.05; CI 0.6–4.7) (Figure 4E and Table 6).
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Table 6. Impact of L119F-GSTe2 mutation on the efficacy of various bed nets in repellency.
Exophily
Genotype OR PV CI
Olyset Plus
RR vs. SS 3.1 >0.05 1.1–9
RR vs. RS 2.48 >0.05 0.83–7.42
RS vs. SS 1.25 >0.05 0.67–2.26
R vs. S 1.1 >0.05 0.6–2.2
Unfed Alive
RR vs. SS 11.76 <0.01 2.59–53.4
RR vs. RS 3.9 1 0.8–18.59
RS vs. SS 2.99 <0.01 1.58–5.6
R vs. S 3.4 <0.001 1.67–6.9
RS vs. SS 1.18 >0.05 0.6–2.1
R vs. S 1.17 >0.05 0.62–2.2
PermaNet 3.0
RR vs. SS 1.22 1 0.46–3.2
RR vs. RS 1.68 >0.05 0.6–4.7
RS vs. SS 0.59 >0.05 0.31–1.12
R vs. S 0.94 1 0.5–1.8
PermaNet 2.0
RS vs. SS 1.35 <0.01 0.75–2.43
R vs. S 1.22 >0.05 0.65–2.3
Unfed Alive
RS vs. SS 3.37 <0.001 1.84–6.17
R vs. S 1.8 >0.05 0.99–3.38
3.10. Correlation between L119F-GSTe2 and Mortality from Cone Assays
Due to the low number of dead mosquitoes obtained from the experimental huts, the impact of
the L119F-GSTe2 on the ability of mosquitoes to survive exposure to various nets was assessed using
samples from cone assays. Only a few dead were obtained for Yorkool and Olyset, preventing the
assessment of these nets.
3.10.1. Olyset Plus
No association was observed between the mutation and the mortality (40 dead vs. 40 alive
mosquitoes) at both allelic level (OR = 1.04; p = 1; CI 0.5–1.8) and genotypic for RR vs. SS (OR = 1.1;
p > 0.05; CI 0.4–2.7) (Figure 5A and Table 7).
3.10.2. PermaNet 2.0
Resistant 119F-GSTe2 mosquitoes exhibited a greater ability to survive than susceptible mosquitoes
(34 dead and 46 alive) at both allelic level (OR = 1.8; p < 0.01; CI 0.9–3.5) and genotypic frequency RR v
SS (OR = 2.09; p < 0.01; CI 1.1–4.2) (Figure 5B and Table 7).
3.10.3. PermaNet 3.0
Resistant 119F-GSTe2 mosquitoes when exposed to PermaNet 3.0 showed a greater ability to
survive than susceptible mosquitoes even than with PermaNet 2.0 at allelic level (OR = 3.8; p < 0.001;
CI 1.8–7.7). A higher correlation was further observed when comparing the genotypic frequencies for
RR vs. SS (OR = 30.1; p < 0.001; CI 3.8–234), RS vs. SS (OR = 2.4; p <0.01; CI 1.3–4.5) and RR vs. RS
(OR = 12.3; p < 0.001; CI 1.8–7.7) (Figure 5C and Table 7). This result applies only to PermaNet 3.0 side
net as no mosquito survived exposure to PermaNet top containing PBO.
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3.11. Validation of the Association between L119F-GSTe2 and Resistance to Pyrethroids and DDT in Mibellon
To further validate the impact of L119F-GSTe2 on LLINs, we established the association between
this marker and the ability to survive exposure to the pyrethroids used for Olyset (permethrin)
and PermaNet (deltamethrin) nets besides DDT. Correlation analysis between L119F genotypes and
deltamethrin revealed that homozygote resistant mosquitoes were significantly more likely to survive
exposure to deltamethrin than both homozygote susceptible SS (OR = 4.6; p < 0.001) and heterozygotes
(OR = 3.75; p < 0.001). However, there was no significant difference between RS and SS (Figure 5D).
A similar pattern was observed for permethrin (Figure 5E and Table 5). Analysis of the correlation
with DDT revealed a much stronger association between L119F and DDT resistance as RR exhibited
a greater ability to survive exposure to DDT than SS (OR = 66.7; p < 0.001) and also more than RS
(OR = 4.8; p < 0.001). Contrary to both pyrethroids heterozygote RS mosquitoes are also more able to
survive exposure to DDT than homozygote susceptible (OR = 14.0; p < 0.001) (Figure 5F and Table 7).
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Figure 5. Association between L119F-GSTe2 mutation and ability to survive exposure to LLINs (cone
assays) and WHO papers (bioassays): (A) Genotype distribution of L119F-GSTe2 between alive and
dead mosquitoe after exposure to Olyset Plus showing no associatio ; (B) Genotype distribution
of L119F-GSTe2 between alive and dead mosquitoes after exposure to PermaNet 2.0 showing a
significantly increased ability of resistant mosquitoes to survive (R vs. S: p < 0.01); (C) Genotype
distribution of L119F-GSTe2 between alive and dead mosquitoes after exposure to PermaNet 3.0
showing a significantly greater ability of resistant mosquitoes to survive than that seen for PermaNet
2.0 (RR vs. SS: OR = 30.1; p < 0.001); (D) Genotype distribution of L119F-GSTe2 between alive (90 min)
and dead (30 min) mosquitoes after exposure to deltamethrin showing a significantly greater ability
of homozygote resistant mosquitoes to survive (RR vs. SS: OR = 4.6; p < 0.001); (E) Simil rly for
permethrin, homozygote resistant mosquitoes exhibit a significantly greater ability of to survive (RR vs.
SS: OR = 4.8; p < 0.001); (F) For DDT, a much greater ability of mosquitoes with the resistance allele to
survive exposure to DDT papers (RR vs. SS: OR = 66.7; p < 0.001).
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40 alive vs. 40 dead
OR PV CI
RR vs. SS 1.1 >0.05 0.4–2.7
RS vs. SS 0.9 1.0 0.5–1.8
RR vs. RS 1.1 >0.05 0.4–2.7
R vs. S 1.04 1.0 0.5–1.8
PermaNet 2.0
46 alive vs. 34 dead
RR vs. SS 2.09 <0.01 1.1–4.2
RS vs. SS 2.3 <0.001 1.2–4.4
RR vs. RS 0.8 >0.05 0.3–2.4
R vs. S 1.8 <0.01 0.9–3.5
PermaNet 3.0
39 alive vs. 31 dead
RR vs. SS 30.1 <0.001 0.8–5.3
RS vs. SS 2.4 <0.01 1.3–4.5
RR vs. RS 12.3 <0.001 1.5–98.6
R vs. S 3.8 <0.001 1.8–7.7
WHO Bioassays
Deltamethrin
38 alive vs. 38 dead
OR PV CI
RR vs. SS 4.6 <0.001 2.5–8.4
RS vs. SS 1.22 >0.05 0.69–2.15
RR vs. RS 3.75 <0.001 2.1–6.8
R vs. S 2.80 <0.01 1.54–5.1
Permethrin
28 alive vs. 37 dead
RR vs. SS 4.8 <0.001 2.66–8.8
RS vs. SS 1.6 >0.05 0.86–2.8
RR vs. RS 3.1 <0.001 1.7–5.5
R vs. S 2.99 <0.001 1.7–5.3
DDT
29 alive vs. 30 dead
RR vs. SS 66.7 <0.001 27.1–164
RS vs. SS 14.0 <0.001 6.3–31.2
RR vs. RS 4.8 <0.001 2.4–9.5
R v S 15.3 <0.001 7.7–30.5
OR, Odds ratio; PV, p value; CI, Confidence interval.
4. Discussion
This study has taken advantage of the predominant presence of metabolic resistance in An. funestus
and the recent availability of a simple DNA-based diagnostic tool for GSTe2, to establish the impact of
GST-mediated metabolic resistance on the effectiveness of both pyrethroid-only and PBO-based LLINs
against An. funestus.
4.1. PBO plus pyrethroid-Based Nets are More Effective than Pyrethroid-Only Nets against Pyrethroid
Resistant An. funestus
4.1.1. Mortality
The mortality rates obtained in this study with experimental huts were generally low (7.3 to
30.1%), but such mortality levels are similar to those observed in other experimental hut studies
including in Benin [5], or recently in Burkina Faso where the mortality rates ranged from 9.5% to
46.1% in two locations of high pyrethroid resistance in An. gambiae [31]. However, higher mortality
has been observed for another highly resistant pyrethroid resistant population of An. gambiae in
Ivory Coast (Yaokoffikro) for PermaNet 3.0 (54%) and PermaNet 2.0 (34.7%) [32] than seen here for
the An. funestus population in Mibellon, which could potentially be associated with differences in
resistance mechanisms. The low level of mortality observed is likely due to the level of pyrethroid
resistance in An. funestus in Mibellon with permethrin mortality around 48.88 ± 5.76% and deltamethrin
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mortality around 38.34 ± 5.79% [18]. Nevertheless, despite the ongoing resistance both PBO-based nets
induced a significantly higher mortality than the pyrethroid-only LLINs against both An. funestus and
Mansonia spp. This higher mortality of PermaNet 3.0 and Olyset Plus with An. funestus is also in line
with the cone assay results although PermaNet 3.0 (Top) presented a higher mortality for both huts
and cone assays than Olyset Plus as also seen for An. gambiae in Burkina Faso [31]. Overall, the higher
mortality with both PBO-nets suggests that, in areas of pyrethroid resistance, these new generation
LLINs (PermaNet 3.0 and Olyset Plus) provide a better protection against both malaria vectors and
nuisance mosquitoes such as Mansonia spp.
4.1.2. Blood Feeding
The blood feeding rate of all the five nets, an indicator of the personal protection, provided by the
net was significantly lower (≤23.8%; p < 0.001) compared with the untreated control (40.8%). However,
the blood feeding inhibition rate was higher for PermaNet 3.0 (61.5%) than PermaNet 2.0 (51.4%) this
was not the case between Olyset Plus (55.6%) and Olyset (62.4%). Similar results have been obtained for
An. gambiae in Benin [6] where comparable blood feeding inhibition rates were observed for Olyset Plus
(85%) and Olyset (82%) despite the greater mortality rate with Olyset Plus (81%) vs. 42% for Olyset.
The same pattern of blood feeding inhibition was observed here for An. funestus and Mansonia spp.
with PermaNet 3.0 providing the highest inhibition level in Mansonia spp. whereas Olyset Plus was
even lower than Olyset.
4.1.3. Exophily
The excito-repellency effect of all the nets was at least twice higher compared to control showing
that An. funestus mosquitoes were affected by the repellent effect of pyrethroids. These results are
in line with previous results demonstrating the repellent effect of pyrethroid nets against Anopheles
mosquitoes [19,32]. No significant difference was observed in the level of exophily between the
conventional nets compared to synergist suggesting that PBO did not impact the repellent effect of
pyrethroids. Comparing An. funestus to Mansonia spp., revealed a significant difference in term of
exophily with only 6.9% of An. funestus exiting the hut with untreated net whereas 42.4% Mansonia spp.
exited the room with control net. This is different from the previous observation in Ivory Coast where
a similar exophily (~35%) was observed for both An. gambiae and Mansonia spp. in experimental
huts [32]. Furthermore, while all the 5 LLINs significantly increased the exophily rate for An. funestus,
this was not the case in Mansonia spp. with no significant change observed probably as Mansonia spp.
are more exophilic [33].
4.2. GSTe2 Mediated Metabolic Resistance Is Reducing Efficacy of LLINs
With the design of the L119F-GSTe2 diagnostic tool [8], this study has investigated for the first
time the impact of GST-mediated metabolic resistance on the efficacy of LLINs.
4.2.1. Experimental Hut Study
A significant association was observed between the blood feeding ability of An. funestus and
the L119F-GSTe2 mutation as mosquitoes with the 119F resistance allele have significantly higher
blood feeding rate compared to those with L119 susceptible allele against Olyset Net (p < 0.001)
and Olyset plus (p < 0.001). This is similar with observations for the cytochrome P450s CYP6P9a
and CYP6P9b for which the resistant alleles CYP6P9a_R and CYP6P9b_R were recently shown, in a
release-recapture experimental hut study, to also provide a greater ability to blood feed and to survive
exposure to pyrethroid-only LLIN (PermaNet 2.0) [14,34]. This suggests that L119F-GSTe2 mutation
likely contributes to an increased malaria transmission as every additional bite increases the chance
of sporozoite to be passed to the populations. This is particularly a concern as 119F-RR resistant
mosquitoes have also been shown to live longer [27,28] and to have a greater vectorial capacity to
transmit Plasmodium [12]. However, it is noticeable that the impact of L119F-GSTe2 on blood feeding
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ability is mainly seen for Olyset Plus and Olyset LLINs impregnated with permethrin but present
an opposite effect for PermaNet 3.0 and 2.0 both impregnated with deltamethrin. The cause of such
difference between permethrin- and deltamethrin-based nets is unclear at this point since the greater
blood feeding in Olyset net is not associated with greater survivorship. Functional analyses with
transgenic Drosophila, In vitro metabolism assays with recombinant GSTe2 enzyme combined with
genotype/phenotypes analyses had shown that GSTe2 was able to confer resistance to both permethrin
and deltamethrin but more so to permethrin [35,36]. This could partly explain the differences observed
between permethrin- and deltamethrin-based nets although further studies will be needed to fully
establish the underlying reason. Similar genotype/phenotype studies performed to assess the impact
of the knockdown target-site resistance (kdr) on resistance did not reveal such a significant association
with blood feeding potentially due to the fact that kdr frequency was already very high in tested
An. gambiae population [21]. However, indirect comparison of kdr effect in two separate populations of
An. gambiae in Benin; one with high kdr frequency (Ladji) and another with low frequency (Malanville)
did suggest that kdr could also impact the efficacy of LLINs [19].
Interestingly, the L119F-GSTe2 mutation was also associated with an increased exophily for Olyset
Plus and PermaNet 2.0 suggesting that the increased expression of GSTe2 could impact mosquito’s
behavior helping them avoids exposure to insecticides. Similarly, over-expression of carboxylesterase in
Culex pipiens [37] has been previously associated with a behavioral change as resistant mosquitoes were
found to have a reduced mobility [37] supporting that metabolic resistance could impact mosquitoes’
behavior in the presence of insecticide-based interventions.
No significant association was observed between L119F-GSTe2 and mortality in the experimental
hut’s samples for all LLINs potentially due to the low number of dead mosquitoes which did not
provide statistical power coupled with lower frequency of RR in this location. However, a trend was
observed for PermaNet 3.0 with an increased proportion of 119F homozygote resistant mosquitoes
able to survive exposure to this LLIN than both homozygote susceptible L119-SS (OR = 3.47; p > 0.05)
and heterozygotes (OR = 3.46; p > 0.05).
However, other mechanisms than GSTs are also at play in this location of Mibellon, as shown
recently [14], revealing the over-expression of cytochrome P450 genes such as CYP6P5 and CYP325a.
Unfortunately, there is not yet a molecular marker to help assess the impact of these genes with the
different samples collected after experimental huts. Generating more DNA-based markers as done for
the CYP6P9a/b [14] and for L119F-GSTe2 [8] will further help to gain a more complete picture of the
impact of resistance as a whole. No kdr target-site resistance has yet been detected in An. funestus
(Irving et Wondji 2017) including in Mibellon [18].
4.2.2. Impact from Cone Assays
The trend for a correlation between GSTe2 and reduced mortality with LLINs was supported by
results from cone assays where a very strong association was observed between L119F-GSTe2 and
ability to survive exposure to PermaNet 3.0 (side) (OR = 30.1) and PermaNet 2.0 although at lower
extent (OR = 2.09). The lack of association observed with Olyset Plus could be explained by the effect
of PBO which for this net is incorporated on the entire net whereas for PermaNet 3.0 PBO is only on the
top. The PermaNet 3.0 (side) used here does not contain PBO. One reason why a greater association is
found with PermaNet 3.0 (side) could be the fact that with higher deltamethrin concentration than
PermaNet 2.0, mosquitoes surviving exposure to PermaNet 3.0 are those likely to be much more
resistant because of a greater expression of GSTe2 and other cytochrome P450s. So the higher dose of
deltamethrin in PermaNet 3.0 has further selected mosquitoes with 119F-GSTe2 resistant allele than
with the lower dose in PermaNet 2.0. This is also the likely reason why a trend of a greater ability to
survive was seen in the experimental hut for PermaNet 3.0.This suggests that mosquitoes displaying
several resistance mechanisms than just P450-based resistance could avoid even PBO-based nets as
when cytochrome P450 enzymes are inhibited by PBO, mosquitoes bearing other mechanisms, as in
this case the 119F resistance allele, are able to better survive exposure to PBO-based nets. However,
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this cannot explain why such results were not observed with Olyset Plus the other PBO-net. However,
the spread of a GSTe2-mediated metabolic resistance conferring the ability of mosquitoes to survive
exposure to synergist LLINs will constitute a concern at a time when such nets are gradually being
introduced to fight pyrethroid resistant mosquitoes. GST resistance will also need to be taken into
consideration than just cytochrome P450 resistance. Nevertheless the greater efficacy seen with the
roof of PermaNet 3.0 in cone bioassays shows that P450 role remains important. Future studies will
need to also perform synergist assays with DEM and PBO to establish the contribution of both GSTs
and cytochrome P450s to better inform of the likely efficacy of LLINs.
5. Conclusions
This study has revealed a loss of efficacy of LLINs against pyrethroid resistant populations of
An. funestus in Cameroon using experimental huts. However, PBO based nets (PermaNet 3.0 and Olyset
Plus) are more efficient than conventional pyrethroid-only nets. It is the reason why as suggested by
WHO 2017 report we recommend the deployment of PBO nets in area where pyrethroid resistance is
confirmed and at least partly conferred by P450. Noticeably, the GST-mediated metabolic resistance not
impacted by PBO could threaten the continued effectiveness of the PBO-based LLINs and the impact
of this mechanism needs also to be considered to maximize the effectiveness of LLINs. One option
could be to generate new mosaic LLINs also incorporating the Diethyl Maleate (DEM) beside PBO to
inhibit GST metabolic activity and further increase the efficacy of these nets. However, further studies
will need to be performed before including establishing the extent of synergism provided by DEM in
various mosquito populations and the most suitable position on the net (either on top as PBO or on the
entire net).
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/11/2/143/s1,
Figure S1: Impact of the L119F-GSTe2 mediated metabolic resistance on bednet efficacy looking at the mortality
rate after exposure to LLINs, Table S1: Linear mixed effect model analysis showing different sources of variations
that may influenced the exophily, Table S2: Linear mixed effect model analysis showing different sources of
variations that may influenced the mortality, Table S3: Linear mixed model effect analysis showing different
sources of variations that may influenced the Blood feeding.
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Cis-regulatory CYP6P9b P450 variants associated
with loss of insecticide-treated bed net efficacy
against Anopheles funestus
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Elucidating the genetic basis of metabolic resistance to insecticides in malaria vectors is
crucial to prolonging the effectiveness of insecticide-based control tools including long lasting
insecticidal nets (LLINs). Here, we show that cis-regulatory variants of the cytochrome P450
gene, CYP6P9b, are associated with pyrethroid resistance in the African malaria vector
Anopheles funestus. A DNA-based assay is designed to track this resistance that occurs near
fixation in southern Africa but not in West/Central Africa. Applying this assay we demon-
strate, using semi-field experimental huts, that CYP6P9b-mediated resistance associates
with reduced effectiveness of LLINs. Furthermore, we establish that CYP6P9b combines with
another P450, CYP6P9a, to additively exacerbate the reduced efficacy of insecticide-treated
nets. Double homozygote resistant mosquitoes (RR/RR) significantly survive exposure to
insecticide-treated nets and successfully blood feed more than other genotypes. This study
provides tools to track and assess the impact of multi-gene driven metabolic resistance to
pyrethroids, helping improve resistance management.
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Malaria remains a major public health burden in Africa.Control strategies rely predominantly on insecticide-based interventions such as indoor residual spraying
and long-lasting insecticide nets (LLINs). These tools have been
estimated to be responsible for more than 68% of the decrease in
malaria mortality in the past 15 years having helped prevent more
than 663 million clinical cases of malaria1. Increasing insecticide
resistance in malaria vector species presents a major challenge to
the continued success of public health interventions. The eluci-
dation of the molecular basis of insecticide resistance in these
vectors and its evolution across Africa is a crucial step to design
resistance management strategies to prevent potentially devas-
tating public health consequences. Detailed information on
resistance mechanisms is a prerequisite to detect resistance
markers facilitating the design of field-applicable diagnostic tools.
Unlike current WHO bioassays that only detect resistance once it
is well established in the population2, these molecular diagnostic
tools can detect and track resistance at an early stage, which is an
essential requirement of resistance management efforts.
Resistance to insecticides is primarily caused by two major
mechanisms: target-site resistance (e.g., knockdown resistance,
kdr) and metabolic resistance through elevated expression of
detoxification genes, especially the cytochrome P450s3,4.
Target-site resistance through knockdown resistance (kdr)
mutations in the voltage-gated sodium channel gene is well
characterised with DNA-based diagnostic tools designed since
the late 1990s5,6.
In contrast, metabolic resistance, considered to be more likely
to cause control failure7, remains—despite recent progress8–11—
poorly characterised due to the complexity of this resistance
mechanism12. This is the reason why although several cyto-
chrome P450 genes associated with pyrethroid resistance have
been reported, only a single DNA-based marker has been
detected to date13 limiting the design of field applicable diagnostic
tools to detect and track this resistance. Indeed, progress was
recently made with the detection of the first DNA-based P450
resistance marker in mosquitoes in the CYP6P9a gene on the rp1
(resistance to pyrethroid 1) quantitative trait locus (QTL)14,15
allowing assessment of the impact of metabolic resistance on the
effectiveness of insecticide-treated nets13.
However, the CYP6P9a marker does not explain all of the
genetic variance in pyrethroid resistance and is currently only
present in southern Africa13,16,17. Thus, there is a need to
characterise the molecular basis of pyrethroid resistance Africa-
wide and detect related genetic variants so that DNA-based
diagnostic assays can be designed to enhance our ability to detect
resistance and rigorously characterise the impact on insecticide-
based interventions.
To tackle the molecular complexity of metabolic resistance to
pyrethroids and detect resistance markers and design reliable
diagnostic assays, we carry out large scale transcriptional and
genomic profiling of Anopheles funestusmosquitoes across Africa.
Our results reveal the complex and diverse molecular changes
underlying insecticide resistance across the species’ range char-
acterised by differential gene expression patterns and genomic
signatures, notably transcription factor binding sites (cis-acting
regulatory elements) regulating expression of detoxification
genes. This thorough elucidation of metabolic resistance leads to
the detection of a P450 DNA-based marker in the CYP6P9b gene
from which a simple field-applicable polymerase chain reaction
(PCR) diagnostic assay is designed. Field assessment of the
impact of pyrethroid resistance using this marker in semi-field
conditions in experimental huts revealed that this metabolic
resistance marker in combination with the other P450 marker
(CYP6P9a) is associated with exacerbated loss of efficacy of
insecticide-treated nets.
Results
Transcription analysis of resistant An. funestus Africa-wide.
Previous efforts to detect genes associated with pyrethroid resis-
tance Africa-wide have compared mosquitoes alive after perme-
thrin exposure to the lab-susceptible FANG strain only13. A
limitation of this approach is that the over-expressed genes might
not be necessarily linked to resistance but rather other differences
in genetic background. Therefore, to detect potential genes
associated with pyrethroid resistance across Africa [Southern
(Malawi), East (Uganda), Central (Cameroon) and West
(Ghana)], we used here two additional approaches by first com-
paring permethrin-resistant mosquitoes from one country to
permethrin-resistant mosquitoes from another country to detect
the genes specific for each region of Africa. Second, we performed
in Malawi a triangular comparison of the expression patterns of
mosquitoes alive after exposure (R) to those not exposed (Con-
trol; C) as well as the lab-susceptible strain FANG (S).
Comparisons of the transcription profiles between the four
African regions were performed to detect or confirm genes
differentially expressed according to their resistance background.
When the southern Africa population (Malawi) is compared to all
other regions directly, the striking difference is the high up-
regulation of two P450 genes CYP6P9a and CYP6P9b in Malawi
with fold change (FC) of 28.3, 22.7 and 9.5 greater than in
Cameroon, Uganda and Ghana for CYP6P9a (Supplementary
Data 1). Both genes result from a recent duplication event14. A
similar but lower difference is observed for CYP6P9b with FC
values of 5.5, 3.4 and 3.5, respectively. In contrast to CYP6P9b,
CYP6P9a is also significantly more over-expressed in Ghana
compared to Cameroon and Uganda. The southern Africa
mosquito population has more genes significantly up-regulated
than other regions including cytochrome P450s, CYP4H25,
CYP4H28, CYP9J11 (except Ghana) and CYP6P2 (except
Cameroon) although the FC is much lower than for the
duplicated genes. Two cuticular protein genes, potentially
involved in cuticular resistance (AFUN005672 and
AFUN009940) were also significantly over-expressed in Malawi
compared to the three other regions (Supplementary Data 1).
The biggest difference between the West African sample of
Ghana and others was the duplicated CYP6P4a and CYP6P4b that
are significantly more up-regulated in Ghana than other regions
with FC values of 25.8, 7.6 and 21.2 for CYP6P4a, respectively,
against Cameroon, Malawi and Uganda or FC values of 22.7, 6.5
and 9 for CYP6P4b. These genes are also significantly more
expressed in mosquitoes from southern Africa than in Central
and East Africa.
The Central African population of Cameroon exhibited a
greater difference than other regions for the cytochrome P450
CYP325A gene with FC values of 5.3, 12.1 and 4.5 against Malawi,
Uganda and Ghana, respectively, although the overall abundance
of reads for this gene is lower (<500). The carboxylesterase gene
AFUN002514 was also significantly overexpressed in Cameroon
compared to the south (FC 3.8) and the east (FC 4.7) but not
against Ghana where it is also over-expressed compared to
Malawi (FC 2.5) and Uganda (FC 3.3). This suggests that the
over-expression of the carboxylesterase AFUN002514 is specific
to West-Central Africa.
The East African population from Uganda exhibited the
greatest difference in expression to all other regions for the
cytochrome P450 CYP9K1 with FC values of 4.6, 2.6 and 1.8
against Cameroon, Malawi and Ghana suggesting that this gene is
potentially specific to pyrethroid resistance in the East Africa
region. The P450 CYP307A1 is also up-regulated in Uganda
relative to other regions (Supplementary Data 1). Further
differences between regions are highlighted in Supplementary
Note 1.
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In addition, a triangular analysis of transcriptional profiles
between resistant (R), unexposed control (C) and susceptible (S)
mosquito samples in Malawi confirmed the major role potentially
played by CYP6P9a and CYP6P9b in these countries with a
slightly higher level in R–S compared to C–S (FC 60.1 vs. 57.1 for
CYP6P9a; FC 23.7 vs. 18.5 for CYP6P9b) (Supplementary Table 1;
Supplementary Note 2). Moreover, the quantitative reverse
transcription (qRT) PCR expression patterns broadly supported
the differences observed with RNAseq in the main genes driving
pyrethroid resistance in different African regions (Fig. 1;
Supplementary Note 3).
Genetic polymorphisms of CYP6P9b-mediated resistance. To
detect potential genetic variants associated with pyrethroid
resistance, we focused our attention on the CYP6P9b P450
because this gene was highly over-expressed in resistant mos-
quitoes especially in southern Africa and after the recent char-
acterisation of CYP6P9a, the other over-expressed gene in
southern Africa13.
To have a full view of the potential regulatory elements driving
the over-expression of CYP6P9b, we amplified and sequenced the
full 1 kb intergenic region (Supplementary Fig. 1; Supplementary
Note 4) between CYP6P9b and CYP6P5 in individual resistant
(FUMOZ_R) and susceptible (FANG) mosquitoes. An indel of 3
bp (AAC) was consistently observed with deletion in the resistant
FUMOZ and presence in susceptible FANG. The core promoter
elements detected using GPminer include TATA boxes (8 in
FUMOZ and 7 in FANG and 1 GC box in each strain), 1 GC box
and 1 CCAAT box. The CYP6P9b promoter also exhibits two
sites for the putative arthropod initiator (Inr) contrary to one for
the 800 bp promoter fragment of CYP6P9a previously studied13.
Furthermore, several transcription factor binding sites were
detected including six sites for the CncC nrf2/MAF (in both
strains) and several sites for GATA, MYB or AHR transcription
factors.
The polymorphism pattern of the promoter region of CYP6P9b
was also assessed Africa-wide by sequencing the 1 kb intergenic
region in mosquitoes from West, Central, East and Southern
Africa. All populations from southern Africa (Mozambique,
Malawi and Zambia) exhibited a low genetic diversity with
Mozambique presenting the least diverse set with a number of
haplotype (h)= 2 and a haplotype diversity (hd)= 0.189.
However, the population of Benin (West Africa) exhibited no
segregating sites with only a single haplotype observed. This
absence of polymorphism in Benin (similar for CYP6P9a)
contrasts highly with neighbouring populations notably that of
Nigeria which exhibits the highest diversity (40 segregating sites,
h= 13; hd= 0.95) (Supplementary Table 2).
Overall, southern Africa populations consistently exhibited a
different polymorphism pattern to other regions notably with the
presence of an AAC deletion 50 bp upstream of nrf2/MAF
binding sites and 72 bp from a CCAAT box. The AAC deletion
located 703 bp from start codon is tightly associated with other
polymorphisms in a haplotype (STH13) (Supplementary Fig. 2).
This haplotype predominates in southern Africa (68/82) reflect-
ing the marked selective sweep observed around this gene in this
region18. A maximum likelihood phylogenetic tree of all
haplotypes (Fig. 2a) revealed three broad clusters corresponding
to southern Africa, West and Central Africa; the unique Benin
haplotype is different from other West Africa haplotypes and is
closer to the Central Africa Cluster (Fig. 2a).
The difference in genetic diversity between southern Africa and
other regions was further supported by the higher genetic
differentiation between these populations as shown by the
neighbour-joining tree of the genetic distance (NST estimates)
(Fig. 2b). A haplotype network built with the Templeton,
Crandall and Sing (TCS) programme, further highlights the
reduced diversity in southern Africa with the predominant
STH13 haplotype in all populations from this region (Fig. 2c);
greater diversity is seen in other samples with a high number of
mutational steps between haplotypes observed particularly in
Nigeria. Nevertheless, other countries such as Benin and Ghana
also have a predominant haplotype suggesting possible selection
also acting on this gene or in nearby genes in these locations.
To assess whether the differences observed in the 5’UTR region
of CYP6P9b between southern Africa and other regions could
have resulted from selection due to insecticide pressure, we
assessed the polymorphism of the 1 kb fragment of CYP6P9b in
samples collected before the scale-up of LLINs in Mozambique
(2002) and samples collected after scale-up (2016). This 1 kb
fragment was polymorphic before scale-up with many segregating
sites (18) and haplotypes (h= 6; hd= 0.797) as well as high
nucleotide diversity (π= 0.011) (Supplementary Table 2; Fig. 2d).
In contrast, the post-intervention samples exhibited very low
diversity with low haplotypes number (h= 2; hd= 0.189) and
reduced nucleotide diversity (π= 0.0053). Construction of
the maximum likelihood tree further highlights the contrast
between both sets of samples as the pre-intervention mosquitoes
cluster together and become more diverse (Fig. 2d). In contrast,
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Fig. 1 Comparative transcription profiles of An. funestus between countries. qRT-PCR comparison of the expression profile of major detoxification genes
associated with pyrethroid resistance between populations of An. funestus from different African regions supporting a shift in the role of these genes
between regions. The data shown are mean+ SEM (n= 3). Source data are provided as a Source Data file
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pre-intervention with a drastically reduced haplotype number.
The TCS haplotype network further supported the drastic
difference between pre- and post-intervention samples with more
mutational steps observed between pre-intervention haplotypes
whereas a highly predominant haplotype is observed in post-
intervention samples (18/20). This is not observed in the pre-
intervention samples, which is probably an indication of its low
frequency before bed nets (Fig. 2e). Furthermore, the AAC motif
now undetectable in the southern populations and located 50 bp
upstream of a nrf2/MAF binding site was present in all pre-
intervention samples suggesting that this deletion plays a role in
the regulation of CYP6P9b. These major differences between pre-
and post-intervention samples show that scale up of insecticide-
treated nets is likely a major factor that has driven this evolution
in An. funestus populations in southern Africa.
CYP6P9b promoter analysis detects resistance variants. The 1
kb fragment upstream of the translation start site of CYP6P9b was
assessed for its promoter activity using a luciferase assay in the
An. gambiae 4a-2 cell line. To narrow down the regions con-
taining the potential regulatory motifs, six different sized frag-
ments of the 1 kb, 600 base pairs (bp), 400 bp, 300 bp, 100 bp and
80 bp immediately upstream of the translation start codon from
both the resistant FUMOZ and the susceptible FANG strain were
cloned upstream of a reporter gene in a pGL3 vector. These
constructs were used in luciferase reporter gene assays but did not
show a significant difference in the relative luciferase activity of
the 1 kb insert between the two strains. Similarly, the shorter
versions of the putative promoter did not present a significantly
different activity between these two strains. Nevertheless, the
progressive truncation of the 1 kb insert helped identify the major
regulatory elements in either strain. Shortening the promoter
fragment to 600, 400 and 300 bp reduced their activity in
FUMOZ by 49.9 (P < 0.0001; unpaired t test), 21.1 (P= 0.0074;
unpaired t test) and 39.0% (P= 0.0043; unpaired t test) respec-
tively, and similarly in FANG with reductions of 54.4 (P= 0.0014;
unpaired t test), 57.6 (P < 0.0001; unpaired t test) and 57.7 (P <
0.0001; unpaired t test), respectively (Fig. 3a). However, for both
strains, a much higher reduction in luciferase activity is seen
when the promoter fragment is further truncated to just 100
(>91%) and 80 bp (>93%) (P < 0.0001; unpaired t test) with
deletion of all regulatory elements including CncC nrf2/MAF and
CCAAT boxes (Fig. 3a).
A DNA-based diagnostic tool to detect CYP6P9b resistance. To
design a DNA-based diagnostic assay to detect CYP6P9b-medi-
ated resistance, we screened the 1 kb for suitable restriction sites
in complete linkage with the AAC deletion in the resistant
mosquitoes across southern Africa including in the FUMOZ
strain (Supplementary Fig. 3a). This allowed the design of a
simple PCR restriction fragment length polymorphism (RFLP).
We found a restriction site for the NmuCl (Tsp45I) (cut site 5′-
GTSAC-3′) spanning a C/T mutation located 11 bp downstream
of the AAC deletion and designed a PCR-RFLP that, in mos-
quitoes carrying the CYP6P9b variants associated with suscept-
ibility to insecticides, cuts the 550 bp amplicon in two fragments
of 400 and 150 bp, whereas the amplicon carrying the resistance-
associated allele remains uncut (Fig. 3b; Supplementary Fig. 3b).
To assess the efficacy of this diagnostic assay, we genotyped the
FUMOZ-R and FANG strains for the CYP6P9b-R marker and
establish that all 50 tested FUMOZ-R mosquitoes were homo-
zygote resistant RR whereas all the FANG were homozygote
susceptible SS.
To further validate the ability of CYP6P9b_R marker to predict
pyrethroid resistance phenotype in An. funestus, mosquitoes were
crossed between FUMOZ and FANG at the F8 generation.
Genotyping of the same mosquitoes previously used to validate















































Fig. 2 Genetic diversity patterns of the cis-regulatory region of CYP6P9b. a Maximum likelihood phylogenetic tree of CYP6P9a promoter haplotypes across
Africa. b Neighbour-joining phylogenetic tree of CYP6P9b-based genetic distance between nine African populations (NST estimates). c Africa-wide TCS
network for the CYP6P9b haplotypes showing predominant haplotypes in southern Africa. A fixed haplotype is observed in Benin (sky blue) and a nearly
fixed haplotype is seen in Ghana (black). Other locations show a greater diversity. Lines connecting haplotypes and each node represent a single mutation
event. d A maximum likelihood phylogenetic tree of CYP6P9b showing a cluster of highly diverse haplotypes before scale up of bed nets (pre-intervention)
but a nearly fixed haplotype post-intervention. e TCS haplotype network in Mozambique pre- and post-intervention revealing a major resistant haplotype
post-intervention but a more diverse set of haplotypes before pre-bed nets
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permethrin for 180 min are predominantly homozygote resistant
(10/48) and heterozygotes (36/48) with two bearing the homo-
zygote susceptibility genotype. From the 47 dead mosquitoes after
30 min exposure to permethrin (highly susceptible), 46/47 were
homozygote susceptible and one heterozygote (Supplementary
Fig. 3c). A significant association was observed between
permethrin resistance and the CYP6P9b genotype with a highly
significant odds ratio when comparing RR vs. SS (OR= infinity;
P= 1.1 × 10−50, Fisher’s exact test) and RS vs. SS (OR= 715; P=
2.4 × 10−45, Fisher’s exact test) (Fig. 3c).
The contribution of CYP6P9b to pyrethroid resistance was also
compared to that of CYP6P9a revealing that both genes combine
additively to confer higher level of resistance. Indeed, all
mosquitoes with the double homozygote resistant genotypes
(RR/RR) were alive after 180 min exposure. However, only half of
the homozygous resistance-genotype carriers for CYP6P9b also
had the homozygous resistant genotype for CYP6P9a with the
other half being only heterozygous for CYP6P9a (Supplementary
Fig. 3d). 66.7% of mosquitoes that survived were double
heterozygous (RS/RS), whereas only 10.4% were RR/RR carriers
and 16.7% RR/RS carriers (Fig. 3d: Supplementary Fig. 3d)
suggesting possible fitness cost associated with possessing double
resistance alleles for both genes. None of the dead mosquitoes had
RR/RR, RR/RS or RS/RS genotypes; this shows a strong
correlation with permethrin resistance with high OR (infinity;
P < 0.0001, Fisher’s exact test).
Distribution of the resistant CYP6P9b allele across Africa.
Genotyping of the CYP6P9b was successful in most countries, but
some samples failed to amplify in Kenya, Uganda, Cameroon and
DR Congo (western region only). It is possible that a structural
variant is present in these countries preventing the amplification
of the 550 bp fragment. The CYP6P9b resistant allele
(CYP6P9b_R) is detected throughout southern Africa at a very
high frequency (>90%) with fixation observed in Mozambique
(Fig. 4a), consistent with previous results from CYP6P9a19. An
intermediate frequency is observed in Tanzania (63.4% for
CYP6P9b_R) and in Eastern Democratic Republic of Congo
(66.6%). CYP6P9b_R is absent from other parts of Africa
including East (Kenya, Uganda), Central (Democratic Republic of
Congo (DRC)-West, Cameroon) and West Africa (Fig. 4b).
Furthermore, the potential association of CYP6P9b_R with
CYP6P9a_R in field populations was assessed in Tanzania and
DRC where there is segregation of these genotypes. This implies
that there is a greater linkage of CYP6P9a and CYP6P9b geno-
types in Tanzania with 71.8% of identical genotypes; this is much
lower in DRC where only 51% identical genotypes are observed
between the two genes in assessed mosquitoes (Fig. 4c). However,
the RS/RS genotype is predominant (>36%) in both countries
with double homozygote resistant RR/RR being higher in Tan-
zania (28.5%) than DRC (16.7%).
CYP6P9b_R associated with reduced efficacy of insecticide-
treated nets. The impact of the CYP6P9b resistance allele on the
effectiveness of conventional (PermaNet 2.0) and PBO-based
(PermaNet 3.0) nets was assessed using a release-recapture of
mosquitoes from the hybrid strain between highly resistant
FUMOZ-R and fully susceptible FANG as described for
CYP6P9a13. Mosquitoes from FANG/FUMOZ crosses (F4) were
moderately resistant to pyrethroids with mortality rates of >70%
for both permethrin and deltamethrin after 1 h exposure.
To assess the impact of CYP6P9b on the efficacy of LLINs, we
first analysed this impact on the mortality of mosquitoes after
exposure to PermaNet 2.0 because the number of live mosquitoes
was too low with PermaNet 3.0. Both nets are impregnated with
deltamethrin. The association between CYP6P9b genotypes and
the ability to survive exposure to PermaNet 2.0 was first assessed
using only mosquitoes collected in the room and unfed to avoid
possible bias due to feeding or exophily status. This analysis
revealed a significant difference in the distribution of genotypes
between dead and live mosquitoes (chi square= 1180; P < 0.0001,






















































Fig. 3 DNA-based diagnostic assay for CYP6P9b-mediated metabolic resistance to pyrethroids. a Comparative luciferase assay between promoter
fragment from the highly resistant FUMOZ and highly susceptible (FANG) lab strains with progressive serial deletions of CYP6P9b 5′ flanking region to
detect the causative variants. Bars represent the mean ± S.D. of four independent transfections of three replicates (n= 6). b Agarose gel of PCR-RFLP with
NmuCl of CYP6P9b showing the RR, RS, and SS genotypes. c Distribution of the CYP6P9b genotypes between susceptible and resistant mosquitoes showing
a very strong correlation between CYP6P9b and resistance phenotype. d Distribution of the combined genotypes of both CYP6P9a and CYP6P9b showing
that both genotypes combined to increase the pyrethroid resistance. Source data are provided as a Source Data file
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genotypes according to mortality outcome revealed that CYP6P9b
homozygote resistant (RR) were significantly more able to survive
exposure to PermaNet 2.0 than homozygotes-susceptible mos-
quitoes (OR= 109.3; CI= 40.7–293.2; P < 0.0001, Fisher’s exact
test) (Table 1). This correlation is even stronger than previously
observed for CYP6P9a in the same mosquitoes (OR= 34.9; CI=
15.8–77.1; P < 0.0001, Fisher’s exact test)13.
Similarly, heterozygote mosquitoes (RS) survived exposure to
PermaNet 2.0 significantly better than homozygote susceptible
(SS) (OR= 34.7; CI= 14.6–82.5; P < 0.0001, Fisher’s exact test).
The additive resistance conferred by each allele of CYP6P9b was
shown by the fact that homozygote resistant mosquitoes (RR)
could also survive better than heterozygotes (OR= 3.14; CI=
1.4–6.9: P= 0.0058, Fisher’s exact test). Overall, the strength of
this association was further shown by the significant ability to
survive exposure when possessing a single CYP6P9b-resistant
allele (R) compared to the susceptible allele (S) (OR= 7.2; CI=
3.813.4; P < 0.0001, Fisher’s exact test) (Fig. 5b). A similar pattern
of significant correlation between CYP6P9b genotypes and
mortality was also observed when analysing all the dead and
live samples regardless of blood feeding and exophilic status but
with a lower OR value (Table 1).
The impact of the CYP6P9b_R was also assessed on the ability
to blood feed against PBO-based net (PermaNet 3.0). A
significant difference was observed in the distribution of
CYP6P9b genotypes between blood-fed and unfed mosquitoes
when exposed to PermaNet 3.0 (chi square= 28.8; P < 0.0001,
chi-square). This resulted in a significant association between
CYP6P9b genotypes and the ability to blood feed with homo-
zygote resistant (RR) mosquitoes feeding significantly more than
homozygote susceptible (SS) mosquitoes (OR= 5.04: CI=
1.7–14.6; P= 0.0001, Fisher’s exact test). This is also true for
homozygote resistant (RR) when compared to heterozygotes
(OR= 2.4: CI= 1.3–4.39; P= 0.0085, Fisher’s exact test). No
significant difference was observed between heterozygotes and
susceptible genotype (Table 1). However, CYP6P9b did not
impact blood feeding when mosquitoes were exposed to
PermaNet 2.0, and no difference was observed for the control
net (Fig. 5c; Table 1). No significant association was observed for
PermaNet 2.0 (Supplementary Fig. 4a) or in the control untreated
net (Supplementary Fig. 4b).
Combined effect of CYP6P9b and 6P9a on LLIN efficacy. As
CYP6P9b genotypes were shown to be independent from those of
CYP6P9a, we next assessed how combinations of genotypes at
both genes impact the efficacy of LLINs focusing on PermaNet
2.0 for mortality and PermaNet 3.0 for blood feeding. Analysis of
the impact of combined genotypes on mortality with PermaNet
2.0 confirmed the independent segregation of genotypes at both
genes with several combinations of genotypes observed including
RR/RR, RR/RS, RS/RS, RS/SS and SS/SS (Fig. 6a). A comparison
of the distribution of both sets of genotypes revealed that double
homozygote resistant (RR/RR) mosquitoes at both genes had a far
greater ability to survive exposure to PermaNet 2.0 than all other
combinations. This shows that both genes act additively to confer
a greater resistance to pyrethroids associated with a higher
reduction of bed net efficacy when mosquitoes are double resis-
tant. The additive resistance was further supported in that RR/RR
mosquitoes had the greatest ability to survive exposure to Per-
maNet 2.0 when compared to double susceptible (SS/SS) (OR=
76.5; CI= 15.1–387.7) when considering all samples. There was
even greater correlation if only considering unfed mosquitoes in
the room (Fig. 6b). A significantly increased survival is also
observed in RR/RR when compared to other combinations
although with a lower odds ratio, such as against RS/SS (OR=


















































































































































Fig. 4 Geographical distribution of CYP6P9b Africa-wide. a Frequency of the CYP6P9B_R allele across Africa showing that it is highly predominant
in southern Africa, moderately present in East Africa but completely absent elsewhere on the continent. b Map of Africa showing the distribution of
the CYP6P9b-resistant alleles with a near fixation in southern Africa. The map was generated using a blank map freely available from https://www.
rkkerkenschijndel.nl/map-of-africa-drawing.html and pie-charts representing frequency of both alleles in each location were added on the map.
c Comparative distribution of the combined genotypes of CYP6P9a and CYP6P9b in Tanzania and RD Congo supporting an independent segregation of
genotypes of both genes in the field. Source data are provided as a Source Data file
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P= 0.01, Fisher’s exact test) and against RS/RS (OR= 3.2; P=
0.042, Fisher’s exact test). No significant difference was observed
between RR/RR and RR/RS (OR= 1.6; P= 0.82, Fisher’s exact
test) (Fig. 6b). A similar trend is observed when comparing
homozygote resistant mosquitoes to one gene and heterozygote to
the other (RR/RS) against other combinations although at a lower
strength (Fig. 6c). No significant difference is observed between
RR/RS and RS/RS suggesting that having one resistance-
associated allele of each gene is as good as having homozygote
resistance for one gene.
Overall, a gradual decrease of impact is seen for genotypes RR/
RR > RR/RS > RS/RS > RR/SS > RS/SS > SS/SS. Analysis of the
combined genotype distribution for blood feeding (Fig. 6d) also
revealed a significantly increased ability to blood feed for double
homozygote-resistant mosquitoes when exposed to PermaNet 3.0
with the highest significance against double homozygote
susceptible (OR= 6.5; P < 0.0001, Fisher’s exact test) (Fig. 6e;
Supplementary Table 3). No significant association was observed
for PermaNet 2.0 (Supplementary Fig. 4c) and in the control
untreated net (Supplementary Fig. 4d).
Discussion
The detection of the resistance markers associated with CYP6P9b
over-expression described here provides a tool to monitor pyre-
throid resistance in field populations of the major malaria vector
An. funestus. In addition, it also allows the assessment of the
interplay between P450 genes in their overall genetic variance to
resistance as seen here between CYP6P9a and CYP6P9b. Overall,
this study established key insights regarding the molecular basis
of pyrethroid resistance in malaria vectors in Africa.
Genomic analyses performed in this study suggest differences
in the genomic evolution of metabolic resistance to pyrethroids
across Africa: mosquitoes from different geographic regions
exhibited specific sets of genes and genetic variants associated
with resistance. The comparative RNAseq-based transcription
profiling between regions revealed key differences in the level of
expression of major resistance genes, including CYP6P9a and
CYP6P9b which are highly expressed in southern Africa. This
difference in gene expression is in line with previous
reports11,13,17. Other genes predominate in other regions with
CYP9K1 in Uganda, CYP6P5 and CYP325A in Central Africa
(Cameroon) and CYP6P4a/b in Ghana (West Africa). The resis-
tance profile does not reflect the relatedness between popula-
tions13 suggesting each population independently evolves
resistance mechanisms. This contrasting expression profile also
supports previous observations16 and highlights the challenges in
designing diagnostic tools for metabolic resistance in the face of
Table 1 Correlation between genotypes of CYP6P9b and mortality and blood feeding after exposure to insecticide-treated nets in
experimental huts
OR P value CI OR P value CI
Mortality
PermaNet 2.0 CYP6P9a CYP6P9b
Unfed RR vs. SS 34.9 <0.0001 15.8–77.1 109.3 <0.0001 40.7–293.2
RS vs. SS 19.9 <0.0001 9.7–40.9 34.7 <0.0001 14.6–82.5
RR vs. RS 1.75 0.26 0.81–3.8 3.14 0.0058 1.4–6.9
R vs. S 6.25 <0.0001 3.3–11.7 7.2 <0.0001 3.8–13.4
All samples RR vs. SS 10.8 <0.0001 5.6–20.8 62.1 <0.0001 23.6–163.6
RS vs. SS 5.3 <0.0001 2.8–9.8 21.9 <0.0001 8.7–55.1
RR vs. RS 2.04 0.0002 1.1–3.7 2.8 0.0025 1.48–5.2
R vs. S 3.17 0.02 1.78–5.65 4.7 <0.0001 2.6–8.7
Blood feeding
PermaNet 2.0 RR vs. SS 1.75 0.19 0.82–3.7 1.29 0.54 0.58–2.9
RR vs. RS 2.5 0.052 1.09–5.75 0.92 0.5 0.49–1.7
RS vs. SS 0.7 0.67 0.28–1.7 1.68 1 0.79–3.5
R vs. S 1.43 0.26 0.82–2.5 0.94 1 0.5–1.6
PermaNet 3.0 RR vs. SS 4.54 <0.0001 2.3–8.7 5.04 <0.0001 1.7–14.6
RR vs. RS 2.6 0.0012 1.43–4.7 2.4 0.0085 1.31–4.39
RS vs. SS 1.74 0.17 0.87–3.47 2.1 0.3 0.73–6.03










































Fig. 5 Impact of the CYP6P9b-based metabolic resistance on bed nets’
efficacy. a Distribution of CYP6P9b genotypes between dead and alive
mosquitoes after exposure to PermaNet 2.0 net in experimental huts
showing that CYP6P9b_R significantly allows mosquitoes to survive
exposure to this insecticide-treated net. b Association between frequency
of CYP6P9b-R and ability to survive exposure to PermaNet 2.0.
c Distribution of CYP6P9b genotypes between blood-fed and unfed
mosquitoes after exposure to the PBO-based net PermaNet 3.0 showing
that CYP6P9b_R allele increases the ability to take a blood meal. Source
data are provided as a Source Data file
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such molecular plasticity of populations of malaria vectors.
However, some of the differences observed between geographic
regions could be the consequence of differences in genetic
background between populations rather than just insecticide
resistance. Further functional characterisation of these over-
expressed genes both in vivo and in vitro16 will allow to confirm
their role in resistance.
The detection of another P450 DNA-based marker in this
study is a great progress in our efforts to detect and track the
spread of metabolic resistance to insecticides in malaria vectors.
The mutation associated with resistance here is located in the cis-
regulatory region as established for CYP6P9a13 or for previous
observations in the mosquito Culex quinquefasciatus20 and in
Drosophila21. Similarly, the CYP6P9b AAC indel resistance
mutation is associated with transcription factor binding sites
notably to the insect ortholog of the mammalian transcript factor
Nrf2, Cap ‘n’ Collar isoform-C (CncC) with Maf-S; these regulate
transcription of detoxification genes in several insects22. This
suggests that more attention should be paid to cis-regulatory
regions to detect potential causative mutations that could drive
resistance although this is not the unique mechanism as trans-
acting regulatory loci12 or allelic variations of resistance genes9
may also be involved.
Because of the physical proximity of CYP6P9b to CYP6P9a,
one could have assumed that both genes might be in complete
linkage disequilibrium and any marker on one of the genes will
fully explain resistance associated with the other. However, our
data suggest otherwise; while we observed significant co-
occurrence of resistance alleles in both genes, the genotypes at
both genes can segregate independently and we observe increased
pyrethroid resistance in mosquitoes with the combined genotype.
The percentage of linkage between both genotypes varies sig-
nificantly from nearly 100% in southern Africa to 71% in the East
(Tanzania) and 51% in DRC. This suggests that both genotypes
are not fully physically linked. The higher proportion of linked
genotypes in southern Africa and Tanzania is possibly a result of
a greater selection acting on this population as seen in southern
Africa where proportion of identity is close to 100% and where
high level of resistance has been reported23,24.
The independent segregation between CYP6P9a and
CYP6P9b is also observed in the lab—the hybrid strain between
the lab-resistant FUMOZ and lab-susceptible FANG exhibited
significant independent genotypes for both genes at the F4
generation. Therefore, the availability of the CYP6P9b_R diag-
nostic assay developed here is an important tool that should
increase our ability to detect and track the spread of resistance.
Moreover, when combined with CYP6P9a_R, it could help to
assess the risk of multi-gene driven high-resistance in this
malaria vector. The current P450 diagnostic tools should allow
control programmes to monitor both P450 alleles to track
escalating pyrethroid resistance intensity in the field. This
marker only applies to An. funestus and not to other malaria
vectors including those of the An. gambiae complex. However,
because CYP6P3, an ortholog of CYP6P9a/b, has also been
shown to play an important role in insecticide resistance in An.
gambiae, the results described here can serve as a model to



































































Fig. 6 CYP6P9b combines with CYP6P9a to further reduce bed nets’ efficacy. a Distribution of the combined genotypes of both CYP6P9a and CYP6P9b
showing that genotypes at both genotypes combined to additively increase the ability to survive after exposure to PermaNet 2.0. b Ability to survive
exposure to PermaNet 2.0 (Odds ratio) of the double homozygote-resistant (RR/RR) genotypes of CYP6P9a and CYP6P9b compared to other genotypes
supporting the additive resistance effect of both genes. Significance is shown by *P < 0.05, **P < 0.01, ***P < 0.001, as estimated using Fisher’s exact test.
c Ability to survive exposure to PermaNet 2.0 (odds ratio) of the combined homozygote resistant and heterozygote (RR/RS) genotypes of CYP6P9a and
CYP6P9b compared to other genotypes. d Distribution of the combined genotypes of both CYP6P9a and CYP6P9b after exposure to PermaNet 3.0 revealing
an additive effect of both genes in increasing the ability to blood feed. e Comparison of blood feeding ability of combined genotypes of CYP6P9a and
CYP6P9b showing a significantly higher ability (odds ratio) to blood feed for mosquitoes that double homozygote resistant (RR/RR). Source data are
provided as a Source Data file
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12686-5
8 NATURE COMMUNICATIONS |         (2019) 10:4652 | https://doi.org/10.1038/s41467-019-12686-5 | www.nature.com/naturecommunications
The experimental hut study performed here assessed the
impact of CYP6P9b and revealed that CYP6P9b is associated with
reduced efficacy of bed nets, particularly pyrethroid-only nets,
independent of CYP6P9a13. However, the key message from this
study is that a greater reduction of bed net efficacy is observed
when the CYP6P9b resistant genotype combines with the
CYP6P9a resistant genotype because double homozygote resistant
mosquitoes survived exposure to pyrethroid-only nets much
better than all other genotypes tested.
This shows the great risk that metabolic resistance poses to
insecticide-based interventions as highlighted in the WHO global
plan for insecticide-resistance management which states that if
nothing is done pyrethroid resistance could lead to an increase
burden of malaria in Africa2. This concern is further supported
by a recent report from the 2018 World Malaria Report indicating
that after nearly two decades of continued decline, malaria cases
have significantly increased in 201725. The spread of both
CYP6P9b_R and CYP6P9a_R alleles poses a significant risk to the
effectiveness of control programmes notably in southern Africa
where both alleles are nearing fixation. The diagnostic tools
designed here should help track their spread and help anticipate
the management of such resistance. PBO-based nets (here Per-
maNet 3.0) are far more effective against such populations than
pyrethroid-only nets, as also recently revealed in field trials in
Tanzania26. Nevertheless, the high blood-feeding ability of resis-
tant mosquitoes even against PBO-nets suggests that metabolic
resistance affects the efficacy of such nets and calls for the
development of other management options, for example nets that
do not rely on pyrethroids. Our experimental hut trial study is
based on a test with hybrid strains from two laboratory strains
and the impact of the resistance alleles described here on the
efficacy of LLINs in natural populations remains to be estab-
lished, work that must be undertaken urgently.
In conclusion, this study used a comprehensive transcriptomic
and targeted genomic approach to detect a P450-based resistance
marker and designed a simple PCR assay to detect and track
P450-mediated metabolic resistance to pyrethroid in the major
malaria vector An. funestus in Africa. We show that the
CYP6P9b_R resistance allele described here can combine with the
previously detected CYP6P9a_R19 present on the same rp1 QTL,
conferring greater insecticide resistance in our bed nets test than
either resistance genotype in isolation. Out of the tested popu-
lations, we detected this allele only in southern and eastern
African mosquito populations. The greater reduction of efficacy
of insecticide-treated nets observed in double-resistant mosqui-
toes is a major concern for the sustainability of insecticide-based
interventions solely relying on pyrethroids. Therefore, PBO-based
nets should be preferably deployed for greater impact while
encouraging the development of alternative mosquito manage-
ment options in malaria-endemic regions.
Methods
Collection and rearing of mosquitoes. The two An. funestus laboratory colonies
used here are the FANG colony—a completely insecticide-susceptible colony ori-
ginating from Angola—and the FUMOZ colony derived from southern Mozam-
bique that is highly resistant to pyrethroids and carbamates27. Mosquito collection
was performed to cover the four main regions in sub-Saharan regions: southern
(Malawi, Chikwawa (16°1’ S, 34°47’ E) in 201428), eastern (Uganda, Tororo (0°45’
N, 34°5’ E) 201429), central (Cameroon, Mibellon (6°46′ N, 11°70′ E) in 201530),
and west (Ghana, Obuasi (5°56′ N, 1°37′ W) in 201431) across the continental
range of An. funestus as recently described13. Overall, blood-fed, gravid females
were collected indoor in houses using electric aspirators between 06:00 AM-
10.00AM in each location. Females were left to become fully gravid for 4 days and
then introduced into 1.5 ml Eppendorf tube to lay eggs following the forced-egg
laying method32. Larvae were reared to generate F1 adults and used for WHO
bioassays as done by Weedall et al13. These populations are all resistant to pyre-
throids and as well as to other insecticide classes28–31. Morphological and mole-
cular identifications were performed to establish the species following Weedall
et al.13.
RNA extraction with library preparation and sequencing. The total RNA from
three pools of ten female mosquitoes (alive after 1 h permethrin exposure) was
extracted using the Arcturus PicoPure RNA isolation kit (Life Technologies,
Carlsbad, CA, USA), according to the manufacturer’s instructions. This included a
DNase treatment step. The total RNA was depleted for ribosomal RNA (rRNA)
with Ribo-Zero low input kit for human/mouse/rat (Epicentre, Madison, WI, USA)
using 100 ng of starting material. The Ribo-Zero mRNA-enriched material was
used to prepare RNAseq libraries with the ScriptSeq v2 RNAseq library preparation
kit (Epicentre) (15 cycles of PCR amplification). Agencourt AMPure XP beads
(Beckman and Coulter, Beverly, MA, USA) were used to purify the libraries fol-
lowed by a quantification using a Qubit fluorometer (Life Technologies). The size
distribution was measured with a 2100 Bioanalyzer (Agilent, Santa Clara,
CA, USA).
Pools of libraries (8/lane) were sequenced (2 × 125 bp paired-end sequencing)
with v4 chemistry on a HiSeq 2500 (Illumina, San Diego, CA, USA). All sequence
library preparation and sequencing were performed by the Centre for Genomic
Research (CGR), University of Liverpool.
Analysis of RNAseq data. RNAseq data were analysed as recently described when
analysing the contribution of the CYP6P9a gene13, including the initial processing
and quality assessment of the sequence data. The Subread aligner version 1.4.633
was used to align the RNAseq R1/R2 read pairs to the reference sequence for which
the annotation was improved using BLAST2GO version 4.0.734.
FeatureCounts version 1.4.635 was used to count the fragments mapped in the
sense orientation to annotated An. funestus genes (automated predictions from
gene set AfunF1.4, downloaded from VectorBase). EdgeR36 was used to analyse the
differential gene expression with pairwise comparisons performed.
The differences in total tag counts among samples were corrected by calculating
normalisation factors using the “TMM” (Trimmed Mean M-values) method in
edgeR36 with default parameters. The P values associated with logFC were adjusted
for multiple testing using the false-discovery rate (FDR) approach37. Differentially
expressed genes were defined as those with an FDR-adjusted P value < 5% and>
twofold absolute difference in expression level. Tag counts and the total CDS
lengths were used to calculate the fragments per kilobase of gene sequence per
million mapped reads.
Further analyses of the RNAseq data were performed using the Strand NGS
software (Strand Life Sciences, version 3.0) following RNA alignment and RNA-seq
analysis pipeline with standard parameters. Genes differentially expressed in each
country and between different countries (generated from Venn diagrams) were
detected using DESeq normalisation with a FC > 2. Multiple test correction used
Benjamini–Hochberg method with a false discovery rate of 5% (adjusted P value <
0.05).
Quantitative reverse transcriptase PCR. The expression patterns of the most
differentially expressed detoxification genes between countries (Cameroon,
Uganda, Malawi, Ghana and Benin) were validated using qRT-PCR. The primers
are listed in Supplementary Table 4. Total RNA was extracted from three biological
replicates from mosquitoes that survived 1 h exposure to permethrin in each
country. One microgram was used as the template for cDNA synthesis using
Superscript III (Invitrogen) with oligo-dT20 and RNase H according to the
manufacturer’s instructions. The qRT-PCR amplification was performed following
standard protocol11,38 after establishing the standard curves for each gene to assess
PCR efficiency and quantitative differences between samples using serial dilution.
The relative expression level and FC of each target gene was established for
comparisons to Cameroon; these were calculated according to the 2−ΔΔCT method
incorporating the PCR efficiency39 after normalisation with the housekeeping
genes ribosomal protein S7 (RSP7; AFUN007153) and actin 5C (AFUN006819).
Analysis of CYP6P9b polymorphism patterns Africa-wide. Due to the high up-
regulation of CYP6P9b, the polymorphism of its 5′UTR between CYP6P9b and
CYP6P5 was analysed by amplifying and sequencing a 1-kb fragment, following
same protocol as for CYP6P9a18 in 15 mosquitoes in different regions of the
continent. This included southern (Mozambique, Malawi and Zambia), central
(DR Congo and Cameroon), eastern (Kenya and Uganda), and western Africa
(Benin, Nigeria and Ghana) and in the two laboratory strains FANG and FUMOZ.
The primers are presented in Supplementary Table 4. ClustalW40 was used to align
the sequences, and the polymorphisms were identified in DnaSPv5.1041. The
maximum likelihood tree was constructed using MEGA 7.0 with bootstrapping
(500 replicates)42.
The 1 kb 5′UTR fragment of CYP6P9b was also amplified in mosquitoes
collected in Mozambique before the scale up of bed nets (pre-intervention) in 2000
and in mosquitoes collected in 2016 in the same region after the deployment of
long-lasting insecticidal nets in these countries. The PCR products were cloned and
sequenced, and the sequencing data was analysed as described above while also
constructing a haplotype network using TCS43.
Promoter activity of 5′-flanking region sequences of CYP6P9b. To investigate
the regulatory regions controlling CYP6P9b, the intergenic region between this
gene and the preceding gene CYP6P5 was used to design primers (6P9dplF and
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6P9a/b) to amplify this region in the laboratory colonies FANG and FUMOZ. The
PCR products were then cloned in to PJET1.2 (Thermo Scientific, St. Leon-Rot,
Germany) and sequenced using the Pjet1.2 forward and reverse sequencing
primers.
The promoter activities of the 5′-flanking region sequences were evaluated
using a luciferase reporter assay. Primers (KpnI_6P9bF1.0 and HindIII_6P9a/b)
were used to amplify the 5′-flanking region sequences for the resistant and the
susceptible strains cloned in Pjet1.2 and then sub-cloned into the PGL3-basic
(Promega, Madison, WI, USA) firefly luciferase vector between the Kpn1 and
Hind111 restriction sites to form the recombinant promoter PGL3 for testing.
The recombinant constructs were transfected in An. gambiae cell line 4a-2 cell
line (MRA-917 MR4, ATCC® Manassas Virginia) maintained at 25 °C in
Schneider’s Drosophila medium supplemented with 10% heat inactivated foetal calf
serum and 1% penicillin/streptomycin. One day prior to transfection, about 5 × 105
cells were plated in each well of 24-well plates and allowed to reach 60–70%
confluence. At about 60% confluence, the constructs were introduced in the cells
using Qiagen Effectene Transfection Reagent by co-transfecting 600 ng
recombinant reporter constructs (CYP6P9b 5’flanking region in pGL3-Basic),
LRIM promoter in pGL3 and pGL3 without promoter with 1 ng actin-Renilla
internal control in 60 ml DNA condensation buffer, 4.8 ml enhancer and 6 ml
Effectene in triplicates. Two independent replicates were carried out. Two days
after incubation at 25 °C, the cells were washed with PBS and lysed in 100 ml
passive lysis buffer (Promega); a luminometer (EG & G Berthold) was used to
measure the luciferase activity, which was normalised to Renilla luciferase activity.
To localise the enhancer elements responsible for the up-regulation of CYP6P9b
in the resistant as opposed to the susceptible populations, progressive 5′ deletion
fragments of the 5′ flanking region from −978 to +97 (from the predicted
transcription start site) was performed. Serially deleted fragments −630 to +97,
−440 to +97, −181 to +97 and −128 to +97 were constructed using
HindIII_6P9a/b common reverse primer, and each of the forward primer
KpnI_6P9bF(1.0), KpnI_6P9bF(0.6), KpnI_6P9bF(0.4), KpnI_6P9bF(0.3) and
KpnI_6P9bF(0.1) was tested to check if the deleted fragments −978 to −631, −630
to −441, −440 to −182 and −181 to −129 enhanced the promoter activity.
Design of PCR-RFLP diagnostic for CYP6P9b genotyping. The SNP-RFLPing
244 tool was used to design a PCR-RFLP that could discriminate between the
CYP6P9b promoter of the resistant (FUMOZ) and the susceptible (FANG) strains.
Primers 6P9brflp_0.5F and 6p9brflp_0.5R were designed to amplify a region in the
promoter common both to FUMOZ and FANG. Each PCR reaction was performed
in a 15-µL volume consisting of 1× buffer A, 25 mMMgCl2, 25 mM dNTPs, 10 mM
of each primer 1U KAPA Taq polymerase (Kapa Biosystems, Boston, MA, USA).
The following PCR amplification conditions were used initial denaturation step of
3 min at 95 °C, followed by 35 cycles of 30 s at 94 °C, 30 s at 58 °C, and 60 s at 72 °C
with 10 min at 72 °C for final extension according to the KAPA kit instructions.
Five microlitre of the PCR product was digested by adding 1 µL of CutSmart buffer
0.2 µL of Tsp45I restriction enzyme (New England Biolabs) and 3.8 µL of water.
The mix was incubated at 65 °C for 2 h. The digested product was migrated on 2%
agarose and stained with Midori Green Advance DNA Stain (Nippon genetics
Europe GmbH) and visualised using a gel imaging system to confirm the product
sizes; there was one band at 550 bp for the resistant (undigested) sample and two
bands at 400 bp and 150 bp for the susceptible samples.
To validate the robustness of the PCR-RFLP to detect the pyrethroid resistance
in the field population, the F8 progeny from a cross between highly resistant
(FUMOZ) and highly susceptible (FANG) strains previously used for QTL
mapping14 were genotyped and correlated with the resistance phenotype
established using the odds ratio and Fisher’s exact test.
The pattern of geographical distribution of the resistant allele of CYP6P9b allele
across the continent was assessed by genotyping the CYP6P9b_R in 30–50 field-
collected females of An. funestus from several countries in Africa using the DNA-
based diagnostic assay.
Impact of CYP6P9b-on LLINs’ efficacy using hut trials. The study was per-
formed in Mibellon (6°4′60″ N and 11°30′0″ E)—a village in the Adamawa region
of Cameroon where 12 experimental huts have recently been built with concrete
bricks following the specific design for experimental hut from the West Africa
region45.
The study used a hybrid An. funestus strain generated from reciprocal crossing
between the highly pyrethroid resistant strain FUMOZ-R (CYP6P9b_R) and the
fully susceptible FANG strain (CYP6P9b_S)9. The F5 and F6 generations were used
for the release experiments in the huts after the initial reciprocal crossing between
the laboratory susceptible (FANG and resistant (FUMOZ) strains using 50 males
and 50 females of both strains. The susceptibility of these strains to insecticides is
reported by Weedall et al13 using pyrethroids (0.75% permethrin and 0.05%
deltamethrin), DDT (4%) and the carbamate and bendiocarb (0.1%) according to
WHO protocol45.
The following three treatments were compared in the experimental huts: (i)
untreated polyethylene net; (ii) PermaNet 2.0® (deltamethrin incorporated into
polyethylene net); and (iii) PermaNet 3.0® (PBO+Deltamethrin incorporated into
polyethylene net). To simulate a worn net, six 4 cm × 4 cm holes were made on
each net according to WHO guidelines. The hybrid FANG/FUMOZ strain was
released in each hut for 6 nights (80 mosquitoes per hut).
Three adult volunteers were recruited from the Mibellon village to sleep under
the nets and collect mosquitoes in the morning. Each volunteer provided a written
consent to participate in this study and were also given chemoprophylaxis during
the trial. Ethical approval was obtained from the National Ethic Committee of the
Ministry of the Health in Cameroon.
Mosquito collection was performed in the morning by each volunteer in their
respective room using glass tubes. Mosquitoes were collected in three compartments
including the main room (the walls, floor and the hut ceiling), inside of each net and
in the exit traps (veranda). A single bag was used for each compartment to avoid the
risk of mixing samples from different areas. A sugar solution was provided to
mosquitoes found alive and they were kept in paper cups for 24 h to assess the
delayed mortality. The status of collected mosquitoes was recorded in observation
sheets either as alive/blood fed, dead/blood fed, alive/unfed and dead/unfed.
An untreated net was used as control to estimate the effect of each treatment by
assessing several parameters including the induced exophily (the proportion of
mosquitoes exiting the room early through the exit traps), the mortality rates
(which provides an indication of the potential mass killing effect of the bed nets)
and the blood feeding rate (which estimates the level of personal protection).
A direct comparison to the untreated control net was used to establish the effect
of both treated nets. A logistic regression model using the Wald statistic that
follows a chi-squared distribution (with df= 1) was used to assess the statistical
significance of the difference.
The CYP6P9b_R resistance allele was genotyped in a subset of each treatment
to determine the impact of the CYP6P9b-mediated metabolic resistance to
pyrethroids on the effectiveness of the bed nets. The following were included: the
dead, alive, blood-fed, and unfed mosquitoes in the veranda, in the net and in the
room. The association between the mutation and the performance of each net was
assessed using the Vassar stats (http://vassarstats.net/) with a 2 × 2 contingency
table for the odds ratio calculation based on Fisher’s exact probability test.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNAseq: PRJEB24351 and PRJEB10294; CYP6P9b sequences: GenBank MK457459-
MK457689. Data analysed in this study are available on public repositories or available
within the article and its Supplementary Information files. Further details are available
from the authors upon request.
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M A L A R I A  V E C T O R  C O N T R O L
A cytochrome P450 allele confers pyrethroid  
resistance on a major African malaria vector, reducing 
insecticide-treated bednet efficacy
Gareth D. Weedall1,2, Leon M. J. Mugenzi3,4, Benjamin D. Menze1,3,4, Magellan Tchouakui3,4, 
Sulaiman S. Ibrahim1,5, Nathalie Amvongo-Adjia4,6, Helen Irving1, Murielle J. Wondji1,3,4, 
Micareme Tchoupo3,4, Rousseau Djouaka7, Jacob M. Riveron1,3,4, Charles S. Wondji1,3,4*
Metabolic resistance to insecticides such as pyrethroids in mosquito vectors threatens control of malaria in Africa. 
Unless it is managed, recent gains in reducing malaria transmission could be lost. To improve monitoring and assess 
the impact of insecticide resistance on malaria control interventions, we elucidated the molecular basis of pyre-
throid resistance in the major African malaria vector, Anopheles funestus. We showed that a single cytochrome 
P450 allele (CYP6P9a_R) in A. funestus reduced the efficacy of insecticide-treated bednets for preventing transmission 
of malaria in southern Africa. Expression of key insecticide resistance genes was detected in populations of this 
mosquito vector throughout Africa but varied according to the region. Signatures of selection and adaptive evo-
lutionary traits including structural polymorphisms and cis-regulatory transcription factor binding sites were 
detected with evidence of selection due to the scale-up of insecticide-treated bednet use. A cis-regulatory polymor-
phism driving the overexpression of the major resistance gene CYP6P9a allowed us to design a DNA-based assay 
for cytochrome P450–mediated resistance to pyrethroid insecticides. Using this assay, we tracked the spread of 
pyrethroid resistance and found that it was almost fixed in mosquitoes from southern Africa but was absent from 
mosquitoes collected elsewhere in Africa. Furthermore, a field study in experimental huts in Cameroon demon-
strated that mosquitoes carrying the resistance CYP6P9a_R allele survived and succeeded in blood feeding more 
often than did mosquitoes that lacked this allele. Our findings highlight the need to introduce a new generation 
of insecticide-treated bednets for malaria control that do not rely on pyrethroid insecticides.
INTRODUCTION
Prevention of malaria relies heavily on the use of insecticide-based 
vector control interventions, most notably pyrethroid-based long- 
lasting insecticidal bednets. These tools have been credited with more 
than 70% of the decrease in malaria mortality in the past 15 years, 
having helped avert more than 663 million clinical cases of malaria 
(1). However, resistance of mosquito vectors to insecticides, partic-
ularly pyrethroids, is threatening their continued effectiveness. Un-
less it is managed, the recent gains in reducing malaria transmission 
could be lost (2). Elucidating the genetic basis and evolution of in-
secticide resistance among mosquito vectors of malaria is crucial for 
designing resistance management strategies and preventing the re-
surgence of malaria (2).
Without genetic information on insecticide resistance genes and 
associated molecular markers in the mosquito vector, it is difficult 
to track and anticipate the course of insecticide resistance or assess 
its impact on malaria transmission and the effectiveness of control 
tools such as long-lasting insecticide-treated bednets. The current 
inability to track metabolic resistance in this way in all major malaria 
vectors in Africa including Anopheles gambiae and Anopheles funestus 
is a major obstacle to the design of rational, evidence-based resis-
tance management strategies. Of the four classes of insecticides de-
ployed in public health, pyrethroids are the most widely used and 
are the main class recommended for use in insecticide-treated bednets. 
Therefore, understanding the mechanisms conferring pyrethroid 
resistance on mosquitoes is of critical importance.
Two major causes of insecticide resistance are metabolic resistance 
and target-site insensitivity (3). Target-site insensitivity to pyrethroids 
is due to knockdown resistance (kdr) caused by a modification of the 
insecticide target (a sodium channel) in mosquitoes (4). In contrast, 
metabolic resistance remains less well characterized despite posing a 
greater risk to malaria control interventions (5). Although candidate 
resistance genes have been detected (6–9), it has proved difficult to 
dissect the molecular bases of metabolic resistance and to detect asso-
ciated molecular markers because of the size of gene families involved 
in detoxification, redundancy among their members, and the mul-
tiple mechanisms through which metabolic resistance can arise (10). 
Cytochrome P450 monooxygenases have consistently been associated 
with pyrethroid resistance but, unlike kdr (4), there is no DNA- based 
marker to track P450-mediated resistance and to assess its impact on 
malaria control strategies.
Here, we elucidated the complex molecular basis and genomic 
evolution of metabolic resistance to pyrethroids in the major African 
malaria vector A. funestus. We detected key DNA-based markers of 
pyrethroid resistance and designed a field-applicable diagnostic assay. 
We used this assay to track pyrethroid resistance across Africa and 
to demonstrate that this metabolic resistance in mosquitoes reduced 
the efficacy of insecticide-treated bednets for preventing malaria 
transmission.
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RESULTS
RNA sequencing transcriptional profiling of mosquitoes 
identifies candidate pyrethroid  
resistance genes
To identify genes associated with pyrethroid resistance in the mos-
quito vector A. funestus Africa-wide, we performed RNA sequenc-
ing (RNA-seq)–based transcriptional profiling of mosquitoes from 
four different African regions: southern (Malawi), East (Uganda), 
West (Ghana), and Central (Cameroon). We compared these RNA-
seq profiles to those from a laboratory colony of mosquitoes (FANG) 
that were susceptible to all insecticides. 
The quality metrics and the alignment 
parameters are presented in table S1. The 
number of differentially expressed genes 
between each of the four populations and 
the FANG susceptible strain is shown in 
Venn diagrams (Fig. 1A and fig. S1A); 
the expression profile is shown in the 
volcano plots for each country (fig. S1, 
B to E). After quality control and analyses 
(table S1), Gene Ontology (GO) enrich-
ment was performed to assess the generic 
metabolic terms associated with resist-
ance. Permethrin- resistant mosquitoes 
in Malawi showed enrichment of gene 
ontologies associated with cytochrome 
P450 genes in genes overexpressed rela-
tive to the fully susceptible FANG strain. 
These GO terms included heme binding, 
tetrapyrrole binding, oxidoreductase ac-
tivity, and iron binding (fig. S2A). These 
GO terms among others were also en-
riched in the overexpressed gene set in 
mosquitoes from Ghana (fig. S2B). In 
Ugandan mosquitoes, more GO terms 
were enriched among the overexpressed 
genes but were not directly associated 
with detoxification activities (fig. S2C).
Pronounced differences in the expres-
sion of key candidate genes were observed 
among A. funestus from the four differ-
ent African regions (Fig. 1, A to C; fig. S1, 
A to E; and table S1). Genes encoding 
cytochrome P450 were frequently over-
expressed (adjusted P < 0.05) with the 
genes CYP6P9a (AFUN015792; 60.5-fold) 
and CYP6P9b (AFUN015889; 23.9-fold) 
showing increased overexpression in 
Malawi mosquitoes compared to those 
from other regions (<7-fold; Fig. 1, B 
and C). Other cytochrome P450s were 
overexpressed more in mosquitoes from 
one region than in mosquitoes from other 
African regions (Fig. 1, B and C) including 
CYP9K1 (AFUN007549), which was 
highly overexpressed in mosquitoes from 
Uganda (5.2-fold), only moderately over-
expressed in those from Ghana (2.9-fold), 
and not overexpressed in mosquitoes from 
Malawi or Cameroon compared to FANG mosquitoes. CYP6P5 
(AFUN015888) was overexpressed in mosquitoes from Ghana (6.3-fold), 
Cameroon (5.8-fold), and Uganda (4.1-fold), but not in those from 
Malawi compared to FANG mosquitoes. The duplicated CYP6P4a 
and CYP6P4b were highly overexpressed in mosquitoes from Ghana 
(44.8- and 23.9-fold, respectively), moderately so in those from Malawi 
and Uganda (<6-fold), and not overexpressed in those from Cameroon 
compared to FANG mosquitoes. CYP325A was highly overexpressed 
in mosquitoes from Cameroon (26.9-fold) but less so in those from 
other regions (<6-fold) compared to FANG mosquitoes. Other 
Fig. 1. RNA-seq transcriptional profiling of pyrethroid-resistant populations of A. funestus Africa-wide. (A) The 
Venn diagrams show the number of differentially up-regulated genes in A. funestus mosquitoes from different countries 
in Africa relative to the pyrethroid-susceptible FANG laboratory strain at a false discovery rate of <0.01 and a fold 
change of >2. (B) Volcano plots of differential gene expression between pyrethroid-exposed mosquitoes from four 
different countries in Africa (Cameroon, CMR; Malawi, MWI; Ghana, GHA; and Uganda, UGA) and the susceptible FANG 
strain. The volcano plots highlight differences in the expression of key resistance genes (e.g., CYP6P9a and CYP9K1 in 
mosquitoes from different African countries). (C) Heatmap showing the differential expression of candidate detoxifi-
cation genes among mosquitoes from different African countries. (D) Fragments per kilobase of transcript per million 
mapped reads (FPKM) for genes from the rp1 pyrethroid resistance QTL. The histogram highlights differences among 
mosquitoes from four different African countries. (E) Correlation between RNA-seq and qRT-PCR data. The data shown 
are mean ± SEM (n = 3).
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cytochrome P450s were moderately over-
expressed, including two paralogous genes, 
CYP9J11 and CYP6N1, which were up- 
regulated in mosquitoes from southern 
and West Africa, whereas CYP315A1 was 
overexpressed in mosquitoes from all 
sites but Malawi.
Other detoxification-associated gene 
families were also overexpressed, includ-
ing a cluster of glutathione S-transferase 
epsilon genes (GSTe1, GSTe3, GSTe4, GSTe5, 
and GSTe2), known dichlorodiphenyltri-
chloroethane (DDT) resistance genes (11) 
that were up-regulated in mosquitoes from 
all regions except East Africa (table S2). The 
GSTD1 gene was overexpressed in mos-
quitoes from Malawi, Ghana, and Uganda, 
suggesting a role for this gene in these re-
gions but not in Cameroon where it was 
not sig nificantly overexpressed (table S2). 
A carboxylesterase (AFUN002514) was 
also overexpressed in mosquitoes from 
Central and West Africa with 5.5- and 
3.6-fold expression, respectively, in mos-
quitoes from Cameroon and Ghana 
(table S2). Quantitative reverse transcrip-
tion polymerase chain reaction (qRT- 
PCR) with 15 genes confirmed these 
regional differences, with a close correla-
tion observed between qRT- PCR and 
RNA-seq results for the four countries 
when compared to FANG mosquitoes 
(R2 = 0.85; P < 0.001) (Fig. 1E and fig. S3, 
A to C). Control mosquitoes not exposed 
to insecticides also showed a strong 
correlation (R2 = 0.695, P = 0.002 in mos-
quitoes from Malawi) with permethrin- 
resistant samples used for RNA-seq (Fig. 
1E), supporting a constitutive expression 
of these candidate resistance genes to 
confer resistance. However, differences 
were observed for the expression of some 
genes such as the CYP6Z1 P450, which, 
with qRT-PCR (but not RNA-seq), ex-
hibited an up- regulation in Malawi (FC 
66) and Ghana (FC13.4) mosquitoes (fig. 
S3). This gene has previously been shown 
to be overexpressed in southern Africa 
using micro array and qRT-PCR (7), sug-
gesting that RNA- seq could have missed or that the primers were 
not efficient with the susceptible FANG strain.
Whole-genome polymorphism analysis of mosquitoes 
collected in the field identifies insecticide resistance loci
Metabolic resistance could be conferred by point mutations in coding 
and cis-/trans-regulatory regions of the mosquito genome. Therefore, 
we scanned the whole genome for pyrethroid resistance–related sig-
natures of selective sweeps (that is, a marked reduction in genetic 
diversity in a genomic region because of intense selection of a pre-
dominant allele) in the highly pyrethroid-resistant population of 
mosquitoes from Malawi to detect pyrethroid resistance loci. We 
performed pooled-template whole-genome sequencing on field- 
collected population samples from southern Africa where high ex-
pression of CYP6P9a and CYP6P9b genes has been observed. We also 
comparatively assessed the genomes of mosquitoes from Malawi 
and compared these genomes to those of the laboratory pyrethroid- 
resistant FUMOZ-R strain and the pyrethroid- susceptible FANG 
strain. We detected contrasting patterns of polymorphisms between 
the genomes of these strains and also between the genomes of the 
Fig. 2. Genetic signatures in the mosquito genome associated with pyrethroid resistance. (A) Contrasting poly-
morphism patterns among resistant FUMOZ and susceptible FANG mosquito strains. Also shown are contrasting 
polymorphism signatures between pre-bednet intervention (MWI-2002) and post-bednet intervention (MWI-2014) 
mosquito samples from Malawi. Data were aligned to 120 kb rp1 bacterial artificial chromosome sequence (Integrative 
Genomics Viewer screenshot). Each row shows the alignment depth (on a log scale for display purposes); coverage 
depth is capped at >100×. Gray columns represent bases identical to the reference sequence, whereas colored columns 
indicate variant sites with a minor allele frequency > 10%. The genes of the cytochrome P450 cluster are indicated 
below the panel. An increased read coverage was observed between CYP6P9a and CYP6P9b in pyrethroid-resistant 
mosquito samples indicating a 6.5-kb insertion. (B) Shown is the major gene signature after a selective sweep through 
the mosquito genome detected around the rp1 QTL pyrethroid resistance region on the 2R chromosome. This signature 
contained cytochrome P450 genes from the CYP6 cluster and was found in mosquitoes from southern Africa but not in 
the susceptible FANG strain, after plotting minor allele frequency (MAF).
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MWI-2002 and MWI-2014 mosquito samples collected in Malawi be-
fore and after bednet intervention, respectively (Fig. 2A and table S3). 
The major selective sweep for genomes of Malawi and FUMOZ-R 
mosquitoes was on scaffold KB119169, spanning the rp1 pyrethroid 
resistance region on chromosome arm 2R (Fig. 2B). Plotting minor 
allele frequencies across the region revealed a valley of reduced ge-
netic diversity around the cluster of cytochrome P450 genes on the 
rp1 pyrethroid resistance QTL, correlating a selected rp1 haplotype 
with CYP6P9a overexpression (Fig. 1D). This selective sweep appeared 
to be at or near fixation in a contemporary Malawian mosquito pop-
ulation as well as in the FUMOZ-R strain, with little diversity observed 
around the cytochrome P450 gene cluster in this highly pyrethroid- 
resistant mosquito population (Fig. 2B). No reduced diversity was 
observed in the pyrethroid-susceptible FANG strain, suggesting an 
association between this selective sweep and pyrethroid resistance 
in line with the very low CYP6P9a expression in FANG mosquitoes 
(Fig. 2, A and B). These results are consistent with previous reports 
of selection on highly overexpressed resistance genes (9).
Complex evolution of the rp1 cluster of CYP6 genes 
associated with pyrethroid resistance
As the rp1 gene cluster was consistently associated with pyrethroid 
resistance, a fine-scale analysis of this locus (120 kb) was performed, 
revealing evidence of complex molecular evolution that was most likely 
under insecticide-driven selection. Inspection of pooled- template 
whole-genome alignments showed two anomalous features in the 
8.2-kb sequence between CYP6P9a and CYP6P9b (Fig. 2A and fig. S4A). 
In some samples, the coverage depth was greater than for the surround-
ing sequence, and some samples showed read pairs in the correct rela-
tive orientation but with greater than expected insert sizes. This was 
indicative of a large indel, that is, either a “deletion” in the sequenced 
genome or an “insertion” in the reference genome (fig. S4A). This in-
sertion corresponded to 6545 base pairs (bp) and appeared to be fixed 
in the FUMOZ mosquito colony sample with evidence that the inserted 
sequence was homologous to another region nearby (on the same 
assembly scaffold) in the genome (fig. S4B). In contrast, the FANG 
pyrethroid-susceptible mosquito strain showed evidence of the dele-
tion form of the indel (fig. S4A). This insertion, nearly fixed across the 
genomes of mosquitoes from southern Africa (26 of 27), was absent 
from the genomes of mosquitoes collected from elsewhere on the con-
tinent in which only a 1.7-kb intergenic region was observed after PCR 
(table S4). RNA-seq data showed that the inserted region was a tran-
scribed region, showing evidence of splicing and containing three 
microRNAs but no cytochrome P450 genes.
We assessed the composition of this 6.5-kb insert to elucidate its 
role by sequencing the full 8.2-kb CYP6P9a/b intergenic region and 
analyzing it using GPMiner, a program for identifying promoter re-
gions and annotating regulatory features (12). This insert contained 
Fig. 3. Genetic diversity of the CYP6P9a 5UTR region in mosquitoes from different regions of Africa. (A) Molecular phylogenetic analysis of the CYP6P9a 5′UTR region 
in genomes of A. funestus mosquitoes collected across Africa, generated by the ML method. The evolutionary history of CYP6P9a promoter haplotypes of mosquitoes from 
across Africa was inferred using the ML method based on the Tamura three-parameter model. (B) Africa-wide TCS network for the CYP6P9a haplotypes showing four pre-
dominant regional haplotypes in southern Africa (STH10), West Africa (Ghana, GHA11), Central Africa (Benin/Democratic Republic of Congo, BEN/DRC21), and East/Central 
Africa (EST/CNT24). “*” indicates ancestral haplotype. Lines connecting haplotypes and each node represent a single mutation event (respective polymorphic positions are 
given on each branch). (C) Neighbor-joining phylogenetic tree of CYP6P9a-based genetic distance between 10 different populations of A. funestus mosquitoes from across 
Africa (NST estimates). MOZ, Mozambique; ZMB, Zambia; TNZ, Tanzania; DRC, Democratic Republic of Congo; FNG, FANG mosquito strain; FMZ, FUMOZ mosquito strain.
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abundant binding sites for transcription factors including a CpG island 
(1.3 kb); several GATA, TATA (35), CCAAT (12), and GC (11) boxes; 
and overrepresented oligonucleotides. It also contained several binding 
sites for key transcription factors associated with xenobiotic detoxifica-
tion, including Cap-n-Collar-C (CnCC) (51 sites) and muscle aponeu-
rosis fibromatosis (MafK), suggesting that this insertion may be able to 
drive CYP6P9a/b overexpression. The insertion also contained a mi-
crosatellite (FUNR) between 6082 and 6482 bp, which was only 80 bp 
from the 5′ untranslated region (5′UTR) of CYP6P9a. Previous geno-
typing of this marker in mosquitoes Africa-wide revealed marked dif-
ferences associated with a pyrethroid resistance profile (13). The FUNR 
microsatellite marker was not present within the 1.7-kb intergenic re-
gion between CYP6P9a and CYP6P9b in the genome of the pyrethroid- 
susceptible FANG mosquito strain. It has been shown in other insects 
such as aphids that microsatellite loci are involved in up-regulation of 
cytochrome P450, conferring insecticide resistance (14).
CYP6P9a regulatory region polymorphisms associated with 
pyrethroid resistance
To detect cis-regulatory mutations controlling CYP6P9a/b-based 
pyrethroid resistance, we compared an 800-bp sequence immediately 
upstream of CYP6P9a in mosquito samples from across Africa. Ge-
nomes of mosquitoes from several locations exhibited low or no 
polymorphisms in this region (fig. S5A). The sample with the high-
est diversity was the fully susceptible FANG mosquito strain, with 
diversity indices supporting selection acting on the CYP6P9a gene 
in field populations of mosquitoes resistant to pyrethroids. Despite 
the low diversity in the 800-bp sequence upstream of CYP6P9a ob-
served in genomes of mosquitoes from different regions, mosquito 
populations from southern Africa consist ently exhibited a different 
polymorphism pattern to those from other regions, including the 
presence of an AA insertion 8 bp upstream of a putative CCAAT 
box present only in southern Africa mosquito samples through an 
A/C substitution (fig. S5A). The AA insertion located 359 bp from 
the start codon of CYP6P9a was tightly 
associated with other polymorphisms in 
a haplotype (STH10) that was nearly fixed 
in the genomes of southern Africa mos-
quitoes (63 of 68), reflecting the marked 
selective sweep observed around this 
gene in this African region. Analysis of 
the phylogenetic tree revealed four clus-
ters of haplotypes in mosquitoes from dif-
ferent regions: southern Africa (Malawi, 
Mozambique, and Zambia plus the 
FUMOZ-R strain), East-Central Africa 
(Kenya, Uganda, and Cameroon), West 
Africa (Ghana), and West-Central Africa 
(Benin and Democratic Republic of 
Congo) (Fig. 3A). The FANG pyrethroid- 
susceptible strain formed its own cluster 
that was divergent from the other clusters.
Closer analysis of the haplotypes us-
ing a haplotype network confirmed the 
presence of four major haplotypes corre-
sponding to these four geographical clus-
ters: STH10 in southern Africa, EST/
CNT24 in East-Central Africa, BEN/
DRC21 in West-Central Africa, and 
GHA11 in Ghana only (West Africa) (Fig. 3B). Unexpectedly, the 
other three geographical regions compared to southern Africa also 
exhibited predominant haplotypes in the mosquito populations to 
near fixation, contrary to previous data where they were found to be 
more polymorphic (13). This result suggested that resistance to py-
rethroid beyond southern Africa could have been selected through 
CYP6P9a or other genes in the vicinity of the rp1 QTL region. The 
neighbor-joining phylogenetic tree showing the genetic distances 
based on the NST genetic differentiation index between different 
countries (Fig. 3C) correlated with the polymorphism patterns 
showing countries clustering according to the haplotype diversity 
patterns from the maximum likelihood (ML) tree (Fig. 3A) or the 
Templeton, Crandall, and Sing (TCS) network (Fig. 3B).
CYP6P9a regulatory region changes selected for by 
insecticide-treated bednet scale-up
We next assessed whether the differences observed in the 5′UTR and 
upstream region of the CYP6P9a gene in mosquitoes from southern 
Africa compared to those from other regions were a result of selective 
pressure from insecticides. We compared mosquito samples from 
southern Africa before the scale-up of insecticide-based interventions, 
such as use of long-lasting insecticide-treated bednets, and mosquito 
samples after scale-up of bednet use. Thirty-nine clones of the 800-bp 
fragment upstream of CYP6P9a were obtained and sequenced from 
mosquitoes from Mozambique and Malawi before the bednet inter-
vention and were compared to 52 clones obtained after the bednet 
intervention. Preintervention mosquito samples showed highly poly-
morphic regions in the 800-bp fragment (table S5 and fig. S5B). Be-
fore bednet intervention, there were many segregating sites (61 in 
Malawi mosquitoes and 25 in Mozambique mosquitoes), many haplo-
types (19 of 30 and 12 of 30, respectively), and high nucleotide di-
versity ( = 0.027 and 0.012) (table S5 and fig. S5B). By contrast, in 
the mosquito samples from Malawi and Mozambique obtained after 
the bednet intervention, there was low diversity as revealed by a number 
Fig. 4. Impact of bednet usage on the genetic diversity of the CYP6P9a promoter in mosquitoes. (A) Shown is 
the ML phylogenetic tree of CYP6P9a in A. funestus mosquitoes from Malawi collected before and after introduction 
of pyrethroid-treated bednets. This tree shows a cluster of highly diverse haplotypes (pink) before bednet interven-
tion but a nearly fixed haplotype (blue) after bednet intervention. (B) TCS haplotype network in mosquitoes collected 
in Malawi (MWI) and Mozambique (MOZ) before bednet intervention (Pre) and after bednet intervention (Post). The 
network reveals a major resistant haplotype after intervention (Post1), but a very diverse set of haplotypes before 
bednet intervention.
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of polymorphic sites (S) of 4 and 3 and a haplo type number of 2 and 
4, respectively, with extremely low nucleotide diversity ( = 0.00066 
and 0.0008). These differences were reflected on the ML phylogenetic 
tree, showing that mosquito samples taken before bednet intervention 
not only clustered together but also were more diverse and showed 
several haplotypes (Fig. 4A). In contrast, mosquito samples obtained 
after bednet intervention showed a markedly reduced haplotype num-
ber (Fig. 4A). A haplotype network confirmed that the major haplo-
type associated with pyrethroid resist ance and now nearly fixed in 
all southern Africa mosquito populations was present in the pre-bednet 
intervention samples but at a much lower frequency of only 4 of 39 
(10.2%) (Fig. 4B). This was compared to a much higher frequency of 
44 of 52 (84.6%) in post-bednet intervention samples, with other hap-
lotypes being only one or two mutational steps away from the pre-
dominant one (Fig. 4B). The pre- bednet intervention haplotypes were 
polymorphic and were separated by a number of mutational steps, 
whereas the post- bednet interven tion mosquito samples showed a 
markedly reduced diversity (Fig. 4B). A detailed analysis of the poly-
morphisms between pre- and post-bednet intervention mosquito 
samples revealed that the AA insertion as well as the CCAAT box 
were now fixed (52 of 52) in all southern Africa mosquito populations 
after bednet intervention. The CCAAT box was also present in pre- 
bednet intervention samples but only at a very low frequency (7 of 24 
and 0 of 15 for Malawi and Mozambique mosquito populations, re-
spectively). Furthermore, a second binding site for the Nrf2:MafK 
xenobiotic transcription factor was found only in post-bednet inter-
vention samples and was linked to both the AA insertion and the 
CCAAT box. These major modifications suggest that scale-up of 
use of insecticide- treated bednets is likely to have been a major fac-
tor driving evolution in A. funestus mosquito populations in south-
ern Africa.
A molecular marker associated with overexpression of a 
pyrethroid resistance gene
Having confirmed that genomic changes upstream of CYP6P9a 
were associated with pyrethroid resistance in mosquitoes, we next 
searched for the mutations responsible for the overexpression of 
CYP6P9a in pyrethroid-resistant mosquitoes. We used a luciferase 
assay to assess the role of polymorphisms found in the 800-bp se-
quence upstream of the translation start site of CYP6P9a (including 
the 5′UTR). The 800-bp sequence up-
stream of the CYP6P9a translation start 
site in both FUMOZ and FANG mos-
quito strains was successfully cloned and 
sequenced. To narrow down the region 
containing the regulatory motifs, four 
different-sized fragments (800, 500, 300, 
and 150 bp) immediately upstream of 
the translation start codon were cloned 
upstream of a reporter gene in a pGL3 
vector. These constructs were used in 
luciferase reporter gene assays. The as-
says demonstrated that although 800-bp 
insertions from both FUMOZ and FANG 
mosquito strains drove reporter gene 
expression, expression driven by the 
FUMOZ strain insertion was three times 
higher than that driven by the FANG 
strain insertion (fig. S6A). This finding 
supported a role for this region in the dif-
ferential expression of CYP6P9a between 
pyrethroid-resistant and pyrethroid- 
susceptible mosquitoes. Progressive de-
letion of the 800-bp pGL3-FZ-CYP6P9a 
was performed to identify the major reg-
ulatory elements driving this differential 
gene expression. The first deletion from 
800 to 500 bp did not affect the activity 
of the fragment. However, cutting the 
fragment from 500 to 300 bp (remov-
ing the AA insert and the CCAAT box) 
resulted in a 33% reduction of CYP6P9a 
activity in the FUMOZ strain (P < 0.001) 
(Fig. 5A). Subsequent deletion from 300 
to 150 bp, which removed the AA insert, 
the CCAAT box, and the pyrethroid 
resistance–specific CnCC/MafK binding 
site, led to an 89% reduction in CYP6P9a 
activity (P < 0.001). This showed that 
Fig. 5. A DNA-based assay to detect cytochrome P450–mediated metabolic-based pyrethroid resistance in 
mosquitoes. (A) Luciferase promoter assay for detecting the CYP6P9a 5′ flanking region. Shown are progressive se-
rial deletions in an 800-bp fragment of the promoter region of CYP6P9a enabling detection of the variants causing 
pyrethroid resistance (mean ± SD; n = 6). (B) Agarose gel showing CYP6P9a fragments from the Taq I PCR-RFLP assay 
distinguishing the three genotypes of pyrethroid resistance: RR (homozygous resistance), RS (heterozygous resistance), 
and SS (susceptible). (C) Significant correlation (P < 0.0001) between the CYP6P9a resistance allele (CYP6P9a_R) and 
pyrethroid (permethrin) resistance. (D) Africa-wide distribution of the CYP6P9a resistance allele (CYP6P9a_R) in A. funestus 
mosquitoes showing near fixation in mosquitoes from southern Africa. The blue line represents the geographical 
limit of the spread of the CYP6P9a_R allele in Africa. Circles represent the frequency distribution of alleles in each location.









Weedall et al., Sci. Transl. Med. 11, eaat7386 (2019)     20 March 2019
S C I E N C E  T R A N S L A T I O N A L  M E D I C I N E  |  R E S E A R C H  A R T I C L E
7 of 13
both the CCAAT box and the CnCC/MafK binding sites were key reg-
ulatory enhancer elements driving the overexpression of CYP6P9a.
A DNA-based diagnostic assay to detect CYP6P9a-mediated 
pyrethroid resistance
To design a DNA-based diagnostic assay to detect CYP6P9a-mediated 
pyrethroid resistance, we screened the most active portion (500 bp) 
for the presence of restriction site polymorphisms that could be used 
to design a simple restriction fragment length polymorphism PCR 
(PCR-RFLP) assay. We found a restriction site for the Taq I enzyme 
(cut site, 5′-TCGA-3′) spanning an A/G mutation located 18 bp up-
stream of the AA insertion (fig. S6B) and completely linked with the 
CCAAT box and other regulatory elements on the resistance hap-
lotype. The Taq I enzyme cut the 450-bp fragment from the puta-
tive pyrethroid resistance haplotype into two fragments of 350 and 
100 bp; the putative pyrethroid-susceptible haplotype remained uncut 
(Fig. 5B), allowing us to genotype the resistance allele (CYP6P9a_R) 
in single mosquitoes. To validate the robustness of this PCR-RFLP 
assay to detect pyrethroid resistance, we used F8 progeny from a cross 
between highly resistant (FUMOZ) and highly susceptible (FANG) 
mosquito strains. The genotyping of 46 mosquitoes that were highly 
resistant to permethrin (alive after 180 min of exposure) (15) revealed 
9 RR, 35 RS, and only 2 SS genotypes. By contrast, 42 highly pyrethroid- 
susceptible mosquitoes (dead after 30 min of permethrin exposure) 
had 0 RR, 1 RS, and 41 SS genotypes. Therefore, the odds ratio (OR) 
of the likelihood of surviving exposure to permethrin when homo-
zygous for the resistance allele (RR) of the CYP6P9a gene (with the 
CCAAT box and CnCC/MafK binding sites) increased to 922 (P < 
0.0001) compared to mosquitoes homozygous for the susceptible allele 
(SS) (Fig. 5C), thus demonstrating the reliability of this DNA- based 
diagnostic assay.
Geographical distribution of the CYP6P9a resistance allele 
across Africa
Genotyping of the CYP6P9a_R allele across Africa revealed that it 
was nearly fixed in mosquitoes from southern Africa and was 
present at an intermediate frequency (55.7%) in mosquitoes from 
Tanzania (East Africa) (Fig. 5D). However, CYP6P9a_R was absent 
from mosquitoes from Central/West Africa (Fig. 5D and fig. S6C). In 
the Democratic Republic of Congo, a geographical contrast was ob-
served with the CYP6P9a_R allele present in mosquitoes from the east-
ern part of the country but absent from mosquitoes from the western 
part of the country including the capital Kinshasa (Fig. 5D). This pat-
tern suggested a new allele/haplotype that arose in mosquitoes in 
southern Africa and that spread northward. Regional differences 
in CYP6P9a_R distribution were similar to those reported for previ-
ous markers (7, 11).
Impact of CYP6P9a-mediated pyrethroid resistance on 
bednet efficacy in an experimental field hut trial
To assess the impact of the CYP6P9a-R haplotype on the effective-
ness of long- lasting insecticide-treated bednets, we opted to use 
lab strains as this mutation is nearly fixed in the field in southern 
Africa. We crossed the highly resistant laboratory strain FUMOZ-R 
(where CYP6P9a_R is fixed) with the fully susceptible laboratory 
strain FANG (where CYP6P9a_R is completely absent). Using re-
ciprocal crosses between the two strains, we generated a hybrid strain 
at the F4 generation that we used for semi-field studies in experimen-
tal huts.
The bioassays performed with the reciprocal FANG/FUMOZ 
strains revealed that both hybrid strains were resistant to pyrethroids 
and carbamates and moderately resistant to DDT (93% mortality) 
(fig. S7A). As expected, resistance was lower than in the fully resist-
ant strain FUMOZ_R, with a mortality rate of 76.1 to 80.7% when 
exposed to permethrin. However, a difference was observed for del-
tamethrin with a higher mortality rate recorded for the strain gen-
erated from crossing female FUMOZ_R to male FANG (48.5%) than 
in the strain from female FANG and male FUMOZ_R (77.3%). This 
difference could indicate the role of some candidate genes in the X 
chromosome for deltamethrin resistance (CYP9K1, for instance). The 
resistance pattern was similar for the carbamate bendiocarb in both 
reciprocal strains.
Before any field studies were conducted with the hybrid FANG/
FUMOZ strain, the role of the CYP6P9a_R allele in observed pyre-
throid resistance was confirmed. World Health Organization (WHO) 
bioassays showed a mortality of 39.0 and 42.3% after 30 min of expo-
sure and mortality rates of 81.3 and 86.3% after 90 min of exposure, 
respectively, to permethrin and deltamethrin (Fig. 6A and fig. S7B). 
The OR of surviving exposure to permethrin when homozygous for 
Fig. 6. Impact of CYP6P9a-mediated metabolic-based pyrethroid resistance 
on the efficacy of insecticide-treated bednets. (A) CYP6P9a genotypes correlate 
with pyrethroid resistance in the hybrid mosquito strain FUMOZ (pyrethroid resist-
ant)/FANG (pyrethroid susceptible). This suggests that the FANG/FUMOZ hybrid 
mosquito strain can be used to assess the impact of CYP6P9a-mediated pyrethroid 
resistance on bednet efficacy. Mosquitoes were exposed to insecticide-treated 
bednets for 30 or 90 min to define pyrethroid-resistant and susceptible individuals. 
(B) Shown are blood feeding and mortality rates (mean ± SD; n = 4) for the FANG/
FUMOZ hybrid mosquito strain after release-recapture studies in experimental 
field huts in Cameroon. Huts had untreated control bednets (blue), PermaNet 2.0 
bednets (green), or PermaNet 3.0 bednets (yellow). (C) Shown is the CYP6P9a geno-
type (RR, RS, and SS) frequency in dead and alive mosquitoes after exposure to 
PermaNet 2.0 bednets. The CYP6P9a_R allele was associated with the ability of 
mosquitoes to survive exposure to pyrethroid-treated PermaNet 2.0 bednets 
(P < 0.0001). (D) Shown is the CYP6P9a genotype (RR, RS, and SS) frequency in mos-
quitoes that did or did not take a blood meal after exposure to PBO-treated PermaNet 
3.0 bednets. The CYP6P9a_R allele was associated with the ability of pyrethroid- 
resistant mosquitoes to take a blood meal from individuals lying under PBO-treated 
PermaNet 3.0 bednets.
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the resistant CYP6P9a_R allele (RR) was high at 693 [confidence in-
terval (CI), 88 to 5421; P < 0.0001] compared to the homozygous 
susceptible allele (SS) (fig. S7, C and D). The OR was 131 (CI, 27 to 978; 
P < 0.0001) when comparing RR to RS, indicating that the resistance 
conferred by CYP6P9a was additive.
Females from the F4 generation of the FANG/FUMOZ hybrid strain 
were used in a release-recapture experiment in huts in Cameroon 
with PermaNet 2.0 bednets treated with deltamethrin or PermaNet 
3.0 bednets treated with deltamethrin and piperonyl butoxide (PBO), 
a cytochrome P450 inhibitor, or control nets that were untreated. 
After four consecutive nights of mosquito release and then recapture, 
analysis of the mosquitoes collected showed no induced exophily 
(mosquitoes exiting the room) with either PermaNet 2.0 or PermaNet 
3.0 bednets compared to the control (P > 0.05) (Table 1). The per-
centage of females that had taken a blood meal was lower for both 
pyrethroid-treated bednets compared to untreated control bednets. 
PermaNet 3.0 bednets showed a lower number of female mosquitoes 
taking a blood meal than did PermaNet 2.0 bednets (P < 0.001) 
(Fig. 6B). This was reflected in the percentage inhibition of blood 
feeding, which was higher for PermaNet 3.0 (76.8%) than for 
PermaNet 2.0 (49.8%) bednets (P < 0.0001). Treated bednets pro-
vided greater personal protection from blood feeding than did the 
untreated bednets, with greater protection from PermaNet 3.0 
(79.0%) than from PermaNet 2.0 (61.9%) bednets (Table 1). Anal-
ysis of mosquito mortality rates revealed higher mortality of the 
hybrid FANG/FUMOZ strain exposed to PermaNet 3.0 (98.7%) 
compared to PermaNet 2.0 (33.3%) bednets (P < 0.001) (Fig. 6B); 
low mortality was observed for mosquitoes exposed to control 
untreated bednets (6.2%). Mosquitoes that had taken a blood 
meal through the bednets showed a higher mortality rate after ex-
posure to PermaNet 3.0 (95.5%) compared to PermaNet 2.0 (40%) 
bednets (Table 1).
The role of CYP6P9a in the loss of PermaNet 2.0  
bednet efficacy
Genotyping of the CYP6P9a marker allowed us to assess the impact 
of cytochrome P450–based resistance in mosquitoes on the loss of 
efficacy of the pyrethroid-only treated PermaNet 2.0 bednet. Most of 
the mosquitoes released in the huts containing PermaNet 3.0 bed-
nets died because of PBO inhibition of cytochrome P450s including 
CYP6P9a. Therefore, the impact of the CYP6P9a genotypes on the 
ability of mosquitoes to survive exposure to long-lasting insecticide- 
treated bednets was studied using the pyrethroid-only PermaNet 
2.0 bednet. To avoid confounding effects from blood feeding, bednet 
entry, or exophily status, the distribution of the CYP6P9a genotypes 
was assessed first only among unfed mosquitoes collected in the huts. 
We observed significant differences in the frequency of the three 
genotypes between dead and alive mosquitoes (2 = 375; P < 0.0001) 
(Fig. 6B). Analysis of the correlation between each genotype and 
mortality revealed that CYP6P9a homozygous resistant mosquitoes 
(RR) were better able to survive exposure to PermaNet 2.0 bednets 
than were homozygous susceptible mosquitoes (SS) (OR, 34.9; CI, 15.8 
to 77.1; P < 0.0001) (table S6). Similarly, possessing the heterozygous 
(RS) CYP6P9a genotype also conferred a significant survival advan-
tage compared to the homozygous SS genotype (OR, 19.9; CI, 9.7 to 
40.9; P < 0.0001). Although a higher frequency of alive mosquitoes 
with the RR genotype was observed compared to the RS genotype, 
this difference was not significant (OR, 1.75; CI, 0.82 to 3.7; P = 0.26). 
Overall, a single CYP6P9a resistance allele (R) conferred a greater 
ability to survive than did a susceptible allele (OR, 6.25; CI, 3.3 to 11.7; 
P < 0.0001) (Fig. 6C). The same association between CYP6P9a_R 
and the ability to survive exposure to PermaNet 2.0 bednets was 
observed when analyzing all collected samples although with lower 
ORs (e.g., for RR versus SS; OR, 10.8; CI, 5.6 to 20.8; P < 0.0001) 
(table S6). The impact of the CYP6P9a resistance gene on the ability 
of mosquitoes to blood feed was also assessed. We found that the 
distribution of the three genotypes was significantly different among 
blood-feeding and unfed mosquitoes for both PermaNet 2.0 (2 = 16.9; 
P < 0.0001) and PermaNet 3.0 bednets (2 = 30.5; P < 0.0001) 
(Fig. 6D). Homozygous RR mosquitoes were significantly more 
likely to blood feed when exposed to PermaNet 3.0 bednets than 
either susceptible SS mosquitoes (OR, 4.54; P < 0.0001) or heterozy-
gous RS mosquitoes (OR, 2.6; P = 0.0012) (Fig. 6D). A similar trend 
was observed for PermaNet 2.0 bednets, although this was not sig-
nificant (fig. S7, E and F).
DISCUSSION
This study investigated the genetic basis of metabolic resistance to 
pyrethroids in the mosquito A. funestus, a major malaria vector in 
Africa. We detected a DNA-based resistance marker for cytochrome 
P450–mediated metabolic resistance to pyrethroids and designed a 
field-applicable diagnostic assay to detect and track the spread of 
insecticide resistance across Africa. We established a direct impact 
of metabolic-mediated pyrethroid resistance on the efficacy of 
insecticide-treated bednets in an experimental field hut trial. Gene 
expression analyses underlined the importance of cytochrome P450 
monooxygenases for pyrethroid resistance in the A. funestus vector 
of malaria in Africa, as has been previously reported for other 
A. funestus populations (9, 15) and other mosquito species (16–18). 
Important heterogeneities in gene expression were observed among 
mosquito populations from different geographical regions of Africa. 
Table 1. Experimental field hut study with the FANG/FUMOZ 
mosquito strain. For each comparison, estimates not sharing the same 
symbols (§ or ‡) are statistically different at P < 0.05. ns, not significant. 
Untreated 
nets
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A cluster of CYP6 genes in the rp1 pyrethroid resistance QTL showed 
the greatest differences in expression in mosquitoes from different 
locations. The southern Africa mosquitoes showed marked overex-
pression of CYP6P9a and CYP6P9b, whereas West African mosquitoes 
from Ghana showed overexpression of CYP6P5 and CYP6P4a/b. 
Such differences showed that the molecular basis of pyrethroid re-
sistance in mosquitoes varied across the African continent, as previ-
ously suggested for this species (19) and for other vectors of malaria 
such as A. gambiae (8, 20), possibly due to a combination of varia-
tion in selective pressures and restricted gene flow among regions 
(13, 21).
The association of the rp1 QTL locus with pyrethroid resistance 
was further supported by the detection of several adaptive evolu-
tionary features across this locus including signatures of selective 
sweep, large structural variations in the 6.5-kb insertion, and cis- 
regulatory polymorphisms. The selective sweep detected in the rp1 
QTL locus in mosquitoes from southern Africa coincided with in-
creased expression of the duplicated CYP6P9a and CYP6P9b genes 
encoding cytochrome P450s in mosquitoes from Malawi. This sup-
ported a key role for these genes in pyrethroid resistance (9). How-
ever, the presence of a predominant haplotype for the CYP6P9a 5′UTR 
in the other three African regions suggests that resistance to pyre-
throid beyond southern Africa could have been selected through 
CYP6P9a or other genes in the vicinity of the rp1 QTL region. The 
hypothesis of a possible hitchhiking effect here rather than the di-
rect involvement of CYP6P9a was supported by the important dif-
ferences observed between the four major haplotypes with more than 
20 mutational steps of difference between them. Therefore, it is likely 
that resistance conferred by the rp1 locus occurred through inde-
pendent selective events with different genes. This is supported by 
RNA-seq data showing that although rp1 genes are overexpressed 
in mosquitoes Africa-wide, the main genes are different. CYP6P4a 
is predominant in mosquitoes from Ghana but not in those from 
other geographical regions; CYP6P5 is predominant in mosquitoes 
from Cameroon and Uganda, whereas CYP6P9a is the major gene 
overexpressed in mosquitoes from southern Africa. Selective sweeps 
associated with insecticide resistance have been reported recently in 
A. gambiae mosquitoes from across Africa (22).
The cis-regulatory changes that we detected in CYP6P9a includ-
ed binding sites for transcription factors such as CnCC and MafK, 
which have recently been shown to be involved in insecticide resist-
ance in A. gambiae (23) and other insects (24). This suggested that 
cis-regulatory modifications may be important drivers of resistance 
to insecticides. However, because cis-regulatory elements and en-
hancers are able to drive expression of genes from distant locations 
and can be upstream or downstream of these genes, future studies 
will need to establish the role of the 6.5-kb insertion in the overex-
pression of CYP6P9a and CYP6P9b. The strong association of these 
regulatory variations with pyrethroid resistance enabled us to de-
sign a DNA-based diagnostic tool for detecting metabolic-mediated 
pyrethroid resistance in mosquitoes, which should facilitate the de-
tection and management of this major resistance mechanism in the 
field. This molecular assay for cytochrome P450–based metabolic 
resistance to pyrethroids in a malaria vector comes two decades 
after a DNA-based diagnostic test was designed for target-site resistance 
(kdr) (4) and should facilitate the study of the impact of metabolic re-
sistance on pyrethroid resistance and malaria control interventions. 
Although SNPs associated with pyrethroid resistance have been de-
tected in the dengue vector Aedes aegypti, no markers have been 
reported (25). Another DNA-based diagnostic test has been de-
signed for the glutathione S-transferase gene (GSTe2) in A. funestus 
to demonstrate resistance to both pyrethroids and DDT in West/
Central Africa, but it used a single amino acid change (L119F) in the 
coding region of the gene and not the putative causative variant reg-
ulating gene expression as done here for CYP6P9a (11).
The CYP6P9a_R allele is present principally in mosquitoes from 
southern Africa where it is nearly fixed in the mosquito population, 
but it is completely absent from mosquitoes from other regions. This 
difference among African populations of A. funestus has previously 
been observed, most notably for the distribution of other resistance 
markers such as the L119F-GSTe2 (11) and the A296S-RDL alleles 
conferring resistance to the insecticide dieldrin (26), which are pre-
sent in mosquitoes from West/Central and East Africa but are com-
pletely absent from those in southern Africa. In contrast, the N485I-ace-1 
carbamate resistance allele is present only in mosquitoes from 
southern Africa (7). Furthermore, patterns of FST-based genetic dif-
ferentiation among populations of this species indicate a restriction 
of gene flow and increased genetic divergence in mosquitoes from 
southern Africa compared to those from other regions (13, 21). 
However, there seems to be a gradual increase of CYP6P9a_R fre-
quency from south to north in the southern Africa region as seen in 
Malawi, with 98% in the south (Chikwawa), 90% in the center (Salima), 
and 78% in the north of the country (Fulirwa) (fig. S6C). This cor-
relates with previous observations that CYP6P9a overexpression was 
lower in the north of southern Africa and that the spread of pyre-
throid resistance likely originated from far south and is spreading 
northward (27). It will be important to monitor the spread of such al-
leles across the African continent as there is the risk that super- resistant 
mosquitoes could be generated if, for instance, CYP6P9a- mediated 
pyrethroid resistance becomes combined with the GSTe2-based DDT 
resistance seen in West/Central Africa. The Democratic Republic of 
Congo will be particularly important to monitor as both insecticide 
resistance mechanisms are present in this country (28).
Using a new DNA-based diagnostic CYP6P9a_R assay, we as-
sessed the direct impact of metabolic-mediated pyrethroid resistance 
in mosquito vectors of malaria on the efficacy of insecticide-treated 
bednets. We showed that cytochrome P450–mediated pyrethroid 
resistance reduced the efficacy of insecticide-treated bednets. Our 
findings help to clarify the debate about whether pyrethroid resist-
ance directly affects the efficacy of insecticide-treated bednets (29). 
Bednets containing the insecticide synergist PBO (such as PermaNet 
3.0 bednets in this study), which inhibits the activity of cytochrome 
P450 enzymes, provided better efficacy than did bednets treated 
with pyrethroid alone (PermaNet 2.0 bednets). Despite the high 
mosquito mortality observed here with the PBO-treated PermaNet 
3.0 bednets, the CYP6P9_R allele resulted in pyrethroid-resistant 
mosquitoes being more likely than susceptible mosquitoes to bite 
individuals under the bednet and potentially transmit malaria. This 
suggests that efforts to eliminate malaria in Africa will be impeded 
unless the overreliance on pyrethroid-treated bednets to control 
transmission is addressed.
There are several limitations to our study. It is important to 
highlight that the DNA-based assay designed in this study detects 
pyrethroid resistance principally in mosquitoes collected in south-
ern Africa and only applies to A. funestus. Therefore, further studies 
are needed to detect similar markers in mosquitoes from other re-
gions of Africa and in other mosquito species such as A. gambiae s.l. 
to track cytochrome P450–mediated resistance to pyrethroids across 
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Africa. Furthermore, even though CYP6P9a exhibited a strong cor-
relation with the pyrethroid resistance phenotype, it might not be 
the only gene involved and further studies should be performed to 
establish the contribution of other genes, notably CYP6P9b. Last, 
the impact of metabolic-mediated resistance has been assessed in 
this study in a hybrid mosquito lab strain, which might not be iden-
tical to mosquitoes in the field; thus, future studies will need to use 
field populations of mosquitoes.
MATERIALS AND METHODS
Study design
The objectives of this study were to detect key genetic variants con-
ferring metabolic-mediated pyrethroid resistance on the mosquito 
A. funestus, a major vector of malaria in Africa, and to design a simple 
DNA-based assay to monitor such resistance in field populations of 
mosquitoes from different African regions. Transcriptome profil-
ing of A. funestus populations from four African regions—southern 
(Malawi), East (Uganda), West (Ghana), and Central (Cameroon)— 
was analyzed to detect key candidate resistance genes. Because 
metabolic-based pyrethroid resistance could also be conferred by point 
mutations in coding and cis-/trans-regulatory regions, we per-
formed comparative whole-genome sequencing of pyrethroid 
(permethrin)–resistant and –susceptible mosquitoes collected in the 
field to screen for genomic resistance regions and polymorphisms. 
To comprehensively detect resistance loci, we also scanned the whole 
genome for pyrethroid resistance–related signatures of selective 
sweeps in mosquitoes from southern Africa. Because the rp1 QTL 
was consistently associated with pyrethroid resistance, a fine-scale 
analysis of this locus was performed to detect potential structural 
variants associated with resistance such as indels and copy number 
variations. To detect cis-regulatory mutations potentially controlling 
CYP6P9a/b-mediated pyrethroid resistance, we compared an 800-bp 
sequence immediately upstream of CYP6P9a in resistant and sus-
ceptible mosquitoes. The role of insecticide-based interventions in 
the selection of CYP6P9a cis-regulatory changes was assessed by se-
quencing the genomes of mosquitoes collected from before and after 
the introduction of widespread insecticide-treated bednet usage. To 
establish the specific mutations controlling CYP6P9a overexpres-
sion, a comparative luciferase assay based on pyrethroid-resistant 
and pyrethroid-susceptible CYP6P9a promoter sequences was per-
formed. To design a DNA-based assay to detect CYP6P9a-mediated 
pyrethroid resistance, we screened the CYP6P9a promoter for re-
striction sites and used this information in a PCR-RFLP assay to assess 
pyrethroid resistance in mosquitoes collected from across Africa.
Last, we assessed the impact of CYP6P9a-mediated metabolic- 
based pyrethroid resistance on the effectiveness of long-lasting 
insecticide-treated bednets using experimental field huts in Cameroon, 
Central Africa. The following three bednet treatments were com-
pared in the experimental huts: untreated control polyethylene 
bednets, PermaNet 2.0-treated polyethylene bednets (deltamethrin), 
and PermaNet 3.0-treated polyethylene bednets (PBO + deltamethrin). 
To simulate a worn bednet, six holes (4 cm by 4 cm) were made 
in each bednet, according to WHO guidelines (30). The hybrid 
FANG/FUMOZ mosquito strain was released in each hut for six 
nights (80 mosquitoes per hut). Three adult volunteers were recruited 
from the Mibellon village in Cameroon to sleep under the bednets 
and to collect mosquitoes in the morning. They were provided with a 
written consent form and given chemoprophylaxis during the trial 
to prevent malaria. Ethical approval was obtained from the National 
Ethics Committee of the Ministry of Health in Cameroon.
Collection and rearing of mosquitoes
Two A. funestus laboratory colonies were used in the study. The 
FANG colony is a fully insecticide-susceptible colony derived from 
Angola (31). The FUMOZ colony is a multi-insecticide–resistant 
colony derived from southern Mozambique. Mosquitoes were col-
lected from four primary locations across the continental range of 
A. funestus. Mosquitoes were collected in March 2014 from Obuasi 
(5°56′N, 1°37′W) in Ghana (32), in February 2015 from Mibellon 
(6°46′N, 11°70′E) in Cameroon, in March 2014 from Tororo (0°45′N, 
34°5′E) in Uganda (33), and in January 2014 from Chikwawa (16°1′S, 
34°47′E) in southern Malawi (34).
Collected mosquitoes were kept until fully gravid and forced to 
lay eggs using the forced-egg laying method (35). All F0 females that 
laid eggs were morphologically identified as belonging to the A. funestus 
group according to a morphological key (36). Parents (F0) and egg 
batches were transported to the Liverpool School of Tropical Medi-
cine under a Department for Environment, Food and Rural Affairs 
(DEFRA) license (PATH/125/2012). Eggs were allowed to hatch in 
cups and mosquitoes were reared to adulthood in the insectaries 
under conditions described previously (35). Insecticide resistance 
bioassays on these samples have been previously described (32–34).
Transcription profiling of pyrethroid resistance using 
RNA-seq
Total RNA was extracted from pools of 10 female mosquitoes (alive 
after 1 hour of permethrin exposure) using the Arcturus PicoPure 
RNA Isolation Kit (Life Technologies), according to the manufacturer’s 
instructions (Supplementary Materials and Methods). Pools of 
libraries were sequenced, eight per lane of the HiSeq 2500 (Illumina, 
San Diego, CA, USA) at 2 × 125-bp paired-end sequencing. Sequence 
library preparation and sequencing were done at the Centre for 
Genomic Research (CGR), University of Liverpool. RNA-seq data 
were analyzed as described previously (37). This involved an initial 
processing, quality assessment of sequences, and alignment to the 
reference sequence using the AfunF1.4 annotation. Differential 
gene expression analysis was performed using edgeR and the Strand 
NGS program (Strand Life Sciences, version 3.0).
Whole-genome sequencing of mosquito samples from 
southern Africa
Genomic DNA was extracted from whole mosquitoes from F0 
Malawi samples (2002 and 2014), the pyrethroid-resistant FUMOZ-R 
laboratory strain, and the fully susceptible FANG strain using the 
DNeasy kit (Qiagen, Hilden, Germany). For each sample, genomic 
DNA was extracted from individuals and pooled in equal amounts 
to form pools of DNA. These were sequenced on an Illumina HiSeq 
2500 (2 × 150 bp, paired-end). Initial processing and quality as-
sessment of the sequence data were performed as for RNA-seq data. 
Alignment of POOLseq R1/R2 read pairs and R0 reads to the ref-
erence sequence (the same as that used for RNA-seq alignment) as 
well as variant calling were performed as described previously (13).
Analysis of polymorphisms in the CYP6P9a promoter region
To detect potential causative mutations conferring pyrethroid resist-
ance on A. funestus, the polymorphism of the cis-regulatory region 
of the pyrethroid resistance gene CYP6P9a was analyzed.
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Detection of the causative mutations driving up-regulation 
of CYP6P9a
An 800-bp region upstream of the start codon of CYP6P9a was 
amplified and directly sequenced in 15 field-collected mosquitoes 
each from 10 countries across different regions of Africa including 
southern (Mozambique, Malawi, and Zambia), East (Uganda, Kenya, and 
Tanzania), Central (Democratic Republic of Congo and Cameroon), 
and West (Benin and Ghana). Primers are listed in table S7. Amplifi-
cation and purification of PCR products were performed as previously 
described (13). Sequences were aligned using ClustalW (38), whereas 
haplotype reconstruction and polymorphism analysis were done using 
DnaSP version 5.10 (39), MEGA (Molecular Evolutionary Genetics 
Analysis) (40), and TCS (41).
Investigation of the content of the CYP6P9a and CYP6P9b 
intergenic region
The entire 8.2-kb intergenic region between both genes was am-
plified for the FUMOZ and FANG strains in two to three frag-
ments using primers listed in table S7. PCR was performed using 
the Phusion polymerase following the manufacturer’s instruc-
tions. PCR products were purified and cloned into pJET1.2 
plasmid.
Assessing the impact of insecticide-treated bednet intervention 
scale-up on changes in polymorphisms of the CYP6P9a 
promoter region
The same 800-bp region upstream of the CYP6P9a was amplified in 
mosquitoes collected before (pre-intervention) the scale-up of 
insecticide-treated nets and also after the scale-up (post-intervention) 
in Malawi (2002 and 2014) and Mozambique (2000 and 2016). The 
PCR products were cloned and sequenced, and sequencing data 
were analyzed as described above.
Genotyping of the CYP6P9a resistance allele using a  
PCR-RFLP assay
A restriction site (5′-TCGA-3′) for the Taq I enzyme at the A/G mutation 
located 18 bp of the AA insertion and completely tight with the CCAAT 
box on the resistance haplotype was used to design a PCR-RFLP assay 
to genotype the CYP6P9a_R allele. The RFLP6P9aF forward primer, 
5′-TCCCGAAATACAGCCTTTCAG-3′, and the RFLP6P9aR reverse 
primer, 5′-ATTGGTGCCATCGCTA GAAG-3′, were used to am-
plify a partial CYP6P9a upstream region containing the restriction 
site. Ten microliters of the digestion mix made of 1 l of CutSmart 
buffer, 0.2 l of 2 U of Taq I restriction enzyme (New England Biolabs, 
Ipswich, MA, USA), 5 l of PCR product, and 3.8 l of dH2O was 
incubated at 65°C for 2 hours. Restriction digest was separated on 
2.0% agarose gel (Fig. 3D).
Validation of the DNA-based diagnostic test
To validate the robustness of the PCR-RFLP to detect the pyrethroid 
resistance in field population, F8 progeny from a cross between highly 
resistant (FUMOZ) and highly susceptible (FANG) strains previ-
ously used for QTL mapping (15) were genotyped, and correlation 
with resistance phenotype was established using OR.
Geographical distribution of the resistance CYP6P9a allele 
across Africa
The geographical distribution of the resistant CYP6P9a allele across 
Africa was established by genotyping the CYP6P9a_R in 30 to 50 
field-collected females of A. funestus from several countries in Africa 
using the PCR-RFLP.
Luciferase reporter assay for the CYP6P9a core  
promoter region
The region immediately 5′ of CYP6P9a from both FUMOZ and 
FANG strains was amplified using primers 6P9a1F and 6P9R a/b. 
These primers gave an 817-bp product for both FUMOZ and 
FANG, which were cloned into pJET1.2 (Thermo Fisher Scientific) 
and sequenced. Primers were designed (table S7) to obtain con-
structs of progressive serial 5′ deletions of the CYP6P9a promoter 
of 800, 500, 300, and 150 bp for the different primers. The primers 
incorporated either the Sac I or Mlu I (for the FUMOZ) and Kpn I 
or Hind III (for the FANG) to facilitate cloning in the pGL3 basic 
vector. Products were amplified with Phusion polymerase (Thermo 
Fisher Scientific) and cloned into pJET 1.2. The product was then 
excised from pJET1.2, ligated to pGL 3 basic (Promega), and se-
quenced. Plasmids were then extracted using Midiprep kit (Qiagen) 
to obtain high concentrations for the transfection. Dual luciferase 
assay was undertaken using A. gambiae 4a-2 cell line (MRA-917 MR4; 
American Type Culture Collection, Manassas, VA). Approximately 
5 × 105 cells (600 l) were subcultured from a T75 culture and seeded 
in each well of a 24-well plate 1 day before transfection and allowed 
to reach 60 to 70% confluency.
Transfection of the construct was carried out using the Qiagen 
Effectene transfection reagent, and the promoter activity was mea-
sured using the Dual Luciferase Reporter Assay (Promega, Madison, 
WI, USA). Reporter constructs (600 ng; CYP6P9a upstream se-
quences in pGL3-Basic), pGL3 without insert, and LRIM promoter 
in pGL3 basic were cotransfected with 1 ng of actin-Renilla internal 
control in 60 ml of DNA condensation buffer, 4.8 ml of enhancer, 
and 6 ml of Effectene in triplicate. After 48 hours of incubation at 
25°C, the cells were washed with phosphate-buffered saline and 
harvested in 100 ml of passive lysis buffer (Promega), and luciferase 
activity was measured on a luminometer (EG & G Berthold, Wildbad, 
Germany). Renilla luciferase activity was used to normalize the con-
struct luciferase activity. The values obtained after measuring the 
firefly (LAR II) luciferase activity, which represent the activity of the 
promoter, were divided by the corresponding Renilla luciferase ac-
tivity values and the ratio used to compare different promoters.
Evaluating the impact of CYP6P9a-based pyrethroid 
resistance on the efficacy of insecticide-treated bednets 
using experimental field huts
Study area and field hut description
The study was performed in Mibellon (6°4′60″N and 11°30′0″E), a 
village in the Adamawa region of Cameroon where we recently built 
12 experimental huts of concrete bricks, following the specific de-
sign for experimental huts from the West Africa region (42).
Mosquito strains
The study was carried out with a hybrid strain generated from recip-
rocal crossing between the highly pyrethroid-resistant strain FUMOZ-R 
(CYP6P9a_R) and the fully susceptible FANG strain (CYP6P9a_S) 
(43). After the initial F1 generation obtained from the reciprocal crosses 
of 50 males and 50 females of both strains, the hybrid strain was reared 
to F5 and F6 generations, which were used for the release in the huts.
Susceptibility of the hybrid FANG/FUMOZ mosquito strain
WHO bioassays were carried out to assess the susceptibility profile 
of the two reciprocal hybrid strains for the pyrethroids (0.75% 
permethrin and 0.05% deltamethrin), DDT (4%), and the carbamate 
bendiocarb (0.1%). The bioassays were performed according to 
WHO protocol (42).
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Mosquito collection in field huts
Early in the morning, mosquitoes were collected using glass tubes 
from the room (the floor, walls, and roof of the hut), inside the bed-
net, and from the exit traps on the veranda. Each compartment of 
the hut had its own bag to avoid mixture between samples. Surviv-
ing mosquitoes were provided with sugar solution and held for 
24 hours in paper cups after which delayed mortality was assessed. 
Samples were recorded in observation sheets as dead/blood-fed, alive/
blood-fed, dead/unfed, and alive/unfed.
The effect of each treatment was expressed relative to the control 
(untreated bednets) by assessing induced exophily (the proportion 
of mosquitoes that exited early through the exit traps because of the 
treatment); the mortality rate, an indicator of the potential killing 
effect of the insecticide-treated bednets; and the rate of blood feed-
ing, an indicator of insecticide resistance and personal protection.
Genotyping of the CYP6P9a metabolic resistance marker
To establish the impact of the CYP6P9a-mediated metabolic resist-
ance to pyrethroids on the effectiveness of the insecticide-treated 
nets, the PCR-RFLP diagnostic assay was used to genotype a subset 
of each treatment including the dead, alive, blood-fed, and unfed 
mosquitoes on the veranda, in the net, and in the room.
Statistical analysis
Genes that were differentially expressed in each country and between 
different countries (generated from Venn diagrams) were detected 
using DESeq normalization with a fold change of >2. A multiple test 
correction was then performed using the method of Benjamini and 
Hochberg, at a false discovery rate of 5% (adjusted P < 0.05). Statis-
tical significance of the luciferase assays was assessed after an un-
paired Student’s t test with respective replicates between the FUMOZ 
and FANG mosquito strains. Correlation between the CYP6P9a_R 
allele and the pyrethroid resistance phenotype was established using 
OR and Fisher’s exact test. The effect of pyrethroid-treated bednets 
was established by direct comparison to untreated control bednets. 
The statistical significance of the difference was estimated by a lo-
gistic regression model using Wald statistic that follows a 2 distri-
bution (with df = 1). OR and Fisher’s exact test were used to assess 
the impact of CYP6P9a_R on the ability of mosquitoes to survive 
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